[{"FundingRoundType": "funding_round_type", "CompanyCategory": "company_category_list", "CompanyName": "company_name", "Amount": "raised_amount_usd", "FundingRoundCode": "funding_round_code", "Date": "funded_at", "Investor": "investor_name"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "10X Genomics", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2015-01-12", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "10X Genomics", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2015-01-12", "Investor": "Paladin Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "10X Genomics", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2015-01-12", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "20/20 Gene Systems Inc.", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2012-09-25", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "1.15e+08", "FundingRoundCode": "E", "Date": "2015-07-03", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-10-03", "Investor": "Genentech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "12600000", "FundingRoundCode": "B", "Date": "2009-06-18", "Investor": "Google"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-10-03", "Investor": "Google"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2010-11-09", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "57949900", "FundingRoundCode": "D", "Date": "2012-12-21", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2010-11-09", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2011-01-07", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-10-03", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "57949900", "FundingRoundCode": "D", "Date": "2012-12-21", "Investor": "MPM Capital"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2014-07-29", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2010-11-09", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "57949900", "FundingRoundCode": "D", "Date": "2012-12-21", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-10-03", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-10-03", "Investor": "Stephens Investment Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "1.15e+08", "FundingRoundCode": "E", "Date": "2015-07-03", "Investor": "Xfund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "57949900", "FundingRoundCode": "D", "Date": "2012-12-21", "Investor": "Anne Wojcicki"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2005-11-02", "Investor": "Eric Lederman"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "57949900", "FundingRoundCode": "D", "Date": "2012-12-21", "Investor": "Sergey Brin"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Search", "CompanyName": "23andMe", "Amount": "12600000", "FundingRoundCode": "B", "Date": "2009-06-18", "Investor": "Sergey Brin"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2013-06-21", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2012-01-05", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "8089000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-07-10", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "28500000", "FundingRoundCode": "D", "Date": "2014-12-30", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2013-06-21", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2012-01-05", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "8089000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-07-10", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "28500000", "FundingRoundCode": "D", "Date": "2014-12-30", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "28500000", "FundingRoundCode": "D", "Date": "2014-12-30", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3-V Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-07-10", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3D Biomatrix", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-10-05", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3DR Laboratories", "Amount": "7200000", "FundingRoundCode": "NA", "Date": "2012-08-23", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3Scan", "Amount": "6673012", "FundingRoundCode": "A", "Date": "2014-12-05", "Investor": "Data Collective"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3Scan", "Amount": "6673012", "FundingRoundCode": "A", "Date": "2014-12-05", "Investor": "Dolby Family Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "3Scan", "Amount": "6673012", "FundingRoundCode": "A", "Date": "2014-12-05", "Investor": "Lux Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "3Scan", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-07-16", "Investor": "Iron Yard Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "3Scan", "Amount": "350000", "FundingRoundCode": "NA", "Date": "2012-04-23", "Investor": "Thiel Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "480 Biomedical", "Amount": "1200000", "FundingRoundCode": "C", "Date": "2015-06-19", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "480 Biomedical", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2012-02-14", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "480 Biomedical", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2012-02-14", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "480 Biomedical", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2012-02-14", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Therapeutics", "CompanyName": "7TM Pharma", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2007-06-12", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Therapeutics", "CompanyName": "7TM Pharma", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2007-06-12", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Therapeutics", "CompanyName": "7TM Pharma", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2007-06-12", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "A&G Pharmaceutical", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2005-09-08", "Investor": "Crocker Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "A&G Pharmaceutical", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2005-09-08", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "A&G Pharmaceutical", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2005-09-08", "Investor": "New England Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Aarden Pharmaceuticals", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2011-01-03", "Investor": "Innovate Indiana Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aastrom Biosciences", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2012-03-09", "Investor": "Eastern Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AbCelex Technologies", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2014-04-28", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics|Technology", "CompanyName": "aBioBot", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-02-03", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics|Technology", "CompanyName": "aBioBot", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-02-03", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablative Solutions", "Amount": "9575077", "FundingRoundCode": "B", "Date": "2014-02-04", "Investor": "BioStar Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablative Solutions", "Amount": "5300000", "FundingRoundCode": "A", "Date": "2012-06-19", "Investor": "BioStar Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Ablative Solutions", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2013-03-26", "Investor": "CKM Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablative Solutions", "Amount": "9575077", "FundingRoundCode": "B", "Date": "2014-02-04", "Investor": "Michigan Accelerator Fund I"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablexis", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2010-06-04", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablexis", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2010-06-04", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablynx", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2006-08-23", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablynx", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-04-06", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ablynx", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2006-08-23", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acacia Pharma", "Amount": "23500000", "FundingRoundCode": "B", "Date": "2013-09-03", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ACADIA Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "F", "Date": "2003-03-31", "Investor": "Hambrecht & Quist Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ACADIA Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2011-01-11", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ACADIA Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "F", "Date": "2003-03-31", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ACADIA Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "F", "Date": "2003-03-31", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ACADIA Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2011-01-11", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "10250006", "FundingRoundCode": "NA", "Date": "2010-06-10", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3.1e+07", "FundingRoundCode": "C", "Date": "2007-10-01", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3e+07", "FundingRoundCode": "F", "Date": "2011-12-23", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "10250006", "FundingRoundCode": "NA", "Date": "2010-06-10", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "10250006", "FundingRoundCode": "NA", "Date": "2010-06-10", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "10250006", "FundingRoundCode": "NA", "Date": "2010-06-10", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3.1e+07", "FundingRoundCode": "C", "Date": "2007-10-01", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acceleron Pharma", "Amount": "10250006", "FundingRoundCode": "NA", "Date": "2010-06-10", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accera", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2004-09-16", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accera", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2008-11-12", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Acclarent", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2007-04-23", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Acclarent", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2007-04-23", "Investor": "Meritech Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Acclarent", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2007-04-23", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Acclarent", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2007-04-23", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accu-Break Pharmaceuticals", "Amount": "5650000", "FundingRoundCode": "NA", "Date": "2007-06-01", "Investor": "Institutional Investor"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accu-Break Pharmaceuticals", "Amount": "5650000", "FundingRoundCode": "NA", "Date": "2007-06-01", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "Arnerich Massena & Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "16600000", "FundingRoundCode": "E", "Date": "2010-01-21", "Investor": "Arnerich Massena & Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "28800000", "FundingRoundCode": "D", "Date": "2008-02-21", "Investor": "Arnerich Massena & Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "16600000", "FundingRoundCode": "E", "Date": "2010-01-21", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "28800000", "FundingRoundCode": "D", "Date": "2008-02-21", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "Fisher Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "16600000", "FundingRoundCode": "E", "Date": "2010-01-21", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "28800000", "FundingRoundCode": "D", "Date": "2008-02-21", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "KB Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "28800000", "FundingRoundCode": "D", "Date": "2008-02-21", "Investor": "KB Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "Pinto Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "28800000", "FundingRoundCode": "D", "Date": "2008-02-21", "Investor": "PTV Healthcare Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "16600000", "FundingRoundCode": "E", "Date": "2010-01-21", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "28800000", "FundingRoundCode": "D", "Date": "2008-02-21", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "Sterling Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "16600000", "FundingRoundCode": "E", "Date": "2010-01-21", "Investor": "Sterling Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "28800000", "FundingRoundCode": "D", "Date": "2008-02-21", "Investor": "Sterling Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "Telegraph Hill Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accumetrics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2004-07-01", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2007-04-30", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2008-07-08", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "6e+06", "FundingRoundCode": "E", "Date": "2010-10-19", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "4e+06", "FundingRoundCode": "D", "Date": "2009-08-10", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "6e+06", "FundingRoundCode": "E", "Date": "2010-10-19", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "4e+06", "FundingRoundCode": "D", "Date": "2009-08-10", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2008-07-08", "Investor": "Fidelity Biosciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2008-07-08", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "6e+06", "FundingRoundCode": "E", "Date": "2010-10-19", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "4e+06", "FundingRoundCode": "D", "Date": "2009-08-10", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Accuri Cytometers", "Amount": "4e+06", "FundingRoundCode": "D", "Date": "2009-08-10", "Investor": "Jenny Rooke"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "AcelRx Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2013-12-19", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Acetylon Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-02-09", "Investor": "Celgene"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Acetylon Pharmaceuticals", "Amount": "1e+08", "FundingRoundCode": "NA", "Date": "2013-07-29", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acetylon Pharmaceuticals", "Amount": "7250000", "FundingRoundCode": "A", "Date": "2009-08-01", "Investor": "Kraft Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "18905707", "FundingRoundCode": "D", "Date": "2013-03-22", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2006-10-10", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2010-04-07", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "18905707", "FundingRoundCode": "D", "Date": "2013-03-22", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2010-04-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "18905707", "FundingRoundCode": "D", "Date": "2013-03-22", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2006-10-10", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2010-04-07", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "18905707", "FundingRoundCode": "D", "Date": "2013-03-22", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2006-10-10", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2010-04-07", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "18905707", "FundingRoundCode": "D", "Date": "2013-03-22", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2010-04-07", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "18905707", "FundingRoundCode": "D", "Date": "2013-03-22", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2006-10-10", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2010-04-07", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "15700000", "FundingRoundCode": "A", "Date": "2004-08-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "18905707", "FundingRoundCode": "D", "Date": "2013-03-22", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achaogen", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2006-10-10", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "Bear Stearns"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "50100000", "FundingRoundCode": "NA", "Date": "2010-08-18", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "50100000", "FundingRoundCode": "NA", "Date": "2010-08-18", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "ING Furman Selz Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "KBL Healthcare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "Oakwood Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "50100000", "FundingRoundCode": "NA", "Date": "2010-08-18", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "50100000", "FundingRoundCode": "NA", "Date": "2010-08-18", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Achillion Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "NA", "Date": "2002-01-28", "Investor": "SG Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aciex Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2007-09-01", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-09-09", "Investor": "Aclaris Therapeutics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-09-09", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-09-09", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2012-10-24", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-09-09", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-09-09", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-09-09", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2012-10-24", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-09-09", "Investor": "Vivo Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2012-10-24", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aclaris Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acologix", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2004-05-04", "Investor": "JAIC America"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acologix", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2004-05-04", "Investor": "Nomura Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Acorda Therapeutics", "Amount": "55300000", "FundingRoundCode": "C", "Date": "2003-05-20", "Investor": "Cross Atlantic Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Acorda Therapeutics", "Amount": "55300000", "FundingRoundCode": "C", "Date": "2003-05-20", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Acorda Therapeutics", "Amount": "55300000", "FundingRoundCode": "C", "Date": "2003-05-20", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Acorda Therapeutics", "Amount": "55300000", "FundingRoundCode": "C", "Date": "2003-05-20", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Acorda Therapeutics", "Amount": "55300000", "FundingRoundCode": "C", "Date": "2003-05-20", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "ACT Biotech", "Amount": "6567000", "FundingRoundCode": "A", "Date": "2008-05-06", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Actimis Pharmaceuticals", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2005-04-28", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Actimis Pharmaceuticals", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2005-04-28", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Actimis Pharmaceuticals", "Amount": "9600000", "FundingRoundCode": "NA", "Date": "2008-06-06", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Actinobac Biomed", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2009-03-20", "Investor": "Foundation Venture Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Actinobac Biomed", "Amount": "1e+05", "FundingRoundCode": "B", "Date": "2013-02-21", "Investor": "Foundation Venture Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Action Pharma", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2006-10-27", "Investor": "InCube Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Activaero", "Amount": "6755000", "FundingRoundCode": "A", "Date": "2011-02-16", "Investor": "LSP BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Activaero", "Amount": "6755000", "FundingRoundCode": "A", "Date": "2011-02-16", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Active Life Scientific", "Amount": "5e+05", "FundingRoundCode": "A", "Date": "2013-05-16", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acton Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2010-01-06", "Investor": "Sequoia Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "ActX", "Amount": "1920391", "FundingRoundCode": "NA", "Date": "2014-01-12", "Investor": "Alliance of Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "ActX", "Amount": "750003", "FundingRoundCode": "NA", "Date": "2014-07-18", "Investor": "Alliance of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Acumen Pharmaceuticals", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2006-08-17", "Investor": "NeuroVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acutus Medical", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2013-08-20", "Investor": "GE Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acutus Medical", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2013-08-20", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acylin Therapeutics", "Amount": "4400000", "FundingRoundCode": "A", "Date": "2011-01-11", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acylin Therapeutics", "Amount": "4400000", "FundingRoundCode": "A", "Date": "2011-01-11", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acylin Therapeutics", "Amount": "4400000", "FundingRoundCode": "A", "Date": "2011-01-11", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Acylin Therapeutics", "Amount": "4400000", "FundingRoundCode": "A", "Date": "2011-01-11", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "Merlin Nexus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "Ridgeback Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adaptimmune", "Amount": "1.04e+08", "FundingRoundCode": "A", "Date": "2014-09-25", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Health Care", "CompanyName": "Adaptive Biotechnologies", "Amount": "1.95e+08", "FundingRoundCode": "F", "Date": "2015-05-07", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Health Care", "CompanyName": "Adaptive Biotechnologies", "Amount": "104999480", "FundingRoundCode": "D", "Date": "2014-04-15", "Investor": "Viking Global Investors"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Adarza BioSystems", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-04-17", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Adarza BioSystems", "Amount": "6800000", "FundingRoundCode": "A", "Date": "2014-10-02", "Investor": "Cultivation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Adarza BioSystems", "Amount": "2e+05", "FundingRoundCode": "A", "Date": "2014-06-04", "Investor": "Serra Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Adarza BioSystems", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-04-17", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "ADC Therapeutics", "Amount": "8e+07", "FundingRoundCode": "NA", "Date": "2015-09-02", "Investor": "Auven Therapeutics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ADC Therapeutics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2013-10-16", "Investor": "Auven Therapeutics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ADC Therapeutics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2013-10-16", "Investor": "MedImmune"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "Boston Scientific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "Oakwood Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adiana", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2005-08-25", "Investor": "Tullis-Dickerson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "8200000", "FundingRoundCode": "D", "Date": "2010-01-22", "Investor": "Borealis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2008-11-20", "Investor": "Borealis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "8200000", "FundingRoundCode": "D", "Date": "2010-01-22", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2012-04-03", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "8200000", "FundingRoundCode": "D", "Date": "2010-01-22", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2008-11-20", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "8200000", "FundingRoundCode": "D", "Date": "2010-01-22", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2012-04-03", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2008-11-20", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2007-07-20", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "5900000", "FundingRoundCode": "A", "Date": "2007-09-21", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "8200000", "FundingRoundCode": "D", "Date": "2010-01-22", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2012-04-03", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2008-11-20", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2007-07-20", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adimab", "Amount": "5900000", "FundingRoundCode": "A", "Date": "2007-09-21", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adlyfe", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2006-01-17", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Adlyfe", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2006-01-17", "Investor": "Canaan Partners"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Adlyfe", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2013-02-20", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology", "CompanyName": "ADMA Biologics", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-12-15", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology", "CompanyName": "ADMA Biologics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-02-27", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-06-26", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2003-01-01", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "15500000", "FundingRoundCode": "C", "Date": "2007-08-07", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-06-26", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2003-01-01", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "15500000", "FundingRoundCode": "C", "Date": "2007-08-07", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-06-26", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2003-01-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "15500000", "FundingRoundCode": "C", "Date": "2007-08-07", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-06-26", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Adnexus", "Amount": "15500000", "FundingRoundCode": "C", "Date": "2007-08-07", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aduro BioTech", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aduro BioTech", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-06-11", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aduro BioTech", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Animal Diagnostics", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-12-08", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Animal Diagnostics", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2011-03-15", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Animal Diagnostics", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2013-04-10", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Animal Diagnostics", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-12-08", "Investor": "Kansas Bioscience Authority"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioHealing", "Amount": "25500000", "FundingRoundCode": "C", "Date": "2007-02-27", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioHealing", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2005-11-21", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioHealing", "Amount": "25500000", "FundingRoundCode": "C", "Date": "2007-02-27", "Investor": "Channel Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioHealing", "Amount": "25500000", "FundingRoundCode": "C", "Date": "2007-02-27", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioHealing", "Amount": "25500000", "FundingRoundCode": "C", "Date": "2007-02-27", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioHealing", "Amount": "25500000", "FundingRoundCode": "C", "Date": "2007-02-27", "Investor": "Wheatley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioHealing", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2005-11-21", "Investor": "Wheatley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioNutrition", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2005-01-14", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioNutrition", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2005-01-14", "Investor": "Eastbourne Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioNutrition", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2005-01-14", "Investor": "Maryland Department of Business and Economic Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced BioNutrition", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2005-01-14", "Investor": "Sherbrooke Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced Cardiac Therapeutics", "Amount": "7300000", "FundingRoundCode": "NA", "Date": "2014-04-21", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Life Sciences", "CompanyName": "Advanced Catheter Therapies", "Amount": "3400000", "FundingRoundCode": "B", "Date": "2014-08-20", "Investor": "Blank Slate Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Life Sciences", "CompanyName": "Advanced Catheter Therapies", "Amount": "3400000", "FundingRoundCode": "B", "Date": "2014-08-20", "Investor": "Chattanooga Renaissance Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Life Sciences", "CompanyName": "Advanced Catheter Therapies", "Amount": "450000", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "Innova Memphis"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Life Sciences", "CompanyName": "Advanced Catheter Therapies", "Amount": "3400000", "FundingRoundCode": "B", "Date": "2014-08-20", "Investor": "Innova Memphis"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Life Sciences", "CompanyName": "Advanced Catheter Therapies", "Amount": "3400000", "FundingRoundCode": "B", "Date": "2014-08-20", "Investor": "Launch Tennessee"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Life Sciences", "CompanyName": "Advanced Catheter Therapies", "Amount": "3400000", "FundingRoundCode": "B", "Date": "2014-08-20", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Cell Diagnostics", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-06-18", "Investor": "Kenson Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Cell Diagnostics", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2014-10-08", "Investor": "National Cancer Institute"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Cell Diagnostics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2012-11-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Cell Diagnostics", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-06-18", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Advanced Cell Diagnostics", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-06-18", "Investor": "Summit Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Advanced Ophthalmic Pharma", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2010-05-02", "Investor": "Coronis Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AdvanDx", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Advantagene", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2011-05-25", "Investor": "Massachusetts Life Sciences Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ADVENTRX Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "NA", "Date": "2011-01-07", "Investor": "RA Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Adynxx", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AEGEA Medical", "Amount": "3.6e+07", "FundingRoundCode": "C", "Date": "2015-05-04", "Investor": "Alloy Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AEGEA Medical", "Amount": "13366498", "FundingRoundCode": "NA", "Date": "2011-05-25", "Investor": "Alloy Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AEGEA Medical", "Amount": "13366498", "FundingRoundCode": "NA", "Date": "2011-05-25", "Investor": "Covidien Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AEGEA Medical", "Amount": "3.6e+07", "FundingRoundCode": "C", "Date": "2015-05-04", "Investor": "Delphi Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AEGEA Medical", "Amount": "13366498", "FundingRoundCode": "NA", "Date": "2011-05-25", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AEGEA Medical", "Amount": "3.6e+07", "FundingRoundCode": "C", "Date": "2015-05-04", "Investor": "Medtronic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2014-01-09", "Investor": "ATX Tech Incubator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2014-02-06", "Investor": "KBI Biopharma"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2014-02-06", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2015-03-23", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2015-03-23", "Investor": "New Ground Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2014-02-06", "Investor": "UT Horizon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2015-03-23", "Investor": "UT Horizon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Aeglea BioTherapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2015-03-23", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerial BioPharma", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2012-07-12", "Investor": "Rex Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerie Pharmaceuticals", "Amount": "41364965", "FundingRoundCode": "B", "Date": "2011-03-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerie Pharmaceuticals", "Amount": "41364965", "FundingRoundCode": "B", "Date": "2011-03-07", "Investor": "Clarus Ventures"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Aerie Pharmaceuticals", "Amount": "1.25e+08", "FundingRoundCode": "NA", "Date": "2014-09-09", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerie Pharmaceuticals", "Amount": "41364965", "FundingRoundCode": "B", "Date": "2011-03-07", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerie Pharmaceuticals", "Amount": "41364965", "FundingRoundCode": "B", "Date": "2011-03-07", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerie Pharmaceuticals", "Amount": "41364965", "FundingRoundCode": "B", "Date": "2011-03-07", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2007-03-28", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2007-03-28", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2007-03-28", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2007-03-28", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Clarus Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2008-03-28", "Investor": "Comerica Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2007-03-28", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2007-03-28", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "ProQuest Investments"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Aerovance", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2008-03-28", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2013-11-06", "Investor": "Athenian Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-08-30", "Investor": "Athenian Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2013-11-06", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "NA", "Date": "2014-04-23", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-08-30", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "NA", "Date": "2014-04-23", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2013-11-06", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "NA", "Date": "2014-04-23", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-08-30", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2013-11-06", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aerpio Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-08-30", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2009-12-16", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2015-07-08", "Investor": "Jennison Associates"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2003-08-29", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2015-07-08", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2009-12-16", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2009-12-16", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2015-07-08", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2003-08-29", "Investor": "Slater Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2015-07-08", "Investor": "Tekla Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Afferent Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2009-12-16", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affimed Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2007-04-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affinergy", "Amount": "3e+06", "FundingRoundCode": "B", "Date": "2006-03-08", "Investor": "Charleston Angel Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affinergy", "Amount": "3e+06", "FundingRoundCode": "B", "Date": "2006-03-08", "Investor": "NC IDEA"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affinergy", "Amount": "3e+06", "FundingRoundCode": "B", "Date": "2006-03-08", "Investor": "Trinity Healthcare Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affinergy", "Amount": "3e+06", "FundingRoundCode": "B", "Date": "2006-03-08", "Investor": "Wilmington Investor Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affinimark Technologies", "Amount": "1359394", "FundingRoundCode": "NA", "Date": "2010-10-13", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affinimark Technologies", "Amount": "1359394", "FundingRoundCode": "NA", "Date": "2010-10-13", "Investor": "LaunchCapital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-08-29", "Investor": "Forward Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "11900000", "FundingRoundCode": "NA", "Date": "2013-09-11", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2007-03-26", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-08-29", "Investor": "Genesis Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "11900000", "FundingRoundCode": "NA", "Date": "2013-09-11", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2007-03-26", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-08-29", "Investor": "SV Life Sciences"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "11900000", "FundingRoundCode": "NA", "Date": "2013-09-11", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Affinium Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2007-03-26", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affomix Corporation", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2008-02-22", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affomix Corporation", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2008-02-22", "Investor": "Elm Street Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affomix Corporation", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2008-02-22", "Investor": "Four Seasons Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affymax", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-04-14", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affymax", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-04-14", "Investor": "Bear Stearns Health Innoventures L.P"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affymax", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-04-14", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Affymax", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-04-14", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgBiome", "Amount": "17500000", "FundingRoundCode": "A", "Date": "2013-04-11", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgBiome", "Amount": "34500000", "FundingRoundCode": "B", "Date": "2015-08-20", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgBiome", "Amount": "17500000", "FundingRoundCode": "A", "Date": "2013-04-11", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgBiome", "Amount": "17500000", "FundingRoundCode": "A", "Date": "2013-04-11", "Investor": "Polaris Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Agencourt Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "1998-01-01", "Investor": "Base Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Agencourt Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "1998-01-01", "Investor": "Erik Moore"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "41300000", "FundingRoundCode": "D", "Date": "2007-07-12", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "42800000", "FundingRoundCode": "C", "Date": "2002-03-04", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "41300000", "FundingRoundCode": "D", "Date": "2007-07-12", "Investor": "Bear Stearns"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "42800000", "FundingRoundCode": "C", "Date": "2002-03-04", "Investor": "Bear Stearns"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "42800000", "FundingRoundCode": "C", "Date": "2002-03-04", "Investor": "Hambrecht & Quist Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "41300000", "FundingRoundCode": "D", "Date": "2007-07-12", "Investor": "Icon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "41300000", "FundingRoundCode": "D", "Date": "2007-07-12", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agensys", "Amount": "42800000", "FundingRoundCode": "C", "Date": "2002-03-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agenus", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2009-08-04", "Investor": "Hudson Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agenus", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2009-08-04", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ageria", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AGI Biopharmaceuticals", "Amount": "4710000", "FundingRoundCode": "NA", "Date": "2011-11-28", "Investor": "Mentor Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agile Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2012-07-19", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agile Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2012-07-19", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agile Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2012-07-19", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agile Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2012-07-19", "Investor": "Novitas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agile Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2012-07-19", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Agios Pharmaceuticals", "Amount": "7.8e+07", "FundingRoundCode": "C", "Date": "2011-11-17", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Agios Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2008-07-07", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Agios Pharmaceuticals", "Amount": "7.8e+07", "FundingRoundCode": "C", "Date": "2011-11-17", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Agios Pharmaceuticals", "Amount": "7.8e+07", "FundingRoundCode": "C", "Date": "2011-11-17", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Agios Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2008-07-07", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Agios Pharmaceuticals", "Amount": "7.8e+07", "FundingRoundCode": "C", "Date": "2011-11-17", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Agios Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2008-07-07", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agradis", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2012-01-18", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgraQuest", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2007-03-13", "Investor": "Otter Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgraQuest", "Amount": "17700000", "FundingRoundCode": "NA", "Date": "2011-03-21", "Investor": "Otter Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgraQuest", "Amount": "9400000", "FundingRoundCode": "NA", "Date": "2003-02-07", "Investor": "Otter Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AgraQuest", "Amount": "9400000", "FundingRoundCode": "NA", "Date": "2003-02-07", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2012-09-12", "Investor": "Cornerstone Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "12348733", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2012-09-12", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "12348733", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2012-09-12", "Investor": "Gentry Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "12348733", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "Gentry Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "Gentry Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2006-11-22", "Investor": "incTANK Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2012-09-12", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "12348733", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "12348733", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "Middleland Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "Middleland Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2012-09-12", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "12348733", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "10700000", "FundingRoundCode": "D", "Date": "2015-08-18", "Investor": "Prairie Gold"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2012-09-12", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "12348733", "FundingRoundCode": "D", "Date": "2015-01-05", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Agrivida", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2012-09-12", "Investor": "Presidio Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-03-09", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2002-08-19", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2005-01-19", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-03-09", "Investor": "Castile Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2002-08-19", "Investor": "Castile Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2005-01-19", "Investor": "Castile Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-03-09", "Investor": "GF Private Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2005-01-19", "Investor": "GF Private Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ahura Scientific", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2005-01-19", "Investor": "Southern Ute"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2013-11-18", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2013-01-14", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "E", "Date": "2014-10-29", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "10500000", "FundingRoundCode": "B", "Date": "2008-04-15", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-06-11", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-06-07", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2006-12-01", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2013-11-18", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2013-01-14", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "E", "Date": "2014-10-29", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-06-11", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2013-11-18", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2013-01-14", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "E", "Date": "2014-10-29", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-06-11", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2013-11-18", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2013-01-14", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "E", "Date": "2014-10-29", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aileron Therapeutics", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-06-11", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Airway Therapeutics", "Amount": "4600000", "FundingRoundCode": "A", "Date": "2014-09-10", "Investor": "Cincinnati Children\u2019s Hospital Medical Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Airway Therapeutics", "Amount": "4600000", "FundingRoundCode": "A", "Date": "2014-09-10", "Investor": "CincyTech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Airway Therapeutics", "Amount": "4600000", "FundingRoundCode": "A", "Date": "2014-09-10", "Investor": "Queen City Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1.1e+07", "FundingRoundCode": "D", "Date": "2012-04-20", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "9e+06", "FundingRoundCode": "E", "Date": "2013-06-03", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1e+06", "FundingRoundCode": "E", "Date": "2014-09-03", "Investor": "Heron Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1.1e+07", "FundingRoundCode": "D", "Date": "2012-04-20", "Investor": "Heron Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2006-12-29", "Investor": "Heron Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "10308000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Heron Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2011-03-02", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1e+06", "FundingRoundCode": "E", "Date": "2014-09-03", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1.1e+07", "FundingRoundCode": "D", "Date": "2012-04-20", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2006-12-29", "Investor": "Prolog Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "10308000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1080000", "FundingRoundCode": "D", "Date": "2012-01-23", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "9e+06", "FundingRoundCode": "E", "Date": "2013-06-03", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1e+06", "FundingRoundCode": "E", "Date": "2014-09-03", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1.1e+07", "FundingRoundCode": "D", "Date": "2012-04-20", "Investor": "Vivo Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "10308000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "1080000", "FundingRoundCode": "D", "Date": "2012-01-23", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "9e+06", "FundingRoundCode": "E", "Date": "2013-06-03", "Investor": "Vivo Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AirXpanders", "Amount": "10308000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Western Technology Investment"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Akadeum Life Sciences", "Amount": "905063", "FundingRoundCode": "NA", "Date": "2015-08-13", "Investor": "Michigan eLab"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AkaRx", "Amount": "6050000", "FundingRoundCode": "A", "Date": "2005-08-22", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AkaRx", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2006-10-23", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AkaRx", "Amount": "8050000", "FundingRoundCode": "A", "Date": "2006-05-10", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AkaRx", "Amount": "6050000", "FundingRoundCode": "A", "Date": "2005-08-22", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AkaRx", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2006-10-23", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AkaRx", "Amount": "8050000", "FundingRoundCode": "A", "Date": "2006-05-10", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2011-04-26", "Investor": "Athenian Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4100000", "FundingRoundCode": "B", "Date": "2012-01-09", "Investor": "Athenian Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "Athenian Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Athenian Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2011-04-26", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4100000", "FundingRoundCode": "B", "Date": "2012-01-09", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2011-04-26", "Investor": "Orchard Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4100000", "FundingRoundCode": "B", "Date": "2012-01-09", "Investor": "Orchard Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "Orchard Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Orchard Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Technology Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2011-04-26", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4100000", "FundingRoundCode": "B", "Date": "2012-01-09", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2011-04-26", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4100000", "FundingRoundCode": "B", "Date": "2012-01-09", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Akebia Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Akermin", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-11-12", "Investor": "OnPoint Technologies"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Akermin", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-11-12", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Akermin", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-02-19", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Akermin", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-11-12", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Akermin", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-02-19", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Akonni Biosystems", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2012-08-17", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Akonni Biosystems", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2011-04-11", "Investor": "National Institutes of Health"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Akonni Biosystems", "Amount": "3200000", "FundingRoundCode": "NA", "Date": "2009-12-01", "Investor": "National Institutes of Health"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Akonni Biosystems", "Amount": "435000", "FundingRoundCode": "NA", "Date": "2010-07-27", "Investor": "National Institutes of Health"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Akonni Biosystems", "Amount": "280000", "FundingRoundCode": "NA", "Date": "2012-10-02", "Investor": "National Institutes of Health"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Akonni Biosystems", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2010-09-28", "Investor": "National Institutes of Health"}, {"FundingRoundType": "non_equity_assistance", "CompanyCategory": "Biotechnology", "CompanyName": "Alafair Biosciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-12-20", "Investor": "Texas Venture Labs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Albireo", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2008-02-01", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alcresta", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-07-22", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alcresta", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2012-04-17", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alcresta", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-07-22", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alcresta", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2012-04-17", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alcresta", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-07-22", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alcresta", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2012-04-17", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alcyone Lifesciences", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2014-01-15", "Investor": "Harbor Light Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2007-09-01", "Investor": "CNF Investments, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "14300000", "FundingRoundCode": "C", "Date": "2006-12-20", "Investor": "Harbert Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "18400000", "FundingRoundCode": "D", "Date": "2008-04-23", "Investor": "Harbert Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2007-09-01", "Investor": "Harbert Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "14300000", "FundingRoundCode": "C", "Date": "2006-12-20", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "18400000", "FundingRoundCode": "D", "Date": "2008-04-23", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2007-09-01", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "14300000", "FundingRoundCode": "C", "Date": "2006-12-20", "Investor": "Tall Oaks Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "18400000", "FundingRoundCode": "D", "Date": "2008-04-23", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2007-09-01", "Investor": "Tullis-Dickerson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aldagen", "Amount": "18400000", "FundingRoundCode": "D", "Date": "2008-04-23", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALDEA Pharmaceuticals", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALDEA Pharmaceuticals", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-08-25", "Investor": "Canaan Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "ALDEA Pharmaceuticals", "Amount": "4513491", "FundingRoundCode": "NA", "Date": "2012-05-08", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALDEA Pharmaceuticals", "Amount": "11483692", "FundingRoundCode": "A", "Date": "2013-11-18", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALDEA Pharmaceuticals", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-08-25", "Investor": "Correlation Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "ALDEA Pharmaceuticals", "Amount": "4513491", "FundingRoundCode": "NA", "Date": "2012-05-08", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2007-12-01", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "D", "Date": "2012-04-19", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2006-07-01", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "D", "Date": "2012-04-19", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2006-07-01", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2005-07-01", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "D", "Date": "2012-04-19", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2007-12-01", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "D", "Date": "2012-04-19", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2006-07-01", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2005-07-01", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Alder Biopharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "D", "Date": "2012-04-19", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alector", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2015-09-16", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alector", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2015-09-16", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alector", "Amount": "NA", "FundingRoundCode": "A", "Date": "2013-10-31", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alector", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2015-09-16", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alector", "Amount": "NA", "FundingRoundCode": "A", "Date": "2013-10-31", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alector", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2015-09-16", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alector", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2015-09-16", "Investor": "Topspin Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alere Analytics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-10-25", "Investor": "Edison Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alexar Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-04-30", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alexar Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-04-30", "Investor": "Third Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Alexza Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2002-09-23", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Alexza Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2002-09-23", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Alexza Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2002-09-23", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Alexza Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2002-09-23", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Alexza Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2002-09-23", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Alexza Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2002-09-23", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Alexza Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2002-09-23", "Investor": "Zesiger Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "26750000", "FundingRoundCode": "A", "Date": "2004-07-09", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "31800000", "FundingRoundCode": "B", "Date": "2005-11-30", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "26750000", "FundingRoundCode": "A", "Date": "2004-07-09", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "31800000", "FundingRoundCode": "B", "Date": "2005-11-30", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "26750000", "FundingRoundCode": "A", "Date": "2004-07-09", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "31800000", "FundingRoundCode": "B", "Date": "2005-11-30", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "26750000", "FundingRoundCode": "A", "Date": "2004-07-09", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "31800000", "FundingRoundCode": "B", "Date": "2005-11-30", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "31800000", "FundingRoundCode": "B", "Date": "2005-11-30", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Alimera Sciences", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alios BioPharma", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2014-04-07", "Investor": "SR One"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AlixaRx", "Amount": "1e+08", "FundingRoundCode": "NA", "Date": "2013-07-02", "Investor": "Fillmore Capital Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Alkeus Pharmaceuticals", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2010-10-21", "Investor": "MassChallenge"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allakos", "Amount": "24500000", "FundingRoundCode": "A", "Date": "2014-08-27", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allakos", "Amount": "27949545", "FundingRoundCode": "NA", "Date": "2015-03-25", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allakos", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-09-30", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allakos", "Amount": "27949545", "FundingRoundCode": "NA", "Date": "2015-03-25", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allakos", "Amount": "24500000", "FundingRoundCode": "A", "Date": "2014-08-27", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allakos", "Amount": "27949545", "FundingRoundCode": "NA", "Date": "2015-03-25", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allakos", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-09-30", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Allegro Diagnostics", "Amount": "5400000", "FundingRoundCode": "A", "Date": "2011-07-07", "Investor": "Catalyst Health & Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Allegro Diagnostics", "Amount": "5400000", "FundingRoundCode": "A", "Date": "2011-07-07", "Investor": "Kodiak Venture Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Allegro Ophthalmics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2015-02-03", "Investor": "Helmsley Charitable"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allena Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2014-12-04", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allena Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2011-11-16", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allena Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2014-12-04", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allena Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2011-11-16", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allena Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2014-12-04", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allena Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2011-11-16", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allocade", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2010-04-07", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AlloCure", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2012-04-02", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AlloCure", "Amount": "14500000", "FundingRoundCode": "A", "Date": "2008-07-02", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allon Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-03-03", "Investor": "Yorkville Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-10-26", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2005-12-06", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-10-26", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2005-12-06", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-10-26", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2005-12-06", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-10-26", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2005-12-06", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Allozyne", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-10-26", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "18200000", "FundingRoundCode": "NA", "Date": "2012-03-12", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2010-01-28", "Investor": "Bluegrass Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "3350000", "FundingRoundCode": "NA", "Date": "2007-11-29", "Investor": "Bluegrass Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "18200000", "FundingRoundCode": "NA", "Date": "2012-03-12", "Investor": "Cultivian Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2010-01-28", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "3350000", "FundingRoundCode": "NA", "Date": "2007-11-29", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2010-01-28", "Investor": "Pasadena Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "3350000", "FundingRoundCode": "NA", "Date": "2007-11-29", "Investor": "Pasadena Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2010-01-28", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Pharmaceuticals", "CompanyName": "Allylix", "Amount": "3350000", "FundingRoundCode": "NA", "Date": "2007-11-29", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Alnara Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2008-10-30", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Alnara Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2008-10-30", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Alnara Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-01-28", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Alnara Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2008-10-30", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "AlphaCare Holdings", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-08-14", "Investor": "Magellan Health Services"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altair Therapeutics", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-02-02", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altair Therapeutics", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-02-02", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altair Therapeutics", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-02-02", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altheos", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2010-04-05", "Investor": "Atheneos Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altheos", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-02-09", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altheos", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2010-04-05", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altheos", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-02-09", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altheos", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2010-04-05", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Altheos", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2010-04-05", "Investor": "Life Science Angels"}, {"FundingRoundType": "non_equity_assistance", "CompanyCategory": "Biotechnology", "CompanyName": "Altogen Labs", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-12-20", "Investor": "Texas Venture Labs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Accelerator Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2014-05-19", "Investor": "Allos Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Allos Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2010-10-11", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2012-02-06", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "BlueTree Allied Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2010-10-11", "Investor": "Eagle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Eagle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2012-02-06", "Investor": "Eagle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Smithfield Trust"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2014-05-19", "Investor": "West Capital Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ALung Technologies", "Amount": "15800000", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "West Capital Advisors LLC"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "NA", "Date": "2013-05-14", "Investor": "AbbVie Biotech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Black River Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Panorama Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2006-09-06", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2006-09-06", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Alvine Pharmaceuticals", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AM Pharma", "Amount": "15773584", "FundingRoundCode": "E", "Date": "2014-09-11", "Investor": "AbbVie Biotech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amaranth Medical", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2013-10-08", "Investor": "Charter Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-06", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "3.1e+07", "FundingRoundCode": "C", "Date": "2005-05-12", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "49300000", "FundingRoundCode": "D", "Date": "2007-11-14", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "3.1e+07", "FundingRoundCode": "C", "Date": "2005-05-12", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-06", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "49300000", "FundingRoundCode": "D", "Date": "2007-11-14", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "49300000", "FundingRoundCode": "D", "Date": "2007-11-14", "Investor": "Horizon Technology Finance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-06", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "49300000", "FundingRoundCode": "D", "Date": "2007-11-14", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "NovaQuest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "49300000", "FundingRoundCode": "D", "Date": "2007-11-14", "Investor": "NovaQuest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-06", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "49300000", "FundingRoundCode": "D", "Date": "2007-11-14", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-06", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambit Biosciences", "Amount": "49300000", "FundingRoundCode": "D", "Date": "2007-11-14", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambrx", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2009-04-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambrx", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2009-04-01", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambrx", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2009-04-01", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambrx", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2009-04-01", "Investor": "Tavistock Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ambrx", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2009-04-01", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amedica", "Amount": "13200000", "FundingRoundCode": "D", "Date": "2007-05-17", "Investor": "Creation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amedica", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2010-09-07", "Investor": "Creation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amedica", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2010-09-07", "Investor": "Zions First National Bank"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "American Pathology Partners", "Amount": "5999999", "FundingRoundCode": "NA", "Date": "2012-09-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Targazyme", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2009-07-15", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amicas", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2001-11-19", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2004-05-13", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2004-05-13", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2004-05-13", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-12-31", "Investor": "MidCap Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2004-05-13", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-12-31", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2004-05-13", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2004-05-13", "Investor": "Radius Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Amicus Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-12-31", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amira Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2007-03-23", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amira Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2007-03-23", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amira Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2007-03-23", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amphora Discovery", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-12-08", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amphora Discovery", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-12-08", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amphora Discovery", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-12-08", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amphora Discovery", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-12-08", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ampla Pharmaceuticals", "Amount": "5470000", "FundingRoundCode": "A", "Date": "2006-12-06", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ampla Pharmaceuticals", "Amount": "5470000", "FundingRoundCode": "A", "Date": "2006-12-06", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AmpliMed Corporation", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2008-01-14", "Investor": "Solstice Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AmpliMed Corporation", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2008-01-14", "Investor": "Valley Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Amplimmune", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2006-01-01", "Investor": "InterWest Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Amplion Research", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-01-07", "Investor": "Bend Venture Conference"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Amplion Research", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-01-07", "Investor": "Cascade Angels Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Amplion Research", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-01-07", "Investor": "Portland Seed Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Amplion Research", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-01-07", "Investor": "Seven Peaks Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AmpliPhi Biosciences", "Amount": "12490999", "FundingRoundCode": "NA", "Date": "2013-07-10", "Investor": "RA Capital Management"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AmpliPhi Biosciences", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2013-12-16", "Investor": "ROTH Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "AmpliPhi Biosciences", "Amount": "12490999", "FundingRoundCode": "NA", "Date": "2013-07-10", "Investor": "Third Security"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amrit Advanced Biotech", "Amount": "2394302", "FundingRoundCode": "A", "Date": "2009-10-01", "Investor": "Amaranth Advisors"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Amrit Advanced Biotech", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2007-04-01", "Investor": "Amaranth Advisors"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Amrit Advanced Biotech", "Amount": "698097", "FundingRoundCode": "NA", "Date": "2008-07-01", "Investor": "Amaranth Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amrit Advanced Biotech", "Amount": "2394302", "FundingRoundCode": "A", "Date": "2009-10-01", "Investor": "Satori Capital"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Amrit Advanced Biotech", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2007-04-01", "Investor": "Satori Capital"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Amrit Advanced Biotech", "Amount": "698097", "FundingRoundCode": "NA", "Date": "2008-07-01", "Investor": "Satori Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amulet Pharmaceuticals", "Amount": "1700000", "FundingRoundCode": "A", "Date": "2007-03-05", "Investor": "Springboard Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Amulet Pharmaceuticals", "Amount": "1700000", "FundingRoundCode": "A", "Date": "2007-03-05", "Investor": "Wilmington Investor Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2008-08-14", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2007-09-19", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2008-08-14", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2006-10-12", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2007-09-19", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "41750000", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2008-08-14", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2006-10-12", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2007-09-19", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "41750000", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2008-08-14", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2006-10-12", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2007-09-19", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology|Renewable Energies", "CompanyName": "Amyris Biotechnologies", "Amount": "41750000", "FundingRoundCode": "C", "Date": "2009-10-01", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2002-11-01", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2005-05-11", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2009-01-06", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2005-05-11", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2009-01-06", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-07-30", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2009-01-06", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-06-12", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2005-05-11", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2005-05-11", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2009-01-06", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2002-11-01", "Investor": "Rho Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2010-11-04", "Investor": "United States Department of the Treasury"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2005-05-11", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anacor Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2009-01-06", "Investor": "Venrock"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Diagnostics|Pharmaceuticals", "CompanyName": "Analiza", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2007-08-22", "Investor": "JumpStart Inc."}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Diagnostics|Pharmaceuticals", "CompanyName": "Analiza", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2008-09-04", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anaphore", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2009-06-09", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anaphore", "Amount": "3300000", "FundingRoundCode": "NA", "Date": "2008-01-31", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anaphore", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2008-04-15", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anaphore", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2009-06-09", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anaphore", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2009-06-09", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anaphore", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2008-04-15", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AnaptysBio", "Amount": "33900000", "FundingRoundCode": "B", "Date": "2007-11-08", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AnaptysBio", "Amount": "33900000", "FundingRoundCode": "B", "Date": "2007-11-08", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AnaptysBio", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2006-07-31", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AnaptysBio", "Amount": "33900000", "FundingRoundCode": "B", "Date": "2007-11-08", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AnaptysBio", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2015-07-15", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AnaptysBio", "Amount": "33900000", "FundingRoundCode": "B", "Date": "2007-11-08", "Investor": "Numenor Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AnaptysBio", "Amount": "33900000", "FundingRoundCode": "B", "Date": "2007-11-08", "Investor": "WS Investments"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ancera", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-03-14", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ancera", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-03-14", "Investor": "LaunchCapital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anchor Therapeutics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2010-08-20", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ancora Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "A", "Date": "2007-05-03", "Investor": "University Venture Fund"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Analytics|Biotechnology|Clean Technology|Water Purification", "CompanyName": "ANDalyze", "Amount": "325000", "FundingRoundCode": "NA", "Date": "2013-04-16", "Investor": "Serra Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "AndersonBrecon", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2013-05-13", "Investor": "Golub Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AndroBioSys", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2009-01-09", "Investor": "Erie County Industrial Development Agency"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AndroBioSys", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2009-01-09", "Investor": "Excell Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AndroBioSys", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2009-01-09", "Investor": "Western New York Venture Association"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anesiva", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-12-18", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anexon", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-10-20", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AngioScore", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2007-10-09", "Investor": "California Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AngioScore", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2007-10-09", "Investor": "Pelion Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AngioScore", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2007-10-09", "Investor": "Psilos Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AngioScore", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2007-10-09", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AngioScore", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2011-04-20", "Investor": "Saints Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AngioScore", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2007-10-09", "Investor": "Telegraph Hill Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Animated Dynamics", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2014-09-02", "Investor": "National Science Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ankasa Regenerative Therapeutics", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-06-23", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ankasa Regenerative Therapeutics", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-06-23", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Annexon", "Amount": "3.4e+07", "FundingRoundCode": "A", "Date": "2014-12-15", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Annovation BioPharma", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2012-07-26", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Annovation BioPharma", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2012-09-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Annovation BioPharma", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2012-09-10", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anokion SA", "Amount": "37500000", "FundingRoundCode": "A", "Date": "2014-05-09", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ansata Therapeutics", "Amount": "2500000", "FundingRoundCode": "B", "Date": "2003-04-02", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ansata Therapeutics", "Amount": "2500000", "FundingRoundCode": "B", "Date": "2003-04-02", "Investor": "Domain Associates"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Antegrin Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-04-02", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anthera Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anthera Pharmaceuticals", "Amount": "31500000", "FundingRoundCode": "NA", "Date": "2010-09-21", "Investor": "Caxton Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anthera Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "Mitsubishi Corporation Life Sciences Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anthera Pharmaceuticals", "Amount": "31500000", "FundingRoundCode": "NA", "Date": "2010-09-21", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anthera Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anthera Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Anthera Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "18300000", "FundingRoundCode": "E", "Date": "2010-06-07", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2006-07-25", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "18300000", "FundingRoundCode": "E", "Date": "2010-06-07", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2006-07-25", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "18300000", "FundingRoundCode": "E", "Date": "2010-06-07", "Investor": "MB Venture Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2006-07-25", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "18300000", "FundingRoundCode": "E", "Date": "2010-06-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2006-07-25", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2006-07-25", "Investor": "SightLine Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Anulex", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2006-07-25", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "12900000", "FundingRoundCode": "D", "Date": "2009-03-20", "Investor": "Clearstone Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-05-30", "Investor": "Clearstone Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "4.2e+07", "FundingRoundCode": "E", "Date": "2012-08-23", "Investor": "Clearstone Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "12900000", "FundingRoundCode": "D", "Date": "2009-03-20", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-05-30", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "4.2e+07", "FundingRoundCode": "E", "Date": "2012-08-23", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "12900000", "FundingRoundCode": "D", "Date": "2009-03-20", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "4.2e+07", "FundingRoundCode": "E", "Date": "2012-08-23", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "12900000", "FundingRoundCode": "D", "Date": "2009-03-20", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-05-30", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "12900000", "FundingRoundCode": "D", "Date": "2009-03-20", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "4.2e+07", "FundingRoundCode": "E", "Date": "2012-08-23", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "4.2e+07", "FundingRoundCode": "E", "Date": "2012-08-23", "Investor": "True Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "12900000", "FundingRoundCode": "D", "Date": "2009-03-20", "Investor": "W Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biometrics|Biotechnology|Security", "CompanyName": "AOptix Technologies", "Amount": "4.2e+07", "FundingRoundCode": "E", "Date": "2012-08-23", "Investor": "W Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AorTx", "Amount": "5800000", "FundingRoundCode": "NA", "Date": "2006-12-12", "Investor": "BioStar Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AorTx", "Amount": "5800000", "FundingRoundCode": "NA", "Date": "2006-12-12", "Investor": "Wilson Sonsini Goodrich & Rosati"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apama Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2015-01-13", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apama Medical", "Amount": "3200000", "FundingRoundCode": "A", "Date": "2013-09-16", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apama Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2015-01-13", "Investor": "Incept"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apama Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2015-01-13", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apellis Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2014-12-02", "Investor": "Morningside Private Investors"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Diagnostics", "CompanyName": "Aperiomics, Inc.", "Amount": "375000", "FundingRoundCode": "NA", "Date": "2015-04-01", "Investor": "National Science Foundation- SBIR/STTR Program"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Developer APIs|Manufacturing", "CompanyName": "Apertus Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "BioGenerator"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Apex Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-10-01", "Investor": "Innovate Indiana Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apexigen", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2013-08-06", "Investor": "Amkey Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apexigen", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2013-08-06", "Investor": "Sycamore Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apieron", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2007-06-29", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apieron", "Amount": "5900000", "FundingRoundCode": "D", "Date": "2009-06-02", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apieron", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2005-01-01", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apieron", "Amount": "5900000", "FundingRoundCode": "D", "Date": "2009-06-02", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apieron", "Amount": "4600000", "FundingRoundCode": "A", "Date": "2003-01-01", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apieron", "Amount": "5900000", "FundingRoundCode": "D", "Date": "2009-06-02", "Investor": "ONSET Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "APIM Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-11-10", "Investor": "Sarsia Seed Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Apitope", "Amount": "13456610", "FundingRoundCode": "B", "Date": "2015-09-29", "Investor": "PMV Pharmaceutcals"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Athyrium Capital Management, LP"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2013-12-18", "Investor": "East West Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "11500000", "FundingRoundCode": "A", "Date": "2007-10-08", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2013-12-18", "Investor": "MidCap Financial"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2013-12-18", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "11500000", "FundingRoundCode": "A", "Date": "2007-10-08", "Investor": "PTV Healthcare Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "47600000", "FundingRoundCode": "NA", "Date": "2012-02-06", "Investor": "UT Horizon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Apollo Endosurgery", "Amount": "60727392", "FundingRoundCode": "C", "Date": "2014-08-01", "Investor": "UT Horizon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aposense", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2010-05-23", "Investor": "Ziegler Meditech Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aposense", "Amount": "7300000", "FundingRoundCode": "NA", "Date": "2008-08-20", "Investor": "Ziegler Meditech Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aposense", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2006-11-09", "Investor": "Ziegler Meditech Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "37500000", "FundingRoundCode": "B", "Date": "2012-11-19", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2003-11-01", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "37500000", "FundingRoundCode": "B", "Date": "2012-11-19", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "11800000", "FundingRoundCode": "C", "Date": "2009-06-09", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2003-11-01", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "37500000", "FundingRoundCode": "B", "Date": "2012-11-19", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "11800000", "FundingRoundCode": "C", "Date": "2009-06-09", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2003-11-01", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "37500000", "FundingRoundCode": "B", "Date": "2012-11-19", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "11800000", "FundingRoundCode": "C", "Date": "2009-06-09", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "37500000", "FundingRoundCode": "B", "Date": "2012-11-19", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2003-11-01", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Applied Genetics Technologies Corporation", "Amount": "37500000", "FundingRoundCode": "B", "Date": "2012-11-19", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Applied Proteomics", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2013-08-20", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Applied Proteomics", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2013-08-20", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aprecia Pharmaceuticals", "Amount": "139000", "FundingRoundCode": "NA", "Date": "2007-05-18", "Investor": "Alpha Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aprecia Pharmaceuticals", "Amount": "139000", "FundingRoundCode": "NA", "Date": "2007-05-18", "Investor": "Harbor View Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Apsara Therapeutics", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2014-03-31", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Apsara Therapeutics", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2014-02-27", "Investor": "Mercury Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Apse", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "BioGenerator"}, {"FundingRoundType": "seed", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Apse", "Amount": "350000", "FundingRoundCode": "NA", "Date": "2015-03-04", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Apse", "Amount": "1e+05", "FundingRoundCode": "A", "Date": "2015-06-12", "Investor": "The Yield Lab"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2008-09-30", "Investor": "Charter Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2007-10-05", "Investor": "Charter Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2008-09-30", "Investor": "Great Point Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2007-10-05", "Investor": "Great Point Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2008-09-30", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2008-09-30", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2008-09-30", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2008-09-30", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2007-10-05", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2008-09-30", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "APT Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2007-10-05", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aqueduct Critical Care", "Amount": "3712304", "FundingRoundCode": "NA", "Date": "2015-08-27", "Investor": "Alliance of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-04-03", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "14500000", "FundingRoundCode": "A", "Date": "2007-06-12", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-06-17", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-04-03", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "14500000", "FundingRoundCode": "A", "Date": "2007-06-12", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-06-17", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-04-03", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aquinox Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-06-17", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2012-10-04", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2010-04-22", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2012-10-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2010-04-22", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2009-05-27", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2012-10-04", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2010-04-22", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2009-05-27", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "4.2e+07", "FundingRoundCode": "C", "Date": "2012-03-06", "Investor": "Topspin Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Aragon Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2012-10-04", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aranex Biotech", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aratana Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-12-07", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aratana Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2011-01-07", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aratana Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-12-07", "Investor": "Cultivian Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aratana Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2011-01-07", "Investor": "Kansas Bioscience Authority"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aratana Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-12-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Aratana Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2011-01-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arbor Pharmaceuticals", "Amount": "34800000", "FundingRoundCode": "B", "Date": "2010-11-11", "Investor": "Signet Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2006-03-03", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2006-03-03", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2006-03-03", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARCA biopharma", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "The Peierls Foundation"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arcadia Biosciences", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2014-05-08", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arcadia Biosciences", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2014-05-08", "Investor": "CMEA Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arcadia Biosciences", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2014-05-08", "Investor": "Saints Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "51750000", "FundingRoundCode": "A", "Date": "2002-08-15", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2004-04-07", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "51750000", "FundingRoundCode": "A", "Date": "2002-08-15", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2004-04-07", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2004-04-07", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "51750000", "FundingRoundCode": "A", "Date": "2002-08-15", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2004-04-07", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "51750000", "FundingRoundCode": "A", "Date": "2002-08-15", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2004-04-07", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2004-04-07", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "51750000", "FundingRoundCode": "A", "Date": "2002-08-15", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "51750000", "FundingRoundCode": "A", "Date": "2002-08-15", "Investor": "US Trust Private Equit"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archemix", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2004-04-07", "Investor": "US Trust Private Equit"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Archimedes Pharma", "Amount": "9.9e+07", "FundingRoundCode": "C", "Date": "2010-04-05", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arcion Therapeutics", "Amount": "8850000", "FundingRoundCode": "A", "Date": "2007-12-13", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arcion Therapeutics", "Amount": "8850000", "FundingRoundCode": "A", "Date": "2007-12-13", "Investor": "InterWest Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Arcturus BioCloud", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-01-20", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Arcturus BioCloud", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-01-20", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arcxis Biotechnologies", "Amount": "2e+06", "FundingRoundCode": "B", "Date": "2007-10-01", "Investor": "Alafi Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arcxis Biotechnologies", "Amount": "2e+06", "FundingRoundCode": "B", "Date": "2007-10-01", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arcxis Biotechnologies", "Amount": "2e+06", "FundingRoundCode": "B", "Date": "2007-10-01", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials", "CompanyName": "Ardais Corporation", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2003-01-13", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials", "CompanyName": "Ardais Corporation", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2003-01-13", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials", "CompanyName": "Ardais Corporation", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2003-01-13", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials", "CompanyName": "Ardais Corporation", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2003-01-13", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ardana Bioscience", "Amount": "32360000", "FundingRoundCode": "B", "Date": "2003-07-30", "Investor": "Techno Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ardelyx", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2011-08-31", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ardelyx", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2011-08-31", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ardelyx", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2011-08-31", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arena Pharmaceuticals", "Amount": "151760000", "FundingRoundCode": "NA", "Date": "2009-06-17", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "arGEN-X", "Amount": "43849000", "FundingRoundCode": "B", "Date": "2011-12-01", "Investor": "LSP BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "arGEN-X", "Amount": "43849000", "FundingRoundCode": "B", "Date": "2011-12-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cutting Edge Information", "Amount": "15800000", "FundingRoundCode": "A", "Date": "2007-06-25", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cutting Edge Information", "Amount": "15800000", "FundingRoundCode": "A", "Date": "2007-06-25", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cutting Edge Information", "Amount": "15800000", "FundingRoundCode": "A", "Date": "2007-06-25", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Argos Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2014-09-30", "Investor": "Horizon Technology Finance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Argos Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2012-04-24", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Argos Therapeutics", "Amount": "42500000", "FundingRoundCode": "E", "Date": "2013-08-26", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Argos Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2012-04-24", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Argos Therapeutics", "Amount": "17500000", "FundingRoundCode": "E", "Date": "2013-11-20", "Investor": "yet2Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Innovation Management|Services", "CompanyName": "Aria Biosystems", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2004-06-15", "Investor": "Agilent Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Innovation Management|Services", "CompanyName": "Aria Biosystems", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2004-06-15", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Innovation Management|Services", "CompanyName": "Aria Biosystems", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2004-06-15", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Innovation Management|Services", "CompanyName": "Aria Biosystems", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2004-06-15", "Investor": "Versant Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ariadne Diagnostics", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2013-01-01", "Investor": "TEDCO"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ariosa Diagnostics, Inc.", "Amount": "52700000", "FundingRoundCode": "C", "Date": "2012-01-09", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ariosa Diagnostics, Inc.", "Amount": "52700000", "FundingRoundCode": "C", "Date": "2012-01-09", "Investor": "Meritech Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ariosa Diagnostics, Inc.", "Amount": "52700000", "FundingRoundCode": "C", "Date": "2012-01-09", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ariosa Diagnostics, Inc.", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2009-01-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ariosa Diagnostics, Inc.", "Amount": "12800000", "FundingRoundCode": "B", "Date": "2010-05-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arius Research", "Amount": "21500000", "FundingRoundCode": "NA", "Date": "2006-03-01", "Investor": "Efficacy Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arius Research", "Amount": "21500000", "FundingRoundCode": "NA", "Date": "2006-03-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ArmaGen Technologies", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2012-11-29", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ArmaGen Technologies", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2012-11-29", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARMO BioSciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-05-28", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARMO BioSciences", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2013-11-25", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARMO BioSciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-05-28", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARMO BioSciences", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2013-11-25", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARMO BioSciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-05-28", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARMO BioSciences", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2013-11-25", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Armune BioScience", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2010-12-22", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Armune BioScience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-08-25", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arno Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "NA", "Date": "2013-10-30", "Investor": "Commercial Capital LLC"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arno Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "NA", "Date": "2013-10-30", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arno Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "NA", "Date": "2013-10-30", "Investor": "Soros Fund Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arno Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-09-14", "Investor": "UTA Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Array Bridge", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "BioGenerator"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Array Bridge", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Arrow Therapeutics", "Amount": "34898793", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Arrow Therapeutics", "Amount": "34898793", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Atlas Venture"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Arrowhead Research", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-10-14", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsanis", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2013-09-03", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsanis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2011-02-28", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsanis", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2013-09-03", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsanis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2011-02-28", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsanis", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2013-09-03", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsanis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2011-02-28", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2011-10-26", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-05-19", "Investor": "Intersouth Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-03-01", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2011-10-26", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-05-19", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-03-01", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2011-10-26", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-05-19", "Investor": "Polaris Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Vascular", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-03-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Medical", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Medical", "Amount": "13100000", "FundingRoundCode": "B", "Date": "2007-09-28", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Medical", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Medical", "Amount": "13100000", "FundingRoundCode": "B", "Date": "2007-09-28", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Medical", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arsenal Medical", "Amount": "13100000", "FundingRoundCode": "B", "Date": "2007-09-28", "Investor": "Polaris Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "ARTA Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arteaus Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2011-10-19", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arteaus Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2011-10-19", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arthrosurface", "Amount": "10500000", "FundingRoundCode": "D", "Date": "2005-02-11", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artielle ImmunoTherapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2004-06-23", "Investor": "Northwest Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artielle ImmunoTherapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2004-06-23", "Investor": "Pelion Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artielle ImmunoTherapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2004-06-23", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artielle ImmunoTherapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2004-06-23", "Investor": "Tenex Greenhouse Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artisan Pharma", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2006-09-06", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artisan Pharma", "Amount": "3e+06", "FundingRoundCode": "C", "Date": "2010-07-20", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artisan Pharma", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2006-09-06", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artisan Pharma", "Amount": "3e+06", "FundingRoundCode": "C", "Date": "2010-07-20", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artisan Pharma", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2010-03-01", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artisan Pharma", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2006-09-06", "Investor": "NovaQuest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Artisan Pharma", "Amount": "3e+06", "FundingRoundCode": "C", "Date": "2010-07-20", "Investor": "NovaQuest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2015-10-21", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-09-26", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2015-10-21", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-09-26", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-09-26", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-09-26", "Investor": "Elm Street Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2015-10-21", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2015-10-21", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arvinas", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2015-10-21", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2004-06-01", "Investor": "ATEL Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "6300000", "FundingRoundCode": "NA", "Date": "2010-08-16", "Investor": "Lighthouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2004-06-01", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2004-06-01", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2004-06-01", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "21600000", "FundingRoundCode": "NA", "Date": "2008-11-12", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "21600000", "FundingRoundCode": "NA", "Date": "2008-11-12", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2004-06-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ARYx Therapeutics", "Amount": "21600000", "FundingRoundCode": "NA", "Date": "2008-11-12", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arzeda", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2009-02-27", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Arzeda", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2009-02-27", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "Ascendant Dx", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2014-05-20", "Investor": "Arkansas Science & Technology Authority"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asceneuron", "Amount": "30693206", "FundingRoundCode": "A", "Date": "2015-09-29", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Care", "CompanyName": "Ascension Orthopedics", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2008-01-22", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascent Therapeutics", "Amount": "18999997", "FundingRoundCode": "A", "Date": "2007-11-05", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-11-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2007-04-10", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-11-01", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2007-04-10", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2007-04-10", "Investor": "Perseus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-11-01", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2007-04-10", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ascenta Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-11-01", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Ash Access Technology", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2004-01-01", "Investor": "Partisan Management Group"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Ash Access Technology", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-01-01", "Investor": "Partisan Management Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asmacure Lt\u00e9e", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-05-10", "Investor": "Domain Associates"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Assembly Pharma", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-04-10", "Investor": "BioCrossroads"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2014-12-23", "Investor": "Allos Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "12500000", "FundingRoundCode": "C", "Date": "2012-05-30", "Investor": "Allos Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-05-21", "Investor": "Allos Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2011-03-25", "Investor": "Allos Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2012-01-31", "Investor": "Allos Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-05-21", "Investor": "Cincinnati Children\u2019s Hospital Medical Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2014-12-23", "Investor": "CincyTech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-05-21", "Investor": "CincyTech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2014-12-23", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "12500000", "FundingRoundCode": "C", "Date": "2012-05-30", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-05-21", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2011-03-25", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "12500000", "FundingRoundCode": "C", "Date": "2012-05-30", "Investor": "Four Rivers Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2014-12-23", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2011-01-11", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2014-12-23", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "12500000", "FundingRoundCode": "C", "Date": "2012-05-30", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-05-21", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2011-03-25", "Investor": "Sequoia Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2012-01-31", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2014-05-21", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Assurex Health", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2008-06-15", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asterand", "Amount": "3e+06", "FundingRoundCode": "C", "Date": "2003-11-26", "Investor": "Apjohn ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asterand", "Amount": "3e+06", "FundingRoundCode": "C", "Date": "2003-11-26", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asterand", "Amount": "3e+06", "FundingRoundCode": "C", "Date": "2003-11-26", "Investor": "Fort Washington Capital Partners Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asterand", "Amount": "3e+06", "FundingRoundCode": "C", "Date": "2003-11-26", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asteres", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2007-11-01", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asteres", "Amount": "NA", "FundingRoundCode": "A", "Date": "2003-09-23", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asteres", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2007-11-01", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asteres", "Amount": "NA", "FundingRoundCode": "B", "Date": "2004-11-12", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Asteres", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2008-06-05", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-03-08", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "40400000", "FundingRoundCode": "C", "Date": "2012-06-07", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "26500000", "FundingRoundCode": "B", "Date": "2010-05-12", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-03-08", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "40400000", "FundingRoundCode": "C", "Date": "2012-06-07", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "6250000", "FundingRoundCode": "A", "Date": "2008-05-01", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "26500000", "FundingRoundCode": "B", "Date": "2010-05-12", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-03-08", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "40400000", "FundingRoundCode": "C", "Date": "2012-06-07", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "26500000", "FundingRoundCode": "B", "Date": "2010-05-12", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-03-08", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "40400000", "FundingRoundCode": "C", "Date": "2012-06-07", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "26500000", "FundingRoundCode": "B", "Date": "2010-05-12", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "40400000", "FundingRoundCode": "C", "Date": "2012-06-07", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Astute Medical", "Amount": "40400000", "FundingRoundCode": "C", "Date": "2012-06-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Asuragen", "Amount": "4.9e+07", "FundingRoundCode": "A", "Date": "2006-06-01", "Investor": "Growth Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Asuragen", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2007-12-10", "Investor": "Growth Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Asuragen", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2007-12-10", "Investor": "PTV Healthcare Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Asuragen", "Amount": "4.9e+07", "FundingRoundCode": "A", "Date": "2006-06-01", "Investor": "Telegraph Hill Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Asuragen", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2007-12-10", "Investor": "Telegraph Hill Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2014-01-10", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2014-01-10", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2013-12-17", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2014-01-10", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2013-12-17", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2014-01-10", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2013-12-17", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2014-01-10", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2013-12-17", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2014-01-10", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2013-12-17", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "13500000", "FundingRoundCode": "B", "Date": "2014-01-10", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atara Biotherapeutics", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2013-12-17", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ataxion", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2014-03-17", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ataxion", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2014-03-17", "Investor": "Biogen Idec"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2001-09-10", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2006-01-06", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2004-01-20", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2006-01-06", "Investor": "Covera Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2004-01-20", "Investor": "Covera Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2006-01-06", "Investor": "Eastman Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2004-01-20", "Investor": "Eastman Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2006-01-06", "Investor": "Finistere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2008-07-23", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2001-09-10", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2006-01-06", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2004-01-20", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2008-07-23", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2001-09-10", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2006-01-06", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Athenix", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2004-01-20", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ativa Medical", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2015-09-17", "Investor": "LabCorp"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Atlas Genetics", "Amount": "28399065", "FundingRoundCode": "B", "Date": "2014-04-28", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Atlas Genetics", "Amount": "27184389", "FundingRoundCode": "B", "Date": "2011-07-18", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atox Bio", "Amount": "2.3e+07", "FundingRoundCode": "E", "Date": "2014-07-24", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atreca", "Amount": "5.6e+07", "FundingRoundCode": "A", "Date": "2015-11-04", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atreca", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2012-09-25", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atreca", "Amount": "5.6e+07", "FundingRoundCode": "A", "Date": "2015-11-04", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atreca", "Amount": "5.6e+07", "FundingRoundCode": "A", "Date": "2015-11-04", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atterocor", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2012-08-03", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atterocor", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2012-08-03", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atterocor", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2012-08-03", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Atterocor", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2012-08-03", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2010-10-26", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2009-09-15", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2013-07-29", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "10500000", "FundingRoundCode": "B", "Date": "2007-04-18", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2010-10-26", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2009-09-15", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2013-07-29", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "10500000", "FundingRoundCode": "B", "Date": "2007-04-18", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2010-10-26", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2013-07-29", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2010-10-26", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2009-09-15", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2013-07-29", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "10500000", "FundingRoundCode": "B", "Date": "2007-04-18", "Investor": "Polaris Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-07-29", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "aTyr Pharma", "Amount": "7.6e+07", "FundingRoundCode": "E", "Date": "2015-03-31", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-07-18", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "42500000", "FundingRoundCode": "B", "Date": "2014-12-02", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "42500000", "FundingRoundCode": "B", "Date": "2014-12-02", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-07-18", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "42500000", "FundingRoundCode": "B", "Date": "2014-12-02", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "42500000", "FundingRoundCode": "B", "Date": "2014-12-02", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "42500000", "FundingRoundCode": "B", "Date": "2014-12-02", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "C", "Date": "2015-10-13", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-07-18", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audentes Therapeutics", "Amount": "42500000", "FundingRoundCode": "B", "Date": "2014-12-02", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Audion Therapeutics", "Amount": "9273777", "FundingRoundCode": "NA", "Date": "2015-09-08", "Investor": "Shapeways"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aura Biosciences", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2015-03-05", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aura Biosciences", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2015-03-05", "Investor": "Chiesi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AuraSense Therapeutics", "Amount": "5400000", "FundingRoundCode": "B", "Date": "2011-12-21", "Investor": "Abbott Biotech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AuraSense Therapeutics", "Amount": "NA", "FundingRoundCode": "B", "Date": "2013-07-31", "Investor": "AbbVie Biotech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AuraSense Therapeutics", "Amount": "13600000", "FundingRoundCode": "C", "Date": "2014-06-17", "Investor": "Bill Gates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "7e+06", "FundingRoundCode": "D", "Date": "2010-04-14", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2002-09-30", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2005-08-04", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "7e+06", "FundingRoundCode": "D", "Date": "2010-04-14", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "7e+06", "FundingRoundCode": "D", "Date": "2010-04-14", "Investor": "Pfizer"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2005-08-04", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "7e+06", "FundingRoundCode": "D", "Date": "2010-04-14", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2002-09-30", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aureon Laboratories", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2005-08-04", "Investor": "Sprout Group"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Aurinia Pharmaceuticals", "Amount": "5.2e+07", "FundingRoundCode": "NA", "Date": "2014-02-24", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Aurinia Pharmaceuticals", "Amount": "5.2e+07", "FundingRoundCode": "NA", "Date": "2014-02-24", "Investor": "Great Point Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Aurinia Pharmaceuticals", "Amount": "5.2e+07", "FundingRoundCode": "NA", "Date": "2014-02-24", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Aurinia Pharmaceuticals", "Amount": "5.2e+07", "FundingRoundCode": "NA", "Date": "2014-02-24", "Investor": "RA Capital Management"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Aurinia Pharmaceuticals", "Amount": "5.2e+07", "FundingRoundCode": "NA", "Date": "2014-02-24", "Investor": "Redmile Group"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Aurinia Pharmaceuticals", "Amount": "5.2e+07", "FundingRoundCode": "NA", "Date": "2014-02-24", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Auris Surgical Robotics", "Amount": "34377390", "FundingRoundCode": "A", "Date": "2014-03-31", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Auris Surgical Robotics", "Amount": "34377390", "FundingRoundCode": "A", "Date": "2014-03-31", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Auris Surgical Robotics", "Amount": "34377390", "FundingRoundCode": "A", "Date": "2014-03-31", "Investor": "Mithril Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Auris Surgical Robotics", "Amount": "34377390", "FundingRoundCode": "A", "Date": "2014-03-31", "Investor": "NaviMed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AURSOS", "Amount": "560000", "FundingRoundCode": "NA", "Date": "2008-04-29", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aushon BioSystems", "Amount": "7780000", "FundingRoundCode": "A", "Date": "2006-11-16", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aushon BioSystems", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2008-01-14", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aushon BioSystems", "Amount": "2400000", "FundingRoundCode": "B", "Date": "1998-12-01", "Investor": "Westcon Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2012-11-08", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2010-10-13", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2014-01-08", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2014-01-08", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-01-08", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2012-11-08", "Investor": "Panorama Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2014-01-08", "Investor": "Panorama Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2012-11-08", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2010-10-13", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Auspex Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2014-01-08", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "AutekBio", "Amount": "1e+06", "FundingRoundCode": "B", "Date": "2007-10-22", "Investor": "Acorn Campus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "AutekBio", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2007-08-07", "Investor": "Acorn Campus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Autifony Therapeutics", "Amount": "12336350", "FundingRoundCode": "A", "Date": "2015-07-10", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Autifony Therapeutics", "Amount": "12336350", "FundingRoundCode": "A", "Date": "2015-07-10", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Innovation Management|Market Research", "CompanyName": "Auxilium Pharmaceuticals", "Amount": "4.3e+07", "FundingRoundCode": "D", "Date": "2003-11-07", "Investor": "CIP Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Innovation Management|Market Research", "CompanyName": "Auxilium Pharmaceuticals", "Amount": "4.3e+07", "FundingRoundCode": "D", "Date": "2003-11-07", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Innovation Management|Market Research", "CompanyName": "Auxilium Pharmaceuticals", "Amount": "4.3e+07", "FundingRoundCode": "D", "Date": "2003-11-07", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Innovation Management|Market Research", "CompanyName": "Auxilium Pharmaceuticals", "Amount": "4.3e+07", "FundingRoundCode": "D", "Date": "2003-11-07", "Investor": "SCP Private Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Innovation Management|Market Research", "CompanyName": "Auxilium Pharmaceuticals", "Amount": "4.3e+07", "FundingRoundCode": "D", "Date": "2003-11-07", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avalanche Biotech", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avalanche Biotech", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Deerfield"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avalanche Biotech", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avalanche Biotech", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avalanche Biotech", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Venrock"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Avanir Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-06-26", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Avanir Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-06-26", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-07", "Investor": "AbbVie Biotech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-07", "Investor": "Beacon Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "4100000", "FundingRoundCode": "A", "Date": "2012-02-14", "Investor": "Beacon Angels"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-04-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-07", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-12-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-06-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "NA", "FundingRoundCode": "B", "Date": "2012-12-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "4100000", "FundingRoundCode": "A", "Date": "2012-02-14", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Fort Point Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-07", "Investor": "Golden Seeds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-07", "Investor": "LaunchPad Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "4100000", "FundingRoundCode": "A", "Date": "2012-02-14", "Investor": "LaunchPad Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-07", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Avaxia Biologics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Oleg Uritsky"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avelas Biosciences", "Amount": "6800000", "FundingRoundCode": "B", "Date": "2014-01-09", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avelas Biosciences", "Amount": "7650000", "FundingRoundCode": "A", "Date": "2012-12-06", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avelas Biosciences", "Amount": "7400000", "FundingRoundCode": "B", "Date": "2014-09-10", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avelas Biosciences", "Amount": "6800000", "FundingRoundCode": "B", "Date": "2014-01-09", "Investor": "Torrey Pines Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avelas Biosciences", "Amount": "7400000", "FundingRoundCode": "B", "Date": "2014-09-10", "Investor": "Torrey Pines Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Greylock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2010-05-28", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "D", "Date": "2007-05-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Pharmaceuticals", "CompanyName": "AVEO Pharmaceuticals", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2003-10-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "St. Paul Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avera Pharmaceutical", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2004-08-05", "Investor": "Windamere Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avesthagen", "Amount": "5530000", "FundingRoundCode": "NA", "Date": "2007-05-07", "Investor": "New York Life Investment Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2015-01-09", "Investor": "Deerfield"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "AveXis", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2015-09-08", "Investor": "Venrock"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Avexxin", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-01-10", "Investor": "Sarsia Seed Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2007-05-09", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2007-05-09", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "8900000", "FundingRoundCode": "A", "Date": "2006-01-05", "Investor": "BioAdvance"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2005-01-25", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2007-05-09", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "8900000", "FundingRoundCode": "A", "Date": "2006-01-05", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2007-05-09", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "8900000", "FundingRoundCode": "A", "Date": "2006-01-05", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2007-05-09", "Investor": "RK Ventures Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "RK Ventures Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "8900000", "FundingRoundCode": "A", "Date": "2006-01-05", "Investor": "RK Ventures Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2007-05-09", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avid Radiopharmaceuticals", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2009-05-21", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "43800000", "FundingRoundCode": "C", "Date": "2006-05-09", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "28500000", "FundingRoundCode": "B", "Date": "2005-05-06", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "43800000", "FundingRoundCode": "C", "Date": "2006-05-09", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "43800000", "FundingRoundCode": "C", "Date": "2006-05-09", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "28500000", "FundingRoundCode": "B", "Date": "2005-05-06", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "43800000", "FundingRoundCode": "C", "Date": "2006-05-09", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "43800000", "FundingRoundCode": "C", "Date": "2006-05-09", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "43800000", "FundingRoundCode": "C", "Date": "2006-05-09", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Avidia", "Amount": "43800000", "FundingRoundCode": "C", "Date": "2006-05-09", "Investor": "Texas Pacific Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avidity NanoMedicines", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2014-10-07", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avidity NanoMedicines", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2014-10-07", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-06-21", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "11350000", "FundingRoundCode": "NA", "Date": "2007-09-20", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-10-19", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "4200000", "FundingRoundCode": "NA", "Date": "2010-01-15", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "7800000", "FundingRoundCode": "NA", "Date": "2008-12-02", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-08-05", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2011-06-21", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-02-12", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2011-12-20", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-06-21", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "11350000", "FundingRoundCode": "NA", "Date": "2007-09-20", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-10-19", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "4200000", "FundingRoundCode": "NA", "Date": "2010-01-15", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "7800000", "FundingRoundCode": "NA", "Date": "2008-12-02", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-08-05", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2011-06-21", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-02-12", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2011-12-20", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-06-21", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-02-12", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2011-12-20", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-06-21", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "11350000", "FundingRoundCode": "NA", "Date": "2007-09-20", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-10-19", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "4200000", "FundingRoundCode": "NA", "Date": "2010-01-15", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "7800000", "FundingRoundCode": "NA", "Date": "2008-12-02", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-08-05", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2011-06-21", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2013-02-12", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2011-12-20", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "130000", "FundingRoundCode": "NA", "Date": "2007-03-01", "Investor": "Ritchie Capital"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1450000", "FundingRoundCode": "NA", "Date": "2007-08-10", "Investor": "Ritchie Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2006-10-24", "Investor": "Ritchie Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Aviir", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2012-09-19", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Avila Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2007-08-20", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Avila Therapeutics", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2012-01-20", "Investor": "Clovis Oncology"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Avila Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2007-08-20", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avitide", "Amount": "7600000", "FundingRoundCode": "C", "Date": "2015-08-06", "Investor": "Borealis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avitide", "Amount": "7600000", "FundingRoundCode": "C", "Date": "2015-08-06", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avitide", "Amount": "7600000", "FundingRoundCode": "C", "Date": "2015-08-06", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Avitide", "Amount": "7600000", "FundingRoundCode": "C", "Date": "2015-08-06", "Investor": "SV Life Sciences"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Avraham Pharmaceuticals", "Amount": "4500000", "FundingRoundCode": "NA", "Date": "2014-09-17", "Investor": "Integra LifeSciences Holdings"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Axerion Therapeutics", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2011-10-13", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Axerion Therapeutics", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2010-04-05", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Axial Biotech", "Amount": "15300000", "FundingRoundCode": "B", "Date": "2007-03-27", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Axial Biotech", "Amount": "4100000", "FundingRoundCode": "A", "Date": "2005-03-01", "Investor": "Medtronic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Axial Biotech", "Amount": "4100000", "FundingRoundCode": "A", "Date": "2005-03-01", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Axial Biotech", "Amount": "15300000", "FundingRoundCode": "B", "Date": "2007-03-27", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Axikin Pharmaceuticals", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2009-01-22", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Axikin Pharmaceuticals", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2009-01-22", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AxioMx", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-10-08", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AxioMx", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2012-12-06", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AxoGen", "Amount": "12100000", "FundingRoundCode": "C", "Date": "2007-12-17", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AxoGen", "Amount": "12100000", "FundingRoundCode": "C", "Date": "2007-12-17", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AxoGen", "Amount": "12100000", "FundingRoundCode": "C", "Date": "2007-12-17", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "AxoGen", "Amount": "12100000", "FundingRoundCode": "C", "Date": "2007-12-17", "Investor": "Springboard Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Azelon Pharmaceuticals", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "Lighthouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Azelon Pharmaceuticals", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bacterial Barcodes", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2003-02-12", "Investor": "Baylor College of Medicine"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Bacterial Barcodes", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2010-04-27", "Investor": "Houston Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bacterial Barcodes", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2003-02-12", "Investor": "Pacific Rim Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bacterial Barcodes", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2003-02-12", "Investor": "Techxas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bacterioscan", "Amount": "5720000", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bacterioscan", "Amount": "5720000", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bacterioscan", "Amount": "5720000", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "Warson Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BaroFold", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-05-29", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BaroFold", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2006-03-01", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BaroFold", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-05-29", "Investor": "The Peierls Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BaroFold", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2006-03-01", "Investor": "The Peierls Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "6200000", "FundingRoundCode": "NA", "Date": "2006-01-01", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "2.7e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "6200000", "FundingRoundCode": "NA", "Date": "2006-01-01", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "2.7e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "2.7e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "2.7e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "RWI Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "2.7e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "2.7e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "University Venture Fund"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Barosense", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2004-12-09", "Investor": "University Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "baseclick", "Amount": "1710600", "FundingRoundCode": "B", "Date": "2011-09-02", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "BEAT BioTherapeutics", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2013-04-16", "Investor": "CET Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BeiGene", "Amount": "96600000", "FundingRoundCode": "B", "Date": "2015-05-12", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BeiGene", "Amount": "96600000", "FundingRoundCode": "B", "Date": "2015-05-12", "Investor": "T. Rowe Price"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Bell Biosystems", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2012-09-30", "Investor": "Band of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "94357588", "FundingRoundCode": "C", "Date": "2014-08-27", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "94357588", "FundingRoundCode": "C", "Date": "2014-08-27", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "94357588", "FundingRoundCode": "C", "Date": "2014-08-27", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "94357588", "FundingRoundCode": "C", "Date": "2014-08-27", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2012-03-08", "Investor": "Remeditex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "14700000", "FundingRoundCode": "B", "Date": "2014-01-07", "Investor": "Remeditex Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "1450000", "FundingRoundCode": "NA", "Date": "2007-10-09", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bellicum Pharmaceuticals", "Amount": "94357588", "FundingRoundCode": "C", "Date": "2014-08-27", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benchling", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2015-04-16", "Investor": "Andreessen Horowitz"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Benchling", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-08-18", "Investor": "Rock Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benchling", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2015-04-16", "Investor": "Thrive Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Benchling", "Amount": "9e+05", "FundingRoundCode": "NA", "Date": "2014-02-20", "Investor": "Y Combinator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "7300000", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Alexandria Venture"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2013-01-04", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "7300000", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Cultivation Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2014-08-20", "Investor": "iSELECT FUND"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-06-09", "Investor": "iSELECT FUND"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "7300000", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "7300000", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Middleland Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "7300000", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Prelude Ventures, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Benson Hill Biosystems", "Amount": "7300000", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Prolog Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Benthic Labs", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-07-10", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Benthic Labs", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-07-10", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BerGenBio", "Amount": "8800000", "FundingRoundCode": "A", "Date": "2012-01-09", "Investor": "Sarsia Seed Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BG Medicine", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2008-07-17", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BG Medicine", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2008-07-17", "Investor": "GE Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BG Medicine", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2008-07-17", "Investor": "Smallcap World Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Bicon Pharmaceutical", "Amount": "NA", "FundingRoundCode": "A", "Date": "2009-11-01", "Investor": "Sequoia Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "6027784", "FundingRoundCode": "NA", "Date": "2012-12-10", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-10-14", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "6027784", "FundingRoundCode": "NA", "Date": "2012-12-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-10-14", "Investor": "Atlas Venture"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "6027784", "FundingRoundCode": "NA", "Date": "2012-12-10", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-10-14", "Investor": "SR One"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "6027784", "FundingRoundCode": "NA", "Date": "2012-12-10", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bicycle Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-10-14", "Investor": "SV Life Sciences"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics|Nanotechnology", "CompanyName": "Bikanta", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "Marc Bell Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics|Nanotechnology", "CompanyName": "Bikanta", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "QueensBridge Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics|Nanotechnology", "CompanyName": "Bikanta", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "Y Combinator"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics|Nanotechnology", "CompanyName": "Bikanta", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "Nasir \"Nas\" Jones"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BIND Therapeutics", "Amount": "12400000", "FundingRoundCode": "C", "Date": "2010-06-29", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BIND Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-11-27", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BIND Therapeutics", "Amount": "12400000", "FundingRoundCode": "C", "Date": "2010-06-29", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BIND Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-11-27", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BIND Therapeutics", "Amount": "12400000", "FundingRoundCode": "C", "Date": "2010-06-29", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BIND Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-11-27", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "BIND Therapeutics", "Amount": "25500000", "FundingRoundCode": "D", "Date": "2012-02-13", "Investor": "RUSNANO"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BIO-IVT Group", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-07-16", "Investor": "Thompson Street Capital Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "BIO-NEMS", "Amount": "725000", "FundingRoundCode": "NA", "Date": "2012-11-11", "Investor": "In-Q-Tel"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "BioAmber", "Amount": "18585460", "FundingRoundCode": "NA", "Date": "2014-06-23", "Investor": "Comerica Bank"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "BioAmber", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-07-18", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioAmber", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2011-05-04", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bioapter", "Amount": "2033700", "FundingRoundCode": "NA", "Date": "2007-05-08", "Investor": "Mobius Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioBehavioral Diagnostics", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2007-02-02", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioBehavioral Diagnostics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioBehavioral Diagnostics", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2007-02-02", "Investor": "Tullis-Dickerson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioBehavioral Diagnostics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "secondary_market", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biocartis", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-11-01", "Investor": "blisce/"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biocartis", "Amount": "84763024", "FundingRoundCode": "F", "Date": "2014-09-04", "Investor": "Hitachi Chemical Diagnostics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biocartis", "Amount": "95708000", "FundingRoundCode": "C", "Date": "2011-11-17", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biocartis", "Amount": "44831977", "FundingRoundCode": "D", "Date": "2012-12-12", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biocartis", "Amount": "40087836", "FundingRoundCode": "B", "Date": "2010-04-08", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biocartis", "Amount": "38598000", "FundingRoundCode": "E", "Date": "2013-11-05", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biocartis", "Amount": "84763024", "FundingRoundCode": "F", "Date": "2014-09-04", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioCellection", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Biocept", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2006-06-23", "Investor": "Needham Capital Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Bioceptive", "Amount": "135000", "FundingRoundCode": "NA", "Date": "2011-08-15", "Investor": "First Light Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Bioceptive", "Amount": "1100000", "FundingRoundCode": "NA", "Date": "2013-04-23", "Investor": "New World Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioCision", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2012-12-04", "Investor": "BroadOak Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioCision", "Amount": "5847600", "FundingRoundCode": "NA", "Date": "2014-03-12", "Investor": "Brooks Automation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bioconnect Systems", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2007-04-06", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bioconnect Systems", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2007-04-06", "Investor": "Fidelity Biosciences"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Bioconnect Systems", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2006-07-24", "Investor": "MentorTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioConsortia", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2014-04-07", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioConsortia", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2014-04-07", "Investor": "Otter Capital"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "BioCryst Pharmaceuticals", "Amount": "4099999", "FundingRoundCode": "NA", "Date": "2014-08-13", "Investor": "National Institute of Allergy and Infectious Diseases"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Biodel", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2011-05-13", "Investor": "Great Point Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Biodel", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2011-05-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "BioDelivery Sciences International", "Amount": "20700000", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "MidCap Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biodesy", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-10-17", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biodesy", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-10-17", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "BioDetego", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2014-03-26", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioDigital", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2013-09-24", "Investor": "FirstMark Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioDigital", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2013-09-24", "Investor": "NYU Innovation Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioDigital", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2013-09-24", "Investor": "Amish Jani"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bioenvision", "Amount": "7410000", "FundingRoundCode": "NA", "Date": "2007-04-30", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bioenvision", "Amount": "7410000", "FundingRoundCode": "NA", "Date": "2007-04-30", "Investor": "Perseus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bioenvision", "Amount": "7410000", "FundingRoundCode": "NA", "Date": "2007-04-30", "Investor": "SCO Capital Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "3D Printing|Biotechnology|Health and Wellness", "CompanyName": "BioFab", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-02-02", "Investor": "500 Startups"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioFire Diagnostics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-05-02", "Investor": "Athyrium Opportunities Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioFire Diagnostics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2012-09-19", "Investor": "Athyrium Opportunities Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-10-31", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "2415000", "FundingRoundCode": "NA", "Date": "2008-02-20", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-06-30", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-05-17", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2006-10-31", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-01-09", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "2415000", "FundingRoundCode": "NA", "Date": "2008-02-20", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biofisica", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2006-10-31", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "13600000", "FundingRoundCode": "A", "Date": "2012-03-13", "Investor": "Arsenal Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "NA", "FundingRoundCode": "B", "Date": "2015-04-30", "Investor": "Arsenal Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "13600000", "FundingRoundCode": "A", "Date": "2012-03-13", "Investor": "Braemar Energy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "NA", "FundingRoundCode": "B", "Date": "2015-04-30", "Investor": "Braemar Energy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "NA", "FundingRoundCode": "B", "Date": "2015-04-30", "Investor": "GM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "13600000", "FundingRoundCode": "A", "Date": "2012-03-13", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "NA", "FundingRoundCode": "B", "Date": "2015-04-30", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "Square 1 Bank"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Sirrus", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "Trinity Capital Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioImagene", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2008-08-19", "Investor": "Artiman Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioImagene", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2008-08-19", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioImagene", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2008-08-19", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "BioImagene", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2008-08-19", "Investor": "National Healthcare Services"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Mobile Health", "CompanyName": "BioIQ", "Amount": "436000", "FundingRoundCode": "NA", "Date": "2009-09-09", "Investor": "Persistence Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Mobile Health", "CompanyName": "BioIQ", "Amount": "492942", "FundingRoundCode": "NA", "Date": "2010-01-28", "Investor": "Persistence Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioKier", "Amount": "1700000", "FundingRoundCode": "NA", "Date": "2013-07-24", "Investor": "American Heart Association"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioKier", "Amount": "1700000", "FundingRoundCode": "NA", "Date": "2013-07-24", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolase", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-02-11", "Investor": "Oracle Investment Management Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioLeap", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2010-01-12", "Investor": "Adams Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioLeap", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2010-01-12", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Academy Centennial Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "Dogwood Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Dogwood Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Franklin Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2005-09-01", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2005-09-01", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2005-01-07", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2005-09-01", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2005-09-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2005-09-01", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Tall Oaks Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-05-24", "Investor": "The Dow Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2008-10-06", "Investor": "The Dow Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "The Dow Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Trelys Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biolex Therapeutics", "Amount": "24400000", "FundingRoundCode": "NA", "Date": "2003-08-21", "Investor": "Wakefield Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biological Dynamics", "Amount": "26800000", "FundingRoundCode": "C", "Date": "2015-11-05", "Investor": "Heritage Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biological Dynamics", "Amount": "26800000", "FundingRoundCode": "C", "Date": "2015-11-05", "Investor": "Institutional Investor"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BionX\u2122 Medical Technologies, Inc.", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2009-10-21", "Investor": "General Catalyst Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BionX\u2122 Medical Technologies, Inc.", "Amount": "1.7e+07", "FundingRoundCode": "D", "Date": "2012-09-13", "Investor": "General Catalyst Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BionX\u2122 Medical Technologies, Inc.", "Amount": "1.7e+07", "FundingRoundCode": "D", "Date": "2012-09-13", "Investor": "Sigma Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BionX\u2122 Medical Technologies, Inc.", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2009-10-21", "Investor": "WFD Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BionX\u2122 Medical Technologies, Inc.", "Amount": "1.7e+07", "FundingRoundCode": "D", "Date": "2012-09-13", "Investor": "WFD Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "Biomatrica", "Amount": "1192160", "FundingRoundCode": "NA", "Date": "2011-02-15", "Investor": "In-Q-Tel"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "BioMedomics", "Amount": "222950", "FundingRoundCode": "NA", "Date": "2015-09-16", "Investor": "National Institutes of Health"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Mobile Health|Security", "CompanyName": "Biomeme", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-07-15", "Investor": "DreamIt Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMicro Systems", "Amount": "2020000", "FundingRoundCode": "B", "Date": "2007-09-27", "Investor": "Staley Capital Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMicro Systems", "Amount": "2020000", "FundingRoundCode": "B", "Date": "2007-09-27", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMimetic Therapeutics", "Amount": "25700000", "FundingRoundCode": "C", "Date": "2004-11-05", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMimetic Therapeutics", "Amount": "25700000", "FundingRoundCode": "C", "Date": "2004-11-05", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMimetic Therapeutics", "Amount": "25700000", "FundingRoundCode": "C", "Date": "2004-11-05", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMimetic Therapeutics", "Amount": "25700000", "FundingRoundCode": "C", "Date": "2004-11-05", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMimetic Therapeutics", "Amount": "25700000", "FundingRoundCode": "C", "Date": "2004-11-05", "Investor": "Mitsubishi Corporation Life Sciences Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biomoda", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-03-16", "Investor": "Hudson Bay Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biomoda", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-03-16", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Biomoda", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-03-16", "Investor": "Ramius Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioMotiv", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-08-05", "Investor": "Nationwide Mutual Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2008-03-26", "Investor": "21Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2008-03-26", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "5.3e+07", "FundingRoundCode": "C", "Date": "2014-11-20", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2013-10-02", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "23300000", "FundingRoundCode": "B", "Date": "2011-03-17", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2012-07-06", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "5.3e+07", "FundingRoundCode": "C", "Date": "2014-11-20", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2013-10-02", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "23300000", "FundingRoundCode": "B", "Date": "2011-03-17", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2012-07-06", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "5.3e+07", "FundingRoundCode": "C", "Date": "2014-11-20", "Investor": "Gund Investment, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2013-10-02", "Investor": "Gund Investment, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2012-07-06", "Investor": "Gund Investment, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "23300000", "FundingRoundCode": "B", "Date": "2011-03-17", "Investor": "Innovation Valley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2008-03-26", "Investor": "KT Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Maps", "CompanyName": "BioNano Genomics", "Amount": "23300000", "FundingRoundCode": "B", "Date": "2011-03-17", "Investor": "KT Venture Group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Bioniz", "Amount": "599205", "FundingRoundCode": "NA", "Date": "2013-08-15", "Investor": "Signatures Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Bioniz", "Amount": "599205", "FundingRoundCode": "NA", "Date": "2013-08-15", "Investor": "Bobby Yazdani"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioPro Pharmaceutical", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2005-10-18", "Investor": "Edelman Financial Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Media|Technology", "CompanyName": "BioProcessors", "Amount": "10010000", "FundingRoundCode": "C", "Date": "2007-08-06", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Media|Technology", "CompanyName": "BioProcessors", "Amount": "10010000", "FundingRoundCode": "C", "Date": "2007-08-06", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Media|Technology", "CompanyName": "BioProcessors", "Amount": "10010000", "FundingRoundCode": "C", "Date": "2007-08-06", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Media|Technology", "CompanyName": "BioProcessors", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2002-02-01", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Media|Technology", "CompanyName": "BioProcessors", "Amount": "10010000", "FundingRoundCode": "C", "Date": "2007-08-06", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Media|Technology", "CompanyName": "BioProcessors", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2002-02-01", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BiOptix Inc.", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2009-03-25", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "25800000", "FundingRoundCode": "A", "Date": "2007-06-11", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "25800000", "FundingRoundCode": "A", "Date": "2007-06-11", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "25800000", "FundingRoundCode": "A", "Date": "2007-06-11", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "269000", "FundingRoundCode": "NA", "Date": "2012-04-06", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "25800000", "FundingRoundCode": "A", "Date": "2007-06-11", "Investor": "Elm Street Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "25800000", "FundingRoundCode": "A", "Date": "2007-06-11", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "2560000", "FundingRoundCode": "NA", "Date": "2012-03-22", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioRelix", "Amount": "2560000", "FundingRoundCode": "NA", "Date": "2012-03-22", "Investor": "OpGen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioSante Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2010-03-04", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioSante Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2010-03-04", "Investor": "Great Point Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Life Sciences", "CompanyName": "Bioscale", "Amount": "20689200", "FundingRoundCode": "NA", "Date": "2007-12-31", "Investor": "Blackfin Technology"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Life Sciences", "CompanyName": "Bioscale", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2010-06-14", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Life Sciences", "CompanyName": "Bioscale", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2010-06-14", "Investor": "WFD Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bioscan", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2005-09-12", "Investor": "Brook Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioSeek", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "Amylin Pharmaceuticals"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioSET", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "EDF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioSET", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioSET", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioSET", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioStable", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2008-12-15", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biostorage Technologies", "Amount": "8320000", "FundingRoundCode": "A", "Date": "2007-05-29", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biostorage Technologies", "Amount": "8320000", "FundingRoundCode": "A", "Date": "2007-05-29", "Investor": "Spring Mill Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biostorage Technologies", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-01-10", "Investor": "Spring Mill Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biostorage Technologies", "Amount": "8320000", "FundingRoundCode": "A", "Date": "2007-05-29", "Investor": "Twilight Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biostorage Technologies", "Amount": "8320000", "FundingRoundCode": "A", "Date": "2007-05-29", "Investor": "Village Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Therapeutics", "CompanyName": "BioStratum", "Amount": "9500000", "FundingRoundCode": "NA", "Date": "2003-08-22", "Investor": "Equity Resources Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Infrastructure|Life Sciences", "CompanyName": "BioSurplus", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2012-07-17", "Investor": "KI Investment Holdings"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Infrastructure|Life Sciences", "CompanyName": "BioSurplus", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2012-05-11", "Investor": "KI Investment Holdings"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Infrastructure|Life Sciences", "CompanyName": "BioSurplus", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2012-07-17", "Investor": "SJF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosyntech", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-08-14", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosyntech", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-08-14", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosyntech", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-08-14", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosystem Development", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "All Metal Stamping"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosystem Development", "Amount": "6e+05", "FundingRoundCode": "B", "Date": "2007-11-01", "Investor": "Marshfield Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosystem Development", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Marshfield Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosystem Development", "Amount": "6e+05", "FundingRoundCode": "B", "Date": "2007-11-01", "Investor": "Silicon Pastures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biosystem Development", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Silicon Pastures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biotherapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-09-23", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Therapeutics", "CompanyName": "Biotica Technology", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2003-01-10", "Investor": "Biotechnology Value Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Therapeutics", "CompanyName": "Biotica Technology", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2003-01-10", "Investor": "Nordic Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioTrace Medical", "Amount": "3491067", "FundingRoundCode": "A", "Date": "2014-02-25", "Investor": "Life Sciences Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioTrace Medical", "Amount": "3491067", "FundingRoundCode": "A", "Date": "2014-02-25", "Investor": "Okapi Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioTrove", "Amount": "10900000", "FundingRoundCode": "B", "Date": "2004-01-29", "Investor": "Biofrontier Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioTrove", "Amount": "10900000", "FundingRoundCode": "B", "Date": "2004-01-29", "Investor": "Catalyst Health & Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioTrove", "Amount": "10900000", "FundingRoundCode": "B", "Date": "2004-01-29", "Investor": "CB Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioTrove", "Amount": "10900000", "FundingRoundCode": "B", "Date": "2004-01-29", "Investor": "Zero Stage Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioVascular", "Amount": "10870000", "FundingRoundCode": "C", "Date": "2008-02-07", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "28314585", "FundingRoundCode": "C", "Date": "2003-10-06", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2007-11-16", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "4e+07", "FundingRoundCode": "F", "Date": "2009-03-30", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2007-11-16", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "4e+07", "FundingRoundCode": "F", "Date": "2009-03-30", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2007-11-16", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2007-11-16", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2007-11-16", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "4e+07", "FundingRoundCode": "F", "Date": "2009-03-30", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "BioVex", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2007-11-16", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioVigilant Systems", "Amount": "6700000", "FundingRoundCode": "A", "Date": "2006-05-23", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioVigilant Systems", "Amount": "6700000", "FundingRoundCode": "A", "Date": "2006-05-23", "Investor": "Community Investment Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioVigilant Systems", "Amount": "6700000", "FundingRoundCode": "A", "Date": "2006-05-23", "Investor": "Innovation Valley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BioVigilant Systems", "Amount": "6700000", "FundingRoundCode": "A", "Date": "2006-05-23", "Investor": "Pearl Street Venture Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Biovitrum", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2001-11-19", "Investor": "Alta Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Biozone Pharmaceuticals", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-09-04", "Investor": "MusclePharm"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-01-12", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-26", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2004-12-20", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-01-12", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-26", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2004-12-20", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-01-12", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-26", "Investor": "Domain Associates"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2006-06-14", "Investor": "Lighthouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-01-12", "Investor": "Quantum Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-26", "Investor": "Quantum Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2004-12-20", "Investor": "Quantum Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-01-12", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-26", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "BiPar Sciences", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2004-12-20", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bliss Healthcare", "Amount": "5e+05", "FundingRoundCode": "A", "Date": "2011-02-08", "Investor": "LaunchPad Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Blue Heron Biotechnology", "Amount": "3680000", "FundingRoundCode": "D", "Date": "2007-01-16", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Blue Heron Biotechnology", "Amount": "3680000", "FundingRoundCode": "D", "Date": "2007-01-16", "Investor": "Life Technologies"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Blue Sky Biotech", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-03-04", "Investor": "Ampersand Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2011-04-20", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2012-07-25", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "9300000", "FundingRoundCode": "NA", "Date": "2012-10-27", "Investor": "California Institute for Regenerative Medicine"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2012-07-25", "Investor": "Deerfield Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2011-04-20", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2004-10-07", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-03-12", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-03-12", "Investor": "Genzyme Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2012-07-25", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2012-07-25", "Investor": "Ramius Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2011-04-20", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-03-12", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2012-07-25", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "bluebird bio", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2004-10-07", "Investor": "Techno Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2014-01-07", "Investor": "Biotechnology Value Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2014-01-07", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2011-04-11", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2014-01-07", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2014-11-12", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2014-11-12", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2014-11-12", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2014-11-12", "Investor": "Tavistock Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2011-04-11", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2014-01-07", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Blueprint Medicines", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2014-11-12", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bonovo Orthopedics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2010-12-23", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "Boreal Genomics", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-10-04", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "Boreal Genomics", "Amount": "6499999", "FundingRoundCode": "A", "Date": "2010-10-01", "Investor": "In-Q-Tel"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "Boreal Genomics", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-10-04", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical", "CompanyName": "Boston Heart Diagnostics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2010-09-21", "Investor": "Bain Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical", "CompanyName": "Boston Heart Diagnostics", "Amount": "NA", "FundingRoundCode": "B", "Date": "2009-05-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Bostwick Laboratories", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-10-25", "Investor": "Metalmark Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2008-04-01", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-03-01", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "17700000", "FundingRoundCode": "A", "Date": "2005-07-15", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-03-01", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-03-01", "Investor": "NeuroVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "17700000", "FundingRoundCode": "A", "Date": "2005-07-15", "Investor": "NeuroVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2008-04-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-03-01", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "17700000", "FundingRoundCode": "A", "Date": "2005-07-15", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-03-01", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "BrainCells", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-03-01", "Investor": "Technology Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "BrainScope Company", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2014-01-29", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "BrainScope Company", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-11-01", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "BrainScope Company", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Brickell Biotech", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2013-02-26", "Investor": "Palisade Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Bridge Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-14", "Investor": "Granite Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Broad Institute", "Amount": "32500000", "FundingRoundCode": "NA", "Date": "2012-01-26", "Investor": "Klarman Family Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "C8 MediSensors", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2012-02-03", "Investor": "GE Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-01-20", "Investor": "Alliance of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2012-04-26", "Investor": "Alliance of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "1200000", "FundingRoundCode": "B", "Date": "2015-06-25", "Investor": "Frontier Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-01-20", "Investor": "HealthTech Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2012-04-26", "Investor": "HealthTech Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "1200000", "FundingRoundCode": "B", "Date": "2015-06-25", "Investor": "HealthTech Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-01-20", "Investor": "Keiretsu Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2012-04-26", "Investor": "Keiretsu Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-01-20", "Investor": "Sand Hill Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2012-04-26", "Investor": "Sand Hill Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Biomedical", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2012-04-26", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cadence Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-02-01", "Investor": "Bay City Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cagenix", "Amount": "164000", "FundingRoundCode": "NA", "Date": "2012-11-01", "Investor": "Innova Memphis"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cagenix", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2012-03-01", "Investor": "Innova Memphis"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cagenix", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2013-09-01", "Investor": "Innova Memphis"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cagenix", "Amount": "49480", "FundingRoundCode": "NA", "Date": "2012-09-01", "Investor": "Innova Memphis"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calando Pharmaceuticals", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2011-01-18", "Investor": "Arrowhead Research"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Icagen, Inc.", "Amount": "8855000", "FundingRoundCode": "NA", "Date": "2015-01-08", "Investor": "Taglich Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Icagen, Inc.", "Amount": "3170000", "FundingRoundCode": "NA", "Date": "2013-09-11", "Investor": "Taglich Brothers"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Caliber Infosolutions", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-02-17", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2008-08-01", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2008-08-01", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2008-08-01", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2008-08-01", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calibra Medical", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2008-08-01", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "5200000", "FundingRoundCode": "A", "Date": "2008-01-03", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-05-05", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2010-06-30", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2007-03-05", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-05-05", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2010-06-30", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2007-03-05", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "5200000", "FundingRoundCode": "A", "Date": "2008-01-03", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-05-05", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2010-06-30", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2007-03-05", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "5200000", "FundingRoundCode": "A", "Date": "2008-01-03", "Investor": "Frazier Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2010-06-30", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "5200000", "FundingRoundCode": "A", "Date": "2008-01-03", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-05-05", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2010-06-30", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Calistoga Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2007-03-05", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2013-10-29", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2010-07-08", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2013-10-29", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "2e+06", "FundingRoundCode": "C", "Date": "2012-12-31", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2010-07-08", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2013-10-29", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "2e+06", "FundingRoundCode": "C", "Date": "2012-12-31", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2010-07-08", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2010-07-08", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2013-10-29", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "2e+06", "FundingRoundCode": "C", "Date": "2012-12-31", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2010-07-08", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Calithera Biosciences", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cambrian Genomics", "Amount": "0", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Alchemist Accelerator"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cambrian Genomics", "Amount": "0", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Felicis Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cambrian Genomics", "Amount": "0", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "StartCaps Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cambrian Genomics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-09-11", "Investor": "TenOneTen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cambrian Genomics", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-11-20", "Investor": "Velos Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cambrian Genomics", "Amount": "0", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Jim Pitkow"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cambridge Epigenetix", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2014-10-29", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Gas|Health and Wellness|Health Care|Medical", "CompanyName": "CAPNIA", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-03", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Gas|Health and Wellness|Health Care|Medical", "CompanyName": "CAPNIA", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-03", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Capricor", "Amount": "3400000", "FundingRoundCode": "NA", "Date": "2009-07-08", "Investor": "Beechwood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Capricor", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2010-12-18", "Investor": "Broadview Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Capsule Tech", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-07-09", "Investor": "Bulger Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Capsule Tech", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-07-09", "Investor": "JMI Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2006-11-28", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2010-07-21", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2006-11-28", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2010-07-21", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "12300000", "FundingRoundCode": "C", "Date": "2008-07-25", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "4700000", "FundingRoundCode": "B", "Date": "2005-12-21", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2010-07-21", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "12300000", "FundingRoundCode": "C", "Date": "2008-07-25", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2010-07-21", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "12300000", "FundingRoundCode": "C", "Date": "2008-07-25", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "12300000", "FundingRoundCode": "C", "Date": "2008-07-25", "Investor": "Mitsubishi Corporation Life Sciences Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cara Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2010-07-21", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Cardeas Pharma", "Amount": "7535988", "FundingRoundCode": "A", "Date": "2012-03-16", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Cardeas Pharma", "Amount": "7535988", "FundingRoundCode": "A", "Date": "2012-03-16", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "15200000", "FundingRoundCode": "NA", "Date": "2015-03-11", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "15200000", "FundingRoundCode": "NA", "Date": "2015-03-11", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "8500000", "FundingRoundCode": "NA", "Date": "2014-10-07", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2004-03-17", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2007-12-30", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2004-03-17", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2007-12-30", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2007-12-30", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2007-12-30", "Investor": "Montgomery & Co"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2004-03-17", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2007-12-30", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2004-03-17", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2007-12-30", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2004-03-17", "Investor": "The Seattle Times"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical Devices", "CompanyName": "Cardiac Dimensions", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2007-12-30", "Investor": "WestRiver Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardiac Insight", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-07-21", "Investor": "Alliance of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiaLen", "Amount": "1520000", "FundingRoundCode": "B", "Date": "2015-03-26", "Investor": "BELLE Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiaLen", "Amount": "1520000", "FundingRoundCode": "B", "Date": "2015-03-26", "Investor": "BioGenerator"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardiaLen", "Amount": "2402000", "FundingRoundCode": "NA", "Date": "2011-12-19", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiaLen", "Amount": "1520000", "FundingRoundCode": "B", "Date": "2015-03-26", "Investor": "Cultivation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiaLen", "Amount": "1520000", "FundingRoundCode": "B", "Date": "2015-03-26", "Investor": "Heartland Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiaLen", "Amount": "1520000", "FundingRoundCode": "B", "Date": "2015-03-26", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "CardiaLen", "Amount": "138000", "FundingRoundCode": "NA", "Date": "2012-09-01", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "CardiAQ Valve Technologies", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2009-05-13", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiAQ Valve Technologies", "Amount": "37300000", "FundingRoundCode": "B", "Date": "2012-11-29", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiAQ Valve Technologies", "Amount": "37300000", "FundingRoundCode": "B", "Date": "2012-11-29", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardio3 BioSciences", "Amount": "33872431", "FundingRoundCode": "NA", "Date": "2014-06-16", "Investor": "Joint Venture"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Acadia Woods Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "Acadia Woods Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Acadia Woods Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Artiman Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "Artiman Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Artiman Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "20983348", "FundingRoundCode": "NA", "Date": "2014-07-24", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5998000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "DAG Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "DAG Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Duff, Ackerman and Goodrich"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "GE Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Intel Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "Intel Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "Intel Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Intel Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "JPMorgan Partners (JPMP)"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "JP Morgan Chase & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2006-07-21", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5998000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Longitude Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "Longitude Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5998000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Longitude Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2006-07-21", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2012-08-27", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "Pappas Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "5998000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Pappas Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2006-07-21", "Investor": "Texas Pacific Group"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "34500000", "FundingRoundCode": "D", "Date": "2010-05-17", "Investor": "TPG Growth"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CardioDx", "Amount": "30509000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "KBL Healthcare Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "KBL Healthcare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "Manatuck Hill Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "Manatuck Hill Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2013-05-01", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2013-05-01", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2011-03-21", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "SV Life Sciences"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "30600000", "FundingRoundCode": "C", "Date": "2011-02-28", "Investor": "The Aurora Funds"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CardioFocus", "Amount": "2378923", "FundingRoundCode": "NA", "Date": "2014-05-09", "Investor": "The Aurora Funds"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Genetic Testing|Medical", "CompanyName": "CardioGen Sciences", "Amount": "526000", "FundingRoundCode": "NA", "Date": "2014-11-06", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardiokine", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2004-04-13", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardiokine", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2004-04-13", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardiokine", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2004-04-13", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioMind", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-07-03", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioMind", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-07-03", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioMind", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-07-03", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioMind", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-07-03", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioMind", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-07-03", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardioMind", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-07-03", "Investor": "SV Life Sciences"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "CardiOx", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2008-11-07", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CardiOx", "Amount": "786257", "FundingRoundCode": "B", "Date": "2009-08-05", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "CardiOx", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2008-11-07", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardioxyl Pharmaceuticals", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2012-11-13", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardioxyl Pharmaceuticals", "Amount": "14500000", "FundingRoundCode": "A", "Date": "2006-12-06", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardioxyl Pharmaceuticals", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2012-11-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardioxyl Pharmaceuticals", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2012-11-13", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardioxyl Pharmaceuticals", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2012-11-13", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cardioxyl Pharmaceuticals", "Amount": "14500000", "FundingRoundCode": "A", "Date": "2006-12-06", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Networking|Software|Therapeutics", "CompanyName": "CarePoint Partners", "Amount": "2.7e+07", "FundingRoundCode": "NA", "Date": "2011-01-19", "Investor": "Amalgamated Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CareX SA", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-03-08", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Caribou Biosciences", "Amount": "11549904", "FundingRoundCode": "A", "Date": "2015-03-25", "Investor": "Marc Bell Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Caribou Biosciences", "Amount": "11549904", "FundingRoundCode": "A", "Date": "2015-03-25", "Investor": "Jenny Rooke"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Health Care Information Technology|Healthcare Services", "CompanyName": "Cariloop", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "Green Park & Golf Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Health Care Information Technology|Healthcare Services", "CompanyName": "Cariloop", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "Health Wildcatters"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2014-06-13", "Investor": "BlueTree Allied Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2011-04-18", "Investor": "BlueTree Allied Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2014-06-13", "Investor": "Harbor Light Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2011-04-18", "Investor": "Harbor Light Capital Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "303818", "FundingRoundCode": "NA", "Date": "2014-11-12", "Investor": "Innovation Works"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-08-14", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2014-06-13", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2011-04-18", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2011-04-18", "Investor": "Newlin Investment Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "130000", "FundingRoundCode": "NA", "Date": "2008-01-31", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2014-06-13", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmell Therapeutics", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2011-04-18", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Carmot Therapeutics", "Amount": "500159", "FundingRoundCode": "NA", "Date": "2012-07-17", "Investor": "The Column Group"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Carolus Therapeutics", "Amount": "2250000", "FundingRoundCode": "NA", "Date": "2013-03-05", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cartilix", "Amount": "6350000", "FundingRoundCode": "B", "Date": "2006-03-01", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cartiva", "Amount": "8500000", "FundingRoundCode": "D", "Date": "2015-05-11", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cartiva", "Amount": "4300000", "FundingRoundCode": "A", "Date": "2013-07-15", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Cartiva", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-01-08", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cartiva", "Amount": "8500000", "FundingRoundCode": "D", "Date": "2015-05-11", "Investor": "Windham Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Castle Biosciences", "Amount": "11800000", "FundingRoundCode": "NA", "Date": "2014-08-13", "Investor": "HealthQuest Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Castle Biosciences", "Amount": "11700000", "FundingRoundCode": "F", "Date": "2015-07-27", "Investor": "HealthQuest Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Castle Biosciences", "Amount": "11700000", "FundingRoundCode": "F", "Date": "2015-07-27", "Investor": "Industry Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Castle Biosciences", "Amount": "11800000", "FundingRoundCode": "NA", "Date": "2014-08-13", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Castle Biosciences", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2015-04-14", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Medical Devices", "CompanyName": "Castlewood Surgical", "Amount": "NA", "FundingRoundCode": "C", "Date": "2011-11-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Medical Devices", "CompanyName": "Castlewood Surgical", "Amount": "NA", "FundingRoundCode": "B", "Date": "2010-12-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2013-02-06", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "32400000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2010-04-21", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2011-12-13", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2013-02-06", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "32400000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2010-04-21", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2011-12-13", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "32400000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "Lightstone Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2013-02-06", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "32400000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2010-04-21", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2011-12-13", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2013-02-06", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "32400000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2010-04-21", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catabasis Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2011-12-13", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-02-09", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "13407658", "FundingRoundCode": "NA", "Date": "2012-09-25", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2008-12-03", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "5072000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "13407658", "FundingRoundCode": "NA", "Date": "2012-09-25", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2008-12-03", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "5072000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-02-09", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2008-12-03", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "5072000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "13407658", "FundingRoundCode": "NA", "Date": "2012-09-25", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2008-12-03", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "5072000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-02-09", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "13407658", "FundingRoundCode": "NA", "Date": "2012-09-25", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2008-12-03", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "5072000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-02-09", "Investor": "RCT BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-02-09", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "13407658", "FundingRoundCode": "NA", "Date": "2012-09-25", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catalyst Biosciences", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2008-12-03", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Catheter Connections", "Amount": "5286046", "FundingRoundCode": "NA", "Date": "2011-08-08", "Investor": "University Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Nanotechnology", "CompanyName": "Cavis microcaps", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2005-02-03", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "cCAM Biotherapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2012-09-15", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "CCBR-SYNARC", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-04-09", "Investor": "Water Street Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CD Diagnostics", "Amount": "275000", "FundingRoundCode": "NA", "Date": "2012-01-16", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CDI Bioscience", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2007-12-10", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CDI Bioscience", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2007-12-10", "Investor": "Innovation Valley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cebix", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cebix", "Amount": "30900000", "FundingRoundCode": "C", "Date": "2012-10-18", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cebix", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cebix", "Amount": "30900000", "FundingRoundCode": "C", "Date": "2012-10-18", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cebix", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cebix", "Amount": "30900000", "FundingRoundCode": "C", "Date": "2012-10-18", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cedarburg Hauser Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2004-03-04", "Investor": "Signet Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CEL-SCI", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2009-08-20", "Investor": "Alpha Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CEL-SCI", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2009-08-20", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CEL-SCI", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2009-08-20", "Investor": "Midsummer Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CEL-SCI", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2009-08-20", "Investor": "Paramount BioCapital Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CEL-SCI", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2009-08-20", "Investor": "Ramius Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CEL-SCI", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2009-08-20", "Investor": "Rockmore Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2010-09-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "C", "Date": "2008-07-29", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-08-03", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2010-09-01", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "C", "Date": "2008-07-29", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-08-03", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "39300000", "FundingRoundCode": "NA", "Date": "2013-04-30", "Investor": "ROTH Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2010-09-01", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2010-09-01", "Investor": "TL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "C", "Date": "2008-07-29", "Investor": "TL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-08-03", "Investor": "TL Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Celator Pharmaceuticals", "Amount": "39300000", "FundingRoundCode": "NA", "Date": "2013-04-30", "Investor": "Valence Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celcuity", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2014-03-24", "Investor": "Brightstone Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2e+07", "FundingRoundCode": "F", "Date": "2010-10-14", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-01-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-04-10", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2e+07", "FundingRoundCode": "F", "Date": "2010-10-14", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2e+07", "FundingRoundCode": "F", "Date": "2010-10-14", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-01-01", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-04-10", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-01-01", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-04-10", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-01-01", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2e+07", "FundingRoundCode": "F", "Date": "2010-10-14", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2006-01-01", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellBiosciences", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-04-10", "Investor": "The Vertical Group"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cell Therapeutics", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2013-12-18", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2005-12-07", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2005-12-07", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "21800000", "FundingRoundCode": "C", "Date": "2009-11-01", "Investor": "Enterprise Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "39500000", "FundingRoundCode": "NA", "Date": "2015-11-18", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "21800000", "FundingRoundCode": "C", "Date": "2009-11-01", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "4.3e+07", "FundingRoundCode": "NA", "Date": "2012-02-15", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2005-12-07", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-05-08", "Investor": "MPM Capital"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "39500000", "FundingRoundCode": "NA", "Date": "2015-11-18", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "4.3e+07", "FundingRoundCode": "NA", "Date": "2012-02-15", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "39500000", "FundingRoundCode": "NA", "Date": "2015-11-18", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2005-12-07", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "21800000", "FundingRoundCode": "C", "Date": "2009-11-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "4.3e+07", "FundingRoundCode": "NA", "Date": "2012-02-15", "Investor": "Venrock"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Celladon", "Amount": "39500000", "FundingRoundCode": "NA", "Date": "2015-11-18", "Investor": "Vivo Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Cellectar", "Amount": "1.3e+07", "FundingRoundCode": "NA", "Date": "2008-01-08", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Cellectar", "Amount": "1.3e+07", "FundingRoundCode": "NA", "Date": "2008-01-08", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellerant Therapeutics", "Amount": "2094341", "FundingRoundCode": "NA", "Date": "2012-09-28", "Investor": "Allen & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellerant Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2005-05-11", "Investor": "Allen & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellerant Therapeutics", "Amount": "4400000", "FundingRoundCode": "B", "Date": "2007-04-26", "Investor": "Camelot Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellerant Therapeutics", "Amount": "4400000", "FundingRoundCode": "B", "Date": "2007-04-26", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellerant Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2005-05-11", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "CellScape", "Amount": "1100000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "CellScape", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2012-02-01", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "CellScape", "Amount": "1100000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "CellScape", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2010-12-01", "Investor": "XSeed Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "CellScape", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-05-01", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "CellScape", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2012-02-01", "Investor": "Zygote Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "CellScape", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2010-12-01", "Investor": "Zygote Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellular Dynamics International", "Amount": "40600000", "FundingRoundCode": "B", "Date": "2010-04-27", "Investor": "Equity Group Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellular Dynamics International", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2011-04-07", "Investor": "Tactics II Stem Cell Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellular Dynamics International", "Amount": "40600000", "FundingRoundCode": "B", "Date": "2010-04-27", "Investor": "Tactics II Stem Cell Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellumen", "Amount": "8700000", "FundingRoundCode": "B", "Date": "2007-07-10", "Investor": "Novitas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cellumen", "Amount": "8700000", "FundingRoundCode": "B", "Date": "2007-07-10", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "CELLutions Biosystems", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-06-27", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "CELLutions Biosystems", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-06-27", "Investor": "The Carlyle Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "CELLutions Biosystems", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-06-27", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "CELLutions Biosystems", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-06-27", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellzDirect", "Amount": "3400000", "FundingRoundCode": "NA", "Date": "2002-09-06", "Investor": "Desert Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellzDirect", "Amount": "3400000", "FundingRoundCode": "NA", "Date": "2002-09-06", "Investor": "Solstice Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellzDirect", "Amount": "3400000", "FundingRoundCode": "NA", "Date": "2002-09-06", "Investor": "Tuscon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CellzDirect", "Amount": "3400000", "FundingRoundCode": "NA", "Date": "2002-09-06", "Investor": "Village Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celmatix", "Amount": "13500000", "FundingRoundCode": "A", "Date": "2013-02-21", "Investor": "Topspin Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celon Laboratories", "Amount": "15800000", "FundingRoundCode": "NA", "Date": "2010-10-08", "Investor": "Sequoia Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "CeloNova", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2003-03-01", "Investor": "Clayton Associates"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "CeloNova", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2003-03-01", "Investor": "FCA Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celsense", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2007-05-24", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Akari Therapeutics", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "Deerfield"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Akari Therapeutics", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "Foresite Capital"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Akari Therapeutics", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Akari Therapeutics", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "QVT Financial"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Akari Therapeutics", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "RA Capital Management"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Akari Therapeutics", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "Venrock"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Akari Therapeutics", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "Vivo Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Celtaxsys", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2015-06-08", "Investor": "Masters Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Celtic Therapeutics Holdings", "Amount": "1e+08", "FundingRoundCode": "NA", "Date": "2009-10-27", "Investor": "PPD"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cempra", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2009-06-02", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cempra", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2009-06-02", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cempra", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2009-06-02", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Cempra", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2009-06-02", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CeNeRx BioPharma", "Amount": "4600000", "FundingRoundCode": "D", "Date": "2012-02-03", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CeNeRx BioPharma", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2010-08-13", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CeNeRx BioPharma", "Amount": "4600000", "FundingRoundCode": "D", "Date": "2012-02-03", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CeNeRx BioPharma", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2010-08-13", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CeNeRx BioPharma", "Amount": "4600000", "FundingRoundCode": "D", "Date": "2012-02-03", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CeNeRx BioPharma", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2010-08-13", "Investor": "Perseus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centice", "Amount": "6100000", "FundingRoundCode": "C", "Date": "2010-01-17", "Investor": "Fulcrum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centice", "Amount": "11300000", "FundingRoundCode": "B", "Date": "2007-11-19", "Investor": "Innovation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centice", "Amount": "6100000", "FundingRoundCode": "C", "Date": "2010-01-17", "Investor": "Innovation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centice", "Amount": "11300000", "FundingRoundCode": "B", "Date": "2007-11-19", "Investor": "Novak Biddle Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centice", "Amount": "6100000", "FundingRoundCode": "C", "Date": "2010-01-17", "Investor": "Novak Biddle Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centice", "Amount": "11300000", "FundingRoundCode": "B", "Date": "2007-11-19", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centice", "Amount": "6100000", "FundingRoundCode": "C", "Date": "2010-01-17", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Centre for Sight", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2013-07-03", "Investor": "Matrix Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2012-06-05", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2012-06-05", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2012-06-05", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2012-06-05", "Investor": "Osage Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-02-21", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2012-06-05", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-02-21", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceptaris Therapeutics", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2012-06-05", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ception Therapeutics", "Amount": "6.3e+07", "FundingRoundCode": "C", "Date": "2007-01-29", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ception Therapeutics", "Amount": "6.3e+07", "FundingRoundCode": "C", "Date": "2007-01-29", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ception Therapeutics", "Amount": "14700000", "FundingRoundCode": "C", "Date": "2007-05-31", "Investor": "Greenlight Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ception Therapeutics", "Amount": "6.3e+07", "FundingRoundCode": "C", "Date": "2007-01-29", "Investor": "Growth Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ception Therapeutics", "Amount": "6.3e+07", "FundingRoundCode": "C", "Date": "2007-01-29", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ception Therapeutics", "Amount": "14700000", "FundingRoundCode": "C", "Date": "2007-05-31", "Investor": "Third Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cequent Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-06-18", "Investor": "Ampersand Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cequent Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-06-18", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cequent Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2007-06-18", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerecor", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2014-07-21", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerecor", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2014-07-21", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerecor", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2014-07-21", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2007-06-22", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2007-06-22", "Investor": "California Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "California Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2007-06-22", "Investor": "Cell Genesys"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2007-06-22", "Investor": "Hamilton BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2007-06-22", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceregene", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "54061920.8033524", "FundingRoundCode": "B", "Date": "2006-11-13", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "51724000", "FundingRoundCode": "C", "Date": "2010-07-26", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "54061920.8033524", "FundingRoundCode": "B", "Date": "2006-11-13", "Investor": "EDF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "51724000", "FundingRoundCode": "C", "Date": "2010-07-26", "Investor": "EDF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "54061920.8033524", "FundingRoundCode": "B", "Date": "2006-11-13", "Investor": "NIF SMBC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "54061920.8033524", "FundingRoundCode": "B", "Date": "2006-11-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "51724000", "FundingRoundCode": "C", "Date": "2010-07-26", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerenis Therapeutics", "Amount": "51724000", "FundingRoundCode": "C", "Date": "2010-07-26", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Ceres Nanosciences", "Amount": "746000", "FundingRoundCode": "NA", "Date": "2015-06-29", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cerevast Therapeutics", "Amount": "6564658", "FundingRoundCode": "C", "Date": "2011-12-12", "Investor": "UT Horizon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cernostics", "Amount": "1962678", "FundingRoundCode": "NA", "Date": "2015-06-08", "Investor": "Ben Franklin Technology Partners of Northeast Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cernostics", "Amount": "55000", "FundingRoundCode": "NA", "Date": "2012-03-08", "Investor": "Ben Franklin Technology Partners of Northeast Pennsylvania"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Cernostics", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2012-08-09", "Investor": "Ben Franklin Technology Partners of Northeast Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cernostics", "Amount": "1400000", "FundingRoundCode": "B", "Date": "2013-12-03", "Investor": "Geisinger Health System"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cernostics", "Amount": "1400000", "FundingRoundCode": "B", "Date": "2013-12-03", "Investor": "Novitas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cernostics", "Amount": "1400000", "FundingRoundCode": "B", "Date": "2013-12-03", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cervilenz", "Amount": "8350000", "FundingRoundCode": "A", "Date": "2012-02-02", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cervilenz", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2009-05-06", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cervilenz", "Amount": "350000", "FundingRoundCode": "NA", "Date": "2008-08-22", "Investor": "JumpStart Inc."}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cervilenz", "Amount": "350000", "FundingRoundCode": "NA", "Date": "2008-08-22", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceterix Orthopaedics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2014-05-13", "Investor": "5AM Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Ceterix Orthopaedics", "Amount": "3.5e+07", "FundingRoundCode": "NA", "Date": "2015-05-07", "Investor": "CRG"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ceterix Orthopaedics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2014-05-13", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CGI Pharmaceuticals", "Amount": "22300000", "FundingRoundCode": "C", "Date": "2004-01-21", "Investor": "Coastview Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CGI Pharmaceuticals", "Amount": "22300000", "FundingRoundCode": "C", "Date": "2004-01-21", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CGI Pharmaceuticals", "Amount": "22300000", "FundingRoundCode": "C", "Date": "2004-01-21", "Investor": "Emerging Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CGI Pharmaceuticals", "Amount": "22300000", "FundingRoundCode": "C", "Date": "2004-01-21", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CGI Pharmaceuticals", "Amount": "22300000", "FundingRoundCode": "C", "Date": "2004-01-21", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CGI Pharmaceuticals", "Amount": "22300000", "FundingRoundCode": "C", "Date": "2004-01-21", "Investor": "MPM Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Chai", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-05-01", "Investor": "Marc Bell Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "9787000", "FundingRoundCode": "B", "Date": "2013-05-02", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-08-31", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "9787000", "FundingRoundCode": "B", "Date": "2013-05-02", "Investor": "Boston Scientific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-08-31", "Investor": "Boston Scientific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "9787000", "FundingRoundCode": "B", "Date": "2013-05-02", "Investor": "InCube Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-08-31", "Investor": "InCube Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-08-31", "Investor": "Longwood Founders Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-08-31", "Investor": "Scientific Health Development Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Channel Medsystems", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2015-08-31", "Investor": "Third Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chaperone Technologies", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2006-03-06", "Investor": "Life Sciences Greenhouse of Pennsylvania"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Charles River Laboratories International", "Amount": "3.4e+07", "FundingRoundCode": "NA", "Date": "2011-09-29", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ChartWise Medical Systems", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2012-09-20", "Investor": "Clayton Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ChartWise Medical Systems", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2012-09-20", "Investor": "FCA Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Checkmate Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2015-08-12", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Checkmate Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2015-08-12", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "Cheetah Medical", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2010-04-06", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "Cheetah Medical", "Amount": "28849535", "FundingRoundCode": "C", "Date": "2014-02-24", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "Cheetah Medical", "Amount": "28849535", "FundingRoundCode": "C", "Date": "2014-02-24", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chelsea Therapeutics International", "Amount": "14500000", "FundingRoundCode": "A", "Date": "2005-01-12", "Investor": "Paramount BioCapital Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chelsea Therapeutics International", "Amount": "16820000", "FundingRoundCode": "NA", "Date": "2010-02-26", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chemclin", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-05-07", "Investor": "WI Harper Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chemclin", "Amount": "16500000", "FundingRoundCode": "B", "Date": "2008-10-01", "Investor": "WI Harper Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "17700000", "FundingRoundCode": "C", "Date": "2006-08-24", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "29840000", "FundingRoundCode": "D", "Date": "2007-03-22", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2004-06-17", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "17700000", "FundingRoundCode": "C", "Date": "2006-08-24", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "17700000", "FundingRoundCode": "C", "Date": "2006-08-24", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "29840000", "FundingRoundCode": "D", "Date": "2007-03-22", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2004-06-17", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChemoCentryx", "Amount": "17700000", "FundingRoundCode": "C", "Date": "2006-08-24", "Investor": "Bio-Techne"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "7e+07", "FundingRoundCode": "E", "Date": "2015-02-27", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "38500000", "FundingRoundCode": "D", "Date": "2012-07-23", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2006-11-15", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "7e+07", "FundingRoundCode": "E", "Date": "2015-02-27", "Investor": "Blue Chip Venture Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "7e+07", "FundingRoundCode": "E", "Date": "2015-02-27", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "38500000", "FundingRoundCode": "D", "Date": "2012-07-23", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2006-11-15", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "7e+07", "FundingRoundCode": "E", "Date": "2015-02-27", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chiasma", "Amount": "7e+07", "FundingRoundCode": "E", "Date": "2015-02-27", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "23100000", "FundingRoundCode": "D", "Date": "2007-02-23", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "4.5e+07", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "16100000", "FundingRoundCode": "E", "Date": "2009-08-10", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "23100000", "FundingRoundCode": "D", "Date": "2007-02-23", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "4.5e+07", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "16100000", "FundingRoundCode": "E", "Date": "2009-08-10", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "1.1e+07", "FundingRoundCode": "C", "Date": "2004-11-04", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "23100000", "FundingRoundCode": "D", "Date": "2007-02-23", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "4.5e+07", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "16100000", "FundingRoundCode": "E", "Date": "2009-08-10", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "23100000", "FundingRoundCode": "D", "Date": "2007-02-23", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "4.5e+07", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "1.1e+07", "FundingRoundCode": "C", "Date": "2004-11-04", "Investor": "Frazier Technology Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "36100000", "FundingRoundCode": "NA", "Date": "2003-09-09", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "4.5e+07", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "4.5e+07", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "3100000", "FundingRoundCode": "NA", "Date": "2003-09-08", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "23100000", "FundingRoundCode": "D", "Date": "2007-02-23", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "4.5e+07", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "16100000", "FundingRoundCode": "E", "Date": "2009-08-10", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Chimerix", "Amount": "1.1e+07", "FundingRoundCode": "C", "Date": "2004-11-04", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2005-08-12", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2007-09-12", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2007-09-12", "Investor": "Finistere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2005-08-12", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2007-09-12", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2005-08-12", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2007-09-12", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2005-08-12", "Investor": "Redmont Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chlorogen", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2007-09-12", "Investor": "Redmont Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chroma Therapeutics", "Amount": "24500000", "FundingRoundCode": "NA", "Date": "2009-06-23", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chroma Therapeutics", "Amount": "5.3e+07", "FundingRoundCode": "C", "Date": "2006-04-03", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chroma Therapeutics", "Amount": "24500000", "FundingRoundCode": "NA", "Date": "2009-06-23", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chroma Therapeutics", "Amount": "24500000", "FundingRoundCode": "NA", "Date": "2009-06-23", "Investor": "Nomura Securities"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology", "CompanyName": "ChromaDex", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-09-30", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chromatin", "Amount": "1600000", "FundingRoundCode": "NA", "Date": "2006-04-01", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chromatin", "Amount": "3.6e+07", "FundingRoundCode": "E", "Date": "2014-01-09", "Investor": "Illinois Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chromatin", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2011-10-25", "Investor": "Illinois Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chromatin", "Amount": "1.2e+07", "FundingRoundCode": "F", "Date": "2015-01-13", "Investor": "Illinois Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chromatin", "Amount": "1600000", "FundingRoundCode": "NA", "Date": "2006-04-01", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chromatin", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2011-10-25", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chromatin", "Amount": "1600000", "FundingRoundCode": "NA", "Date": "2006-04-01", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chronix Biomedical", "Amount": "1415000", "FundingRoundCode": "NA", "Date": "2012-10-31", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chronix Biomedical", "Amount": "2270000", "FundingRoundCode": "NA", "Date": "2008-08-05", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chrono Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-12", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chrono Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-12", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chrono Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-12", "Investor": "GE Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chrono Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-12", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chrono Therapeutics", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2015-03-04", "Investor": "MedCity News"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Chrono Therapeutics", "Amount": "2300000", "FundingRoundCode": "NA", "Date": "2015-08-26", "Investor": "National Cancer Institute (NCI)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Chrono Therapeutics", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2015-03-04", "Investor": "Rock Health"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ChronoWake", "Amount": "10000", "FundingRoundCode": "NA", "Date": "2009-03-27", "Investor": "Wharton Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "B", "Date": "2015-02-11", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-30", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "B", "Date": "2015-02-11", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-30", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "B", "Date": "2015-02-11", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-30", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2014-06-30", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "B", "Date": "2015-02-11", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "B", "Date": "2015-02-11", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "B", "Date": "2015-02-11", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Cidara Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "B", "Date": "2015-02-11", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ciel Medical", "Amount": "732558", "FundingRoundCode": "NA", "Date": "2014-02-25", "Investor": "Astia Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Circassia", "Amount": "21829006.1187366", "FundingRoundCode": "B", "Date": "2008-01-29", "Investor": "Goldman Sachs"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Clinical Trials|Therapeutics", "CompanyName": "Circle Pharma", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-09-22", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Clinical Trials|Therapeutics", "CompanyName": "Circle Pharma", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-09-22", "Investor": "Pfizer"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cirtemo", "Amount": "NA", "FundingRoundCode": "A", "Date": "2012-12-07", "Investor": "Upstate Carolina Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Alkermes"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Alkermes"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2011-01-10", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2011-01-10", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2013-09-11", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Civitas Therapeutics", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-08-25", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clarient", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2009-05-19", "Investor": "Oak Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Claritas Genomics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2013-12-05", "Investor": "Cerner Capital at Cerner Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Claritas Genomics", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2015-01-26", "Investor": "Cerner Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Claritas Genomics", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2015-01-26", "Investor": "Cincinnati Children\u2019s Hospital Medical Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clarus Therapeutics", "Amount": "8e+06", "FundingRoundCode": "C", "Date": "2007-11-27", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clarus Therapeutics", "Amount": "8e+06", "FundingRoundCode": "C", "Date": "2007-11-27", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Clearbridge Biomedics", "Amount": "7200000", "FundingRoundCode": "B", "Date": "2013-03-13", "Investor": "Vertex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clearside Biomedical", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2014-09-02", "Investor": "Georgia Research Alliance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clearside Biomedical", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2012-01-05", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clearside Biomedical", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2014-09-02", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clearside Biomedical", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2014-09-02", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clearside Biomedical", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-12-03", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clearside Biomedical", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-12-03", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleave Biosciences", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleave Biosciences", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleave Biosciences", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleave Biosciences", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2013-04-09", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleave Biosciences", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleave Biosciences", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleave Biosciences", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2011-10-11", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-06-24", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-06-24", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-06-24", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "A", "Date": "2014-01-09", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2015-01-05", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-06-24", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-06-24", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clementia Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-06-24", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Lasers|Medical", "CompanyName": "Clerio Vision, Inc.", "Amount": "3725000", "FundingRoundCode": "A", "Date": "2015-01-13", "Investor": "Stonehenge Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Lasers|Medical", "CompanyName": "Clerio Vision, Inc.", "Amount": "3725000", "FundingRoundCode": "A", "Date": "2015-01-13", "Investor": "Alex Zapesochny"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleveland HeartLab", "Amount": "18400000", "FundingRoundCode": "B", "Date": "2011-08-22", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleveland HeartLab", "Amount": "18400000", "FundingRoundCode": "B", "Date": "2011-08-22", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cleveland HeartLab", "Amount": "14700000", "FundingRoundCode": "B", "Date": "2012-10-31", "Investor": "Mutual Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "2600000", "FundingRoundCode": "B", "Date": "2008-01-14", "Investor": "Emergent Growth Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-01-15", "Investor": "Harbert Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2011-09-27", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "2600000", "FundingRoundCode": "B", "Date": "2008-01-14", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-01-15", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2011-09-27", "Investor": "Morgan Stanley"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2011-09-27", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "9e+06", "FundingRoundCode": "C", "Date": "2012-10-26", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-01-15", "Investor": "Perella Weinberg Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Medical Devices", "CompanyName": "Clinipace WorldWide", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-01-15", "Investor": "Virgo Investment Group"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Clontech Laboratories Inc", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2001-05-10", "Investor": "Summit Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Clovis Oncology", "Amount": "1.45e+08", "FundingRoundCode": "NA", "Date": "2009-05-26", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Clovis Oncology", "Amount": "1.45e+08", "FundingRoundCode": "NA", "Date": "2009-05-26", "Investor": "Domain Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Clovis Oncology", "Amount": "1.45e+08", "FundingRoundCode": "NA", "Date": "2009-05-26", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Clovis Oncology", "Amount": "1.45e+08", "FundingRoundCode": "NA", "Date": "2009-05-26", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Clovis Oncology", "Amount": "1.45e+08", "FundingRoundCode": "NA", "Date": "2009-05-26", "Investor": "ProQuest Investments"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Clovis Oncology", "Amount": "1.45e+08", "FundingRoundCode": "NA", "Date": "2009-05-26", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Clyde Biosciences", "Amount": "2929258", "FundingRoundCode": "A", "Date": "2015-04-13", "Investor": "Epidarex Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "3720000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "12200000", "FundingRoundCode": "C", "Date": "2003-02-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "22600000", "FundingRoundCode": "E", "Date": "2007-03-29", "Investor": "Alta Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "3720000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "22600000", "FundingRoundCode": "E", "Date": "2007-03-29", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "3720000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "22600000", "FundingRoundCode": "E", "Date": "2007-03-29", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "3720000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "12200000", "FundingRoundCode": "C", "Date": "2003-02-07", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "22600000", "FundingRoundCode": "E", "Date": "2007-03-29", "Investor": "Canaan Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "3720000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "22600000", "FundingRoundCode": "E", "Date": "2007-03-29", "Investor": "Easton Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "3720000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "12200000", "FundingRoundCode": "C", "Date": "2003-02-07", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "22600000", "FundingRoundCode": "E", "Date": "2007-03-29", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "12200000", "FundingRoundCode": "C", "Date": "2003-02-07", "Investor": "Pacific Asset Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "3720000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Saints Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coapt Systems", "Amount": "12200000", "FundingRoundCode": "C", "Date": "2003-02-07", "Investor": "Trellis Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "4977000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2916000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2916000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2011-05-02", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2008-10-20", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2011-05-02", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "4977000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2916000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2008-10-20", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2011-05-02", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2916000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2008-10-20", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "3e+06", "FundingRoundCode": "B", "Date": "2006-11-27", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology", "CompanyName": "Cobalt Technologies", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2008-10-20", "Investor": "@Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoDa Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2012-07-24", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoDa Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2006-10-10", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoDa Therapeutics", "Amount": "19200000", "FundingRoundCode": "B", "Date": "2011-04-18", "Investor": "Domain Associates"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CoDa Therapeutics", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2011-10-06", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codagenix, Inc.", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2015-06-12", "Investor": "Topspin Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codexis", "Amount": "3.7e+07", "FundingRoundCode": "D", "Date": "2006-08-14", "Investor": "Chevron Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codexis", "Amount": "3.7e+07", "FundingRoundCode": "D", "Date": "2006-08-14", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codexis", "Amount": "3.7e+07", "FundingRoundCode": "D", "Date": "2006-08-14", "Investor": "Maxygen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codexis", "Amount": "3.7e+07", "FundingRoundCode": "D", "Date": "2006-08-14", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2006-12-18", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2005-05-30", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2006-12-18", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2005-05-30", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2006-12-18", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2006-12-18", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2006-12-18", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Codon Devices", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2005-05-30", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Clinical Trials|Genetic Testing|Life Sciences", "CompanyName": "Cofactor Genomics", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2015-07-31", "Investor": "Y Combinator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coferon", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coferon", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coferon", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cogentus Pharmaceuticals", "Amount": "62500000", "FundingRoundCode": "C", "Date": "2007-12-21", "Investor": "Apothecary Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cogentus Pharmaceuticals", "Amount": "62500000", "FundingRoundCode": "C", "Date": "2007-12-21", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cogentus Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-04-03", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cogentus Pharmaceuticals", "Amount": "62500000", "FundingRoundCode": "C", "Date": "2007-12-21", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cogentus Pharmaceuticals", "Amount": "62500000", "FundingRoundCode": "C", "Date": "2007-12-21", "Investor": "The Keffi Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "Ariel Southeast Angel Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "15834018", "FundingRoundCode": "B", "Date": "2015-07-22", "Investor": "BlueTree Allied Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "Dolby Family Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "15834018", "FundingRoundCode": "B", "Date": "2015-07-22", "Investor": "Dolby Family Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "Golden Seeds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2011-01-20", "Investor": "Golden Seeds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2011-01-20", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1210000", "FundingRoundCode": "A", "Date": "2009-07-15", "Investor": "Innovation Works"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-10-20", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2011-12-01", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "Ogden Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2011-01-20", "Investor": "Ogden Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1210000", "FundingRoundCode": "A", "Date": "2009-07-15", "Investor": "Ogden Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2011-01-20", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1210000", "FundingRoundCode": "A", "Date": "2009-07-15", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2007-11-27", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "138000", "FundingRoundCode": "NA", "Date": "2013-10-11", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "PLSG Accelerator Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "138000", "FundingRoundCode": "NA", "Date": "2013-10-11", "Investor": "PLSG Accelerator Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognition Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognoptix, Inc.", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2014-09-30", "Investor": "Alopexx Enterprises"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cognoptix, Inc.", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2014-09-30", "Investor": "LaunchPad Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "46271280", "FundingRoundCode": "NA", "Date": "2013-01-14", "Investor": "Helix Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "KKR (Kohlberg Kravis Roberts & Co.)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Coherus Biosciences", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2014-05-19", "Investor": "Vivo Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Logistics", "CompanyName": "Cold Crate", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-08-25", "Investor": "Jumpstart Foundry"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cold Genesys", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2015-08-05", "Investor": "WI Harper Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Health Care", "CompanyName": "Coley Pharmaceutical Group", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2005-03-16", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Health Care", "CompanyName": "Coley Pharmaceutical Group", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2003-08-29", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Health Care", "CompanyName": "Coley Pharmaceutical Group", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2003-08-29", "Investor": "Techno Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Health Care", "CompanyName": "Coley Pharmaceutical Group", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2003-08-29", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2008-07-15", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5500000", "FundingRoundCode": "C", "Date": "2006-11-03", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2008-07-15", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "22500000", "FundingRoundCode": "NA", "Date": "2012-02-15", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "22500000", "FundingRoundCode": "NA", "Date": "2012-02-15", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-03-10", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2008-07-15", "Investor": "Westfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Collegium Pharmaceutical", "Amount": "5500000", "FundingRoundCode": "C", "Date": "2006-11-03", "Investor": "Westfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "AME Cloud Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Formation 8"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Aaron Levie"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Drew Houston"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Julia Hartz"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Laurene Jobs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Max Levchin"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Raymond Tonsing"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing", "CompanyName": "Color Genomics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-04-21", "Investor": "Ruchi Sanghvi"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "37100000", "FundingRoundCode": "C", "Date": "2015-01-13", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-07-01", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-08-30", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "37100000", "FundingRoundCode": "C", "Date": "2015-01-13", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-07-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-08-30", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "37100000", "FundingRoundCode": "C", "Date": "2015-01-13", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-07-01", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-08-30", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "37100000", "FundingRoundCode": "C", "Date": "2015-01-13", "Investor": "Pearl Street Venture Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-07-01", "Investor": "Pearl Street Venture Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-08-30", "Investor": "Pearl Street Venture Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "37100000", "FundingRoundCode": "C", "Date": "2015-01-13", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-07-01", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoLucid Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-08-30", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CombiMatrix", "Amount": "3.6e+07", "FundingRoundCode": "NA", "Date": "2000-08-04", "Investor": "Acacia Research"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "CombiMatrix", "Amount": "6700000", "FundingRoundCode": "NA", "Date": "2011-04-07", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Combinent Biomedical Systems", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2007-05-08", "Investor": "Commons Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Combinent Biomedical Systems", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2009-12-17", "Investor": "Commons Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Combinent Biomedical Systems", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2007-05-08", "Investor": "Cytyc"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Combinent Biomedical Systems", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2009-12-17", "Investor": "Cytyc"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Combinent Biomedical Systems", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2007-05-08", "Investor": "Vimac Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Combinent Biomedical Systems", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2009-12-17", "Investor": "Vimac Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoMentis", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-09-28", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoMentis", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-09-28", "Investor": "Charter Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoMentis", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-09-28", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CoMentis", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-09-28", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Companion Pharma", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2012-05-01", "Investor": "Arch Grants"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Companion Pharma", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Compass Therapeutics", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2015-06-15", "Investor": "Launch Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Compendia Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-11-19", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "3.9e+07", "FundingRoundCode": "E", "Date": "2010-08-19", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2006-03-28", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "3.9e+07", "FundingRoundCode": "E", "Date": "2010-08-19", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "3.9e+07", "FundingRoundCode": "E", "Date": "2010-08-19", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "3.9e+07", "FundingRoundCode": "E", "Date": "2010-08-19", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "3.9e+07", "FundingRoundCode": "E", "Date": "2010-08-19", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2006-03-28", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "3.9e+07", "FundingRoundCode": "E", "Date": "2010-08-19", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2009-08-24", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences", "CompanyName": "Complete Genomics", "Amount": "3.9e+07", "FundingRoundCode": "E", "Date": "2010-08-19", "Investor": "Sands Capital Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Complexa", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-12-20", "Investor": "Innovation Works"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Complexa", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-05-23", "Investor": "Innovation Works"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Complexa", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2013-10-11", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Complexa", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2013-10-11", "Investor": "PLSG Accelerator Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Enterprise Software|Health Care Information Technology", "CompanyName": "Quire", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "Innova Memphis"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Enterprise Software|Health Care Information Technology", "CompanyName": "Quire", "Amount": "1275750", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "Innova Memphis"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Enterprise Software|Health Care Information Technology", "CompanyName": "Quire", "Amount": "1275750", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "Launch Tennessee"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Enterprise Software|Health Care Information Technology", "CompanyName": "Quire", "Amount": "1275750", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Enterprise Software|Health Care Information Technology", "CompanyName": "Quire", "Amount": "1249500", "FundingRoundCode": "NA", "Date": "2013-11-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "COMS Interactive, LLC", "Amount": "4900501", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "Carleton Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "COMS Interactive, LLC", "Amount": "4900501", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "Portal Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "COMS Interactive, LLC", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2013-06-18", "Investor": "Summit Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "COMS Interactive, LLC", "Amount": "4900501", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "Zapis Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Conatus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2011-02-11", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Conatus Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2007-05-09", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Conatus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2011-02-11", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Conatus Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2007-05-09", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Conatus Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-04-12", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "48500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "48500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2011-06-20", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Greylock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-07-17", "Investor": "Greylock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "48500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Greylock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "48500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-07-17", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "48500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-07-17", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "48500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-07-17", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "48500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Concert Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2008-04-30", "Investor": "Westfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confirma", "Amount": "17500000", "FundingRoundCode": "C", "Date": "2008-01-09", "Investor": "Fluke Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confirma", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2003-12-04", "Investor": "Northwest Venture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confirma", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2003-12-04", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confirma", "Amount": "17500000", "FundingRoundCode": "C", "Date": "2008-01-09", "Investor": "Telegraph Hill Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confirma", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2003-12-04", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confirma", "Amount": "17500000", "FundingRoundCode": "C", "Date": "2008-01-09", "Investor": "Versant Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Discovery Technologies", "Amount": "75000", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "2400000", "FundingRoundCode": "B", "Date": "2015-07-28", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2012-09-17", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2014-02-19", "Investor": "Epidarex Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "2400000", "FundingRoundCode": "B", "Date": "2015-07-28", "Investor": "Epidarex Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2012-09-17", "Investor": "Helix Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "2400000", "FundingRoundCode": "B", "Date": "2015-07-28", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "5e+05", "FundingRoundCode": "A", "Date": "2013-10-24", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2012-09-17", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "2400000", "FundingRoundCode": "B", "Date": "2015-07-28", "Investor": "Missouri Technology Corporation"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "75000", "FundingRoundCode": "NA", "Date": "2011-04-01", "Investor": "Missouri Technology Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Confluence Life Sciences", "Amount": "2400000", "FundingRoundCode": "B", "Date": "2015-07-28", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ConjuGon", "Amount": "3300000", "FundingRoundCode": "NA", "Date": "2006-12-13", "Investor": "Rosetta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ConjuGon", "Amount": "3300000", "FundingRoundCode": "NA", "Date": "2006-12-13", "Investor": "Wisconsin Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Consensus Orthopedics", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2014-09-30", "Investor": "Breakwater Investment Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "22250000", "FundingRoundCode": "B", "Date": "2010-06-07", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "17200000", "FundingRoundCode": "A", "Date": "2009-08-13", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-06-06", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "9.5e+07", "FundingRoundCode": "C", "Date": "2012-01-17", "Investor": "Genentech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "22250000", "FundingRoundCode": "B", "Date": "2010-06-07", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-06-06", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "22250000", "FundingRoundCode": "B", "Date": "2010-06-07", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "17200000", "FundingRoundCode": "A", "Date": "2009-08-13", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-06-06", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "22250000", "FundingRoundCode": "B", "Date": "2010-06-07", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "17200000", "FundingRoundCode": "A", "Date": "2009-08-13", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-06-06", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "22250000", "FundingRoundCode": "B", "Date": "2010-06-07", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "17200000", "FundingRoundCode": "A", "Date": "2009-08-13", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Constellation Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-06-06", "Investor": "Venrock"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Continuum Healthcare", "Amount": "13950000", "FundingRoundCode": "NA", "Date": "2015-11-17", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Continuum Healthcare", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2013-07-23", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ContinuumRx", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2012-09-20", "Investor": "Health Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ContinuumRx", "Amount": "13500000", "FundingRoundCode": "NA", "Date": "2015-07-21", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ContinuumRx", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2012-09-20", "Investor": "Redmont Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ContinuumRx", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2012-09-20", "Investor": "Stonehenge Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ContraFect", "Amount": "12502905", "FundingRoundCode": "NA", "Date": "2011-09-15", "Investor": "Maxim Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2014-12-02", "Investor": "BioStar Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2014-12-02", "Investor": "Bluestem Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2014-12-02", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-04-22", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2014-12-02", "Investor": "SightLine Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "11500333", "FundingRoundCode": "NA", "Date": "2013-10-03", "Investor": "SightLine Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "11500333", "FundingRoundCode": "NA", "Date": "2013-10-03", "Investor": "Spray Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Conventus Orthopaedics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-04-22", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Convergence Pharmaceuticals", "Amount": "35400000", "FundingRoundCode": "A", "Date": "2010-10-05", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Convergence Pharmaceuticals", "Amount": "35400000", "FundingRoundCode": "A", "Date": "2010-10-05", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Convergent Dental", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2015-03-31", "Investor": "Long River Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Convergent Dental", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2014-04-16", "Investor": "Long River Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Corcept Therapeutics", "Amount": "10100000", "FundingRoundCode": "NA", "Date": "2007-08-20", "Investor": "Alta Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Corcept Therapeutics", "Amount": "10100000", "FundingRoundCode": "NA", "Date": "2007-08-20", "Investor": "Paperboy Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Corcept Therapeutics", "Amount": "10100000", "FundingRoundCode": "NA", "Date": "2007-08-20", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Core Diagnostics", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2012-07-01", "Investor": "Artiman Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Core Essence Orthopaedics", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2008-07-07", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Core Essence Orthopaedics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2011-03-25", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Core Essence Orthopaedics", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2011-03-25", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CorNova", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2005-04-06", "Investor": "Implant Sciences"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "2300000", "FundingRoundCode": "NA", "Date": "2008-10-23", "Investor": "Acidophil"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "Acidophil"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "Maryland Health Care Product Development"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "2300000", "FundingRoundCode": "NA", "Date": "2008-10-23", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "10750000", "FundingRoundCode": "A", "Date": "2009-10-02", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "10750000", "FundingRoundCode": "A", "Date": "2009-10-02", "Investor": "Osage University Partners"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "2300000", "FundingRoundCode": "NA", "Date": "2008-10-23", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "2300000", "FundingRoundCode": "NA", "Date": "2008-10-23", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "10750000", "FundingRoundCode": "A", "Date": "2009-10-02", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corridor Pharmaceuticals", "Amount": "13012475", "FundingRoundCode": "A", "Date": "2010-06-24", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Strongbridge Biopharma", "Amount": "27500000", "FundingRoundCode": "NA", "Date": "2015-01-13", "Investor": "Broadfin Capital"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Strongbridge Biopharma", "Amount": "27500000", "FundingRoundCode": "NA", "Date": "2015-01-13", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Strongbridge Biopharma", "Amount": "27500000", "FundingRoundCode": "NA", "Date": "2015-01-13", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corthera", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2007-12-20", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corthera", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2007-12-20", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Corthera", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2007-12-20", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Counsyl", "Amount": "3.4e+07", "FundingRoundCode": "B", "Date": "2012-03-01", "Investor": "Felicis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Counsyl", "Amount": "41500000", "FundingRoundCode": "D", "Date": "2014-05-08", "Investor": "Felicis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Counsyl", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2012-08-01", "Investor": "Felicis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Counsyl", "Amount": "41500000", "FundingRoundCode": "D", "Date": "2014-05-08", "Investor": "Goldman Sachs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Counsyl", "Amount": "41500000", "FundingRoundCode": "D", "Date": "2014-05-08", "Investor": "RSTP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Counsyl", "Amount": "3.4e+07", "FundingRoundCode": "B", "Date": "2012-03-01", "Investor": "Raj Sandhu"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Courtagen Life Sciences", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-07-01", "Investor": "Adler & Co."}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Courtagen Life Sciences", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-07-01", "Investor": "Bunker Hill Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Courtagen Life Sciences", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-07-01", "Investor": "First Analysis"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Courtagen Life Sciences", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-07-01", "Investor": "Harbor Light Capital Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Courtagen Life Sciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-01-01", "Investor": "Erik Moore"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Courtagen Life Sciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "Erik Moore"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Covagen", "Amount": "47200000", "FundingRoundCode": "B", "Date": "2013-12-09", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Covagen", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-10-05", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Covagen", "Amount": "6300000", "FundingRoundCode": "A", "Date": "2010-11-29", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Covagen", "Amount": "47200000", "FundingRoundCode": "B", "Date": "2013-12-09", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Covalys Biosciences", "Amount": "NA", "FundingRoundCode": "C", "Date": "2006-03-06", "Investor": "BV Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Covalys Biosciences", "Amount": "NA", "FundingRoundCode": "C", "Date": "2006-03-06", "Investor": "Venture Incubator, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Covenant Surgical Partners", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2013-02-08", "Investor": "DFW Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Covenant Surgical Partners", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2013-02-08", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Creabilis", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2011-10-04", "Investor": "Abbott Biotech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Biologics", "Amount": "26516900", "FundingRoundCode": "A", "Date": "2013-12-17", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Biologics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-12-16", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Biologics", "Amount": "3030502", "FundingRoundCode": "A", "Date": "2014-04-03", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Biologics", "Amount": "7300000", "FundingRoundCode": "A", "Date": "2010-01-20", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2008-06-27", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2011-09-08", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "37600003", "FundingRoundCode": "B", "Date": "2010-07-07", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "2.8e+07", "FundingRoundCode": "D", "Date": "2013-01-03", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2008-06-27", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2011-09-08", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "37600003", "FundingRoundCode": "B", "Date": "2010-07-07", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "2.8e+07", "FundingRoundCode": "D", "Date": "2013-01-03", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "2.8e+07", "FundingRoundCode": "D", "Date": "2013-01-03", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crescendo Bioscience", "Amount": "2.8e+07", "FundingRoundCode": "D", "Date": "2013-01-03", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crinetics Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-11-02", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crinetics Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-11-02", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crinetics Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-11-02", "Investor": "Vivo Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CRISPR THERAPEUTICS", "Amount": "6.4e+07", "FundingRoundCode": "B", "Date": "2015-04-28", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CRISPR THERAPEUTICS", "Amount": "6.4e+07", "FundingRoundCode": "B", "Date": "2015-04-28", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CRISPR THERAPEUTICS", "Amount": "6.4e+07", "FundingRoundCode": "B", "Date": "2015-04-28", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CRISPR THERAPEUTICS", "Amount": "6.4e+07", "FundingRoundCode": "B", "Date": "2015-04-28", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CRISPR THERAPEUTICS", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2014-04-24", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CRISPR THERAPEUTICS", "Amount": "6.4e+07", "FundingRoundCode": "B", "Date": "2015-04-28", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CritiSense", "Amount": "1200000", "FundingRoundCode": "NA", "Date": "2006-06-21", "Investor": "Bridge Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CritiSense", "Amount": "1200000", "FundingRoundCode": "NA", "Date": "2006-06-21", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crown Bioscience", "Amount": "28800000", "FundingRoundCode": "C", "Date": "2011-05-04", "Investor": "Argonaut Private Equity"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Crown Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-01-01", "Investor": "Harbinger Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crown Bioscience", "Amount": "28800000", "FundingRoundCode": "C", "Date": "2011-05-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Crucell", "Amount": "4.43e+08", "FundingRoundCode": "NA", "Date": "2009-09-28", "Investor": "Johnson & Johnson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crux Biomedical", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2009-01-01", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CryoXtract Instruments", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2011-06-15", "Investor": "Allied Minds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Crystalplex", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2007-11-08", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CS-Keys", "Amount": "285000", "FundingRoundCode": "NA", "Date": "2006-06-07", "Investor": "BioCrossroads"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CS-Keys", "Amount": "6250000", "FundingRoundCode": "A", "Date": "2008-01-25", "Investor": "Ceres Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CS-Keys", "Amount": "6250000", "FundingRoundCode": "A", "Date": "2008-01-25", "Investor": "CHV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CS-Keys", "Amount": "6250000", "FundingRoundCode": "A", "Date": "2008-01-25", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CS-Keys", "Amount": "6250000", "FundingRoundCode": "A", "Date": "2008-01-25", "Investor": "Spring Mill Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CS-Keys", "Amount": "6250000", "FundingRoundCode": "A", "Date": "2008-01-25", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CSATS", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2015-05-29", "Investor": "Founders' Co-op"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CSATS", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2015-05-29", "Investor": "Point B Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CSATS", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2015-05-29", "Investor": "The W Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CSATS", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2015-05-29", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cue", "Amount": "7500000", "FundingRoundCode": "A", "Date": "2014-11-18", "Investor": "Sherpa Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CureDM", "Amount": "2500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Calvert Research Institute"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CureDM", "Amount": "2500000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Scientific Health Development Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CureVac", "Amount": "1.1e+08", "FundingRoundCode": "F", "Date": "2015-11-03", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CureVac", "Amount": "5.2e+07", "FundingRoundCode": "E", "Date": "2015-03-05", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CureVac", "Amount": "26675000", "FundingRoundCode": "B", "Date": "2006-01-18", "Investor": "DH Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CureVac", "Amount": "1.1e+08", "FundingRoundCode": "F", "Date": "2015-11-03", "Investor": "Sigma Group"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Custopharm", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-02-03", "Investor": "Water Street Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "8.4e+07", "FundingRoundCode": "E", "Date": "2008-07-30", "Investor": "BB&T"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "1.2e+07", "FundingRoundCode": "F", "Date": "2013-10-30", "Investor": "DaVita"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "8.4e+07", "FundingRoundCode": "E", "Date": "2008-07-30", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "8.4e+07", "FundingRoundCode": "E", "Date": "2008-07-30", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2007-05-10", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "8.4e+07", "FundingRoundCode": "E", "Date": "2008-07-30", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2007-05-10", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "29600000", "FundingRoundCode": "F", "Date": "2013-07-10", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2007-05-10", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "8.4e+07", "FundingRoundCode": "E", "Date": "2008-07-30", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2007-05-10", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "29600000", "FundingRoundCode": "F", "Date": "2013-07-10", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "8.4e+07", "FundingRoundCode": "E", "Date": "2008-07-30", "Investor": "SightLine Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "29600000", "FundingRoundCode": "F", "Date": "2013-07-10", "Investor": "SightLine Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-09-22", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CVRx", "Amount": "29600000", "FundingRoundCode": "F", "Date": "2013-07-10", "Investor": "Sterling Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cyclacel Pharmaceuticals", "Amount": "38769109", "FundingRoundCode": "D", "Date": "2004-01-29", "Investor": "Invesco Private Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cyclacel Pharmaceuticals", "Amount": "38769109", "FundingRoundCode": "D", "Date": "2004-01-29", "Investor": "Quest Capital Management, Inc ."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cydan", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2013-04-11", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cydan", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-10-01", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cydan", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-10-01", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cydan", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2013-04-11", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cydan", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-10-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cydan", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2013-04-11", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2007-01-23", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "26300000", "FundingRoundCode": "B", "Date": "2005-05-26", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2010-09-24", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2007-01-23", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "26300000", "FundingRoundCode": "B", "Date": "2005-05-26", "Investor": "Coastview Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2007-01-23", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2010-09-24", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2007-01-23", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "26300000", "FundingRoundCode": "B", "Date": "2005-05-26", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2007-01-23", "Investor": "Research Corporation Technologies"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2007-01-23", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cylene Pharmaceuticals", "Amount": "26300000", "FundingRoundCode": "B", "Date": "2005-05-26", "Investor": "William Harris Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cylex", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2007-03-07", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cylex", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2007-03-07", "Investor": "Channel Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cylex", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2007-03-07", "Investor": "Chesapeake Partners Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cylex", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2007-03-07", "Investor": "First Analysis"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cylex", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2007-03-07", "Investor": "NJTC Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2004-12-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2004-12-01", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "NA", "Date": "2003-08-29", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2004-12-01", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Charter Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Next Chapter Holdings"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2013-12-11", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2013-12-11", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2004-12-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "3.2e+07", "FundingRoundCode": "D", "Date": "2007-04-19", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "8600000", "FundingRoundCode": "NA", "Date": "2009-11-05", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CymaBay Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2004-12-01", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cynapsus Therapeutics", "Amount": "16602802", "FundingRoundCode": "NA", "Date": "2015-03-31", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cynapsus Therapeutics", "Amount": "16602802", "FundingRoundCode": "NA", "Date": "2015-03-31", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cynapsus Therapeutics", "Amount": "16602802", "FundingRoundCode": "NA", "Date": "2015-03-31", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cyntellect", "Amount": "15100000", "FundingRoundCode": "D", "Date": "2007-07-25", "Investor": "New River Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cyntellect", "Amount": "15100000", "FundingRoundCode": "D", "Date": "2007-07-25", "Investor": "Third Security"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cyntellect", "Amount": "3e+06", "FundingRoundCode": "D", "Date": "2007-09-06", "Investor": "Third Security"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Cynvenio Biosystems", "Amount": "25500000", "FundingRoundCode": "B", "Date": "2015-06-17", "Investor": "Syno Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Sensors", "CompanyName": "Cyrano Sciences", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2000-03-05", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Sensors", "CompanyName": "Cyrano Sciences", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2000-03-05", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Sensors", "CompanyName": "Cyrano Sciences", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2000-03-05", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Sensors", "CompanyName": "Cyrano Sciences", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2000-03-05", "Investor": "Marquette Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Sensors", "CompanyName": "Cyrano Sciences", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2000-03-05", "Investor": "Oak Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Sensors", "CompanyName": "Cyrano Sciences", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2000-03-05", "Investor": "Ridgestone Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Sensors", "CompanyName": "Cyrano Sciences", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2000-03-05", "Investor": "Rustic Canyon Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Software", "CompanyName": "Cyrus Biotechnology", "Amount": "850000", "FundingRoundCode": "NA", "Date": "2015-05-06", "Investor": "The W Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Software", "CompanyName": "Cyrus Biotechnology", "Amount": "850000", "FundingRoundCode": "NA", "Date": "2015-05-06", "Investor": "WINGS"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cyterix Pharmaceuticals", "Amount": "7290000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cyterix Pharmaceuticals", "Amount": "9200000", "FundingRoundCode": "A", "Date": "2011-06-07", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cyterix Pharmaceuticals", "Amount": "9200000", "FundingRoundCode": "A", "Date": "2011-06-07", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CYTIMMUNE SCIENCES", "Amount": "4e+05", "FundingRoundCode": "C", "Date": "2014-05-12", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cytochroma", "Amount": "44117647.0588235", "FundingRoundCode": "C", "Date": "2008-07-30", "Investor": "BDC Capital Corporation"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Nuo Therapeutics", "Amount": "27500000", "FundingRoundCode": "NA", "Date": "2013-02-19", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2012-07-31", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-01-06", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "7e+07", "FundingRoundCode": "D", "Date": "2015-06-16", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "7e+07", "FundingRoundCode": "D", "Date": "2015-06-16", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "7e+07", "FundingRoundCode": "D", "Date": "2015-06-16", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-01-06", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "7e+07", "FundingRoundCode": "D", "Date": "2015-06-16", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "7e+07", "FundingRoundCode": "D", "Date": "2015-06-16", "Investor": "Tekla Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2012-07-31", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-01-06", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2010-09-23", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "7e+07", "FundingRoundCode": "D", "Date": "2015-06-16", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytomX Therapeutics", "Amount": "7e+07", "FundingRoundCode": "D", "Date": "2015-06-16", "Investor": "Wellington Management"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Cytori Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "NA", "Date": "2013-07-01", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Cytori Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "NA", "Date": "2013-07-01", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "CytoSolv", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2010-02-09", "Investor": "Slater Technology Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "CytoVale", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-11-15", "Investor": "Breakout Labs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "CytoVale", "Amount": "4300000", "FundingRoundCode": "A", "Date": "2014-06-10", "Investor": "Dolby Family Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cytovance Biologics", "Amount": "22500000", "FundingRoundCode": "NA", "Date": "2011-03-15", "Investor": "Great Point Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Cytovance Biologics", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-10-28", "Investor": "Monroe Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Cytox", "Amount": "2272877", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "Seneca Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Life Sciences", "CompanyName": "CyVek", "Amount": "5500000", "FundingRoundCode": "D", "Date": "2013-02-04", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2015-03-02", "Investor": "Eastern Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "2800000", "FundingRoundCode": "A", "Date": "2009-10-27", "Investor": "Hub Angels Investment Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "2800000", "FundingRoundCode": "A", "Date": "2009-10-27", "Investor": "LaunchPad Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-12-30", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2015-03-02", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "2800000", "FundingRoundCode": "A", "Date": "2009-10-27", "Investor": "Norwich Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-12-30", "Investor": "Norwich Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2015-03-02", "Investor": "Norwich Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "2800000", "FundingRoundCode": "A", "Date": "2009-10-27", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-12-30", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daktari Diagnostics", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2015-03-02", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daylight Solutions", "Amount": "7500000", "FundingRoundCode": "A", "Date": "2006-06-28", "Investor": "HamiltonTech Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Daylight Solutions", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2011-07-11", "Investor": "Northrop Grumman"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Decibel Therapeutics", "Amount": "5.2e+07", "FundingRoundCode": "A", "Date": "2015-10-15", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Decibel Therapeutics", "Amount": "5.2e+07", "FundingRoundCode": "A", "Date": "2015-10-15", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Decibel Therapeutics", "Amount": "5.2e+07", "FundingRoundCode": "A", "Date": "2015-10-15", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DecImmune Therapeutics", "Amount": "3200000", "FundingRoundCode": "NA", "Date": "2010-09-27", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DecImmune Therapeutics", "Amount": "3200000", "FundingRoundCode": "NA", "Date": "2010-09-27", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "DecImmune Therapeutics", "Amount": "2250000", "FundingRoundCode": "NA", "Date": "2013-02-26", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "DecImmune Therapeutics", "Amount": "2250000", "FundingRoundCode": "NA", "Date": "2013-02-26", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DecImmune Therapeutics", "Amount": "3200000", "FundingRoundCode": "NA", "Date": "2010-09-27", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "DecImmune Therapeutics", "Amount": "2250000", "FundingRoundCode": "NA", "Date": "2013-02-26", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Machine Learning|Software", "CompanyName": "Deep Genomics", "Amount": "3700000", "FundingRoundCode": "NA", "Date": "2015-11-18", "Investor": "Bloomberg Beta"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Machine Learning|Software", "CompanyName": "Deep Genomics", "Amount": "3700000", "FundingRoundCode": "NA", "Date": "2015-11-18", "Investor": "True Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Delenex Therapeutics", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2010-11-12", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Delenex Therapeutics", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2013-11-06", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Delenex Therapeutics", "Amount": "19300000", "FundingRoundCode": "A", "Date": "2011-05-03", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Therapeutics", "CompanyName": "Denali Therapeutics", "Amount": "2.17e+08", "FundingRoundCode": "A", "Date": "2015-05-14", "Investor": "Alaska Permanent Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Therapeutics", "CompanyName": "Denali Therapeutics", "Amount": "2.17e+08", "FundingRoundCode": "A", "Date": "2015-05-14", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Therapeutics", "CompanyName": "Denali Therapeutics", "Amount": "2.17e+08", "FundingRoundCode": "A", "Date": "2015-05-14", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Therapeutics", "CompanyName": "Denali Therapeutics", "Amount": "2.17e+08", "FundingRoundCode": "A", "Date": "2015-05-14", "Investor": "Flagship Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "DeNovo Sciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-05-06", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "DeNovo Sciences", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2013-11-27", "Investor": "CKM Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "5.1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "5.1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "4.2e+07", "FundingRoundCode": "A", "Date": "2011-10-20", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "5.1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2013-06-11", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "4.2e+07", "FundingRoundCode": "A", "Date": "2011-10-20", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "5.1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2013-06-11", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "4.2e+07", "FundingRoundCode": "A", "Date": "2011-10-20", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "5.1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2013-06-11", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dermira", "Amount": "5.1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DesignMedix", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2014-07-17", "Investor": "Oregon Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DesignMedix", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2014-07-17", "Investor": "Portland Seed Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DesignMedix", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2014-07-17", "Investor": "SERAPH"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DesignMedix", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2014-07-17", "Investor": "Tacoma Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DesignMedix", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2014-07-17", "Investor": "Willamette University"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Life Sciences|Software", "CompanyName": "Desktop Genetics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-01-22", "Investor": "Healthbox"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2007-01-12", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "9200000", "FundingRoundCode": "F", "Date": "2009-02-06", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2007-01-12", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2007-01-12", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2007-01-12", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "9200000", "FundingRoundCode": "F", "Date": "2009-02-06", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2007-01-12", "Investor": "Mosaix Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-08-18", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2007-01-12", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2007-01-12", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "diaDexus", "Amount": "9200000", "FundingRoundCode": "F", "Date": "2009-02-06", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Diagnostic BioSystems", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-05-11", "Investor": "BroadOak Capital Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Diagnostic Hybrids", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2004-08-04", "Investor": "Summit Partners"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Diagnostic Photonics", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2014-05-23", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Diagnostic Photonics", "Amount": "175000", "FundingRoundCode": "A", "Date": "2011-08-12", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dialectica", "Amount": "1780000", "FundingRoundCode": "A", "Date": "2006-01-01", "Investor": "State Street Global Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-07-31", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-07-31", "Investor": "Deerfield Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-07-31", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2010-10-21", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "8400000", "FundingRoundCode": "A", "Date": "2008-07-15", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-07-31", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-07-31", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "8400000", "FundingRoundCode": "A", "Date": "2008-07-15", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-07-31", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2010-10-21", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Dicerna Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-07-31", "Investor": "SR One"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Diffinity Genomics", "Amount": "678260", "FundingRoundCode": "NA", "Date": "2012-03-29", "Investor": "LaunchCapital"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "DigiPath", "Amount": "2200000", "FundingRoundCode": "NA", "Date": "2014-05-13", "Investor": "Growth Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Design|Manufacturing|Product Design", "CompanyName": "Digital Solid State Propulsion", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-05-01", "Investor": "In-Q-Tel"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Dignify Therapeutics", "Amount": "159000", "FundingRoundCode": "NA", "Date": "2014-09-02", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dignify Therapeutics", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2015-02-04", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-04-21", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2014-06-23", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-04-21", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-04-21", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-04-21", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2014-06-23", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-04-21", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimension Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-04-21", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dimerix Biosciences Pty Ltd", "Amount": "768887.727014101", "FundingRoundCode": "A", "Date": "2005-09-15", "Investor": "Foundation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DiObex", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2007-04-16", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DiObex", "Amount": "7080000", "FundingRoundCode": "A", "Date": "2005-09-16", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DiObex", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2007-04-16", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DiObex", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2007-04-16", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DiObex", "Amount": "7080000", "FundingRoundCode": "A", "Date": "2005-09-16", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DiObex", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2007-04-16", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DiObex", "Amount": "7080000", "FundingRoundCode": "A", "Date": "2005-09-16", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DIREVO Industrial Biotechnology", "Amount": "16800000", "FundingRoundCode": "C", "Date": "2007-10-18", "Investor": "Signet Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DIREVO Industrial Biotechnology", "Amount": "10500000", "FundingRoundCode": "B", "Date": "2002-12-06", "Investor": "Techno Venture Management"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "DiscoveryBioMed", "Amount": "1610000", "FundingRoundCode": "NA", "Date": "2015-04-08", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dispersol Technologies", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-02-03", "Investor": "Research Corporation Technologies"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Divergence", "Amount": "11800000", "FundingRoundCode": "C", "Date": "2009-02-11", "Investor": "Cultivian Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Divergence", "Amount": "11800000", "FundingRoundCode": "C", "Date": "2009-02-11", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-01-03", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-10-12", "Investor": "Felicis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1550000", "FundingRoundCode": "A", "Date": "2009-08-03", "Investor": "Felicis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-01-03", "Investor": "First Round"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-10-12", "Investor": "First Round"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1550000", "FundingRoundCode": "A", "Date": "2009-08-03", "Investor": "First Round"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-01-03", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-10-12", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-10-12", "Investor": "K9 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1550000", "FundingRoundCode": "A", "Date": "2009-08-03", "Investor": "K9 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-10-12", "Investor": "SoftTech VC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1550000", "FundingRoundCode": "A", "Date": "2009-08-03", "Investor": "SoftTech VC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1550000", "FundingRoundCode": "A", "Date": "2009-08-03", "Investor": "SV Angel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-01-03", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAnexus", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2011-10-12", "Investor": "TPG Biotech"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "10800000", "FundingRoundCode": "NA", "Date": "2014-02-24", "Investor": "Cancer Prevention and Research Institute of Texas"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "4500000", "FundingRoundCode": "NA", "Date": "2012-01-30", "Investor": "Mercury Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "479193", "FundingRoundCode": "NA", "Date": "2008-09-01", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "840000", "FundingRoundCode": "NA", "Date": "2013-08-27", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "160000", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2014-10-14", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "170000", "FundingRoundCode": "NA", "Date": "2010-01-01", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "176000", "FundingRoundCode": "NA", "Date": "2006-05-08", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "1543905", "FundingRoundCode": "NA", "Date": "2013-11-07", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2014-10-14", "Investor": "Targeted Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DNAtriX", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2014-10-14", "Investor": "Texas Halo Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Domain Surgical", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2014-03-06", "Investor": "BioStar Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Domain Surgical", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2014-03-06", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "DOMAIN Therapeutics", "Amount": "230000", "FundingRoundCode": "NA", "Date": "2014-04-14", "Investor": "The Michael J. Fox Foundation"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Dr Lal PathLabs", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-08-26", "Investor": "TA Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dreamerz Foods", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-06-06", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dreamerz Foods", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-06-06", "Investor": "Dean Foods"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dreamerz Foods", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-06-06", "Investor": "Physic Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Dreamerz Foods", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-06-06", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Pharmaceuticals", "CompanyName": "Drik", "Amount": "5e+05", "FundingRoundCode": "A", "Date": "2013-08-12", "Investor": "i2E"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Drug Abuse Sciences", "Amount": "46141068", "FundingRoundCode": "A", "Date": "2001-03-01", "Investor": "Nomura Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Drug Abuse Sciences", "Amount": "46141068", "FundingRoundCode": "A", "Date": "2001-03-01", "Investor": "Rothschild"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Durata Therapeutics", "Amount": "7e+07", "FundingRoundCode": "NA", "Date": "2013-11-07", "Investor": "PDL Biopharma"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "DxUpClose", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2012-08-15", "Investor": "Golden Seeds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EarlySense", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2012-11-12", "Investor": "Bridge Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EarlySense", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2010-07-23", "Investor": "Bridge Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EarlySense", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2012-11-12", "Investor": "JK&B Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EarlySense", "Amount": "2e+07", "FundingRoundCode": "F", "Date": "2015-01-20", "Investor": "JK&B Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2008-06-12", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-04-08", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-10-01", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2008-06-12", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-04-08", "Investor": "Emergent Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-10-01", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2008-06-12", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-10-01", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2008-06-12", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-04-08", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-10-01", "Investor": "St. Paul Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-04-08", "Investor": "St. Paul Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2008-06-12", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "EBR Systems", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-04-08", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EBS Technologies", "Amount": "1218125", "FundingRoundCode": "B", "Date": "2015-08-19", "Investor": "Earlybird"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Eccrine Systems", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2015-02-25", "Investor": "CincyTech"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Finance|Stock Exchanges", "CompanyName": "Ecelles Carson", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2011-08-01", "Investor": "Ecelles Carson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Echo Therapeutics", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2011-01-06", "Investor": "Platinum Montaur Life Sciences"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "EchoPixel", "Amount": "2350000", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eddingpharm (Cayman)", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2010-09-17", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eddingpharm (Cayman)", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2010-09-17", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eddingpharm (Cayman)", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2010-09-17", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Advanced Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Advanced Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Angeleno Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2015-01-20", "Investor": "Angeleno Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "Angeleno Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Angeleno Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "ATEL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "Comerica Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Cyrus Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "Cyrus Capital Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2014-11-03", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2015-01-20", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "6150000", "FundingRoundCode": "NA", "Date": "2013-05-01", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Duff, Ackerman and Goodrich"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Element Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "Element Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Element Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2015-01-20", "Investor": "Flint Hills Resources"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "Flint Hills Resources"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "I2BF Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2015-01-20", "Investor": "I2BF Global Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Morgan Stanley"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2010-05-11", "Investor": "Nimes Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "Omninet"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2012-05-09", "Investor": "The Westly Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "33120000", "FundingRoundCode": "A", "Date": "2008-04-21", "Investor": "The Westly Group"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "EdeniQ", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2013-07-18", "Investor": "Trinity Capital Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edge Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2015-04-09", "Investor": "Franklin Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Edge Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-09-08", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edge Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2015-04-09", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edge Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "Maxim Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edge Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2015-04-09", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edge Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2015-04-09", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edge Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "C", "Date": "2015-04-09", "Investor": "Venrock"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Edgemont Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-05-01", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edico Genome", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-07-17", "Investor": "Qualcomm Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edimer Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2013-07-30", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Edison Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "F", "Date": "2012-11-26", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Deerfield"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2013-11-25", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "4.7e+07", "FundingRoundCode": "NA", "Date": "2015-05-27", "Investor": "Juno Therapeutics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2013-11-25", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2013-11-25", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2013-11-25", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Editas Medicine", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-08-10", "Investor": "Viking Global Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Effector Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Effector Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Effector Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Effector Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Effector Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2013-05-20", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Efficas", "Amount": "4720000", "FundingRoundCode": "A", "Date": "2004-04-20", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Efficas", "Amount": "4720000", "FundingRoundCode": "A", "Date": "2004-04-20", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Efflorus", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-17", "Investor": "SOSV"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Egalet", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-02-11", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Egalet", "Amount": "27600000", "FundingRoundCode": "B", "Date": "2007-04-02", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eiger BioPharmaceuticals", "Amount": "8300000", "FundingRoundCode": "A", "Date": "2009-02-25", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eiger BioPharmaceuticals", "Amount": "8740630", "FundingRoundCode": "A", "Date": "2015-02-13", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eiger BioPharmaceuticals", "Amount": "8300000", "FundingRoundCode": "A", "Date": "2009-02-25", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eiger BioPharmaceuticals", "Amount": "8740630", "FundingRoundCode": "A", "Date": "2015-02-13", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EKR Therapeutics", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2007-08-15", "Investor": "Merrill Lynch"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EKR Therapeutics", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2007-08-15", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EKR Therapeutics", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2007-08-15", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2012-08-13", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "24720101", "FundingRoundCode": "C", "Date": "2014-02-21", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2015-10-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2012-08-13", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "24720101", "FundingRoundCode": "C", "Date": "2014-02-21", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2015-10-01", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2012-08-13", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "24720101", "FundingRoundCode": "C", "Date": "2014-02-21", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elcelyx Therapeutics", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2015-10-01", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2010-01-21", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2011-09-26", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2012-01-04", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2010-01-21", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2011-09-26", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2012-01-04", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2010-01-21", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2011-09-26", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2012-01-04", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2012-01-04", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2010-01-21", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Elevation Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2011-09-26", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Eleven Biotherapeutics", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2010-03-09", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Eleven Biotherapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2012-05-08", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Eleven Biotherapeutics", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2010-03-09", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Eleven Biotherapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2012-05-08", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Elite Pharmaceuticals", "Amount": "8e+05", "FundingRoundCode": "NA", "Date": "2014-04-15", "Investor": "Lincoln Park Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2009-05-27", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "CDIB BioScience Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "Icon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2009-05-27", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2009-05-27", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes|Pharmaceuticals", "CompanyName": "Elixir Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2009-05-27", "Investor": "Physic Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ember Therapeutics", "Amount": "3.4e+07", "FundingRoundCode": "A", "Date": "2011-12-15", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Embera NeuroTherapeutics", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-08-14", "Investor": "Louisiana Fund I"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Embera NeuroTherapeutics", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-08-14", "Investor": "Louisiana Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Embera NeuroTherapeutics", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-08-14", "Investor": "Themelios Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Emerald Therapeutics", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2014-03-01", "Investor": "Schooner Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Emerald Therapeutics", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2015-06-01", "Investor": "Schooner Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Emerald Therapeutics", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2015-06-01", "Investor": "Sound Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Emerald Therapeutics", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2015-06-01", "Investor": "Western Technology Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Emerald Therapeutics", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2014-03-01", "Investor": "Max Levchin"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Emerus Hospital Partners", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2011-01-18", "Investor": "Austin Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Emerus Hospital Partners", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-09-01", "Investor": "Welsh, Carson, Anderson & Stowe"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Technology", "CompanyName": "Emiliem", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-03-04", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Empire Genomics", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2014-07-02", "Investor": "Rand Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Empirical Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-03-22", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Empirical Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-06-30", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Enanta Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2004-01-14", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Enanta Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2004-01-14", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Enanta Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2004-01-14", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Enanta Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2004-01-14", "Investor": "Techno Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Enanta Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2004-01-14", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "seed", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Encoded Genomics", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-10-15", "Investor": "Illumina Accelerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Encycle Therapeutics", "Amount": "2130156.28620331", "FundingRoundCode": "NA", "Date": "2015-09-30", "Investor": "AcelRx Pharmaceuticals"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Encycle Therapeutics", "Amount": "2130156.28620331", "FundingRoundCode": "NA", "Date": "2015-09-30", "Investor": "BDC Capital Corporation"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Encysive Pharmaceuticals", "Amount": "13950000", "FundingRoundCode": "NA", "Date": "2007-08-20", "Investor": "Enable Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Encysive Pharmaceuticals", "Amount": "13950000", "FundingRoundCode": "NA", "Date": "2007-08-20", "Investor": "Hudson Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "EndoChoice", "Amount": "5.7e+07", "FundingRoundCode": "D", "Date": "2015-03-05", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "EndoChoice", "Amount": "NA", "FundingRoundCode": "A", "Date": "2008-05-19", "Investor": "River Cities Capital Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "EndoChoice", "Amount": "5.7e+07", "FundingRoundCode": "D", "Date": "2015-03-05", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "EndoChoice", "Amount": "4.3e+07", "FundingRoundCode": "NA", "Date": "2013-01-04", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2006-11-13", "Investor": "Blue Chip Venture Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-03-26", "Investor": "Blue Chip Venture Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2010-01-19", "Investor": "Blue Chip Venture Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2006-11-13", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-03-26", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2010-01-19", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-08-30", "Investor": "MidCap Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2006-11-13", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-03-26", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2010-01-19", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-08-30", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2006-11-13", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-03-26", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2010-01-19", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endocyte", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2006-11-13", "Investor": "Twilight Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Endologix", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-10-27", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Endosense", "Amount": "40300000", "FundingRoundCode": "C", "Date": "2012-11-27", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EndoStim", "Amount": "9133808", "FundingRoundCode": "NA", "Date": "2013-01-14", "Investor": "Billiken Angels Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EndoStim", "Amount": "14100000", "FundingRoundCode": "D", "Date": "2013-06-05", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EndoStim", "Amount": "2500000", "FundingRoundCode": "E", "Date": "2015-05-11", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EndoStim", "Amount": "14100000", "FundingRoundCode": "D", "Date": "2013-06-05", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EndoStim", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2010-07-19", "Investor": "Sante Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "ENDOTRONIX", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2010-10-08", "Investor": "JumpStart Inc."}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Endovention", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2007-06-14", "Investor": "Signatures Capital"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "Endovention", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2007-06-14", "Investor": "Bobby Yazdani"}, {"FundingRoundType": "seed", "CompanyCategory": "Bio-Pharm|Biotechnology|Life Sciences", "CompanyName": "Energesis Pharmaceuticals", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2010-10-21", "Investor": "MassChallenge"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "enEvolv", "Amount": "1794845", "FundingRoundCode": "A", "Date": "2014-03-13", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "enGene", "Amount": "6400000", "FundingRoundCode": "A", "Date": "2008-03-17", "Investor": "Masa Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EnGeneIC", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2015-01-06", "Investor": "Foley Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Enobia Pharma", "Amount": "37711598.7460815", "FundingRoundCode": "B", "Date": "2007-08-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Pharmaceuticals", "CompanyName": "Enobia Pharma", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2009-08-10", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-11-12", "Investor": "Aeneas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-11-12", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2004-05-12", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-11-12", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-11-12", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2004-05-12", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-11-12", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-11-12", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ensemble Discovery", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2004-05-12", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Entelos", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-06-21", "Investor": "Clearlake Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EnteroMedics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2004-07-01", "Investor": "Bay City Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Entopsis", "Amount": "8e+05", "FundingRoundCode": "NA", "Date": "2015-02-17", "Investor": "Krillion Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Entourage Medical Technologies", "Amount": "3251000", "FundingRoundCode": "NA", "Date": "2013-02-08", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EntreMed", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-01-23", "Investor": "Accel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EntreMed", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-01-23", "Investor": "Emerging Technology Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Enumeral Biomedical", "Amount": "21500000", "FundingRoundCode": "NA", "Date": "2014-08-04", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Envisia Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-11-12", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Envisia Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-11-12", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Envisia Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-11-12", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Envisia Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-11-12", "Investor": "Wakefield Group"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Envoy Therapeutics", "Amount": "1200000", "FundingRoundCode": "NA", "Date": "2012-05-08", "Investor": "The Michael J. Fox Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EnzymeRx", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2008-05-28", "Investor": "Pequot Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "EpiBiome", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-10-15", "Investor": "Illumina Accelerator"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Services Industry|Hospitals|Medical", "CompanyName": "EpiBone", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-06-12", "Investor": "Breakout Labs"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Services Industry|Hospitals|Medical", "CompanyName": "EpiBone", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-06-12", "Investor": "National Science Foundation- SBIR/STTR Program"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Services Industry|Hospitals|Medical", "CompanyName": "EpiBone", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-06-12", "Investor": "Partnership Fund for New York City"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Epic Sciences", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2012-11-13", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Epic Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-07-30", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Epic Sciences", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2012-11-13", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Epic Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-07-30", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Epic Sciences", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Epic Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-07-30", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epiphany", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2007-03-16", "Investor": "CDIB BioScience Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epiphany", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2007-03-16", "Investor": "Wexford Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "8083000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "8083000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "Mousse Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Epirus Biopharmaceuticals", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2009-10-07", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2009-10-07", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2009-10-07", "Investor": "Bay City Capital"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-02-12", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2011-10-14", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2009-10-07", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2011-06-23", "Investor": "Leukemia & Lymphoma Society"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2009-10-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Epizyme", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2009-12-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Business Services|Industrial|Pharmaceuticals", "CompanyName": "EquipNet, Inc.", "Amount": "3600000", "FundingRoundCode": "A", "Date": "2001-03-28", "Investor": "Eastman Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EraGen Biosciences", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2006-01-09", "Investor": "First Analysis"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EraGen Biosciences", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2006-01-09", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EraGen Biosciences", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2006-01-09", "Investor": "Stonehenge Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ESBATech", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ESBATech", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2008-08-07", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ESBATech", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2006-08-02", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ESBATech", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2008-08-07", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Escoublac", "Amount": "6650000", "FundingRoundCode": "A", "Date": "2008-01-09", "Investor": "Biogen Idec"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Esperance Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-06-01", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Esperance Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-06-01", "Investor": "Louisiana Fund I"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Esperance Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-06-01", "Investor": "Louisiana Technology Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Esperance Pharmaceuticals", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-06-01", "Investor": "Themelios Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "22750000", "FundingRoundCode": "A", "Date": "2008-05-01", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "22750000", "FundingRoundCode": "A", "Date": "2008-05-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "22750000", "FundingRoundCode": "A", "Date": "2008-05-01", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "22750000", "FundingRoundCode": "A", "Date": "2008-05-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "Esperion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Essen BioScience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-05-15", "Investor": "SFW Capital Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "EternoGen", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Allen Angel Capital Education Program (AACE)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Information Technology|Pharmaceuticals|Services", "CompanyName": "ETrials Worldwide", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2004-01-14", "Investor": "InfoLogix"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Information Technology|Pharmaceuticals|Services", "CompanyName": "ETrials Worldwide", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2004-01-14", "Investor": "Newlight Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Information Technology|Pharmaceuticals|Services", "CompanyName": "ETrials Worldwide", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2004-01-14", "Investor": "Prodea"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Health and Wellness|Health Care", "CompanyName": "Etubics", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2014-04-30", "Investor": "National Institute of Allergy and Infectious Diseases"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "1300000", "FundingRoundCode": "A", "Date": "2014-09-09", "Investor": "ABC Laboratories"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "7e+05", "FundingRoundCode": "A", "Date": "2015-04-07", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "1300000", "FundingRoundCode": "A", "Date": "2014-09-09", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "7e+05", "FundingRoundCode": "A", "Date": "2015-04-07", "Investor": "Cultivation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "1300000", "FundingRoundCode": "A", "Date": "2014-09-09", "Investor": "Cultivation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "1300000", "FundingRoundCode": "A", "Date": "2014-09-09", "Investor": "Helix Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "1300000", "FundingRoundCode": "A", "Date": "2014-09-09", "Investor": "Missouri Technology Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "7e+05", "FundingRoundCode": "A", "Date": "2015-04-07", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Euclises Pharmaceuticals", "Amount": "174998", "FundingRoundCode": "NA", "Date": "2012-05-01", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eureka Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2014-09-23", "Investor": "Acorn Campus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Acqua Wellington Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Alexandra Investment Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2007-06-28", "Investor": "First Eagle"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Banc of America Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "12530000", "FundingRoundCode": "NA", "Date": "2005-12-13", "Investor": "Bristol Capital Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Clarion Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2007-06-28", "Investor": "Fort Mason Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Fort Mason Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "HBK Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2007-06-28", "Investor": "Heights Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Heights Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Highbridge Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "12530000", "FundingRoundCode": "NA", "Date": "2005-12-13", "Investor": "Highbridge Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2007-06-28", "Investor": "Hudson Bay Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Hudson Bay Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "12530000", "FundingRoundCode": "NA", "Date": "2005-12-13", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2007-06-28", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Nite Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "13970000", "FundingRoundCode": "NA", "Date": "2005-07-19", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2007-06-28", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "12530000", "FundingRoundCode": "NA", "Date": "2005-12-13", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "13970000", "FundingRoundCode": "NA", "Date": "2005-07-19", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EUSA Pharma", "Amount": "18600000", "FundingRoundCode": "NA", "Date": "2006-11-07", "Investor": "Rodman & Renshaw"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euthymics Bioscience", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2010-07-22", "Investor": "Hambrecht & Quist Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Euthymics Bioscience", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2011-03-09", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Eve Biomedical", "Amount": "6002724", "FundingRoundCode": "B", "Date": "2012-12-20", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Eve Biomedical", "Amount": "1666700", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Evelo Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "NA", "Date": "2015-11-04", "Investor": "Flagship Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Evoke Pharma", "Amount": "4500000", "FundingRoundCode": "NA", "Date": "2014-05-28", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Evolutionary Genomics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2008-04-11", "Investor": "Altira Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Evotec", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2013-09-03", "Investor": "Biotechnology Value Fund"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "EVS Glaucoma Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-09-11", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "CRG"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "16900000", "FundingRoundCode": "B", "Date": "2011-02-25", "Investor": "Cottonwood Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "11986707", "FundingRoundCode": "A", "Date": "2011-12-19", "Investor": "Cottonwood Technology Fund"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5427984", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Cottonwood Technology Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "3950000", "FundingRoundCode": "NA", "Date": "2014-07-21", "Investor": "Cottonwood Technology Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "Cottonwood Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "34100000", "FundingRoundCode": "C", "Date": "2012-02-16", "Investor": "Cottonwood Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5300000", "FundingRoundCode": "B", "Date": "2012-09-10", "Investor": "Cottonwood Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "16900000", "FundingRoundCode": "B", "Date": "2011-02-25", "Investor": "EPIC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2005-06-28", "Investor": "EPIC Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5427984", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "EPIC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5400000", "FundingRoundCode": "A", "Date": "2004-01-14", "Investor": "EPIC Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "EPIC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5300000", "FundingRoundCode": "B", "Date": "2012-09-10", "Investor": "EPIC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "16900000", "FundingRoundCode": "B", "Date": "2011-02-25", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5427984", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5300000", "FundingRoundCode": "B", "Date": "2012-09-10", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "16900000", "FundingRoundCode": "B", "Date": "2011-02-25", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "11986707", "FundingRoundCode": "A", "Date": "2011-12-19", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5427984", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "3950000", "FundingRoundCode": "NA", "Date": "2014-07-21", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "34100000", "FundingRoundCode": "C", "Date": "2012-02-16", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5300000", "FundingRoundCode": "B", "Date": "2012-09-10", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "3950000", "FundingRoundCode": "NA", "Date": "2014-07-21", "Investor": "The Capital Royalty Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2005-06-28", "Investor": "Tullis-Dickerson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5400000", "FundingRoundCode": "A", "Date": "2004-01-14", "Investor": "Tullis-Dickerson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "16900000", "FundingRoundCode": "B", "Date": "2011-02-25", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "11986707", "FundingRoundCode": "A", "Date": "2011-12-19", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5427984", "FundingRoundCode": "NA", "Date": "2011-05-11", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "3950000", "FundingRoundCode": "NA", "Date": "2014-07-21", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "34100000", "FundingRoundCode": "C", "Date": "2012-02-16", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5300000", "FundingRoundCode": "B", "Date": "2012-09-10", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2005-06-28", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exagen Diagnostics", "Amount": "5400000", "FundingRoundCode": "A", "Date": "2004-01-14", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Excaliard Pharmaceuticals", "Amount": "15500000", "FundingRoundCode": "A", "Date": "2007-11-27", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Excaliard Pharmaceuticals", "Amount": "15500000", "FundingRoundCode": "A", "Date": "2007-11-27", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Excaliard Pharmaceuticals", "Amount": "15500000", "FundingRoundCode": "A", "Date": "2007-11-27", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hospitality", "CompanyName": "Excel PharmaStudies", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2007-12-01", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Exogenesis", "Amount": "3190000", "FundingRoundCode": "NA", "Date": "2010-12-01", "Investor": "Inflection Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Exogenesis", "Amount": "3190000", "FundingRoundCode": "NA", "Date": "2010-12-01", "Investor": "JDSU"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Exogenesis", "Amount": "3190000", "FundingRoundCode": "NA", "Date": "2010-12-01", "Investor": "Venture Capital Fund of New England"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exosome Diagnostics", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exosome Diagnostics", "Amount": "17600000", "FundingRoundCode": "B", "Date": "2015-09-02", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exosome Diagnostics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2010-05-11", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exosome Diagnostics", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Exosome Diagnostics", "Amount": "17600000", "FundingRoundCode": "B", "Date": "2015-09-02", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "3D Printing|Biotechnology|mHealth", "CompanyName": "Exovite", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-07-22", "Investor": "Microsoft Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Extem", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-01-06", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Extem", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-01-06", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EyeCyte", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2008-06-23", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EyeGate Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2008-03-12", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "EyeGate Pharmaceuticals", "Amount": "2e+06", "FundingRoundCode": "B", "Date": "2007-01-17", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "EyeNetra", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2014-07-29", "Investor": "Khosla Impact"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "EyeNetra", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2014-07-29", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "8252905.71055226", "FundingRoundCode": "A", "Date": "2007-09-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "9400000", "FundingRoundCode": "A", "Date": "2013-10-23", "Investor": "Atlas Venture"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "1950900", "FundingRoundCode": "NA", "Date": "2007-01-08", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "21739500", "FundingRoundCode": "NA", "Date": "2011-04-13", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "9400000", "FundingRoundCode": "A", "Date": "2013-10-23", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "11480000", "FundingRoundCode": "A", "Date": "2010-01-06", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "21739500", "FundingRoundCode": "NA", "Date": "2011-04-13", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "9400000", "FundingRoundCode": "A", "Date": "2013-10-23", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "F-star Biotechnology Limited", "Amount": "21739500", "FundingRoundCode": "NA", "Date": "2011-04-13", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "F2G", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-09-05", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "F2G", "Amount": "11741755.9205785", "FundingRoundCode": "NA", "Date": "2008-08-18", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fabrus", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2010-11-04", "Investor": "OPKO Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Faraday Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "A", "Date": "2014-07-23", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-11-29", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "35988360", "FundingRoundCode": "B", "Date": "2011-05-05", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "35988360", "FundingRoundCode": "B", "Date": "2011-05-05", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "35988360", "FundingRoundCode": "B", "Date": "2011-05-05", "Investor": "Genzyme Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-11-29", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "35988360", "FundingRoundCode": "B", "Date": "2011-05-05", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-11-29", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "35988360", "FundingRoundCode": "B", "Date": "2011-05-05", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-11-29", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fate Therapeutics", "Amount": "35988360", "FundingRoundCode": "B", "Date": "2011-05-05", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fe3 Medical", "Amount": "2800000", "FundingRoundCode": "NA", "Date": "2010-09-28", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Femta Pharmaceuticals", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-07-17", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Femta Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2010-10-12", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FerroKin Biosciences", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-06-18", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FerroKin Biosciences", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-06-18", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FerroKin Biosciences", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-06-18", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FerroKin Biosciences", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-06-18", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Fiberstar", "Amount": "10640000", "FundingRoundCode": "NA", "Date": "2013-07-18", "Investor": "Associated Bank"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Fiberstar", "Amount": "10640000", "FundingRoundCode": "NA", "Date": "2013-07-18", "Investor": "Spell Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Apothecary Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Goldman Sachs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Janus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Och-Ziff Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "Rosewood Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FibroGen", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2005-02-17", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FIRE1", "Amount": "NA", "FundingRoundCode": "A", "Date": "2014-01-09", "Investor": "Lightstone Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FIRE1", "Amount": "NA", "FundingRoundCode": "A", "Date": "2014-01-09", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Firefly BioWorks", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2012-05-24", "Investor": "Massachusetts Life Sciences Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Firefly BioWorks", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2011-10-21", "Investor": "Sands Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "First Aid Shot Therapy", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-02-10", "Investor": "Clearwell Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "First Aid Shot Therapy", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2015-11-18", "Investor": "HealthQuest Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "First Aid Shot Therapy", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2015-11-18", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "First Aid Shot Therapy", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-02-10", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "First Aid Shot Therapy", "Amount": "NA", "FundingRoundCode": "A", "Date": "2013-05-21", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "First Aid Shot Therapy", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2015-11-18", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "First Aid Shot Therapy", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-02-10", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Predictive Analytics|SaaS", "CompanyName": "Cyrcadia Health", "Amount": "540000", "FundingRoundCode": "A", "Date": "2014-04-22", "Investor": "Steve Welch"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FitBionic", "Amount": "2200000", "FundingRoundCode": "NA", "Date": "2013-08-08", "Investor": "High Country Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2005-02-08", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2005-02-08", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2005-02-08", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-04-20", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2005-02-08", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-05-20", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2005-02-08", "Investor": "Texas Pacific Group"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-04-20", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Five Prime Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2005-02-08", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Flexion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2009-10-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Flexion Therapeutics", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2010-01-29", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Flexion Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2009-10-01", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Flexus Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2014-12-17", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Flexus Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2014-12-17", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Flexus Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2014-12-17", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FluGen", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2015-08-25", "Investor": "Knox Payments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FluGen", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2015-08-25", "Investor": "State of Wisconsin Investment Board"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FluGen", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2015-08-25", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FluGen", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2015-08-25", "Investor": "Wisconsin Alumni Research Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "3.7e+07", "FundingRoundCode": "E", "Date": "2007-01-08", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "3.7e+07", "FundingRoundCode": "E", "Date": "2007-01-08", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "3.7e+07", "FundingRoundCode": "E", "Date": "2007-01-08", "Investor": "EuclidSR Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "EuclidSR Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "EuclidSR Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "Fidelity Contrafund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "3.7e+07", "FundingRoundCode": "E", "Date": "2007-01-08", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2004-01-06", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2004-01-06", "Investor": "Invus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "Invus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2004-01-06", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "3.7e+07", "FundingRoundCode": "E", "Date": "2007-01-08", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "Smallcap World Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "3.7e+07", "FundingRoundCode": "E", "Date": "2007-01-08", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2004-01-06", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluidigm", "Amount": "1.7e+07", "FundingRoundCode": "E", "Date": "2007-01-10", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluxion Biosciences", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-10-20", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluxion Biosciences", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Kodiak Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluxion Biosciences", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-10-20", "Investor": "Kodiak Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluxion Biosciences", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-10-20", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fluxion Biosciences", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-10-20", "Investor": "North Bay Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FMP Products", "Amount": "480000", "FundingRoundCode": "NA", "Date": "2010-04-14", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Foldrx Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "NA", "Date": "2010-06-15", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Foldrx Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "NA", "Date": "2010-06-15", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Foldrx Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "NA", "Date": "2010-06-15", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Foldrx Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "NA", "Date": "2010-06-15", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Foldrx Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "NA", "Date": "2010-06-15", "Investor": "TPG Biotechnology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2008-01-04", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2008-08-12", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "7499999", "FundingRoundCode": "B", "Date": "2010-06-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "134999", "FundingRoundCode": "B", "Date": "2010-11-08", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2008-08-12", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "7499999", "FundingRoundCode": "B", "Date": "2010-06-01", "Investor": "PureTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2008-01-04", "Investor": "PureTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "134999", "FundingRoundCode": "B", "Date": "2010-11-08", "Investor": "PureTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Follica", "Amount": "1.1e+07", "FundingRoundCode": "B", "Date": "2008-08-12", "Investor": "PureTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FORMA Therapeutics", "Amount": "3e+06", "FundingRoundCode": "B", "Date": "2009-12-17", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "FORMA Therapeutics", "Amount": "25500000", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2013-06-17", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-04-16", "Investor": "H.I.G. BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-04-16", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-04-16", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2013-06-17", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2014-04-16", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ForSight Labs", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Foundation Radiology Group", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2009-04-13", "Investor": "Health Evolution Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Foundation Radiology Group", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2013-07-08", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fusion Antibodies", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2007-07-26", "Investor": "Invest Northern Ireland"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Fusion Antibodies", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2007-07-26", "Investor": "Viridian Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Pharmaceuticals", "CompanyName": "G-CON", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-06-24", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "G1 Therapeutics, Inc.", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-02-05", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "G1 Therapeutics, Inc.", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2013-10-16", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "G1 Therapeutics, Inc.", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-02-05", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "G1 Therapeutics, Inc.", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2013-10-16", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "G1 Therapeutics, Inc.", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-02-05", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "G1 Therapeutics, Inc.", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2013-10-16", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "G1 Therapeutics, Inc.", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-02-05", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gaia Herbs", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "Partnership Capital Growth Investors"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Galenea", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2012-09-06", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Galera Therapeutics", "Amount": "4700000", "FundingRoundCode": "A", "Date": "2015-03-19", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Galera Therapeutics", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2015-10-14", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Galera Therapeutics", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2012-12-12", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Galera Therapeutics", "Amount": "4700000", "FundingRoundCode": "A", "Date": "2015-03-19", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Galera Therapeutics", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2015-10-14", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Galera Therapeutics", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2012-12-12", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Galera Therapeutics", "Amount": "4700000", "FundingRoundCode": "A", "Date": "2014-08-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Gallus BioPharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-05-18", "Investor": "Ridgemont Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gamida Cell", "Amount": "1e+07", "FundingRoundCode": "E", "Date": "2012-05-15", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gamma Medica", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2014-10-22", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gamma Medica", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2014-10-22", "Investor": "Psilos Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gamma Medica", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2013-07-16", "Investor": "Psilos Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gan & Lee Pharmaceutical", "Amount": "30225682", "FundingRoundCode": "B", "Date": "2011-05-01", "Investor": "Goldman Sachs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Fitness|Manufacturing", "CompanyName": "Ganeden Biotech", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2007-11-05", "Investor": "Capital Resource Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Garnet Biotherapeutics", "Amount": "10400000", "FundingRoundCode": "A", "Date": "2009-02-03", "Investor": "Alliance Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Garnet Biotherapeutics", "Amount": "10400000", "FundingRoundCode": "A", "Date": "2009-02-03", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Garnet Biotherapeutics", "Amount": "10400000", "FundingRoundCode": "A", "Date": "2009-02-03", "Investor": "SCP Vitalife Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Computer Vision|Medical|Mobile|Wireless", "CompanyName": "Gauss Surgical", "Amount": "1499997", "FundingRoundCode": "NA", "Date": "2014-10-30", "Investor": "Promus Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Computer Vision|Medical|Mobile|Wireless", "CompanyName": "Gauss Surgical", "Amount": "3126992", "FundingRoundCode": "A", "Date": "2013-09-01", "Investor": "Promus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Computer Vision|Medical|Mobile|Wireless", "CompanyName": "Gauss Surgical", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Promus Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Computer Vision|Medical|Mobile|Wireless", "CompanyName": "Gauss Surgical", "Amount": "3126992", "FundingRoundCode": "A", "Date": "2013-09-01", "Investor": "Stanford University"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Computer Vision|Medical|Mobile|Wireless", "CompanyName": "Gauss Surgical", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2015-08-26", "Investor": "Summation Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gelzen", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-09-04", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "E", "Date": "2010-08-24", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2010-04-20", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "E", "Date": "2010-08-24", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2010-04-20", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "SB Life Science"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemin X Pharmaceuticals", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2008-07-03", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "3300000", "FundingRoundCode": "B", "Date": "2014-05-13", "Investor": "BlueTree Allied Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2012-06-28", "Investor": "BlueTree Allied Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "3300000", "FundingRoundCode": "B", "Date": "2014-05-13", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2012-06-28", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "3300000", "FundingRoundCode": "B", "Date": "2014-05-13", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2012-06-28", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "3300000", "FundingRoundCode": "B", "Date": "2014-05-13", "Investor": "The Angels' Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2012-06-28", "Investor": "The Angels' Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "3300000", "FundingRoundCode": "B", "Date": "2014-05-13", "Investor": "Wilmington Investor Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gemmus Pharma", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2012-06-28", "Investor": "Wilmington Investor Network"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Gen9", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2013-04-24", "Investor": "Agilent Technologies"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Gen9", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2011-09-09", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genalyte", "Amount": "11800000", "FundingRoundCode": "B", "Date": "2012-03-30", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genalyte", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2015-08-18", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genalyte", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2015-08-18", "Investor": "CLI Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genalyte", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2015-08-18", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genalyte", "Amount": "4.4e+07", "FundingRoundCode": "C", "Date": "2015-08-18", "Investor": "Redmile Group"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Genapsys", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-05-18", "Investor": "Plug & Play Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gendel", "Amount": "366000", "FundingRoundCode": "NA", "Date": "2005-05-25", "Investor": "Invest Northern Ireland"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GeneAssess", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2012-07-02", "Investor": "Foundation Venture Capital Group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "GeneCentric Diagnostics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-01-20", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GeneExcel", "Amount": "7e+05", "FundingRoundCode": "A", "Date": "2005-03-15", "Investor": "ITX International Holdings"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genelabs Technologies", "Amount": "8300000", "FundingRoundCode": "NA", "Date": "2006-06-27", "Investor": "Centrecourt Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genelabs Technologies", "Amount": "8300000", "FundingRoundCode": "NA", "Date": "2006-06-27", "Investor": "Fort Mason Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genelabs Technologies", "Amount": "8300000", "FundingRoundCode": "NA", "Date": "2006-06-27", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genelabs Technologies", "Amount": "8300000", "FundingRoundCode": "NA", "Date": "2006-06-27", "Investor": "Paramount BioCapital Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genelabs Technologies", "Amount": "8300000", "FundingRoundCode": "NA", "Date": "2006-06-27", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Startups", "CompanyName": "Genenta Science", "Amount": "7200000", "FundingRoundCode": "A", "Date": "2015-01-23", "Investor": "VENTURE CAPITAL POST"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "GenePeeks", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2014-06-30", "Investor": "Horizon Technology Finance"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "GeneriCo", "Amount": "435000", "FundingRoundCode": "NA", "Date": "2013-05-15", "Investor": "BioGenerator"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|EdTech|Education|Pharmaceuticals", "CompanyName": "Genetix Fusion", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2013-05-14", "Investor": "Arch Grants"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "GeneWEAVE", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-07-26", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GeneWEAVE", "Amount": "11999998", "FundingRoundCode": "B", "Date": "2014-06-20", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GeneWEAVE", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2012-02-28", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "GeneWEAVE", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2010-07-26", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GeneWEAVE", "Amount": "11999998", "FundingRoundCode": "B", "Date": "2014-06-20", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GeneWEAVE", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2012-02-28", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genizon BioSciences", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2006-03-29", "Investor": "Illumina"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genizon BioSciences", "Amount": "8441091", "FundingRoundCode": "D", "Date": "2007-02-05", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genkyotex", "Amount": "2.6e+07", "FundingRoundCode": "C", "Date": "2012-07-09", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genkyotex", "Amount": "20400000", "FundingRoundCode": "C", "Date": "2011-05-24", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genmab", "Amount": "2.3e+07", "FundingRoundCode": "NA", "Date": "2009-10-01", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "1200000", "FundingRoundCode": "NA", "Date": "2014-09-23", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "20021810", "FundingRoundCode": "C", "Date": "2010-12-01", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2011-01-03", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "25517734", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "20021810", "FundingRoundCode": "C", "Date": "2010-12-01", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2011-01-03", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "25517734", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "20021810", "FundingRoundCode": "C", "Date": "2010-12-01", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2011-01-03", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "25517734", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "20021810", "FundingRoundCode": "C", "Date": "2010-12-01", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2011-01-03", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "25517734", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "20021810", "FundingRoundCode": "C", "Date": "2010-12-01", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2011-01-03", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "25517734", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "20021810", "FundingRoundCode": "C", "Date": "2010-12-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2011-01-03", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "25517734", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2011-01-03", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-10-10", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genocea Biosciences", "Amount": "25517734", "FundingRoundCode": "B", "Date": "2009-12-01", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenoLogics", "Amount": "8e+06", "FundingRoundCode": "D", "Date": "2012-02-10", "Investor": "Illumina"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenoLogics", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2005-02-03", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenoLogics", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2009-02-25", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenoLogics", "Amount": "8e+06", "FundingRoundCode": "D", "Date": "2012-02-10", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenoLogics", "Amount": "NA", "FundingRoundCode": "B", "Date": "2006-10-31", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genome", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2007-09-26", "Investor": "Slater Technology Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "GenomeDx Biosciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-09-28", "Investor": "CRG"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenomeDx Biosciences", "Amount": "NA", "FundingRoundCode": "B", "Date": "2013-09-30", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genometry", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2012-09-21", "Investor": "Sands Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genomind", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2015-09-22", "Investor": "Claritas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genomind", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2014-04-09", "Investor": "Claritas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Fitness|Health and Wellness|Medical Professionals", "CompanyName": "BaseHealth", "Amount": "3632593", "FundingRoundCode": "B", "Date": "2015-05-29", "Investor": "Plug & Play Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Fitness|Health and Wellness|Medical Professionals", "CompanyName": "BaseHealth", "Amount": "1899997", "FundingRoundCode": "NA", "Date": "2012-05-21", "Investor": "Safa Rashtchy"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Fitness|Health and Wellness|Medical Professionals", "CompanyName": "BaseHealth", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2011-05-03", "Investor": "Safa Rashtchy"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genscript Technology", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2009-05-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenSight Biologics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenSight Biologics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenSight Biologics", "Amount": "41673600", "FundingRoundCode": "A", "Date": "2013-04-08", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenSight Biologics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gentis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2007-06-21", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gentis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2007-06-21", "Investor": "Pappas Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Gentris", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2005-04-27", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Genus Oncology", "Amount": "NA", "FundingRoundCode": "A", "Date": "2011-05-01", "Investor": "Lightbank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Storage|Transportation", "CompanyName": "GenVault", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2008-06-09", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Storage|Transportation", "CompanyName": "GenVault", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2008-06-09", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Storage|Transportation", "CompanyName": "GenVault", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2007-04-04", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Storage|Transportation", "CompanyName": "GenVault", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2008-06-09", "Investor": "Montagu Newhall Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Storage|Transportation", "CompanyName": "GenVault", "Amount": "1.3e+07", "FundingRoundCode": "C", "Date": "2008-06-09", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Storage|Transportation", "CompanyName": "GenVault", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2007-04-04", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GenZum Life Sciences", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-06-20", "Investor": "SGVC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-25", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-25", "Investor": "Angel Healthcare Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-25", "Investor": "Catalyst Health & Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-25", "Investor": "Cutlass Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-25", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-01-07", "Investor": "Medtronic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-25", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GI Dynamics", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-05-25", "Investor": "Seedling Enterprises"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "China Rock Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2015-03-18", "Investor": "Data Collective"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2015-03-18", "Investor": "Felicis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Felicis Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2015-03-18", "Investor": "Vast Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Viking Global Investors"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "Y Combinator"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "David Spector"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "Farzad (Zod) Nazem"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ginkgo Bioworks", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2015-03-18", "Investor": "Ken Arnold"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GITR", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2012-06-12", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Gladius Pharmaceuticals", "Amount": "3336438", "FundingRoundCode": "A", "Date": "2015-06-23", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Gladius Pharmaceuticals", "Amount": "3336438", "FundingRoundCode": "A", "Date": "2015-06-23", "Investor": "SR One"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Gland Pharma", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2013-11-28", "Investor": "KKR (Kohlberg Kravis Roberts & Co.)"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Software", "CompanyName": "GlassesOff", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-05-19", "Investor": "SG Cowen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Gliknik", "Amount": "4900000", "FundingRoundCode": "B", "Date": "2012-10-08", "Investor": "Baxter International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GLO Science", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2011-03-07", "Investor": "Bill Budinger"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Global Blood Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "B", "Date": "2015-01-06", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Global Blood Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "B", "Date": "2015-01-06", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Global Blood Therapeutics", "Amount": "40700000", "FundingRoundCode": "A", "Date": "2012-06-14", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Global Blood Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "B", "Date": "2015-01-06", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "34300000", "FundingRoundCode": "B", "Date": "2005-12-16", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "34300000", "FundingRoundCode": "B", "Date": "2005-12-16", "Investor": "Genentech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "34300000", "FundingRoundCode": "B", "Date": "2005-12-16", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "34300000", "FundingRoundCode": "B", "Date": "2005-12-16", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "41200000", "FundingRoundCode": "C", "Date": "2007-09-26", "Investor": "Mellon Family Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "34300000", "FundingRoundCode": "B", "Date": "2005-12-16", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "34300000", "FundingRoundCode": "B", "Date": "2005-12-16", "Investor": "Partners HealthCare"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "41200000", "FundingRoundCode": "C", "Date": "2007-09-26", "Investor": "Richard King Mellon Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "34300000", "FundingRoundCode": "B", "Date": "2005-12-16", "Investor": "Sequel Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "41200000", "FundingRoundCode": "C", "Date": "2007-09-26", "Investor": "Wexford Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlobeImmune", "Amount": "41200000", "FundingRoundCode": "C", "Date": "2007-09-26", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Gloucester Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "D", "Date": "2009-08-25", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Gloucester Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "D", "Date": "2009-08-25", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Gloucester Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "D", "Date": "2009-08-25", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Gloucester Pharmaceuticals", "Amount": "2.9e+07", "FundingRoundCode": "D", "Date": "2009-08-25", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GlowDx", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Glowing Plant", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-07-16", "Investor": "Y Combinator"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "GlucoSentient", "Amount": "30000", "FundingRoundCode": "NA", "Date": "2012-10-12", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Glycart Biotechnology AG", "Amount": "13600000", "FundingRoundCode": "A", "Date": "2003-11-26", "Investor": "Quest Capital Management, Inc ."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2004-08-06", "Investor": "Alliance Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Alliance Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "4300000", "FundingRoundCode": "A", "Date": "2003-05-22", "Investor": "Alliance Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2004-08-06", "Investor": "Anthem Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Anthem Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "4300000", "FundingRoundCode": "A", "Date": "2003-05-22", "Investor": "Anthem Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Genzyme Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2004-08-06", "Investor": "Maryland Department of Business and Economic Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2004-08-06", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "4300000", "FundingRoundCode": "A", "Date": "2003-05-22", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "GlycoMimetics", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2004-08-06", "Investor": "PTV Healthcare Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "4220000", "FundingRoundCode": "B", "Date": "2010-10-20", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "675296", "FundingRoundCode": "A", "Date": "2009-09-29", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2009-05-05", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "375250", "FundingRoundCode": "NA", "Date": "2013-10-10", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "2350000", "FundingRoundCode": "NA", "Date": "2008-02-01", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "4220000", "FundingRoundCode": "B", "Date": "2010-10-20", "Investor": "Draper Nexus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "4220000", "FundingRoundCode": "B", "Date": "2010-10-20", "Investor": "EIV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "4220000", "FundingRoundCode": "B", "Date": "2010-10-20", "Investor": "Gideon Hixon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "4220000", "FundingRoundCode": "B", "Date": "2010-10-20", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "40323", "FundingRoundCode": "NA", "Date": "2014-02-11", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2009-05-05", "Investor": "Mercury Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "375250", "FundingRoundCode": "NA", "Date": "2013-10-10", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Glycos Biotechnologies", "Amount": "2350000", "FundingRoundCode": "NA", "Date": "2008-02-01", "Investor": "Mercury Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "GlyGenix Therapeutics", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2014-03-17", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Goddard Labs", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2014-07-09", "Investor": "Accelerate Long Island"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Good Start Genetics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-05-08", "Investor": "CRG"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Good Start Genetics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2010-09-10", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Good Start Genetics", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2012-04-02", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Good Start Genetics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2010-09-10", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Good Start Genetics", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2012-04-02", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Good Start Genetics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2010-09-10", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Good Start Genetics", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2012-04-02", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GoodBelly", "Amount": "1.6e+07", "FundingRoundCode": "NA", "Date": "2008-08-05", "Investor": "Maveron"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GrayBug", "Amount": "1740000", "FundingRoundCode": "A", "Date": "2015-03-06", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GrayBug", "Amount": "1740000", "FundingRoundCode": "A", "Date": "2015-03-06", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "GrayBug", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-10-29", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "3100000", "FundingRoundCode": "B", "Date": "2010-08-23", "Investor": "Charter Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "3100000", "FundingRoundCode": "B", "Date": "2010-08-23", "Investor": "Early Stage Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2011-10-19", "Investor": "JumpStart Inc."}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2007-08-22", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2008-04-09", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "3100000", "FundingRoundCode": "B", "Date": "2010-08-23", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "3100000", "FundingRoundCode": "B", "Date": "2010-08-23", "Investor": "Ohio TechAngels Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Great Lakes Pharmaceuticals", "Amount": "2400000", "FundingRoundCode": "A", "Date": "2008-04-09", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Green Biologics", "Amount": "3.4e+07", "FundingRoundCode": "NA", "Date": "2015-01-21", "Investor": "Tennenbaum Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Life Sciences|Technology", "CompanyName": "Green & Grow", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2014-08-27", "Investor": "Otter Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Greenlight Biosciences", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2013-08-12", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Greenlight Biosciences", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2013-08-12", "Investor": "Kodiak Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "greenovation Biotech", "Amount": "7062120", "FundingRoundCode": "B", "Date": "2006-11-25", "Investor": "SEED Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2010-04-26", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2011-12-12", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2010-04-26", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2011-12-12", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2010-04-26", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2011-12-12", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2010-04-26", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2011-12-12", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Groove Biopharma", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2010-04-26", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Guava Technologies", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2001-06-22", "Investor": "Fog City Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Guava Technologies", "Amount": "NA", "FundingRoundCode": "D", "Date": "2003-12-10", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Guava Technologies", "Amount": "NA", "FundingRoundCode": "E", "Date": "2005-11-04", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Guava Technologies", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2001-06-22", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Guava Technologies", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2001-06-22", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Guava Technologies", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2001-06-22", "Investor": "St. Paul Venture Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Marvel Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Alex Chang"}, {"FundingRoundType": "angel", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "70000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "Barry Rabkin"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Charlie Zha"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Dale Edmondson"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Eric Goldman"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Karun Sreerama"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Kenneth B. Tepper"}, {"FundingRoundType": "angel", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "70000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "Kent Jenkins"}, {"FundingRoundType": "seed", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "225000", "FundingRoundCode": "NA", "Date": "2012-10-10", "Investor": "Leo Polovets"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "330000", "FundingRoundCode": "NA", "Date": "2015-06-11", "Investor": "Leo Polovets"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Leo Polovets"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Mikihiro Yasuda"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Oliver Nicholas"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Roy Rodenstein"}, {"FundingRoundType": "seed", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "225000", "FundingRoundCode": "NA", "Date": "2012-10-10", "Investor": "Samir Kaji"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "330000", "FundingRoundCode": "NA", "Date": "2015-06-11", "Investor": "Samir Kaji"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Shashi Vaswani"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Suna Yalaz-Angell"}, {"FundingRoundType": "private_equity", "CompanyCategory": "B2B|Biotechnology|Business Development|Business Services|Hardware|Hardware + Software|Mobile|Software", "CompanyName": "Hackers/Founders", "Amount": "1534025", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "Yi Chang"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hadron Systems", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2011-05-05", "Investor": "Mentor Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Hana Biosciences", "Amount": "1e+08", "FundingRoundCode": "NA", "Date": "2010-06-07", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Hana Biosciences", "Amount": "1e+08", "FundingRoundCode": "NA", "Date": "2010-06-07", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HandyLab", "Amount": "19200000", "FundingRoundCode": "D", "Date": "2008-08-05", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HandyLab", "Amount": "19200000", "FundingRoundCode": "D", "Date": "2008-08-05", "Investor": "EDF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HandyLab", "Amount": "19200000", "FundingRoundCode": "D", "Date": "2008-08-05", "Investor": "Lurie Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HandyLab", "Amount": "19200000", "FundingRoundCode": "D", "Date": "2008-08-05", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Hapten Sciences", "Amount": "7e+05", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hapten Sciences", "Amount": "475000", "FundingRoundCode": "NA", "Date": "2014-01-02", "Investor": "MB Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Hapten Sciences", "Amount": "275000", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "MB Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Business Services|Pharmaceuticals", "CompanyName": "Harbin Pharmaceutical", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2004-12-20", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Harbour Antibodies", "Amount": "3216500", "FundingRoundCode": "A", "Date": "2013-07-24", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hawaii Biotech", "Amount": "4400000", "FundingRoundCode": "A", "Date": "2003-06-06", "Investor": "HMS Hawaii Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hawaii Biotech", "Amount": "4400000", "FundingRoundCode": "A", "Date": "2003-06-06", "Investor": "International Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HD Biosciences", "Amount": "NA", "FundingRoundCode": "A", "Date": "2008-08-08", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healionics", "Amount": "2600000", "FundingRoundCode": "B", "Date": "2008-12-11", "Investor": "Alliance of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healionics", "Amount": "2600000", "FundingRoundCode": "B", "Date": "2008-12-11", "Investor": "Bellingham Angel Organization"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healionics", "Amount": "2600000", "FundingRoundCode": "B", "Date": "2008-12-11", "Investor": "Keiretsu Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healionics", "Amount": "2600000", "FundingRoundCode": "B", "Date": "2008-12-11", "Investor": "Tacoma Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healionics", "Amount": "2600000", "FundingRoundCode": "B", "Date": "2008-12-11", "Investor": "ZINO Society"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Health Essentials", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-10-25", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Health Essentials", "Amount": "1006102", "FundingRoundCode": "NA", "Date": "2013-08-02", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Health Essentials", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-10-25", "Investor": "SV Life Sciences"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Health Integrated", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2003-01-01", "Investor": "River Cities Capital Funds"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Health Integrated", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2014-06-11", "Investor": "Western Technology Investment"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Health and Wellness", "CompanyName": "Hi.Q", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2014-12-17", "Investor": "CRV"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Health and Wellness", "CompanyName": "Hi.Q", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2014-12-17", "Investor": "First Round"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Health and Wellness", "CompanyName": "Hi.Q", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2014-12-17", "Investor": "Greylock Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Health and Wellness", "CompanyName": "Hi.Q", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2014-12-17", "Investor": "Menlo Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Health and Wellness", "CompanyName": "Hi.Q", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2014-12-17", "Investor": "Rock Health"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Health and Wellness", "CompanyName": "Hi.Q", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2014-12-17", "Investor": "Western Technology Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Technology", "CompanyName": "Health Outcomes Sciences", "Amount": "12750000", "FundingRoundCode": "A", "Date": "2014-03-12", "Investor": "Kansas Bioscience Authority"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Mansa Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2013-01-07", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "7e+06", "FundingRoundCode": "D", "Date": "2012-09-20", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2014-08-19", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2013-01-07", "Investor": "Radius Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-08-25", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Healthsense", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2013-01-07", "Investor": "West Health Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Heart Metabolics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-04-16", "Investor": "venBio"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "HeartFlow", "Amount": "104699896", "FundingRoundCode": "NA", "Date": "2014-02-27", "Investor": "Capricorn Investment Group"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Heat Biologics", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2014-08-25", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Heliae", "Amount": "8e+07", "FundingRoundCode": "NA", "Date": "2013-09-03", "Investor": "Mars"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Helix Therapeutics", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2010-11-23", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Helix Therapeutics", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2010-11-23", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Helix Therapeutics", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2010-01-11", "Investor": "LaunchCapital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Helixis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2007-08-30", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Helixis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2007-08-30", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Helixis", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2007-08-30", "Investor": "Okapi Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2012-03-12", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-04-21", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2012-03-12", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-04-21", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-11-02", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2012-03-12", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-04-21", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-11-02", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2012-03-12", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2012-03-12", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-04-21", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HemaQuest Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-11-02", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hemarina", "Amount": "1090000", "FundingRoundCode": "A", "Date": "2009-02-16", "Investor": "Finist\u00c3\u00a8re Business Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HepatoChem", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2011-10-14", "Investor": "Heartland Bridge Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "HepatoChem", "Amount": "330000", "FundingRoundCode": "NA", "Date": "2012-04-30", "Investor": "Massachusetts Life Sciences Center"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Hepregen", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2010-01-15", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hepregen", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2008-09-02", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hepregen", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2008-09-02", "Investor": "Innovation Valley Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Hepregen", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2011-05-25", "Investor": "Massachusetts Life Sciences Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Heptares Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2013-06-27", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Heptares Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2013-06-27", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hera Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2015-08-06", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hera Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2015-08-06", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-10-23", "Investor": "Arcturus Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "15700000", "FundingRoundCode": "D", "Date": "2011-02-23", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "15700000", "FundingRoundCode": "D", "Date": "2011-02-23", "Investor": "Merck Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-10-23", "Investor": "Merck Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "15700000", "FundingRoundCode": "D", "Date": "2011-02-23", "Investor": "Solstice Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-10-23", "Investor": "Solstice Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "15700000", "FundingRoundCode": "D", "Date": "2011-02-23", "Investor": "Valley Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "High Throughput Genomics", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2007-10-23", "Investor": "Valley Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Highland Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2015-06-24", "Investor": "Citibank"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Highland Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2015-06-24", "Investor": "Eastern Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Histogenics", "Amount": "13100000", "FundingRoundCode": "B", "Date": "2008-09-04", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Histogenics", "Amount": "13100000", "FundingRoundCode": "B", "Date": "2008-09-04", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Histogenics", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2012-07-23", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Histogenics", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2012-07-23", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HistoRx", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2007-10-24", "Investor": "Brook Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HistoRx", "Amount": "2600000", "FundingRoundCode": "NA", "Date": "2011-05-27", "Investor": "Brook Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HistoRx", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2007-10-24", "Investor": "Commons Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HistoRx", "Amount": "2600000", "FundingRoundCode": "NA", "Date": "2011-05-27", "Investor": "Commons Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HistoRx", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2007-10-24", "Investor": "Navigator Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "HistoRx", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2004-09-14", "Investor": "Navigator Technology Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "HistoSonics", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2015-09-03", "Investor": "Grand Angels"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "HistoSonics", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2015-09-03", "Investor": "Grand Rapids Business Journal"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Holaira", "Amount": "4.2e+07", "FundingRoundCode": "D", "Date": "2014-04-03", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Holaira", "Amount": "4.2e+07", "FundingRoundCode": "D", "Date": "2014-04-03", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Holaira", "Amount": "4.2e+07", "FundingRoundCode": "D", "Date": "2014-04-03", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Holaira", "Amount": "4.2e+07", "FundingRoundCode": "D", "Date": "2014-04-03", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Holaira", "Amount": "4.2e+07", "FundingRoundCode": "D", "Date": "2014-04-03", "Investor": "Vertex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Holaira", "Amount": "4.2e+07", "FundingRoundCode": "D", "Date": "2014-04-03", "Investor": "Windham Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Nutrition", "CompanyName": "Holganix", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2012-01-19", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health and Wellness|Nutrition", "CompanyName": "Holganix", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2015-01-20", "Investor": "The Yield Lab"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hookipa Biotech", "Amount": "25732000", "FundingRoundCode": "B", "Date": "2013-11-04", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Pharmaceuticals", "CompanyName": "Horizon Discovery", "Amount": "9800000", "FundingRoundCode": "C", "Date": "2010-09-28", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Horizon Pharma", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-07-23", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Horizon Pharma", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-07-23", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "H\u03bcREL", "Amount": "9200000", "FundingRoundCode": "A", "Date": "2013-04-03", "Investor": "Spring Mountain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "HTG Molecular Diagnostics", "Amount": "15700000", "FundingRoundCode": "D", "Date": "2011-02-24", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "HTG Molecular Diagnostics", "Amount": "15700000", "FundingRoundCode": "D", "Date": "2011-02-24", "Investor": "Merck Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "HTG Molecular Diagnostics", "Amount": "15700000", "FundingRoundCode": "D", "Date": "2011-02-24", "Investor": "Solstice Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "HTG Molecular Diagnostics", "Amount": "5e+05", "FundingRoundCode": "D", "Date": "2011-06-13", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hubble Telemedical", "Amount": "4e+05", "FundingRoundCode": "A", "Date": "2014-02-25", "Investor": "Launch Tennessee"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Hubble Telemedical", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hubble Telemedical", "Amount": "4e+05", "FundingRoundCode": "A", "Date": "2014-02-25", "Investor": "MB Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Hubble Telemedical", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2012-11-01", "Investor": "MB Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Hubble Telemedical", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Humacyte", "Amount": "1.5e+08", "FundingRoundCode": "B", "Date": "2015-10-20", "Investor": "Access Industries"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "HX Diagnostics", "Amount": "3100000", "FundingRoundCode": "A", "Date": "2009-02-17", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "HX Diagnostics", "Amount": "3100000", "FundingRoundCode": "A", "Date": "2009-02-17", "Investor": "Nanogen"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Cannabis|Pharmaceuticals", "CompanyName": "Hyasynth Bio", "Amount": "520000", "FundingRoundCode": "NA", "Date": "2015-06-29", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Cannabis|Pharmaceuticals", "CompanyName": "Hyasynth Bio", "Amount": "60000", "FundingRoundCode": "NA", "Date": "2014-05-20", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Cannabis|Pharmaceuticals", "CompanyName": "Hyasynth Bio", "Amount": "60000", "FundingRoundCode": "NA", "Date": "2014-05-20", "Investor": "Indie Bio"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Cannabis|Pharmaceuticals", "CompanyName": "Hyasynth Bio", "Amount": "520000", "FundingRoundCode": "NA", "Date": "2015-06-29", "Investor": "Andrew Hessel"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Cannabis|Pharmaceuticals", "CompanyName": "Hyasynth Bio", "Amount": "520000", "FundingRoundCode": "NA", "Date": "2015-06-29", "Investor": "Ethan Oren Perlstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hybrigenics", "Amount": "11598857", "FundingRoundCode": "B", "Date": "2001-12-01", "Investor": "Alafi Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hybrigenics", "Amount": "8531583", "FundingRoundCode": "A", "Date": "2000-06-01", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hybrigenics", "Amount": "11598857", "FundingRoundCode": "B", "Date": "2001-12-01", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hybrigenics", "Amount": "7320000", "FundingRoundCode": "NA", "Date": "2009-09-14", "Investor": "Yorkville Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "18870000", "FundingRoundCode": "B", "Date": "2004-01-12", "Investor": "Abbott Laboratories"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "18870000", "FundingRoundCode": "B", "Date": "2004-01-12", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "3.4e+07", "FundingRoundCode": "C", "Date": "2008-03-13", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "9300000", "FundingRoundCode": "A", "Date": "2002-07-26", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "18870000", "FundingRoundCode": "B", "Date": "2004-01-12", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "3.4e+07", "FundingRoundCode": "C", "Date": "2008-03-13", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "18870000", "FundingRoundCode": "B", "Date": "2004-01-12", "Investor": "Boston Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "9300000", "FundingRoundCode": "A", "Date": "2002-07-26", "Investor": "Boston Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "18870000", "FundingRoundCode": "B", "Date": "2004-01-12", "Investor": "Lilly BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "3.4e+07", "FundingRoundCode": "C", "Date": "2008-03-13", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2009-01-16", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "18870000", "FundingRoundCode": "B", "Date": "2004-01-12", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "3.4e+07", "FundingRoundCode": "C", "Date": "2008-03-13", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "9300000", "FundingRoundCode": "A", "Date": "2002-07-26", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "18870000", "FundingRoundCode": "B", "Date": "2004-01-12", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "3.4e+07", "FundingRoundCode": "C", "Date": "2008-03-13", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Hydra Biosciences", "Amount": "9300000", "FundingRoundCode": "A", "Date": "2002-07-26", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2009-06-30", "Investor": "Bay City Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2007-10-05", "Investor": "Comerica Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2007-09-05", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2009-06-30", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2007-09-05", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2009-06-30", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2009-06-30", "Investor": "Panorama Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2007-09-05", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2009-06-30", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Hyperion Therapeutics", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2007-09-05", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "ICAgen", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2009-09-21", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iCardiac Technologies", "Amount": "NA", "FundingRoundCode": "B", "Date": "2007-11-14", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iCardiac Technologies", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2006-11-08", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "iCardiac Technologies", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-03-06", "Investor": "Norwest Venture Partners - NVP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iCardiac Technologies", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2006-11-08", "Investor": "Stonehenge Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iCardiac Technologies", "Amount": "NA", "FundingRoundCode": "B", "Date": "2007-11-14", "Investor": "Stonehenge Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iCardiac Technologies", "Amount": "NA", "FundingRoundCode": "B", "Date": "2007-11-14", "Investor": "Trillium Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iCeutica", "Amount": "5e+05", "FundingRoundCode": "B", "Date": "2007-01-12", "Investor": "Phoenix IP Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iCeutica", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2005-06-20", "Investor": "Phoenix IP Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iconic Therapeutics", "Amount": "2500000", "FundingRoundCode": "C", "Date": "2009-01-17", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iconic Therapeutics", "Amount": "4587001", "FundingRoundCode": "A", "Date": "2004-12-29", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iconic Therapeutics", "Amount": "1304901", "FundingRoundCode": "B", "Date": "2007-04-30", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iconic Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-08-22", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iconic Therapeutics", "Amount": "2500000", "FundingRoundCode": "C", "Date": "2009-01-17", "Investor": "Elm Street Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iconic Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "H.I.G. BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iconic Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IDEV Technologies", "Amount": "4.6e+07", "FundingRoundCode": "D", "Date": "2010-10-07", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IDEV Technologies", "Amount": "4.6e+07", "FundingRoundCode": "D", "Date": "2010-10-07", "Investor": "Heron Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IDEV Technologies", "Amount": "4.6e+07", "FundingRoundCode": "D", "Date": "2010-10-07", "Investor": "Piper Jaffray Private Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IDEV Technologies", "Amount": "4.6e+07", "FundingRoundCode": "D", "Date": "2010-10-07", "Investor": "PTV Healthcare Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IDEV Technologies", "Amount": "4.6e+07", "FundingRoundCode": "D", "Date": "2010-10-07", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2010-06-14", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2012-06-12", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2014-01-28", "Investor": "5AM Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "215740", "FundingRoundCode": "NA", "Date": "2014-08-07", "Investor": "National Cancer Institute (NCI)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2010-06-14", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2012-06-12", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2014-01-28", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2010-06-14", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2012-06-12", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2014-01-28", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2012-06-12", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Igenica", "Amount": "1.4e+07", "FundingRoundCode": "C", "Date": "2014-01-28", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ignyta", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2012-12-31", "Investor": "City Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ignyta", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2012-12-31", "Investor": "Colt Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ignyta", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-01-06", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ignyta", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2012-12-31", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikaria", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2005-04-27", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikaria", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2005-04-27", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikaria", "Amount": "2.8e+08", "FundingRoundCode": "B", "Date": "2007-03-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikaria", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2005-04-27", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikonisys", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-10-17", "Investor": "Goldman Sachs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikonisys", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-10-17", "Investor": "Lakeview Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikonisys", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-10-17", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ikonisys", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-10-17", "Investor": "Palisade Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImaCor", "Amount": "5450000", "FundingRoundCode": "A", "Date": "2009-02-21", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImaCor", "Amount": "5450000", "FundingRoundCode": "A", "Date": "2009-02-21", "Investor": "WFD Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Imagen Biotech", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2011-10-19", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Imagen Biotech", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2011-10-19", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "ImaginAb", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-03-27", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "ImaginAb", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2014-05-08", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Imago BioSciences", "Amount": "26500000", "FundingRoundCode": "A", "Date": "2014-10-31", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Imago BioSciences", "Amount": "26500000", "FundingRoundCode": "A", "Date": "2014-10-31", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Imago BioSciences", "Amount": "26500000", "FundingRoundCode": "A", "Date": "2014-10-31", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Imago BioSciences", "Amount": "26500000", "FundingRoundCode": "A", "Date": "2014-10-31", "Investor": "Merck Research Laboratories"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Independent Pharmacies|Manufacturing|Pharmaceuticals", "CompanyName": "immatics biotechnologies", "Amount": "51964000", "FundingRoundCode": "B", "Date": "2007-02-08", "Investor": "DH Capital"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Immatics US", "Amount": "19700000", "FundingRoundCode": "NA", "Date": "2015-09-02", "Investor": "Cancer Prevention and Research Institute of Texas"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2008-07-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2010-07-26", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2010-07-26", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2010-07-26", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2008-07-07", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2010-07-26", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "Topspin Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2008-07-07", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "4.9e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Immune Design", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2010-07-26", "Investor": "Versant Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Immunetics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2011-05-25", "Investor": "Massachusetts Life Sciences Center"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Immunetics", "Amount": "3700000", "FundingRoundCode": "NA", "Date": "2012-09-10", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Immunetrics", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2006-04-11", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "ImmuneWorks", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2007-10-30", "Investor": "BioCrossroads"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImmuneXcite", "Amount": "3580000", "FundingRoundCode": "B", "Date": "2014-01-07", "Investor": "Massachusetts Life Sciences Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Market Research", "CompanyName": "Immunocore", "Amount": "3.2e+08", "FundingRoundCode": "NA", "Date": "2015-07-16", "Investor": "Eli Lilly"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Immunologix", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2010-03-12", "Investor": "SC Launch"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Immunome", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2015-02-11", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Immunomic Therapeutics", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2010-03-28", "Investor": "Life Sciences Greenhouse of Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Immunomic Therapeutics", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2010-03-28", "Investor": "Minority Angel Investor Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImmunoPhotonics", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2014-09-03", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImmunoPhotonics", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2014-09-03", "Investor": "Cultivation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImmunoPhotonics", "Amount": "1800000", "FundingRoundCode": "A", "Date": "2014-09-03", "Investor": "iSELECT FUND"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "ImmusanT", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2014-12-22", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "ImmusanT", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2011-12-13", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Immusoft", "Amount": "350000", "FundingRoundCode": "NA", "Date": "2012-04-21", "Investor": "Thiel Foundation"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "ImmuVen", "Amount": "1680000", "FundingRoundCode": "NA", "Date": "2012-05-01", "Investor": "National Institute for Allergy and Infectious Disease"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "ImmuVen", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2011-11-04", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImpactRx", "Amount": "NA", "FundingRoundCode": "C", "Date": "2002-05-01", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImpactRx", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2003-07-08", "Investor": "Merck Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ImpactRx", "Amount": "NA", "FundingRoundCode": "C", "Date": "2002-05-01", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Impedance Cardiology Systems", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2006-11-29", "Investor": "Versant Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Bioinformatics|Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Impedans", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-01-01", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Imperative Health", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2010-01-26", "Investor": "New Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Imperative Health", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2010-01-26", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IMT (Innovative Micro Technology)", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2002-01-01", "Investor": "L-3 Communications"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IMT (Innovative Micro Technology)", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2005-01-01", "Investor": "Miramar Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IMT (Innovative Micro Technology)", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2005-01-01", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "ImThera Medical Inc", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2011-10-05", "Investor": "Cyberonics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "ImThera Medical Inc", "Amount": "4000005", "FundingRoundCode": "C", "Date": "2013-04-02", "Investor": "Cyberonics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InCarda Therapeutics", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2015-04-28", "Investor": "Morningside Private Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inception Sciences", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2013-12-09", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Incline Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2010-06-28", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Incline Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2010-06-28", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Incline Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2010-06-28", "Investor": "Emergent Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Incline Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2010-06-28", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Incline Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2010-06-28", "Investor": "Saints Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Incline Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "A", "Date": "2010-06-28", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Indee", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-08-12", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Industrial Microbes", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "CLI Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Industrial Microbes", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-12-01", "Investor": "Y Combinator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfaCare Pharmaceutical", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2006-03-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Infinity Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2004-01-08", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inflexxion", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "Akoya Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inflexxion", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "Fidus Investment Corporation."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inflexxion", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "Periscope Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "Boynton Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "Broadview Ventures"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1205000", "FundingRoundCode": "NA", "Date": "2013-11-19", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2015-08-05", "Investor": "Excel Venture Management"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-12-12", "Investor": "Fort Point Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "NA", "FundingRoundCode": "A", "Date": "2013-03-11", "Investor": "HealthTech Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "HealthTech Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "Keiretsu Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "LaunchPad Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2015-08-05", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "TiE Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2015-08-05", "Investor": "Zaffre Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-04-08", "Investor": "Zaffre Investments"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "InfoBionic", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-12-12", "Investor": "Oleg Uritsky"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "InformedDNA", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2013-07-08", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ingenuity Systems", "Amount": "15400000", "FundingRoundCode": "NA", "Date": "2010-07-01", "Investor": "Accel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ingenuity Systems", "Amount": "15400000", "FundingRoundCode": "NA", "Date": "2010-07-01", "Investor": "Morgan Stanley Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ingenuity Systems", "Amount": "15400000", "FundingRoundCode": "NA", "Date": "2010-07-01", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ingenuity Systems", "Amount": "15400000", "FundingRoundCode": "NA", "Date": "2010-07-01", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ingram Medical", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2013-09-05", "Investor": "Kickstart Seed Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ingram Medical", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2013-09-05", "Investor": "Mercato Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ingram Medical", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2013-09-05", "Investor": "StepStone Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inhibitex", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2002-02-11", "Investor": "Alliance Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inhibitex", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2002-02-11", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inhibitex", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2002-02-11", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inhibitex", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2002-02-11", "Investor": "Pacific Horizon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inhibitex", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2002-02-11", "Investor": "William Blair Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inimex Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2008-06-02", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inivata", "Amount": "6540899", "FundingRoundCode": "A", "Date": "2014-09-23", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innate Pharma", "Amount": "18199907", "FundingRoundCode": "C", "Date": "2004-09-01", "Investor": "NIF SMBC Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Innate Pharma", "Amount": "26117980", "FundingRoundCode": "NA", "Date": "2013-11-20", "Investor": "QVT Financial"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Innate Pharma", "Amount": "26117980", "FundingRoundCode": "NA", "Date": "2013-11-20", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InnFocus Inc", "Amount": "32800000", "FundingRoundCode": "C", "Date": "2015-09-30", "Investor": "Saints Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "InnoPharma", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2013-11-13", "Investor": "Athyrium Opportunities Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InnoPharma", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2012-06-07", "Investor": "Comerica Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InnoPharma", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2012-06-07", "Investor": "NXT Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InnoPharma", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2011-12-02", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovative Biologics", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2007-10-02", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovative Biosensors", "Amount": "9500000", "FundingRoundCode": "NA", "Date": "2008-05-01", "Investor": "Chart Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovative Biosensors", "Amount": "9500000", "FundingRoundCode": "NA", "Date": "2008-05-01", "Investor": "CNF Investments, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovative Biosensors", "Amount": "9500000", "FundingRoundCode": "NA", "Date": "2008-05-01", "Investor": "Harbert Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovative Biosensors", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2005-05-26", "Investor": "Harbert Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovative Biosensors", "Amount": "9500000", "FundingRoundCode": "NA", "Date": "2008-05-01", "Investor": "Maryland Department of Business and Economic Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovative Biosensors", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2005-05-26", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovent Biologics", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2012-11-16", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Innovent Biologics", "Amount": "1e+08", "FundingRoundCode": "C", "Date": "2015-01-22", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "19300000", "FundingRoundCode": "C", "Date": "2007-08-23", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2004-04-14", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "23600000", "FundingRoundCode": "D", "Date": "2011-07-19", "Investor": "Care Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2013-09-27", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "23600000", "FundingRoundCode": "D", "Date": "2011-07-19", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2013-09-27", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "19300000", "FundingRoundCode": "C", "Date": "2007-08-23", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2004-04-14", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "23600000", "FundingRoundCode": "D", "Date": "2011-07-19", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2013-09-27", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "23600000", "FundingRoundCode": "D", "Date": "2011-07-19", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "19300000", "FundingRoundCode": "C", "Date": "2007-08-23", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2004-04-14", "Investor": "Rho Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Inotek Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2013-09-27", "Investor": "Rho Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Inovio Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2015-09-22", "Investor": "Darpa"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Manufacturing", "CompanyName": "Insectigen", "Amount": "1160000", "FundingRoundCode": "NA", "Date": "2005-11-29", "Investor": "ATDC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Insightra Medical", "Amount": "NA", "FundingRoundCode": "C", "Date": "2013-10-21", "Investor": "Tekla Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Medical|Semiconductors|Testing", "CompanyName": "Insilixa", "Amount": "1.3e+07", "FundingRoundCode": "NA", "Date": "2014-10-22", "Investor": "PointGuard Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "GDN Holdings"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2009-06-29", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "Medtronic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "TGap Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2014-05-15", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware|Health Care", "CompanyName": "Inspire Medical Systems", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2009-06-29", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Instant Labs Medical Diagnostics Corp.", "Amount": "875000", "FundingRoundCode": "NA", "Date": "2012-07-13", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "FirstMark Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "Oakwood Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2002-10-07", "Investor": "Oakwood Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2002-10-07", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2001-08-08", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2002-10-07", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "TIAA-CREF"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "35500000", "FundingRoundCode": "D", "Date": "2004-03-02", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "2.2e+07", "FundingRoundCode": "C", "Date": "2002-10-07", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Insulet", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2001-08-08", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2004-12-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2007-03-20", "Investor": "Alta Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-04-01", "Investor": "Farallon Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-04-01", "Investor": "Foresite Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-04-01", "Investor": "Fred Alger Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "1.6e+08", "FundingRoundCode": "C", "Date": "2012-11-16", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2004-12-01", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2007-03-20", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "1.6e+08", "FundingRoundCode": "C", "Date": "2012-11-16", "Investor": "Marker"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2004-12-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-09-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-15", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2007-03-20", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-09-08", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-15", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2007-03-20", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-04-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2007-03-20", "Investor": "Quadrille Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-04-01", "Investor": "Quadrille Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-04-01", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "1.6e+08", "FundingRoundCode": "C", "Date": "2012-11-16", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2004-12-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-09-08", "Investor": "Venrock"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2012-11-15", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "D", "Date": "2003-01-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intarcia Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2007-03-20", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2011-12-13", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2011-12-13", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "15600000", "FundingRoundCode": "B", "Date": "2011-02-03", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "18100000", "FundingRoundCode": "B", "Date": "2009-11-12", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2011-12-13", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2011-12-13", "Investor": "Greenspring Associates"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-09-22", "Investor": "Horizon Technology Finance"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "15600000", "FundingRoundCode": "B", "Date": "2011-02-03", "Investor": "In-Q-Tel"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2006-08-29", "Investor": "In-Q-Tel"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "18100000", "FundingRoundCode": "B", "Date": "2009-11-12", "Investor": "In-Q-Tel"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2011-12-13", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "IntegenX", "Amount": "18100000", "FundingRoundCode": "B", "Date": "2009-11-12", "Investor": "Western Technology Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-07-14", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-07-14", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-07-14", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2013-12-10", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-10-14", "Investor": "InterWest Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2013-09-20", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "30250000", "FundingRoundCode": "B", "Date": "2014-04-29", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2012-02-22", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-07-14", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-07-14", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|E-Commerce|Fashion|Health Care|Health Diagnostics", "CompanyName": "Integrated Diagnostics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-07-14", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intelect Medical", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-06-14", "Investor": "Boston Scientific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intelect Medical", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2007-06-14", "Investor": "Greatbatch"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellia Therapeutics", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2015-09-01", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellia Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2014-11-18", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellia Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2014-11-18", "Investor": "Caribou Biosciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellia Therapeutics", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2015-09-01", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellia Therapeutics", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2015-09-01", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellia Therapeutics", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2015-09-01", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellia Therapeutics", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2015-09-01", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellicyt", "Amount": "7400000", "FundingRoundCode": "NA", "Date": "2015-10-22", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellicyt", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2013-05-06", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellicyt", "Amount": "7400000", "FundingRoundCode": "NA", "Date": "2015-10-22", "Investor": "New Mexico Community Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellicyt", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2013-05-06", "Investor": "New Mexico Community Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Intellicyt", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2014-06-10", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellicyt", "Amount": "7400000", "FundingRoundCode": "NA", "Date": "2015-10-22", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellicyt", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2013-05-06", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Intelligent Bio-Systems", "Amount": "353000", "FundingRoundCode": "A", "Date": "2008-03-27", "Investor": "Hub Angels Investment Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellikine", "Amount": "5.1e+07", "FundingRoundCode": "B", "Date": "2009-07-22", "Investor": "Biogen Idec"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellikine", "Amount": "5.1e+07", "FundingRoundCode": "B", "Date": "2009-07-22", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellikine", "Amount": "5.1e+07", "FundingRoundCode": "B", "Date": "2009-07-22", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellikine", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-06-01", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intellikine", "Amount": "5.1e+07", "FundingRoundCode": "B", "Date": "2009-07-22", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Intentiva", "Amount": "25000", "FundingRoundCode": "NA", "Date": "2014-01-13", "Investor": "Plug & Play Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intercell", "Amount": "3.4e+07", "FundingRoundCode": "C", "Date": "2003-07-18", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Intercept Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2012-08-10", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Interface Biologics, Inc.", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2008-12-09", "Investor": "BDC Capital Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Interface Biologics, Inc.", "Amount": "NA", "FundingRoundCode": "B", "Date": "2015-01-13", "Investor": "BDC Capital Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Interface Biologics, Inc.", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2008-12-09", "Investor": "Covington Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2008-08-04", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2008-08-04", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2007-01-12", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2008-08-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2007-01-12", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2008-08-04", "Investor": "Sears Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2007-01-12", "Investor": "Sears Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2008-08-04", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2008-08-04", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2007-01-12", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2008-08-04", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InteKrin", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2007-01-12", "Investor": "Vivo Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "InterValve", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2015-01-21", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Interventional Spine", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2007-05-31", "Investor": "MedFocus Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Interventional Spine", "Amount": "2.4e+07", "FundingRoundCode": "C", "Date": "2007-05-31", "Investor": "Wexford Capital"}, {"FundingRoundType": "secondary_market", "CompanyCategory": "Biotechnology", "CompanyName": "Intra-Cellular Therapies", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-09-01", "Investor": "Broadfin Capital"}, {"FundingRoundType": "secondary_market", "CompanyCategory": "Biotechnology", "CompanyName": "Intra-Cellular Therapies", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-09-01", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "21400000", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2006-11-21", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "21400000", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2006-11-21", "Investor": "Emerging Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "21400000", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2006-11-21", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "21400000", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Intradigm Corporation", "Amount": "21400000", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "IntraLuminal Therapeutics", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2002-04-13", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "14600000", "FundingRoundCode": "C", "Date": "2004-07-14", "Investor": "CB Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "14600000", "FundingRoundCode": "C", "Date": "2004-07-14", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "2250000", "FundingRoundCode": "NA", "Date": "2012-04-09", "Investor": "InCube Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "14600000", "FundingRoundCode": "C", "Date": "2004-07-14", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "2250000", "FundingRoundCode": "NA", "Date": "2012-04-09", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "14600000", "FundingRoundCode": "C", "Date": "2004-07-14", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "6201511", "FundingRoundCode": "NA", "Date": "2012-09-04", "Investor": "The Angels' Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "6201511", "FundingRoundCode": "NA", "Date": "2012-09-04", "Investor": "The Halo Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "14600000", "FundingRoundCode": "C", "Date": "2004-07-14", "Investor": "The Halo Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrapace", "Amount": "14600000", "FundingRoundCode": "C", "Date": "2004-07-14", "Investor": "Toucan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrexon Corporation", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-07-07", "Investor": "New River Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrexon Corporation", "Amount": "1e+08", "FundingRoundCode": "E", "Date": "2011-05-31", "Investor": "New River Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrexon Corporation", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2006-03-01", "Investor": "NewVa Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrexon Corporation", "Amount": "1e+08", "FundingRoundCode": "E", "Date": "2011-05-31", "Investor": "NewVa Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrexon Corporation", "Amount": "5e+05", "FundingRoundCode": "B", "Date": "2005-05-17", "Investor": "Third Security"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrexon Corporation", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2007-05-16", "Investor": "Third Security"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Intrexon Corporation", "Amount": "1e+08", "FundingRoundCode": "E", "Date": "2011-05-31", "Investor": "Third Security"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inviragen", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2009-10-06", "Investor": "Charter Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Inviragen", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2009-10-06", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Three Leaf Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2013-12-10", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Genomic Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2013-12-10", "Investor": "Genomic Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "3644999", "FundingRoundCode": "NA", "Date": "2010-09-15", "Investor": "Healthy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "4e+07", "FundingRoundCode": "E", "Date": "2013-12-10", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Invitae", "Amount": "1.2e+08", "FundingRoundCode": "F", "Date": "2014-10-13", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "InVivo Therapeutics", "Amount": "1.3e+07", "FundingRoundCode": "NA", "Date": "2010-12-03", "Investor": "Spencer Trask & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IOD Incorporated", "Amount": "3.5e+07", "FundingRoundCode": "NA", "Date": "2010-07-13", "Investor": "LLR Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iomai Corporation", "Amount": "5.4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iomai Corporation", "Amount": "5.4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Iomai Corporation", "Amount": "5.4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Ion Healthcare", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2004-12-09", "Investor": "J.W. Childs Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ion Torrent", "Amount": "37064376", "FundingRoundCode": "C", "Date": "2010-03-05", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "28970000", "FundingRoundCode": "B", "Date": "2010-11-09", "Investor": "ATEL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "28970000", "FundingRoundCode": "B", "Date": "2010-11-09", "Investor": "Biogen Idec"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "28970000", "FundingRoundCode": "B", "Date": "2010-11-09", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2009-07-08", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "28970000", "FundingRoundCode": "B", "Date": "2010-11-09", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-09-04", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2009-07-08", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "28970000", "FundingRoundCode": "B", "Date": "2010-11-09", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-09-04", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2009-07-08", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "28970000", "FundingRoundCode": "B", "Date": "2010-11-09", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-09-04", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iPierian", "Amount": "28970000", "FundingRoundCode": "B", "Date": "2010-11-09", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2012-11-19", "Investor": "California HealthCare Foundation"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "12180000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2013-04-10", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2011-05-04", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "12180000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2007-02-08", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-05-20", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2009-05-18", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2011-05-04", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "12180000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2013-04-10", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "27343269", "FundingRoundCode": "E", "Date": "2015-03-17", "Investor": "Norwest Venture Partners - NVP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2013-04-10", "Investor": "Norwest Venture Partners - NVP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-05-20", "Investor": "St. Jude Medical"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2013-04-10", "Investor": "Stanford University"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2009-05-18", "Investor": "Stanford University"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2011-05-04", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "12180000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2007-02-08", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-05-20", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2013-04-10", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iRhythm Technologies", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2009-05-18", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IROA Technologies", "Amount": "7e+05", "FundingRoundCode": "NA", "Date": "2013-04-22", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Iroko Pharmaceuticals", "Amount": "7.5e+07", "FundingRoundCode": "NA", "Date": "2013-11-21", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "2759185", "FundingRoundCode": "NA", "Date": "2012-01-27", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "2759185", "FundingRoundCode": "NA", "Date": "2012-01-27", "Investor": "CHV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "CHV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "2759185", "FundingRoundCode": "NA", "Date": "2012-01-27", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "2759185", "FundingRoundCode": "NA", "Date": "2012-01-27", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "20500000", "FundingRoundCode": "F", "Date": "2009-05-05", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Interventional", "Amount": "2759185", "FundingRoundCode": "NA", "Date": "2012-01-27", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2003-03-17", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2003-03-17", "Investor": "De Novo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2005-03-31", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2003-03-17", "Investor": "Pacific Horizon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2005-03-31", "Investor": "Pacific Horizon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2003-03-17", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2005-03-31", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iScience Surgical", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2005-03-31", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Isentio", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2011-01-17", "Investor": "Sarsia Seed Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Isis Pharmaceuticals", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2014-07-02", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Isolation Sciences", "Amount": "48000", "FundingRoundCode": "NA", "Date": "2008-07-01", "Investor": "Syracuse Center of Excellence"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IsoPlexis", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2014-08-11", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IsoPlexis", "Amount": "1250000", "FundingRoundCode": "A", "Date": "2014-08-12", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "IsoPlexis", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2014-06-05", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "IsoPlexis", "Amount": "1250000", "FundingRoundCode": "A", "Date": "2014-08-12", "Investor": "Spring Mountain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Isto Technologies", "Amount": "8800000", "FundingRoundCode": "E", "Date": "2007-08-03", "Investor": "Alafi Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Isto Technologies", "Amount": "8800000", "FundingRoundCode": "E", "Date": "2007-08-03", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Isto Technologies", "Amount": "8800000", "FundingRoundCode": "E", "Date": "2007-08-03", "Investor": "Mid-America Transplant Services"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "IV Diagnostics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-06-05", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "iVeena", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2015-09-25", "Investor": "Park City Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iZumi Bio", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2009-04-14", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "iZumi Bio", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2009-04-14", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "J. Craig Venter Institute", "Amount": "2400000", "FundingRoundCode": "NA", "Date": "2013-09-18", "Investor": "National Science Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Beecken Petty O'Keefe & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "EGS Healthcare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Golden Gate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "KKR (Kohlberg Kravis Roberts & Co.)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Thoma Cressey Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Jazz Pharmaceuticals", "Amount": "2.5e+08", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Jounce Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "B", "Date": "2015-04-23", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Jounce Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "B", "Date": "2015-04-23", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Jounce Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "B", "Date": "2015-04-23", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Jounce Therapeutics", "Amount": "4.7e+07", "FundingRoundCode": "A", "Date": "2013-02-14", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Jounce Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "B", "Date": "2015-04-23", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "JourneyPure", "Amount": "1431000", "FundingRoundCode": "A", "Date": "2015-05-28", "Investor": "Clayton Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Juno Therapeutics", "Amount": "1.2e+08", "FundingRoundCode": "A", "Date": "2013-12-03", "Investor": "Alaska Permanent Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Juno Therapeutics", "Amount": "1.2e+08", "FundingRoundCode": "A", "Date": "2013-12-03", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Juno Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "A", "Date": "2014-04-24", "Investor": "Bezos Expeditions"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Juno Therapeutics", "Amount": "1.34e+08", "FundingRoundCode": "B", "Date": "2014-08-05", "Investor": "Bezos Expeditions"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Juno Therapeutics", "Amount": "5.6e+07", "FundingRoundCode": "A", "Date": "2014-04-24", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Juno Therapeutics", "Amount": "1.34e+08", "FundingRoundCode": "B", "Date": "2014-08-05", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Just. Biotherapeutics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-09-21", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Just. Biotherapeutics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-09-21", "Investor": "Merck & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juvaris BioTherapeutics", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-01-27", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juvaris BioTherapeutics", "Amount": "15880000", "FundingRoundCode": "A", "Date": "2007-01-05", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juvaris BioTherapeutics", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2010-04-12", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juvaris BioTherapeutics", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-01-27", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juvaris BioTherapeutics", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2010-04-12", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Early Stage Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2008-09-30", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Reservoir Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Juventas Therapeutics", "Amount": "22200000", "FundingRoundCode": "B", "Date": "2012-07-16", "Investor": "Venture Investors"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "K94 Discoveries", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2013-09-24", "Investor": "BVM Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "K94 Discoveries", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2013-09-24", "Investor": "Themelios Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kadmus Pharmaceuticals", "Amount": "15300000", "FundingRoundCode": "A", "Date": "2004-02-10", "Investor": "Gray Ghost Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kadmus Pharmaceuticals", "Amount": "15300000", "FundingRoundCode": "A", "Date": "2004-02-10", "Investor": "NeuroVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kadmus Pharmaceuticals", "Amount": "15300000", "FundingRoundCode": "A", "Date": "2004-02-10", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kadmus Pharmaceuticals", "Amount": "15300000", "FundingRoundCode": "A", "Date": "2004-02-10", "Investor": "SB Life Science"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-05-02", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-05-02", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2003-12-04", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-05-02", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2003-12-04", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-05-02", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2003-12-04", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-05-02", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "KAI Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2003-12-04", "Investor": "Skyline Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Kaiima", "Amount": "6.5e+07", "FundingRoundCode": "NA", "Date": "2013-09-03", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kaiima", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2011-04-05", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kaiima", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2011-04-05", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Kaiser Permanente", "Amount": "7400000", "FundingRoundCode": "NA", "Date": "2014-08-05", "Investor": "National Cancer Institute"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "B", "Date": "2014-04-23", "Investor": "AbbVie Biotech Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "7243205", "FundingRoundCode": "NA", "Date": "2012-03-14", "Investor": "Lighthouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "B", "Date": "2014-04-23", "Investor": "Lux Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "7243205", "FundingRoundCode": "NA", "Date": "2012-03-14", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "11500000", "FundingRoundCode": "A", "Date": "2013-02-28", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "B", "Date": "2014-04-23", "Investor": "Polaris Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "7243205", "FundingRoundCode": "NA", "Date": "2012-03-14", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "11500000", "FundingRoundCode": "A", "Date": "2013-02-28", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "22500000", "FundingRoundCode": "B", "Date": "2014-04-23", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "7243205", "FundingRoundCode": "NA", "Date": "2012-03-14", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kala Pharmaceuticals", "Amount": "11500000", "FundingRoundCode": "A", "Date": "2013-02-28", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "kaleo", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-05-29", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kalidex Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kalidex Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kalidex Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kalidex Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kalidex Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kalidex Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Chemicals|Startups", "CompanyName": "Kalion", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-11-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Startups", "CompanyName": "Kalion", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-03-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2008-12-22", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2005-03-16", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2008-09-23", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2008-12-22", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2005-03-16", "Investor": "Alloy Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2003-06-24", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2008-09-23", "Investor": "Alloy Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Fidelity Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2008-12-22", "Investor": "Genzyme Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2008-12-22", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2005-03-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2008-09-23", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2008-12-22", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2005-03-16", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2003-06-24", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "KaloBios Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2008-09-23", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KalVista Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-07-22", "Investor": "Longwood Founders Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KalVista Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-07-22", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KalVista Pharmaceuticals", "Amount": "13207305", "FundingRoundCode": "A", "Date": "2011-08-23", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KalVista Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-07-22", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KalVista Pharmaceuticals", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-07-22", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "1e+08", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "Invemed Catalyst Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "KT Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "1e+08", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "KT Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "Tavistock Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "1e+08", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "Tavistock Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2004-08-05", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Kalypsys", "Amount": "1e+08", "FundingRoundCode": "C", "Date": "2006-11-29", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Cannabis|Pharmaceuticals", "CompanyName": "KannaLife Sciences", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-03-07", "Investor": "Medical Marijuana"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Karus Therapeutics", "Amount": "7600000", "FundingRoundCode": "B", "Date": "2012-09-06", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Karus Therapeutics", "Amount": "7600000", "FundingRoundCode": "B", "Date": "2012-09-06", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Karyopharm Therapeutics", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2013-07-31", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Karyopharm Therapeutics", "Amount": "48200000", "FundingRoundCode": "B", "Date": "2013-05-20", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Karyopharm Therapeutics", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2013-07-31", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Karyopharm Therapeutics", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2013-07-31", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "KemPharm", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "Deerfield"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Keraderm", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2013-10-30", "Investor": "MassChallenge"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Keraderm", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2010-01-17", "Investor": "NewVa Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KeraFAST", "Amount": "2988252", "FundingRoundCode": "A", "Date": "2012-04-11", "Investor": "Clayton Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KeraFAST", "Amount": "2988252", "FundingRoundCode": "A", "Date": "2012-04-11", "Investor": "FCA Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KEW Group", "Amount": "16798000", "FundingRoundCode": "B", "Date": "2014-12-16", "Investor": "Arsenal Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KEW Group", "Amount": "16798000", "FundingRoundCode": "B", "Date": "2014-12-16", "Investor": "HealthCare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KEW Group", "Amount": "16798000", "FundingRoundCode": "B", "Date": "2014-12-16", "Investor": "Signet Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kiadis Pharma", "Amount": "12809000", "FundingRoundCode": "NA", "Date": "2012-11-20", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kiadis Pharma", "Amount": "20190146.3112603", "FundingRoundCode": "NA", "Date": "2007-06-26", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KiloBaser", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-05-02", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KiloBaser", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-05-02", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KinDex Therapeutics", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2015-03-09", "Investor": "Polaris Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Kineta", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-03-13", "Investor": "angelMD"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kite Pharma", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2013-05-15", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kite Pharma", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2011-03-09", "Investor": "Riverbank Capital Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kite Pharma", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2014-04-28", "Investor": "Arie Belldegrun"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KIYATEC", "Amount": "NA", "FundingRoundCode": "A", "Date": "2012-05-23", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "KIYATEC", "Amount": "NA", "FundingRoundCode": "A", "Date": "2012-05-23", "Investor": "Upstate Carolina Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Technology|Nutrition", "CompanyName": "KnipBio", "Amount": "1585523", "FundingRoundCode": "A", "Date": "2015-01-20", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Clean Technology|Nutrition", "CompanyName": "KnipBio", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2013-10-29", "Investor": "MassChallenge"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kolltan Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-03-19", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kolltan Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-03-19", "Investor": "KLP Enterprises"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kolltan Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-03-19", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kolltan Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2008-07-31", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kolltan Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-03-19", "Investor": "Purdue Pharma"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kolltan Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2009-10-12", "Investor": "Purdue Pharma"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kolltan Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2008-07-31", "Investor": "Purdue Pharma"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Koronis Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Koronis Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Pacific Horizon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Kreatech Diagnostics", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2009-11-18", "Investor": "Alafi Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Kreatech Diagnostics", "Amount": "2700000", "FundingRoundCode": "B", "Date": "2010-01-31", "Investor": "Alafi Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Krishidhan Seeds", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2010-05-07", "Investor": "Summit Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kylin Therapeutics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2009-03-04", "Investor": "Golden Pine Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kylin Therapeutics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2009-03-04", "Investor": "In-vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kylin Therapeutics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2009-03-04", "Investor": "Purdue University Endowment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kymab", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2014-05-16", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kypha", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2014-11-21", "Investor": "Arsenal Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kypha", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2013-08-08", "Investor": "Billiken Angels Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kypha", "Amount": "206000", "FundingRoundCode": "NA", "Date": "2012-01-19", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kypha", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2014-11-21", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kypha", "Amount": "206000", "FundingRoundCode": "NA", "Date": "2012-01-19", "Investor": "Missouri Technology Corporation"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Kypha", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2014-07-29", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Kypha", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2014-11-21", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "37400000", "FundingRoundCode": "D", "Date": "2011-09-19", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2008-05-19", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-07-24", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2008-05-19", "Investor": "Apothecary Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "37400000", "FundingRoundCode": "D", "Date": "2011-09-19", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2008-05-19", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-07-24", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "37400000", "FundingRoundCode": "D", "Date": "2011-09-19", "Investor": "BB&T"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2008-05-19", "Investor": "BB&T"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "37400000", "FundingRoundCode": "D", "Date": "2011-09-19", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2008-05-19", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-07-24", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "37400000", "FundingRoundCode": "D", "Date": "2011-09-19", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2005-09-16", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2008-05-19", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-07-24", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2006-07-24", "Investor": "Wilson Sonsini Goodrich & Rosati"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Kythera Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2008-05-19", "Investor": "WS Investments"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Chemicals|Pharmaceuticals", "CompanyName": "Lab Automate Technologies", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2012-10-23", "Investor": "MassChallenge"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labcyte", "Amount": "5300000", "FundingRoundCode": "D", "Date": "2013-01-08", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labcyte", "Amount": "5300000", "FundingRoundCode": "D", "Date": "2013-01-08", "Investor": "Cross Atlantic Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labcyte", "Amount": "5300000", "FundingRoundCode": "D", "Date": "2013-01-08", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labcyte", "Amount": "5300000", "FundingRoundCode": "D", "Date": "2013-01-08", "Investor": "GE Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Labcyte", "Amount": "1.7e+07", "FundingRoundCode": "NA", "Date": "2015-05-05", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Labcyte", "Amount": "1.7e+07", "FundingRoundCode": "NA", "Date": "2015-05-05", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LabNow", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-11-13", "Investor": "Austin Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LabNow", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2004-09-29", "Investor": "Austin Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LabNow", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-11-13", "Investor": "Sammons Enterprises"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Laboratory Partners", "Amount": "1.6e+07", "FundingRoundCode": "D", "Date": "2008-01-14", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labrys Biologics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2013-01-03", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labrys Biologics", "Amount": "14588234", "FundingRoundCode": "NA", "Date": "2012-12-28", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labrys Biologics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2013-01-03", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labrys Biologics", "Amount": "14588234", "FundingRoundCode": "NA", "Date": "2012-12-28", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labrys Biologics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2013-01-03", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labrys Biologics", "Amount": "14588234", "FundingRoundCode": "NA", "Date": "2012-12-28", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Labrys Biologics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2013-01-03", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Laurantis Pharma", "Amount": "7094556", "FundingRoundCode": "NA", "Date": "2012-09-04", "Investor": "Broadview Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Laureate Pharma", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2010-10-07", "Investor": "Saints Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lazarus Therapeutics", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2010-08-02", "Investor": "Ben Franklin Technology Partners of Northeast Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LEAD Therapeutics", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2007-11-05", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LEAD Therapeutics", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2007-11-05", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lectus Therapeutics", "Amount": "14257949", "FundingRoundCode": "A", "Date": "2006-02-13", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lectus Therapeutics", "Amount": "14257949", "FundingRoundCode": "A", "Date": "2006-02-13", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Leonardo Biosystems", "Amount": "1250000", "FundingRoundCode": "NA", "Date": "2011-11-14", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lev Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2006-10-23", "Investor": "Alexandra Investment Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lev Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2006-10-23", "Investor": "Emigrant Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lev Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-11-08", "Investor": "Mast Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lev Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2006-10-23", "Investor": "Rosalind Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lev Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2006-10-23", "Investor": "Southpoint Capital Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lewis and Clark Pharmaceuticals", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2012-11-20", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Lexicon Pharmaceuticals", "Amount": "75040000", "FundingRoundCode": "NA", "Date": "2010-03-15", "Investor": "Invus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LifeBond Ltd.", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-05-23", "Investor": "The Zitelman Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lifecode", "Amount": "20500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Azimuth Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lifecode", "Amount": "20500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lifecode", "Amount": "20500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Mayo Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lifecode", "Amount": "20500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Sequoia Capital"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "Lifeshare Technologies", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-06-06", "Investor": "Allos Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2005-10-11", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2005-12-14", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-07-11", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-07-11", "Investor": "Deephaven Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2005-10-11", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2005-12-14", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-07-11", "Investor": "Fidelity Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2005-10-11", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2005-12-14", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2005-12-14", "Investor": "Larkspur Capital Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-07-11", "Investor": "Lehman Brothers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Light Sciences Oncology", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2005-12-14", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LigoCyte Pharmaceuticals", "Amount": "29490335", "FundingRoundCode": "C", "Date": "2009-08-14", "Investor": "Athenian Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LigoCyte Pharmaceuticals", "Amount": "29490335", "FundingRoundCode": "C", "Date": "2009-08-14", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LigoCyte Pharmaceuticals", "Amount": "29490335", "FundingRoundCode": "C", "Date": "2009-08-14", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Ligon Discovery", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2009-11-19", "Investor": "incTANK Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Limerick BioPharma", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2009-07-15", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Limerick BioPharma", "Amount": "15200000", "FundingRoundCode": "NA", "Date": "2008-06-11", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Limerick BioPharma", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2009-07-15", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Limerick BioPharma", "Amount": "15200000", "FundingRoundCode": "NA", "Date": "2008-06-11", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Limerick BioPharma", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2009-07-15", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Limerick BioPharma", "Amount": "15200000", "FundingRoundCode": "NA", "Date": "2008-06-11", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2013-12-18", "Investor": "Hatteras Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "HealthQuest Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2013-12-18", "Investor": "Kickstart Seed Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "5800000", "FundingRoundCode": "NA", "Date": "2008-12-31", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2013-12-18", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2011-11-04", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "10800000", "FundingRoundCode": "A", "Date": "2010-08-30", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "Petra Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2013-12-18", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2011-11-04", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "10800000", "FundingRoundCode": "A", "Date": "2010-08-30", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "PrairieGold Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "5800000", "FundingRoundCode": "NA", "Date": "2008-12-31", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2013-12-18", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2011-11-04", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "10800000", "FundingRoundCode": "A", "Date": "2010-08-30", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2013-12-18", "Investor": "Signal Peak Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "Signal Peak Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2013-12-18", "Investor": "University Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "12170000", "FundingRoundCode": "C", "Date": "2015-01-26", "Investor": "University Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "5800000", "FundingRoundCode": "NA", "Date": "2008-12-31", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2011-11-04", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lineagen", "Amount": "10800000", "FundingRoundCode": "A", "Date": "2010-08-30", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "2100000", "FundingRoundCode": "B", "Date": "2011-09-09", "Investor": "Big Sky Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2009-02-04", "Investor": "Big Sky Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "2100000", "FundingRoundCode": "B", "Date": "2011-09-09", "Investor": "Fisher Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-05-08", "Investor": "Fisher Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2009-02-04", "Investor": "Fisher Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "1954000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Greenhouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "2100000", "FundingRoundCode": "B", "Date": "2011-09-09", "Investor": "Greenhouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "1545000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Greenhouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2009-02-04", "Investor": "Greenhouse Capital Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Linkage Biosciences", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2007-10-16", "Investor": "Greenhouse Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lipella Pharmaceuticals", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2006-12-05", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lipella Pharmaceuticals", "Amount": "240000", "FundingRoundCode": "NA", "Date": "2008-04-24", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "LipoScience", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2003-08-07", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "LipoScience", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2003-08-07", "Investor": "U.S. Bancorp"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LipoSonix", "Amount": "2.7e+07", "FundingRoundCode": "C", "Date": "2004-07-11", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LipoSonix", "Amount": "2.7e+07", "FundingRoundCode": "C", "Date": "2004-07-11", "Investor": "The Carlyle Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LipoSonix", "Amount": "2.7e+07", "FundingRoundCode": "C", "Date": "2004-07-11", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LipoSonix", "Amount": "2.7e+07", "FundingRoundCode": "C", "Date": "2004-07-11", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LipoSonix", "Amount": "2.7e+07", "FundingRoundCode": "C", "Date": "2004-07-11", "Investor": "Pinnacle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LipoSonix", "Amount": "2.7e+07", "FundingRoundCode": "C", "Date": "2004-07-11", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LipoSonix", "Amount": "2.7e+07", "FundingRoundCode": "C", "Date": "2004-07-11", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lithera", "Amount": "20600000", "FundingRoundCode": "C", "Date": "2012-12-19", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lithera", "Amount": "8e+06", "FundingRoundCode": "C", "Date": "2014-02-12", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lithera", "Amount": "20600000", "FundingRoundCode": "C", "Date": "2012-12-19", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lithera", "Amount": "8e+06", "FundingRoundCode": "C", "Date": "2014-02-12", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lithera", "Amount": "20600000", "FundingRoundCode": "C", "Date": "2012-12-19", "Investor": "Numoda Capital Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lithera", "Amount": "20600000", "FundingRoundCode": "C", "Date": "2012-12-19", "Investor": "RUSNANO"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lithera", "Amount": "6700000", "FundingRoundCode": "C", "Date": "2013-07-18", "Investor": "RUSNANO"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Living Proof", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2013-02-21", "Investor": "Leerink Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Living Proof", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Living Proof", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2013-02-21", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Locus Pharmaceuticals", "Amount": "30200000", "FundingRoundCode": "E", "Date": "2007-02-14", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Logical Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-06-13", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Logical Therapeutics", "Amount": "16900000", "FundingRoundCode": "C", "Date": "2010-05-27", "Investor": "Novitas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Logical Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-06-13", "Investor": "Novitas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Logical Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-06-13", "Investor": "Orchard Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Logical Therapeutics", "Amount": "16900000", "FundingRoundCode": "C", "Date": "2010-05-27", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Logical Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2007-06-13", "Investor": "SV Life Sciences"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Longevity Biotech", "Amount": "350000", "FundingRoundCode": "NA", "Date": "2012-04-26", "Investor": "Thiel Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lotus Tissue Repair", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2011-06-30", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Loxo Oncology", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2013-10-03", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Loxo Oncology", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-05-06", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Loxo Oncology", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-05-06", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Loxo Oncology", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2013-10-03", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Loxo Oncology", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-05-06", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LQ3 Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-09-10", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LQ3 Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-09-10", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LQ3 Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-09-10", "Investor": "Envisia Therapeutics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-12-20", "Investor": "BlackRock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2009-10-29", "Investor": "Chevron Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-12-20", "Investor": "Chevron Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-03-01", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2009-10-29", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-12-20", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-10-09", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2007-03-01", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2009-10-29", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-12-20", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-10-09", "Investor": "Khosla Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2009-10-29", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-12-20", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "LS9", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2007-10-09", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Energy|Renewable Energies", "CompanyName": "Luca Technologies", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2006-09-22", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Energy|Renewable Energies", "CompanyName": "Luca Technologies", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-10-10", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Energy|Renewable Energies", "CompanyName": "Luca Technologies", "Amount": "75900000", "FundingRoundCode": "C", "Date": "2008-12-23", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Energy|Renewable Energies", "CompanyName": "Luca Technologies", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-10-10", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Energy|Renewable Energies", "CompanyName": "Luca Technologies", "Amount": "75900000", "FundingRoundCode": "C", "Date": "2008-12-23", "Investor": "One Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Energy|Renewable Energies", "CompanyName": "Luca Technologies", "Amount": "75900000", "FundingRoundCode": "C", "Date": "2008-12-23", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clean Energy|Renewable Energies", "CompanyName": "Luca Technologies", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-10-10", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumavita", "Amount": "16216216.2162162", "FundingRoundCode": "A", "Date": "2008-09-04", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2013-05-08", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2013-05-08", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2013-05-08", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumena Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-03-11", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumense", "Amount": "2650000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "GRA Venture Fund, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumense", "Amount": "2650000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "Intelligent Systems Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumense", "Amount": "2650000", "FundingRoundCode": "B", "Date": "2013-11-14", "Investor": "The Coca-Cola Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Lumos Pharma", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2014-02-04", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Lumos Pharma", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2014-02-04", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Hardware + Software", "CompanyName": "Luna Innovations", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2014-04-24", "Investor": "Intuitive Surgical"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lux Biosciences", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2009-10-01", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lux Biosciences", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2009-10-01", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lycera", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2009-05-05", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lycera", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2009-05-05", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lycera", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2009-05-05", "Investor": "EDF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lycera", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2009-05-05", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "LYSOGENE", "Amount": "2.2e+07", "FundingRoundCode": "A", "Date": "2014-05-21", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "4800000", "FundingRoundCode": "NA", "Date": "2014-05-12", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2015-02-03", "Investor": "Atlas Venture"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "4800000", "FundingRoundCode": "NA", "Date": "2014-05-12", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2015-02-03", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "4800000", "FundingRoundCode": "NA", "Date": "2014-05-12", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2015-02-03", "Investor": "Lilly Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "4800000", "FundingRoundCode": "NA", "Date": "2014-05-12", "Investor": "Orion Healthcare Equity Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "4800000", "FundingRoundCode": "NA", "Date": "2014-05-12", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2015-02-03", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "4800000", "FundingRoundCode": "NA", "Date": "2014-05-12", "Investor": "Sanofi-Genzyme BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lysosomal Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2015-02-03", "Investor": "Sanofi-Genzyme BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MabVax Therapeutics", "Amount": "5250000", "FundingRoundCode": "B", "Date": "2012-11-20", "Investor": "Burrill & Company"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "MabVax Therapeutics", "Amount": "1750000", "FundingRoundCode": "NA", "Date": "2013-09-25", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MabVax Therapeutics", "Amount": "5250000", "FundingRoundCode": "B", "Date": "2012-11-20", "Investor": "Numoda Capital Innovations"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "MacroCure", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-05-14", "Investor": "Vaizra Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "Biogen Idec New Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MacroGenics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2006-05-17", "Investor": "Texas Pacific Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Madison Vaccines", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2014-01-13", "Investor": "State of Wisconsin Investment Board"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Madison Vaccines", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2014-01-13", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Madison Vaccines", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2014-01-13", "Investor": "Wisconsin Alumni Research Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "MAKO Surgical", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-02-06", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "MAKO Surgical", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-02-06", "Investor": "Ivy Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "MAKO Surgical", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-02-06", "Investor": "Sycamore Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "MAKO Surgical", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2007-02-06", "Investor": "Ziegler Meditech Equity Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "MAKO Surgical", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2008-02-07", "Investor": "Ziegler Meditech Equity Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Medical Devices", "CompanyName": "MAKO Surgical", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2008-10-31", "Investor": "Ziegler Meditech Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Manipal Acunova", "Amount": "NA", "FundingRoundCode": "B", "Date": "2009-12-02", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "MAP Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-03-28", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "MAP Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-03-28", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "MAP Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-03-28", "Investor": "D.E. Shaw & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "MAP Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-03-28", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "MAP Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-03-28", "Investor": "Perseus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "MAP Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-03-28", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marcadia Biotech", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2006-03-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marcadia Biotech", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2007-05-15", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marcadia Biotech", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2007-05-15", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marcadia Biotech", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2006-03-01", "Investor": "Twilight Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marcadia Biotech", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2007-05-15", "Investor": "Twilight Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2013-01-07", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2009-05-03", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2013-01-07", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2009-05-03", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2013-01-07", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2009-05-03", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2013-01-07", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marinus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2009-05-03", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "3750000", "FundingRoundCode": "A", "Date": "2007-05-02", "Investor": "Calvert Social Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "3750000", "FundingRoundCode": "A", "Date": "2007-05-02", "Investor": "Clean Pacific Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "25400000", "FundingRoundCode": "C", "Date": "2011-06-01", "Investor": "Clean Pacific Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "25400000", "FundingRoundCode": "C", "Date": "2011-06-01", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "3750000", "FundingRoundCode": "A", "Date": "2007-05-02", "Investor": "One Earth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "25400000", "FundingRoundCode": "C", "Date": "2011-06-01", "Investor": "One Earth Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-04-20", "Investor": "Point Financial, Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2008-08-14", "Investor": "Stuart Mill Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "25400000", "FundingRoundCode": "C", "Date": "2011-06-01", "Investor": "Stuart Mill Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "25400000", "FundingRoundCode": "C", "Date": "2011-06-01", "Investor": "The Contrarian Group"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-06-05", "Investor": "U.S. Department of Agriculture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "3750000", "FundingRoundCode": "A", "Date": "2007-05-02", "Investor": "Valley Oak Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals", "CompanyName": "Marrone Bio Innovations", "Amount": "3750000", "FundingRoundCode": "A", "Date": "2007-05-02", "Investor": "Wavepoint Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marval Pharma", "Amount": "2500000", "FundingRoundCode": "B", "Date": "2010-01-19", "Investor": "DFJ Frontier"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Marval Pharma", "Amount": "2500000", "FundingRoundCode": "B", "Date": "2010-01-19", "Investor": "Mercury Fund"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Clean Technology|Entrepreneur|Green|High Tech|Life Sciences|Nonprofits|Startups|Venture Capital", "CompanyName": "MassChallenge", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2015-03-12", "Investor": "National Institute of Allergy and Infectious Diseases"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Maven Biotechnologies", "Amount": "1960000", "FundingRoundCode": "NA", "Date": "2010-10-04", "Investor": "National Institute for Allergy and Infectious Disease"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Maverix Biomics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2014-01-07", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Max Endoscopy", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-01-01", "Investor": "Dingman Center Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Max Endoscopy", "Amount": "135000", "FundingRoundCode": "NA", "Date": "2010-10-27", "Investor": "JumpStart Inc."}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Max Endoscopy", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2010-03-09", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Maxcyte", "Amount": "10700000", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Harbert Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Maxcyte", "Amount": "10700000", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Maxcyte", "Amount": "10700000", "FundingRoundCode": "B", "Date": "2004-03-24", "Investor": "Tall Oaks Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "MEDArchon", "Amount": "1577640", "FundingRoundCode": "NA", "Date": "2014-08-27", "Investor": "NueCura Partners, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MedAvail", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-10-16", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MedAvail", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-10-16", "Investor": "Deerfield"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MedAvail", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-10-16", "Investor": "Pura Vida Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MedAvail", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-10-16", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MedAvail", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2014-10-16", "Investor": "Walgreens"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Media|News", "CompanyName": "MedCity News", "Amount": "60000", "FundingRoundCode": "NA", "Date": "2008-12-01", "Investor": "Civic Innovation Lab"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Media|News", "CompanyName": "MedCity News", "Amount": "60000", "FundingRoundCode": "NA", "Date": "2008-12-01", "Investor": "Hatch Partners, LLC"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Media|News", "CompanyName": "MedCity News", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2010-12-30", "Investor": "JumpStart Inc."}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "MedExpress Urgent Care", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-09-01", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medgenics", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2001-06-22", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MediBeacon", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-01-01", "Investor": "Jump Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medicago", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-05-13", "Investor": "Yorkville Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MediciNova", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2012-08-20", "Investor": "Aspire Capital Fund"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "MediProPharma", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-01-06", "Investor": "Salt Lake Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "MediQuest Therapeutics", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2009-06-16", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "MediQuest Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2006-06-15", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "MediQuest Therapeutics", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2009-06-16", "Investor": "Janus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "MediQuest Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2006-06-15", "Investor": "Janus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "MediQuest Therapeutics", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2009-06-16", "Investor": "Masa Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "MediQuest Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2006-06-15", "Investor": "Masa Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medisyn Technologies", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2005-02-17", "Investor": "Andcor Companies"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medisyn Technologies", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2005-02-17", "Investor": "Portage Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medisyn Technologies", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2005-02-17", "Investor": "Sherpa Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medisyn Technologies", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2005-02-17", "Investor": "StarTec Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medivance", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2007-07-27", "Investor": "Camden Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medivance", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2007-07-27", "Investor": "Cross Atlantic Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medivance", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2007-07-27", "Investor": "Partisan Management Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Medivance", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2007-07-27", "Investor": "Skyline Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Hardware", "CompanyName": "Medrobotics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-03-22", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Medusa Medical Technologies", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2004-10-31", "Investor": "Medtronic"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Medusa Medical Technologies", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2003-10-31", "Investor": "Medtronic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2009-01-25", "Investor": "ABS Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "67500000", "FundingRoundCode": "NA", "Date": "2012-11-29", "Investor": "ABS Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2009-01-25", "Investor": "Axiom Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2009-01-25", "Investor": "EuclidSR Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2015-02-09", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2009-01-25", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2009-01-25", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2009-01-25", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "7e+07", "FundingRoundCode": "NA", "Date": "2014-02-10", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "67500000", "FundingRoundCode": "NA", "Date": "2012-11-29", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "6.7e+07", "FundingRoundCode": "D", "Date": "2015-06-10", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2009-01-25", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "67500000", "FundingRoundCode": "NA", "Date": "2012-11-29", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melinta", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2011-01-11", "Investor": "Warburg Pincus"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Melior Discovery", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2005-01-25", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Melior Discovery", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2006-04-05", "Investor": "Osage Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical Devices|Neuroscience", "CompanyName": "Memory Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2007-03-29", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Mendel Biotechnology", "Amount": "8387128", "FundingRoundCode": "NA", "Date": "2007-06-13", "Investor": "CFO Rick, Inc."}, {"FundingRoundType": "private_equity", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Mendel Biotechnology", "Amount": "8387128", "FundingRoundCode": "NA", "Date": "2007-06-13", "Investor": "Monsanto"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Agriculture|Biotechnology", "CompanyName": "Mendel Biotechnology", "Amount": "8387128", "FundingRoundCode": "NA", "Date": "2007-06-13", "Investor": "Ziff Brothers Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MentiNova", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2013-01-28", "Investor": "Foundation Venture Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merganser Biotech", "Amount": "2.8e+07", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merganser Biotech", "Amount": "2.8e+07", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merganser Biotech", "Amount": "2.8e+07", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merganser Biotech", "Amount": "2.8e+07", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Meritage Pharma", "Amount": "22500000", "FundingRoundCode": "A", "Date": "2008-06-16", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Meritage Pharma", "Amount": "22500000", "FundingRoundCode": "A", "Date": "2008-06-16", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Meritage Pharma", "Amount": "22500000", "FundingRoundCode": "A", "Date": "2008-06-16", "Investor": "The Vertical Group"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Merrimack Pharmaceuticals", "Amount": "7.7e+07", "FundingRoundCode": "NA", "Date": "2011-04-14", "Investor": "Crocker Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Merrimack Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "B", "Date": "2002-01-01", "Investor": "Expansion Venture Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Merrimack Pharmaceuticals", "Amount": "7.7e+07", "FundingRoundCode": "NA", "Date": "2011-04-14", "Investor": "Jennison Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Merrimack Pharmaceuticals", "Amount": "7.7e+07", "FundingRoundCode": "NA", "Date": "2011-04-14", "Investor": "TPG-Axon Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Merrimack Pharmaceuticals", "Amount": "2.8e+07", "FundingRoundCode": "D", "Date": "2004-05-05", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Merrimack Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2006-03-28", "Investor": "University Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-11-08", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-07-31", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-03-02", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "14505371", "FundingRoundCode": "A", "Date": "2014-04-08", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-11-08", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-07-31", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-03-02", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "14505371", "FundingRoundCode": "A", "Date": "2014-04-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-07-31", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-03-02", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-11-08", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "A", "Date": "2012-07-31", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-11-08", "Investor": "PureTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2005-11-08", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-03-02", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mersana Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-03-02", "Investor": "Elliott Sigal"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "30306220", "FundingRoundCode": "B", "Date": "2010-01-29", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "39884600", "FundingRoundCode": "B", "Date": "2013-10-03", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "79139323", "FundingRoundCode": "C", "Date": "2015-04-26", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "39884600", "FundingRoundCode": "B", "Date": "2013-10-03", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "30306220", "FundingRoundCode": "B", "Date": "2010-01-29", "Investor": "Pfizer"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "39884600", "FundingRoundCode": "B", "Date": "2013-10-03", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "79139323", "FundingRoundCode": "C", "Date": "2015-04-26", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "79139323", "FundingRoundCode": "C", "Date": "2015-04-26", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "79139323", "FundingRoundCode": "C", "Date": "2015-04-26", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Merus", "Amount": "79139323", "FundingRoundCode": "C", "Date": "2015-04-26", "Investor": "Tekla Capital Management"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology", "CompanyName": "Metabolix", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2014-08-04", "Investor": "Oracle Investment Management Inc."}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology", "CompanyName": "Metabolix", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2011-05-05", "Investor": "U.S. Department of Agriculture"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Chemicals|Clean Technology", "CompanyName": "Metabolix", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2011-05-05", "Investor": "U.S. Department of Energy"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical Devices", "CompanyName": "Metabolomic Diagnostics", "Amount": "849444", "FundingRoundCode": "NA", "Date": "2015-02-11", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical Devices", "CompanyName": "Metabolomic Diagnostics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-06-28", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical Devices", "CompanyName": "Metabolomic Diagnostics", "Amount": "964950", "FundingRoundCode": "NA", "Date": "2014-01-02", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "14999980", "FundingRoundCode": "E", "Date": "2014-01-06", "Investor": "Camden Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "13100000", "FundingRoundCode": "D", "Date": "2011-08-29", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "14999980", "FundingRoundCode": "E", "Date": "2014-01-06", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Fulcrum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "13100000", "FundingRoundCode": "D", "Date": "2011-08-29", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2006-01-18", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "14999980", "FundingRoundCode": "E", "Date": "2014-01-06", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "13100000", "FundingRoundCode": "D", "Date": "2011-08-29", "Investor": "BDCA Venture, Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "13100000", "FundingRoundCode": "D", "Date": "2011-08-29", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2006-01-18", "Investor": "Sevin Rosen Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2003-08-01", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2009-12-07", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "13100000", "FundingRoundCode": "D", "Date": "2011-08-29", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2006-01-18", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "14999980", "FundingRoundCode": "E", "Date": "2014-01-06", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Metabolon", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2006-01-18", "Investor": "The Trelys Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Metacrine", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2015-08-05", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Metacrine", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2015-08-05", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Metacrine", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2015-08-05", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Metacrine", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2015-08-05", "Investor": "venBio"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Metagenomix", "Amount": "7e+05", "FundingRoundCode": "NA", "Date": "2010-04-13", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Metagenomix", "Amount": "7e+05", "FundingRoundCode": "NA", "Date": "2010-04-13", "Investor": "Elm Street Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Metamark Genetics", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2010-08-13", "Investor": "Perseus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Metaome", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-09-09", "Investor": "Microsoft Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MethylGene", "Amount": "34500000", "FundingRoundCode": "NA", "Date": "2011-09-11", "Investor": "ProQuest Investments"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-08-04", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "5.5e+07", "FundingRoundCode": "NA", "Date": "2013-06-25", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "6900000", "FundingRoundCode": "C", "Date": "2007-10-08", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-08-04", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "5.5e+07", "FundingRoundCode": "NA", "Date": "2013-06-25", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "6900000", "FundingRoundCode": "C", "Date": "2007-10-08", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2012-01-24", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "3.3e+07", "FundingRoundCode": "NA", "Date": "2009-01-01", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-08-04", "Investor": "ProQuest Investments"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "5.5e+07", "FundingRoundCode": "NA", "Date": "2013-06-25", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2012-01-24", "Investor": "ProQuest Investments"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-08-04", "Investor": "Venrock"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "5.5e+07", "FundingRoundCode": "NA", "Date": "2013-06-25", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "6900000", "FundingRoundCode": "C", "Date": "2007-10-08", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2012-01-24", "Investor": "Venrock"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Mevion Medical Systems", "Amount": "2e+08", "FundingRoundCode": "NA", "Date": "2014-08-04", "Investor": "YuanMing Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MGB Biopharma", "Amount": "6400000", "FundingRoundCode": "B", "Date": "2014-09-17", "Investor": "ArchAngels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Micell Technologies", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2009-10-01", "Investor": "Invemed Catalyst Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Micell Technologies", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2007-07-12", "Investor": "Invemed Catalyst Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Micell Technologies", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2009-10-01", "Investor": "St. Jude Medical"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Microbia", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2007-03-01", "Investor": "Fidelity Biosciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Microbia", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2004-05-04", "Investor": "Linkage Biosciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Microbia", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2007-03-01", "Investor": "Morgan Stanley"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Microbia", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2004-05-04", "Investor": "Paperboy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Microbia", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2007-03-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Microbia", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2007-03-01", "Investor": "Ridgeback Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Microbia", "Amount": "5e+07", "FundingRoundCode": "E", "Date": "2007-03-01", "Investor": "Venrock"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Microbiome Therapeutics", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2013-12-20", "Investor": "BVM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Microscience", "Amount": "36400000", "FundingRoundCode": "C", "Date": "2002-02-20", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Microscience", "Amount": "36400000", "FundingRoundCode": "C", "Date": "2002-02-20", "Investor": "JPMorgan Partners (JPMP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MicuRx Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2013-08-22", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Middle Peak Medical", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2013-10-28", "Investor": "Edwards Lifesciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Milestone Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2015-06-15", "Investor": "BDC Capital Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Milestone Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2015-06-15", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Milestone Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2015-06-15", "Investor": "Go Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Milestone Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "NA", "Date": "2011-06-13", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Milestone Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2015-06-15", "Investor": "Pappas Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Millennium Pharmacy Systems", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2007-06-13", "Investor": "Boulder Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Millennium Pharmacy Systems", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2007-06-13", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Millennium Pharmacy Systems", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2007-06-13", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Milo Biotechnology", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2012-02-14", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Minoryx Therapeutics", "Amount": "22101545.5891847", "FundingRoundCode": "A", "Date": "2015-10-14", "Investor": "Chiesi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Minoryx Therapeutics", "Amount": "22101545.5891847", "FundingRoundCode": "A", "Date": "2015-10-14", "Investor": "HealthEquity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mira Dx", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2010-07-01", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mirador Biomedical", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2011-07-08", "Investor": "Alliance of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mirador Biomedical", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2011-07-08", "Investor": "Summit Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mirador Biomedical", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2011-07-08", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2009-06-03", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2012-04-24", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "8500000", "FundingRoundCode": "B", "Date": "2015-02-18", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2015-11-10", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-06-27", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "8500000", "FundingRoundCode": "B", "Date": "2015-02-18", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2008-05-19", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2015-11-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2012-04-24", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-06-27", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2009-06-03", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "8500000", "FundingRoundCode": "B", "Date": "2015-02-18", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2008-05-19", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2015-11-10", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2012-04-24", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-06-27", "Investor": "Boulder Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2009-06-03", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "8500000", "FundingRoundCode": "B", "Date": "2015-02-18", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2012-04-24", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-06-27", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2015-11-10", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "8500000", "FundingRoundCode": "B", "Date": "2015-02-18", "Investor": "Remeditex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2015-11-10", "Investor": "Remeditex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2012-04-24", "Investor": "Remeditex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-06-27", "Investor": "Remeditex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miragen Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2009-06-03", "Investor": "The Peierls Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "34500000", "FundingRoundCode": "C", "Date": "2012-10-24", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Eastern Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "34500000", "FundingRoundCode": "C", "Date": "2012-10-24", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "34500000", "FundingRoundCode": "C", "Date": "2012-10-24", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "34500000", "FundingRoundCode": "C", "Date": "2012-10-24", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "34500000", "FundingRoundCode": "C", "Date": "2012-10-24", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Mirna Therapeutics", "Amount": "41800000", "FundingRoundCode": "D", "Date": "2015-04-30", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Miromatrix Medical", "Amount": "5312856", "FundingRoundCode": "NA", "Date": "2012-07-20", "Investor": "Brightstone Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MISSION Therapeutics", "Amount": "30305028", "FundingRoundCode": "B", "Date": "2013-11-18", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MISSION Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-08-25", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MISSION Therapeutics", "Amount": "30305028", "FundingRoundCode": "B", "Date": "2013-11-18", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mithridion", "Amount": "1250000", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Rocket Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mithridion", "Amount": "1250000", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Venture Investors"}, {"FundingRoundType": "seed", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Mitochon Pharmaceuticals", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2014-11-05", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mitra Biotech", "Amount": "4911591", "FundingRoundCode": "B", "Date": "2013-10-24", "Investor": "Accel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mitra Biotech", "Amount": "2200000", "FundingRoundCode": "A", "Date": "2010-01-01", "Investor": "Accel"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "MitrAssist", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2013-07-01", "Investor": "Various Angel Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mnemosyne Pharmaceuticals", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2013-06-21", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mnemosyne Pharmaceuticals", "Amount": "5400000", "FundingRoundCode": "A", "Date": "2012-02-16", "Investor": "Slater Technology Fund"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Mobius Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-02-04", "Investor": "BioGenerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mobius Therapeutics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2013-10-10", "Investor": "Cultivation Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "4.5e+08", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "Alexion Pharmaceuticals"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2014-01-14", "Investor": "Alexion Pharmaceuticals"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "135000044", "FundingRoundCode": "NA", "Date": "2013-11-20", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2012-12-06", "Investor": "Flagship Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "4.5e+08", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "Invus"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "4.5e+08", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "RA Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "4.5e+08", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "Viking Global Investors"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Moderna Therapeutics", "Amount": "4.5e+08", "FundingRoundCode": "NA", "Date": "2015-01-05", "Investor": "Wellington Management"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Modulation Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-02-14", "Investor": "Institute for the Commercialization of Public Research"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "moksha8 Pharmaceuticals", "Amount": "1.25e+08", "FundingRoundCode": "NA", "Date": "2012-10-22", "Investor": "Forest Laboratories"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "moksha8 Pharmaceuticals", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2008-06-02", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "moksha8 Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2010-10-05", "Investor": "Watson Pharmaceuticals"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Biometrics", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2010-01-12", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Biometrics", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2010-01-12", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Biometrics", "Amount": "12500000", "FundingRoundCode": "B", "Date": "2010-01-12", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Biometrics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2008-11-10", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "4700000", "FundingRoundCode": "C", "Date": "2009-12-01", "Investor": "Ben Franklin Technology Partners of Northeast Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "4700000", "FundingRoundCode": "C", "Date": "2009-12-01", "Investor": "MentorTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "1900000", "FundingRoundCode": "B", "Date": "2012-04-16", "Investor": "MentorTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2012-03-07", "Investor": "MentorTech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "4700000", "FundingRoundCode": "C", "Date": "2009-12-01", "Investor": "Mid Atlantic Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2012-03-07", "Investor": "Mid-Atlantic Venture Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "4700000", "FundingRoundCode": "C", "Date": "2009-12-01", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "1900000", "FundingRoundCode": "B", "Date": "2012-04-16", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Detection", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2012-03-07", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Imaging", "Amount": "9900000", "FundingRoundCode": "A", "Date": "2012-03-07", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Imaging", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2011-05-09", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Partners", "Amount": "44200000", "FundingRoundCode": "B", "Date": "2009-12-16", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Partners", "Amount": "15560000", "FundingRoundCode": "A", "Date": "2007-08-14", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Molecular Partners", "Amount": "44200000", "FundingRoundCode": "B", "Date": "2009-12-16", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2014-08-18", "Investor": "Cultivation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "2670000", "FundingRoundCode": "A", "Date": "2014-07-23", "Investor": "Cultivation Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "1350000", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "Launch Tennessee"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-11-15", "Investor": "Launch Tennessee"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "2670000", "FundingRoundCode": "A", "Date": "2014-07-23", "Investor": "Launch Tennessee"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "450000", "FundingRoundCode": "A", "Date": "2013-09-01", "Investor": "Launch Tennessee"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "1350000", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-11-15", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "2670000", "FundingRoundCode": "A", "Date": "2014-07-23", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "125000", "FundingRoundCode": "NA", "Date": "2012-03-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical Devices", "CompanyName": "Molecular Sensing", "Amount": "450000", "FundingRoundCode": "A", "Date": "2013-09-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Molecular Templates", "Amount": "10600000", "FundingRoundCode": "NA", "Date": "2013-10-08", "Investor": "Cancer Prevention and Research Institute of Texas"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Molecular Templates", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-07-03", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Molecular Templates", "Amount": "8500000", "FundingRoundCode": "C", "Date": "2013-10-08", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Molecular Templates", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-07-03", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Molecular Templates", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2009-05-03", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Molecular Templates", "Amount": "8500000", "FundingRoundCode": "C", "Date": "2013-10-08", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "MolecularMD", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2012-04-02", "Investor": "Ballast Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moleculera Labs", "Amount": "1060000", "FundingRoundCode": "NA", "Date": "2015-05-19", "Investor": "i2E"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Moleculera Labs", "Amount": "1840000", "FundingRoundCode": "NA", "Date": "2013-10-03", "Investor": "i2E"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moleculera Labs", "Amount": "1060000", "FundingRoundCode": "NA", "Date": "2015-05-19", "Investor": "i2i, Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moleculera Labs", "Amount": "1060000", "FundingRoundCode": "NA", "Date": "2015-05-19", "Investor": "SeedStep Angels group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Moleculera Labs", "Amount": "1840000", "FundingRoundCode": "NA", "Date": "2013-10-03", "Investor": "SeedStep Angels group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Momenta Pharmaceuticals", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2004-03-02", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Momenta Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2003-05-21", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Momenta Pharmaceuticals", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2004-03-02", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Momenta Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2003-05-21", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Momenta Pharmaceuticals", "Amount": "20500000", "FundingRoundCode": "C", "Date": "2004-03-02", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Momenta Pharmaceuticals", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2003-05-21", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mosaic Biosciences", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2011-11-08", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mosaic Biosciences", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2011-11-08", "Investor": "High Country Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mosaic Biosciences", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2011-11-08", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Motif BioSciences", "Amount": "1870000", "FundingRoundCode": "NA", "Date": "2006-03-02", "Investor": "Amphion Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Motif BioSciences", "Amount": "1e+06", "FundingRoundCode": "C", "Date": "2007-04-05", "Investor": "Amphion Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mousera", "Amount": "20000004", "FundingRoundCode": "A", "Date": "2015-06-09", "Investor": "AME Cloud Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mousera", "Amount": "20000004", "FundingRoundCode": "A", "Date": "2015-06-09", "Investor": "Data Collective"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mousera", "Amount": "8800000", "FundingRoundCode": "A", "Date": "2014-10-29", "Investor": "Data Collective"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mousera", "Amount": "20000004", "FundingRoundCode": "A", "Date": "2015-06-09", "Investor": "Dolby Family Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mousera", "Amount": "20000004", "FundingRoundCode": "A", "Date": "2015-06-09", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mousera", "Amount": "8800000", "FundingRoundCode": "A", "Date": "2014-10-29", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mousera", "Amount": "8800000", "FundingRoundCode": "A", "Date": "2014-10-29", "Investor": "Proteus Digital Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Movetis", "Amount": "63729400", "FundingRoundCode": "A", "Date": "2007-01-08", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moximed", "Amount": "1770000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moximed", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-05-07", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moximed", "Amount": "1770000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moximed", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-05-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moximed", "Amount": "1770000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Moximed", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2015-05-07", "Investor": "Vertex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mpex Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2005-08-09", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mpex Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2005-08-09", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mpex Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2005-08-09", "Investor": "Charitable Leadership Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mpex Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2005-08-09", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Mpex Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2005-08-09", "Investor": "Western States Investment Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Multiplicom", "Amount": "7365050", "FundingRoundCode": "NA", "Date": "2013-02-11", "Investor": "Qbic Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Multispan", "Amount": "6e+05", "FundingRoundCode": "B", "Date": "2007-10-01", "Investor": "Amkey Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Food Processing", "CompanyName": "Muufri", "Amount": "60000", "FundingRoundCode": "NA", "Date": "2014-05-02", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Food Processing", "CompanyName": "Muufri", "Amount": "60000", "FundingRoundCode": "NA", "Date": "2014-05-02", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Food Processing", "CompanyName": "Muufri", "Amount": "60000", "FundingRoundCode": "NA", "Date": "2014-05-02", "Investor": "Sean O'Sullivan"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyCare", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-10-11", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "MyCare", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2012-02-02", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoKardia", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2015-04-30", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoKardia", "Amount": "3.8e+07", "FundingRoundCode": "A", "Date": "2012-09-20", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MYOMO", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2015-05-13", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "10400000", "FundingRoundCode": "B", "Date": "2008-07-11", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "3.3e+07", "FundingRoundCode": "D", "Date": "2012-03-21", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "10400000", "FundingRoundCode": "B", "Date": "2008-07-11", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "3.3e+07", "FundingRoundCode": "D", "Date": "2012-03-21", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "10400000", "FundingRoundCode": "B", "Date": "2008-07-11", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "3.3e+07", "FundingRoundCode": "D", "Date": "2012-03-21", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "10400000", "FundingRoundCode": "B", "Date": "2008-07-11", "Investor": "Saratoga Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MyoScience", "Amount": "3.3e+07", "FundingRoundCode": "D", "Date": "2012-03-21", "Investor": "Saratoga Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "MYR", "Amount": "8813715", "FundingRoundCode": "NA", "Date": "2014-10-31", "Investor": "Maxwell Biotech Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "N-of-One", "Amount": "1700000", "FundingRoundCode": "NA", "Date": "2013-12-16", "Investor": "Converge Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Nivalis Therapeutics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2010-07-12", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Nivalis Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-11-19", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Nivalis Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-11-19", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Nivalis Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-11-19", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Nivalis Therapeutics", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-11-19", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabriva Therapeutics", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-04-07", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabriva Therapeutics", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-04-07", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabriva Therapeutics", "Amount": "1.2e+08", "FundingRoundCode": "B", "Date": "2015-04-07", "Investor": "Vivo Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabsys", "Amount": "35049975", "FundingRoundCode": "D", "Date": "2013-03-13", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabsys", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2009-05-05", "Investor": "Slater Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabsys", "Amount": "35049975", "FundingRoundCode": "D", "Date": "2013-03-13", "Investor": "Stata Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabsys", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2011-09-14", "Investor": "Stata Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nabsys", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2010-03-10", "Investor": "Stata Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Nano Terra", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2011-02-24", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "NanoBio", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2010-11-30", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NanoBio", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2009-07-08", "Investor": "Perseus"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "NanoBio", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2006-10-21", "Investor": "Perseus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NanoCor Therapeutics", "Amount": "6250000", "FundingRoundCode": "B", "Date": "2007-09-10", "Investor": "Medtronic"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Nanofiber Solutions", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-04-23", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NanoHorizons", "Amount": "6700000", "FundingRoundCode": "B", "Date": "2008-06-04", "Investor": "Life Sciences Greenhouse of Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NanoHorizons", "Amount": "6700000", "FundingRoundCode": "B", "Date": "2008-06-04", "Investor": "Penn Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NanoInk", "Amount": "8.8e+07", "FundingRoundCode": "E", "Date": "2012-01-06", "Investor": "Lurie Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Medical Devices", "CompanyName": "Nanomedical Diagnostics", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2015-04-22", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Medical Devices", "CompanyName": "Nanomedical Diagnostics", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2015-10-13", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoMR", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-07-19", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoMR", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-07-19", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoMR", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-07-19", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoMR", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2008-06-27", "Investor": "Sun Mountain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoMR", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2008-06-27", "Investor": "The Dow Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoMR", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2011-07-19", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoMR", "Amount": "5500000", "FundingRoundCode": "A", "Date": "2008-06-27", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "nanoRETE", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-05-23", "Investor": "Michigan Accelerator Fund I"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Nanosphere", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2003-01-06", "Investor": "Lurie Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2013-05-13", "Investor": "Accelerator Corp."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "15300000", "FundingRoundCode": "E", "Date": "2012-12-03", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-02-12", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2013-05-13", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "15300000", "FundingRoundCode": "E", "Date": "2012-12-03", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2009-06-14", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2011-11-07", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "8500000", "FundingRoundCode": "B", "Date": "2007-06-26", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2013-05-13", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "15300000", "FundingRoundCode": "E", "Date": "2012-12-03", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "3800000", "FundingRoundCode": "NA", "Date": "2005-04-27", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2009-06-14", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2011-11-07", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2011-11-07", "Investor": "GE Healthcare"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "15300000", "FundingRoundCode": "E", "Date": "2012-12-03", "Investor": "GE Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "15300000", "FundingRoundCode": "E", "Date": "2012-12-03", "Investor": "Morgan Stanley"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "8500000", "FundingRoundCode": "B", "Date": "2007-06-26", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "15300000", "FundingRoundCode": "E", "Date": "2012-12-03", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "3800000", "FundingRoundCode": "NA", "Date": "2005-04-27", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2009-06-14", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2011-11-07", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-04-03", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Diagnostics|Health Diagnostics|Medical", "CompanyName": "NanoString Technologies", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-04-03", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Manufacturing|Pharmaceuticals", "CompanyName": "Nanotherapeutics", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2014-06-03", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Manufacturing|Pharmaceuticals", "CompanyName": "Nanotherapeutics", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2014-09-24", "Investor": "Trinity Capital Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "NanoVision Diagnostics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2015-01-10", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "NanoVision Diagnostics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2015-01-10", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spirox", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2015-04-20", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spirox", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2015-04-20", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spirox", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2015-04-20", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spirox", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2013-04-26", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spirox", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2015-04-20", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spirox", "Amount": "18500000", "FundingRoundCode": "B", "Date": "2015-04-20", "Investor": "Western Technology Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "Alafi Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2012-01-06", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2008-12-05", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "54600000", "FundingRoundCode": "E", "Date": "2013-05-01", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "55500000", "FundingRoundCode": "F", "Date": "2015-04-06", "Investor": "Franklin Templeton Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "54600000", "FundingRoundCode": "E", "Date": "2013-05-01", "Investor": "Harmony Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "55500000", "FundingRoundCode": "F", "Date": "2015-04-06", "Investor": "HealthCor Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "55500000", "FundingRoundCode": "F", "Date": "2015-04-06", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2012-01-06", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "54600000", "FundingRoundCode": "E", "Date": "2013-05-01", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2011-04-27", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "55500000", "FundingRoundCode": "F", "Date": "2015-04-06", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "54600000", "FundingRoundCode": "E", "Date": "2013-05-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "55500000", "FundingRoundCode": "F", "Date": "2015-04-06", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "55500000", "FundingRoundCode": "F", "Date": "2015-04-06", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2009-01-07", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2012-01-06", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2008-12-05", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "54600000", "FundingRoundCode": "E", "Date": "2013-05-01", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2010-11-01", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Natera", "Amount": "55500000", "FundingRoundCode": "F", "Date": "2015-04-06", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naurex", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2012-12-17", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naurex", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2011-05-11", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naurex", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2012-12-17", "Investor": "Baxter International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naurex", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2012-12-17", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naurex", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2011-05-11", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naurex", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2012-12-17", "Investor": "Savitr Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naurex", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2011-05-11", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nautilus Biotech", "Amount": "11300000", "FundingRoundCode": "NA", "Date": "2007-04-30", "Investor": "Rothschild"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nautilus Neurosciences", "Amount": "17755532", "FundingRoundCode": "A", "Date": "2010-04-12", "Investor": "Tailwind Capital"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Navidea Biopharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2015-05-11", "Investor": "CRG"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Navidea Biopharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2014-03-06", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navigenics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-11-07", "Investor": "Google"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navigenics", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2010-02-04", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navigenics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-11-07", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navigenics", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2010-02-04", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navigenics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-11-07", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navigenics", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2010-02-04", "Investor": "Procter & Gamble (P&G)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navigenics", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-11-07", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naviscan", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-05-03", "Investor": "Mayo Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naviscan", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-05-03", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naviscan", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-05-03", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Naviscan", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2007-05-03", "Investor": "Walker Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navitor Pharmaceuticals", "Amount": "23500000", "FundingRoundCode": "A", "Date": "2014-06-19", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navitor Pharmaceuticals", "Amount": "23500000", "FundingRoundCode": "A", "Date": "2014-06-19", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navitor Pharmaceuticals", "Amount": "23500000", "FundingRoundCode": "A", "Date": "2014-06-19", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Navitor Pharmaceuticals", "Amount": "23500000", "FundingRoundCode": "A", "Date": "2014-06-19", "Investor": "SR One"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "NeighborMD", "Amount": "818886", "FundingRoundCode": "NA", "Date": "2012-11-01", "Investor": "Nashville Capital Network, Investment Arm"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "NeighborMD", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2013-03-01", "Investor": "Nashville Capital Network, Investment Arm"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NellOne Therapeutics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2008-06-04", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NellOne Therapeutics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2008-06-04", "Investor": "Innovation Valley Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Neoantigenics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-04-13", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Neoantigenics", "Amount": "3025713", "FundingRoundCode": "NA", "Date": "2015-02-24", "Investor": "IrishAngels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoChord", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "CHV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoChord", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoChord", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Heron Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoChord", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Hopen Life Science Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "NeoChord", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2013-10-25", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoChord", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "TGap Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoGuide Systems", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-11-18", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoGuide Systems", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-11-18", "Investor": "DC Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoGuide Systems", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-11-18", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoGuide Systems", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-11-18", "Investor": "Pelion Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoGuide Systems", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-11-18", "Investor": "SBV Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoGuide Systems", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-11-18", "Investor": "The Angels' Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeoGuide Systems", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-11-18", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neomend", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-01-27", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neomend", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-01-27", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neomend", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2007-07-14", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neomend", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-01-27", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neomend", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2007-07-14", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neomend", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2010-01-27", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neos Therapeutics", "Amount": "15500000", "FundingRoundCode": "C", "Date": "2014-03-04", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neos Therapeutics", "Amount": "15500000", "FundingRoundCode": "C", "Date": "2014-03-04", "Investor": "CMEA Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Neos Therapeutics", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-04-23", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "NephroGenex", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2007-07-06", "Investor": "BioStratum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "NephroGenex", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2007-07-06", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "NephroGenex", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2007-07-06", "Investor": "Vanderbilt University Office of Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2010-06-25", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2007-08-09", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "42600000", "FundingRoundCode": "D", "Date": "2005-10-19", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2010-06-25", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2007-08-09", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "42600000", "FundingRoundCode": "D", "Date": "2005-10-19", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2010-06-25", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2007-08-09", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2010-06-25", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2007-08-09", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "42600000", "FundingRoundCode": "D", "Date": "2005-10-19", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2007-08-09", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "42600000", "FundingRoundCode": "D", "Date": "2005-10-19", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2007-08-09", "Investor": "Pacific Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "42600000", "FundingRoundCode": "D", "Date": "2005-10-19", "Investor": "Pacific Venture Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nereus Pharmaceuticals", "Amount": "42600000", "FundingRoundCode": "D", "Date": "2005-10-19", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "NERI", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2011-10-25", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "NeuMoDx Molecular", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2014-04-01", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "NeuMoDx Molecular", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2014-04-01", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "NeuMoDx Molecular", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2014-04-01", "Investor": "Wolverine Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2009-03-26", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "9600000", "FundingRoundCode": "B", "Date": "2012-01-31", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "1501000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2009-03-26", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "9600000", "FundingRoundCode": "B", "Date": "2012-01-31", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "1501000", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2009-03-26", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuraltus Pharmaceuticals", "Amount": "9600000", "FundingRoundCode": "B", "Date": "2012-01-31", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurAxon", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2007-08-20", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurAxon", "Amount": "1885227", "FundingRoundCode": "A", "Date": "2004-07-27", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurAxon", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2007-08-20", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurAxon", "Amount": "1885227", "FundingRoundCode": "A", "Date": "2004-07-27", "Investor": "NeuroVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurAxon", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2007-08-20", "Investor": "NeuroVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurAxon", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2007-08-20", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroBionics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2004-12-22", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroBionics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2004-12-22", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurocrine Biosciences", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2009-12-17", "Investor": "Venrock"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroGenetic Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-01-04", "Investor": "Abbott Biotech Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroGenetic Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2002-11-01", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroGenetic Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2002-11-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2005-12-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "22860000", "FundingRoundCode": "B", "Date": "2002-01-23", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2005-12-01", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "22860000", "FundingRoundCode": "B", "Date": "2002-01-23", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "22860000", "FundingRoundCode": "B", "Date": "2002-01-23", "Investor": "Duke University"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "22860000", "FundingRoundCode": "B", "Date": "2002-01-23", "Investor": "Grove Street Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2005-12-01", "Investor": "Mitsubishi Corporation Life Sciences Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2005-12-01", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "22860000", "FundingRoundCode": "B", "Date": "2002-01-23", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2008-01-09", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "22860000", "FundingRoundCode": "B", "Date": "2002-01-23", "Investor": "TIAA-CREF"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2005-12-01", "Investor": "Walden International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurogesX", "Amount": "22860000", "FundingRoundCode": "B", "Date": "2002-01-23", "Investor": "Walden International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurologix", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-12-06", "Investor": "Corriente Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurologix", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2010-12-06", "Investor": "Palisade Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuromed Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2003-11-07", "Investor": "Cogene Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuromed Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2003-11-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuromed Pharmaceuticals", "Amount": "53300000", "FundingRoundCode": "E", "Date": "2007-08-22", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuron Systems", "Amount": "8960000", "FundingRoundCode": "A", "Date": "2008-08-08", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuron Systems", "Amount": "8960000", "FundingRoundCode": "A", "Date": "2008-08-08", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuron Therapeutics", "Amount": "23500000", "FundingRoundCode": "A", "Date": "2015-12-01", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroNascent", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2008-01-23", "Investor": "Maryland Department of Business and Economic Development"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2001-08-22", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "34300000", "FundingRoundCode": "F", "Date": "2015-04-27", "Investor": "GE Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2011-05-16", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-10-27", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-10-27", "Investor": "KBL Healthcare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2011-05-16", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "34300000", "FundingRoundCode": "F", "Date": "2015-04-27", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-10-27", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2011-05-16", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "34300000", "FundingRoundCode": "F", "Date": "2015-04-27", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-10-27", "Investor": "ONSET Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2001-08-22", "Investor": "Partisan Management Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-10-27", "Investor": "Partisan Management Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2011-05-16", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "34300000", "FundingRoundCode": "F", "Date": "2015-04-27", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2011-05-16", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "34300000", "FundingRoundCode": "F", "Date": "2015-04-27", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2011-05-16", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "34300000", "FundingRoundCode": "F", "Date": "2015-04-27", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-10-27", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "E", "Date": "2011-05-16", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "34300000", "FundingRoundCode": "F", "Date": "2015-04-27", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuronetics", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-10-27", "Investor": "Three Arch Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "NeurOp", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-04-20", "Investor": "ATDC"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroPace", "Amount": "NA", "FundingRoundCode": "NA", "Date": "1999-12-22", "Investor": "Accelerated Growth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroPace", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2013-07-09", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroPace", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2013-07-09", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroPace", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2013-07-09", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroPace", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2013-07-09", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroPace", "Amount": "1.8e+07", "FundingRoundCode": "NA", "Date": "2013-07-09", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurOptics", "Amount": "1246627", "FundingRoundCode": "NA", "Date": "2014-04-21", "Investor": "Signatures Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeurOptics", "Amount": "1246627", "FundingRoundCode": "NA", "Date": "2014-04-21", "Investor": "Bobby Yazdani"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neuropure", "Amount": "5e+05", "FundingRoundCode": "A", "Date": "2007-03-20", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurosearch", "Amount": "14330000", "FundingRoundCode": "NA", "Date": "2009-08-17", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroSky", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-11-04", "Investor": "SoftBank Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "Mayflower"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "Pound Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurotech", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2006-11-16", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroTherapeutics Pharma", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2010-05-20", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroTherapeutics Pharma", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2010-05-20", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroTherapeutics Pharma", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2010-05-20", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroTherapeutics Pharma", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2010-05-20", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care Information Technology|Health Diagnostics", "CompanyName": "Neurotrack", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2013-09-26", "Investor": "Rock Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care Information Technology|Health Diagnostics", "CompanyName": "Neurotrack", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2013-09-26", "Investor": "Social Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurovance", "Amount": "6300000", "FundingRoundCode": "A", "Date": "2014-04-03", "Investor": "State of Wisconsin Investment Board"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurovance", "Amount": "6300000", "FundingRoundCode": "A", "Date": "2014-04-03", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Neurovance", "Amount": "6300000", "FundingRoundCode": "A", "Date": "2014-04-03", "Investor": "Timothy J. Barberich"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroVigil", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-05-01", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroVigil", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-05-01", "Investor": "Zone Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroVigil", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-05-01", "Investor": "Elon Musk"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeuroVigil", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-05-01", "Investor": "Tim Draper"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-07-19", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-07-19", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-07-19", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "Covidien Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-07-19", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-07-19", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-07-19", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2013-03-07", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nevro", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-07-19", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "New Century Hospice", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2010-10-13", "Investor": "Petra Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "New Century Hospice", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2010-10-13", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "New Haven Pharmaceuticals", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "New Haven Pharmaceuticals", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "New Haven Pharmaceuticals", "Amount": "6300000", "FundingRoundCode": "NA", "Date": "2015-10-07", "Investor": "Horizon Technology Finance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "New Haven Pharmaceuticals", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "Kuzari Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NewBridge Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2010-09-20", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NewLeaf Symbiotics", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2013-01-09", "Investor": "Open Prairie"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NewLeaf Symbiotics", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-09-15", "Investor": "Open Prairie"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NewLeaf Symbiotics", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-09-15", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NewLeaf Symbiotics", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2013-01-09", "Investor": "RockPort Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NewLeaf Symbiotics", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2014-09-15", "Investor": "RockPort Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "NewLink Genetics", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2008-01-31", "Investor": "Ames Seed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "NewLink Genetics", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2008-01-31", "Investor": "Iowa Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "NewLink Genetics", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2008-01-31", "Investor": "Midwest Oilseeds"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Newsummitbio", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "GGV Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Newsummitbio", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeXeption", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2014-01-02", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeXeption", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2014-01-02", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NeXeption", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2014-01-02", "Investor": "Third Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NexImmune", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2014-07-18", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NexImmune", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2014-07-18", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NexImmune", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2014-07-18", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "NextCode Health", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-10-23", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "NextCode Health", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-10-23", "Investor": "Polaris Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "NextGxDX", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-01-01", "Investor": "Jumpstart Foundry"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextGxDX", "Amount": "2949029", "FundingRoundCode": "B", "Date": "2014-03-05", "Investor": "Nashville Capital Network, Investment Arm"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextGxDX", "Amount": "2949029", "FundingRoundCode": "B", "Date": "2014-03-05", "Investor": "NueCura Partners, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Panorama Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "1819000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2007-02-14", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2011-01-11", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NextWave Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2007-02-14", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nexvet", "Amount": "31500000", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nexvet", "Amount": "31500000", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "Farallon Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nexvet", "Amount": "31500000", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nexvet", "Amount": "31500000", "FundingRoundCode": "B", "Date": "2014-04-16", "Investor": "Tavistock Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "26550000", "FundingRoundCode": "A", "Date": "2009-12-22", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "25550000", "FundingRoundCode": "A", "Date": "2008-02-12", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2013-07-18", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "55389000", "FundingRoundCode": "B", "Date": "2011-11-07", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "26550000", "FundingRoundCode": "A", "Date": "2009-12-22", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "55389000", "FundingRoundCode": "B", "Date": "2011-11-07", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "25550000", "FundingRoundCode": "A", "Date": "2008-02-12", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2013-07-18", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2013-07-18", "Investor": "Solon Mack Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "26550000", "FundingRoundCode": "A", "Date": "2009-12-22", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "25550000", "FundingRoundCode": "A", "Date": "2008-02-12", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "NGM Biopharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2013-07-18", "Investor": "Topspin Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NICO", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-07-26", "Investor": "CHV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NICO", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-07-26", "Investor": "River Cities Capital Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NICO", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-07-26", "Investor": "The Halo Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NICO", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2009-07-26", "Investor": "Twilight Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NightstaRx", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-11-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2015-03-19", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2011-06-28", "Investor": "Atlas Venture"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2011-03-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2015-03-19", "Investor": "Lightstone Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2015-03-19", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2011-06-28", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2015-03-19", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2015-03-19", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2011-06-28", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "4.3e+07", "FundingRoundCode": "B", "Date": "2015-03-19", "Investor": "Bill Gates"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Nimbus Therapeutics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2011-03-10", "Investor": "Bill Gates"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nirmidas Biotech", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2014-08-18", "Investor": "StartX"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Niti Surgical Solutions", "Amount": "18500000", "FundingRoundCode": "F", "Date": "2009-08-11", "Investor": "SCP Vitalife Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nitric Bio", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-03-31", "Investor": "Cardinal Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nitric Bio", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-03-31", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nitric Bio", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-03-31", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Niveus Medical", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2011-09-15", "Investor": "Band of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Niveus Medical", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2011-09-15", "Investor": "HealthTech Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Niveus Medical", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2011-09-15", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Niveus Medical", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2011-09-15", "Investor": "Sand Hill Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NKT Therapeutics", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2009-03-16", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NKT Therapeutics", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2009-03-16", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Ediscovery", "CompanyName": "nLife Therapeutics", "Amount": "2718942", "FundingRoundCode": "NA", "Date": "2014-06-20", "Investor": "HealthEquity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Knopp Biosciences LLC", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2008-01-22", "Investor": "Kramer Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Knopp Biosciences LLC", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-01-01", "Investor": "Kramer Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Knopp Biosciences LLC", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2008-01-22", "Investor": "LaunchCyte"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Knopp Biosciences LLC", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-01-01", "Investor": "LaunchCyte"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Knopp Biosciences LLC", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2008-01-22", "Investor": "Saturn Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Knopp Biosciences LLC", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-01-01", "Investor": "Saturn Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Noble Biomaterials", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2012-02-10", "Investor": "DuPont Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Noble Biomaterials", "Amount": "NA", "FundingRoundCode": "C", "Date": "2013-07-01", "Investor": "Rittenhouse Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Noble Biomaterials", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2012-02-10", "Investor": "TL Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Noble Life Sciences", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2013-01-01", "Investor": "TEDCO"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2010-01-13", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "1540000", "FundingRoundCode": "A", "Date": "2006-08-17", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2010-03-22", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2010-01-17", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2010-01-13", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2010-01-17", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2010-03-22", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "1540000", "FundingRoundCode": "A", "Date": "2006-08-17", "Investor": "Texas Pacific Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Nodality", "Amount": "3500000", "FundingRoundCode": "C", "Date": "2010-01-17", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nora Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2014-04-17", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nora Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2014-04-17", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nora Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2014-04-17", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nora Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2014-04-17", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Norak Biosciences", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2002-02-05", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Norak Biosciences", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2002-02-05", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Norak Biosciences", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2002-02-05", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Norak Biosciences", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2002-02-05", "Investor": "Noro-Moseley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Norak Biosciences", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2002-02-05", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NormOxys", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2010-05-24", "Investor": "Care Capital"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "North Shore InnoVentures", "Amount": "211500", "FundingRoundCode": "NA", "Date": "2011-08-16", "Investor": "U.S. Economic Development Administration"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Testing", "CompanyName": "Notable Labs", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-12-01", "Investor": "Amasia"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Testing", "CompanyName": "Notable Labs", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-09-01", "Investor": "FundersClub"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Testing", "CompanyName": "Notable Labs", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-12-01", "Investor": "Y Combinator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novacea", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2004-01-08", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novacea", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2004-01-08", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novacea", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2004-01-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novacea", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2004-01-08", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novacea", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2004-01-08", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novacea", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2004-01-08", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaDigm Therapeutics", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2013-10-03", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Novadip Biosciences", "Amount": "31390134", "FundingRoundCode": "A", "Date": "2015-09-10", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novalar Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2007-11-02", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novalar Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2007-11-02", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novalar Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2007-11-02", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSom", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2011-06-27", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSom", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2011-06-27", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSom", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2011-06-27", "Investor": "TPG Biotechnology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novast Laboratories", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2012-06-12", "Investor": "Eli Lilly"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovaSys", "Amount": "49500000", "FundingRoundCode": "NA", "Date": "2008-05-16", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-03-24", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-03-24", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-03-24", "Investor": "Canaan Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2011-07-26", "Investor": "Delaware Crossing Investor Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-03-24", "Investor": "Delaware Crossing Investor Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-03-24", "Investor": "Mid Atlantic Angel Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2011-07-26", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-03-24", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Novira Therapeutics", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2013-03-24", "Investor": "Versant Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Novogen", "Amount": "4530000", "FundingRoundCode": "NA", "Date": "2013-07-03", "Investor": "Hudson Bay Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovoPedics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2013-04-19", "Investor": "Foundation Venture Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sample6", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2013-10-09", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sample6", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2013-10-09", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sample6", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2013-10-09", "Investor": "Flybridge Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sample6", "Amount": "5750000", "FundingRoundCode": "A", "Date": "2011-05-31", "Investor": "Founder Collective"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sample6", "Amount": "2500000", "FundingRoundCode": "B", "Date": "2014-11-14", "Investor": "Tim Lu"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovX", "Amount": "7800000", "FundingRoundCode": "C", "Date": "2008-05-02", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NovX", "Amount": "7800000", "FundingRoundCode": "C", "Date": "2008-05-02", "Investor": "GF Private Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuCana BioMed", "Amount": "5.7e+07", "FundingRoundCode": "B", "Date": "2014-04-10", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Nucleonics", "Amount": "49200000", "FundingRoundCode": "B", "Date": "2004-06-02", "Investor": "Anthem Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Nucleonics", "Amount": "49200000", "FundingRoundCode": "B", "Date": "2004-06-02", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Nucleonics", "Amount": "49200000", "FundingRoundCode": "B", "Date": "2004-06-02", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Nucleonics", "Amount": "49200000", "FundingRoundCode": "B", "Date": "2004-06-02", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Nucleonics", "Amount": "49200000", "FundingRoundCode": "B", "Date": "2004-06-02", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Nucleonics", "Amount": "49200000", "FundingRoundCode": "B", "Date": "2004-06-02", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nuevolution", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2003-10-10", "Investor": "Nordic Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuGEN Technologies", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2003-08-20", "Investor": "Band of Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuGEN Technologies", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2003-08-20", "Investor": "MedCapital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuGEN Technologies", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2003-08-20", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuGEN Technologies", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2003-08-20", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuGEN Technologies", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2003-08-20", "Investor": "James N. Wilson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2011-08-19", "Investor": "ARC Angel Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-06-01", "Investor": "Betaspring"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "NA", "FundingRoundCode": "A", "Date": "2012-01-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-01-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "NA", "FundingRoundCode": "A", "Date": "2011-08-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "NA", "FundingRoundCode": "C", "Date": "2015-03-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-11-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuLabel", "Amount": "NA", "FundingRoundCode": "B", "Date": "2013-02-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuMe Health", "Amount": "675000", "FundingRoundCode": "A", "Date": "2011-07-26", "Investor": "BVM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuMe Health", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2012-05-16", "Investor": "BVM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuMedii", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2013-06-26", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuMedii", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2015-08-17", "Investor": "Claremont Creek Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuMedii", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2013-06-26", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuMedii", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2015-08-17", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NuMedii", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2015-08-17", "Investor": "Seraph Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Numerate", "Amount": "8240487", "FundingRoundCode": "C", "Date": "2014-06-06", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Numerate", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2009-03-01", "Investor": "Foundation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Numerate", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2009-03-01", "Investor": "Lanza TechVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Numerate", "Amount": "8240487", "FundingRoundCode": "C", "Date": "2014-06-06", "Investor": "Lilly Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Numira Biosciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-03-07", "Investor": "Kickstart Seed Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Numira Biosciences", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2007-03-21", "Investor": "Pasadena Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Numira Biosciences", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2007-03-21", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Numira Biosciences", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2007-03-21", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nuon Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2008-04-28", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nuon Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-08-12", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nuon Therapeutics", "Amount": "6050000", "FundingRoundCode": "NA", "Date": "2010-03-17", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nuon Therapeutics", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2008-04-28", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nuon Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-08-12", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nuon Therapeutics", "Amount": "6050000", "FundingRoundCode": "NA", "Date": "2010-03-17", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-07-24", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-07-24", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-07-24", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-07-24", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "10062500", "FundingRoundCode": "NA", "Date": "2010-04-23", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-07-24", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2006-09-12", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-07-24", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "NuPathe", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2008-07-24", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nura", "Amount": "9500000", "FundingRoundCode": "A", "Date": "2004-09-23", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nura", "Amount": "9500000", "FundingRoundCode": "A", "Date": "2004-09-23", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Bioinformatics|Biotechnology|Data Mining", "CompanyName": "Nuritas", "Amount": "3200000", "FundingRoundCode": "A", "Date": "2015-10-27", "Investor": "Ali Partovi"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nurix", "Amount": "25100000", "FundingRoundCode": "B", "Date": "2014-05-22", "Investor": "The Column Group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Nurix", "Amount": "3100000", "FundingRoundCode": "NA", "Date": "2012-05-17", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nurix", "Amount": "25100000", "FundingRoundCode": "B", "Date": "2014-05-22", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Nurix", "Amount": "3100000", "FundingRoundCode": "NA", "Date": "2012-05-17", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nurotron Biotechnology", "Amount": "16236400", "FundingRoundCode": "C", "Date": "2013-12-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2015-05-13", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "1800000", "FundingRoundCode": "B", "Date": "2014-06-01", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2014-03-01", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2015-05-13", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2014-03-01", "Investor": "Tennessee Community Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "2083353", "FundingRoundCode": "NA", "Date": "2012-09-01", "Investor": "Tennessee Community Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "Tennessee Community Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2015-05-13", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Medical", "CompanyName": "Nusirt", "Amount": "6e+06", "FundingRoundCode": "C", "Date": "2015-05-13", "Investor": "William Guttman"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "NutraMed", "Amount": "12500000", "FundingRoundCode": "NA", "Date": "2014-01-05", "Investor": "Ampersand Capital Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "NutraMed", "Amount": "12500000", "FundingRoundCode": "NA", "Date": "2014-01-05", "Investor": "Square 1 Bank"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Clinical Trials|Life Sciences|Nanotechnology", "CompanyName": "Nvigen", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-02-18", "Investor": "China Rock Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NVISION MEDICAL", "Amount": "4144999", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "Astia Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Nymirum", "Amount": "550000", "FundingRoundCode": "NA", "Date": "2009-05-22", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oasmia Pharmaceutical", "Amount": "10198952", "FundingRoundCode": "NA", "Date": "2010-07-22", "Investor": "Yorkville Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ObsEva", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-11-23", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ObsEva", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-11-23", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ObsEva", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-11-23", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ObsEva", "Amount": "32936960", "FundingRoundCode": "A", "Date": "2013-08-29", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology", "CompanyName": "Ocata Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-08-19", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "Deerfield Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "Great Point Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "InterWest Partners"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-08-03", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "RA Capital Management"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-08-03", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocera Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2013-11-06", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ocimum Biosolutions", "Amount": "8e+06", "FundingRoundCode": "C", "Date": "2011-01-18", "Investor": "International Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ocimum Biosolutions", "Amount": "8e+06", "FundingRoundCode": "C", "Date": "2011-01-18", "Investor": "Kubera Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "23800000", "FundingRoundCode": "D", "Date": "2013-01-28", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "8500000", "FundingRoundCode": "E", "Date": "2013-06-10", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "8500000", "FundingRoundCode": "E", "Date": "2013-06-10", "Investor": "Baxter International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "23800000", "FundingRoundCode": "D", "Date": "2013-01-28", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2009-06-24", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "23800000", "FundingRoundCode": "D", "Date": "2013-01-28", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2009-06-24", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "23800000", "FundingRoundCode": "D", "Date": "2013-01-28", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ocular Therapeutix", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2009-06-24", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oculeve", "Amount": "7565000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oculeve", "Amount": "7565000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OcuSciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-05-01", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Odyssey Thera", "Amount": "2800000", "FundingRoundCode": "NA", "Date": "2013-02-14", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Okairos", "Amount": "20500000", "FundingRoundCode": "B", "Date": "2010-09-14", "Investor": "Versant Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Medical|Non Profit", "CompanyName": "Oklahoma Medical Research Foundation", "Amount": "14500000", "FundingRoundCode": "NA", "Date": "2014-08-21", "Investor": "National Institutes of Health"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Oligomerix", "Amount": "1700000", "FundingRoundCode": "NA", "Date": "2013-09-11", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "6.3e+07", "FundingRoundCode": "E", "Date": "2007-02-12", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2014-03-05", "Investor": "MidCap Financial"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2014-03-05", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "6.3e+07", "FundingRoundCode": "E", "Date": "2007-02-12", "Investor": "Stanley Medical Research Institute"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2007-01-11", "Investor": "Stanley Medical Research Institute"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "6.3e+07", "FundingRoundCode": "E", "Date": "2007-02-12", "Investor": "The Grosvenor Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "6.3e+07", "FundingRoundCode": "E", "Date": "2007-02-12", "Investor": "Trevi Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Omeros", "Amount": "6.3e+07", "FundingRoundCode": "E", "Date": "2007-02-12", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Life Sciences|Medical", "CompanyName": "Omrix Biopharmaceuticals", "Amount": "4840000", "FundingRoundCode": "NA", "Date": "2005-03-31", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Omthera Pharmaceuticals", "Amount": "33900000", "FundingRoundCode": "B", "Date": "2011-03-14", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "On Demand Therapeutics", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2010-03-18", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2009-12-14", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2012-02-28", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2009-12-14", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2009-12-14", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2012-02-28", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2009-12-14", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2009-12-14", "Investor": "Physic Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "On-Q-ity", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2012-02-28", "Investor": "Physic Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OncoEthix", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2013-07-08", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oncofactor Corporation", "Amount": "2100000", "FundingRoundCode": "A", "Date": "2011-08-02", "Investor": "Accelerator Corp."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oncofactor Corporation", "Amount": "2100000", "FundingRoundCode": "A", "Date": "2011-08-02", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oncofactor Corporation", "Amount": "2100000", "FundingRoundCode": "A", "Date": "2011-08-02", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oncofactor Corporation", "Amount": "2100000", "FundingRoundCode": "A", "Date": "2011-08-02", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oncofactor Corporation", "Amount": "2100000", "FundingRoundCode": "A", "Date": "2011-08-02", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oncofactor Corporation", "Amount": "2100000", "FundingRoundCode": "A", "Date": "2011-08-02", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OncoGenex", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2003-10-29", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "OncoHealth", "Amount": "1250000", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "Band of Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "OncoHealth", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Band of Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "OncoHealth", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "InnoSpring Seed Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OncoHealth", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2011-05-03", "Investor": "Life Science Angels"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "OncoHealth", "Amount": "1250000", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OncoHealth", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2011-05-03", "Investor": "Sand Hill Angels"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology", "CompanyName": "OncoHealth", "Amount": "1250000", "FundingRoundCode": "NA", "Date": "2011-01-01", "Investor": "David Wu"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oncolytics Biotech", "Amount": "2.4e+07", "FundingRoundCode": "NA", "Date": "2010-10-28", "Investor": "RBC Capital Markets"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "Bay Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "OncoMed Pharmaceuticals", "Amount": "1.54e+08", "FundingRoundCode": "B", "Date": "2008-11-04", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OncoPep", "Amount": "6900000", "FundingRoundCode": "B", "Date": "2014-08-28", "Investor": "Leukemia & Lymphoma Society"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Oncothyreon", "Amount": "14900000", "FundingRoundCode": "NA", "Date": "2010-09-24", "Investor": "SG Cowen"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Oncothyreon", "Amount": "14900000", "FundingRoundCode": "NA", "Date": "2010-09-24", "Investor": "Dafna Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Oncothyreon", "Amount": "14900000", "FundingRoundCode": "NA", "Date": "2010-09-24", "Investor": "Heights Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Oncothyreon", "Amount": "14900000", "FundingRoundCode": "NA", "Date": "2010-09-24", "Investor": "Hudson Bay Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Oncothyreon", "Amount": "14900000", "FundingRoundCode": "NA", "Date": "2010-09-24", "Investor": "Iroquois Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Oncothyreon", "Amount": "14900000", "FundingRoundCode": "NA", "Date": "2010-09-24", "Investor": "Ramius Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Onkaido Therapeutics", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-01-14", "Investor": "Moderna Therapeutics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Onyvax", "Amount": "14906222", "FundingRoundCode": "C", "Date": "2006-05-08", "Investor": "MB Venture Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Onyvax", "Amount": "14906222", "FundingRoundCode": "C", "Date": "2006-05-08", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OPAL Therapeutics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2005-10-31", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OPAL Therapeutics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2005-10-31", "Investor": "Alta Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "OpenTrons", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-09-02", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2012-03-07", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "23600000", "FundingRoundCode": "A", "Date": "2007-09-12", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-09-28", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2012-03-07", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2012-03-07", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2012-03-07", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "23600000", "FundingRoundCode": "A", "Date": "2007-09-12", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-09-28", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "23600000", "FundingRoundCode": "A", "Date": "2007-09-12", "Investor": "In-Q-Tel"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2012-03-07", "Investor": "jVen Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-09-28", "Investor": "jVen Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2005-01-27", "Investor": "Mason Wells Biomediacl Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "23600000", "FundingRoundCode": "A", "Date": "2007-09-12", "Investor": "Mason Wells Biomediacl Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-09-28", "Investor": "Mason Wells Biomediacl Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2015-07-14", "Investor": "Merck Global Health Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2005-01-27", "Investor": "State of Wisconsin Investment Board"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2005-01-27", "Investor": "Stonehenge Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2012-03-07", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "23600000", "FundingRoundCode": "A", "Date": "2007-09-12", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2010-09-28", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology", "CompanyName": "OpGen", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2005-01-27", "Investor": "Wisconsin Alumni Research Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "35100000", "FundingRoundCode": "D", "Date": "2006-12-14", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2005-10-11", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "15500000", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "35100000", "FundingRoundCode": "D", "Date": "2006-12-14", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2005-10-11", "Investor": "Gund Investment, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "15500000", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "Gund Investment, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "35100000", "FundingRoundCode": "D", "Date": "2006-12-14", "Investor": "Gund Investment, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2005-10-11", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "35100000", "FundingRoundCode": "D", "Date": "2006-12-14", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2005-10-11", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "15500000", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "35100000", "FundingRoundCode": "D", "Date": "2006-12-14", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Consumers", "CompanyName": "Ophthonix", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2005-10-11", "Investor": "Trex Enterprises"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ophthotech", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-12-15", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ophthotech", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2007-08-13", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ophthotech", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-12-15", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Therapeutics", "CompanyName": "Opsona", "Amount": "43272900", "FundingRoundCode": "C", "Date": "2013-04-29", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Therapeutics", "CompanyName": "Opsona", "Amount": "3859800", "FundingRoundCode": "C", "Date": "2013-10-02", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Therapeutics", "CompanyName": "Opsona", "Amount": "43272900", "FundingRoundCode": "C", "Date": "2013-04-29", "Investor": "Baxter International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Therapeutics", "CompanyName": "Opsona", "Amount": "3859800", "FundingRoundCode": "C", "Date": "2013-10-02", "Investor": "Baxter International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optherion", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2007-10-09", "Investor": "Biogen Idec New Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optherion", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2007-10-09", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optherion", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2007-10-09", "Investor": "GE Healthcare"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optherion", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2007-10-09", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optherion", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2007-10-09", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optherion", "Amount": "3.7e+07", "FundingRoundCode": "A", "Date": "2007-10-09", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optics 1", "Amount": "3.8e+07", "FundingRoundCode": "NA", "Date": "2010-01-21", "Investor": "America's Navy"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optimata", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2008-02-13", "Investor": "Trimaran Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2013-05-10", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "1.6e+07", "FundingRoundCode": "C", "Date": "2008-03-26", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2013-05-10", "Investor": "BlackRock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2013-05-10", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "1.6e+07", "FundingRoundCode": "C", "Date": "2008-03-26", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-05-26", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2013-05-10", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiMedica", "Amount": "1.6e+07", "FundingRoundCode": "C", "Date": "2008-03-26", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optimer Pharmaceuticals", "Amount": "22200000", "FundingRoundCode": "D", "Date": "2005-12-14", "Investor": "Lurie Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optimer Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "NA", "Date": "2005-03-02", "Investor": "Par Pharmaceuticals"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optimer Pharmaceuticals", "Amount": "22200000", "FundingRoundCode": "D", "Date": "2005-12-14", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optimer Pharmaceuticals", "Amount": "22200000", "FundingRoundCode": "D", "Date": "2005-12-14", "Investor": "SB Life Science"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Optimer Pharmaceuticals", "Amount": "22200000", "FundingRoundCode": "D", "Date": "2005-12-14", "Investor": "Strategic Global Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiNose", "Amount": "48500000", "FundingRoundCode": "C", "Date": "2010-06-07", "Investor": "Avista Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiNose", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2014-08-05", "Investor": "Avista Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiNose", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2014-08-05", "Investor": "WFD Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "3.6e+07", "FundingRoundCode": "NA", "Date": "2005-10-10", "Investor": "EGS Healthcare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "3.6e+07", "FundingRoundCode": "NA", "Date": "2005-10-10", "Investor": "JPMorgan Partners (JPMP)"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "30733658", "FundingRoundCode": "NA", "Date": "2013-02-07", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "3.6e+07", "FundingRoundCode": "NA", "Date": "2005-10-10", "Investor": "MedVenture Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "30733658", "FundingRoundCode": "NA", "Date": "2013-02-07", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "3.6e+07", "FundingRoundCode": "NA", "Date": "2005-10-10", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "30733658", "FundingRoundCode": "NA", "Date": "2013-02-07", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "3.6e+07", "FundingRoundCode": "NA", "Date": "2005-10-10", "Investor": "Oakwood Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "3.6e+07", "FundingRoundCode": "NA", "Date": "2005-10-10", "Investor": "Prism Venture Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "OptiScan Biomedical", "Amount": "30733658", "FundingRoundCode": "NA", "Date": "2013-02-07", "Investor": "Wexford Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Diagnostics|Nanotechnology", "CompanyName": "Optofluidics", "Amount": "75000", "FundingRoundCode": "NA", "Date": "2015-05-06", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oraya Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "C", "Date": "2009-07-20", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oraya Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "C", "Date": "2009-07-20", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oraya Therapeutics", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2007-06-18", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oraya Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2008-01-11", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oraya Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "C", "Date": "2009-07-20", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oraya Therapeutics", "Amount": "4.2e+07", "FundingRoundCode": "C", "Date": "2009-07-20", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oraya Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2008-01-11", "Investor": "Synergy Life Science Partner"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Orexigen Therapeutics", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2004-01-22", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Orexigen Therapeutics", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2004-01-22", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Orexigen Therapeutics", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2004-01-22", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orexo", "Amount": "22261405", "FundingRoundCode": "B", "Date": "2003-01-17", "Investor": "Apex Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orexo", "Amount": "22261405", "FundingRoundCode": "B", "Date": "2003-01-17", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Organovo Holdings", "Amount": "15200000", "FundingRoundCode": "NA", "Date": "2012-03-19", "Investor": "Spencer Trask & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Organovo Holdings", "Amount": "3489760", "FundingRoundCode": "A", "Date": "2011-11-02", "Investor": "Michael Brams"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Oricula Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-04-10", "Investor": "University of Washington"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oriel Therapeutics", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2007-11-16", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Origen Therapeutics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2007-10-03", "Investor": "National Institute of Standards and Technology (NIST)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Origene Technologies", "Amount": "21300000", "FundingRoundCode": "C", "Date": "2013-03-21", "Investor": "Accel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Origene Technologies", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2010-03-24", "Investor": "Accel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Origene Technologies", "Amount": "21300000", "FundingRoundCode": "C", "Date": "2013-03-21", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2007-03-27", "Investor": "Boston Scientific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2003-06-24", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2007-03-27", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2007-03-27", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2003-06-24", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2007-03-27", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2003-06-24", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2007-03-27", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2003-06-24", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2007-03-27", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2003-06-24", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orqis Medical", "Amount": "1.2e+07", "FundingRoundCode": "D", "Date": "2007-03-27", "Investor": "Rho Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Orteq", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-01-08", "Investor": "Kensey Nash Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2010-01-31", "Investor": "Gatebridge Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2009-11-11", "Investor": "Gatebridge Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "9600000", "FundingRoundCode": "C", "Date": "2015-04-14", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2010-01-31", "Investor": "PTV Healthcare Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2009-11-11", "Investor": "PTV Healthcare Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "2e+06", "FundingRoundCode": "B", "Date": "2010-12-08", "Investor": "Texas Venture Labs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "2e+06", "FundingRoundCode": "B", "Date": "2010-12-08", "Investor": "TEXO Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "9600000", "FundingRoundCode": "C", "Date": "2015-04-14", "Investor": "TEXO Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2010-01-31", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ortho Kinematics", "Amount": "3500000", "FundingRoundCode": "NA", "Date": "2009-11-11", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Orthomimetics", "Amount": "9812643.91877748", "FundingRoundCode": "A", "Date": "2006-12-01", "Investor": "Goldman Sachs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Customer Service|Medical Devices", "CompanyName": "OrthoScan", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2008-10-06", "Investor": "Aphelion Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Customer Service|Medical Devices", "CompanyName": "OrthoScan", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2008-10-06", "Investor": "California Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Customer Service|Medical Devices", "CompanyName": "OrthoScan", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2008-10-06", "Investor": "River Cities Capital Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OrthoSpace", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2015-05-19", "Investor": "HealthpointCapital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Osprey Pharmaceuticals USA", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2008-09-03", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Osprey Pharmaceuticals USA", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2007-01-30", "Investor": "Cascadia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Osprey Pharmaceuticals USA", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2008-09-03", "Investor": "Western Technology Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Osprey Pharmaceuticals USA", "Amount": "1.1e+07", "FundingRoundCode": "A", "Date": "2008-09-03", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "OsteoBiologics", "Amount": "9200000", "FundingRoundCode": "NA", "Date": "2003-10-03", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "OsteoBiologics", "Amount": "9200000", "FundingRoundCode": "NA", "Date": "2003-10-03", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services", "CompanyName": "OsteoBiologics", "Amount": "9200000", "FundingRoundCode": "NA", "Date": "2003-10-03", "Investor": "Woodside Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otologic Pharmaceutics", "Amount": "4100000", "FundingRoundCode": "A", "Date": "2014-04-03", "Investor": "i2E"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "45900000", "FundingRoundCode": "C", "Date": "2013-09-04", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2010-06-11", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "45900000", "FundingRoundCode": "C", "Date": "2013-09-04", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "45900000", "FundingRoundCode": "C", "Date": "2013-09-04", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2010-08-30", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "45900000", "FundingRoundCode": "C", "Date": "2013-09-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "45900000", "FundingRoundCode": "C", "Date": "2013-09-04", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "45900000", "FundingRoundCode": "C", "Date": "2013-09-04", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2010-08-30", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "45900000", "FundingRoundCode": "C", "Date": "2013-09-04", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "4.9e+07", "FundingRoundCode": "D", "Date": "2014-04-30", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Otonomy", "Amount": "38500000", "FundingRoundCode": "B", "Date": "2010-08-30", "Investor": "TPG Biotechnology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Life Sciences|Medical", "CompanyName": "Ouro_botics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-12-12", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ouroboros", "Amount": "1170000", "FundingRoundCode": "A", "Date": "2007-07-18", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ovalis", "Amount": "6600000", "FundingRoundCode": "B", "Date": "2007-01-13", "Investor": "Abbott Labs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ovalis", "Amount": "6600000", "FundingRoundCode": "B", "Date": "2007-01-13", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ovalis", "Amount": "6600000", "FundingRoundCode": "B", "Date": "2007-01-13", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OvaScience", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2012-04-03", "Investor": "BB&T"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OvaScience", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2012-04-03", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OvaScience", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2012-04-03", "Investor": "General Catalyst Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OvaScience", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2012-04-03", "Investor": "Hunt BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OvaScience", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2012-04-03", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ovizio", "Amount": "8616975.44161999", "FundingRoundCode": "NA", "Date": "2015-11-16", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oxagen", "Amount": "26700000", "FundingRoundCode": "C", "Date": "2009-11-24", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oxagen", "Amount": "26700000", "FundingRoundCode": "C", "Date": "2009-11-24", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oxagen", "Amount": "26700000", "FundingRoundCode": "C", "Date": "2009-11-24", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oxagen", "Amount": "26700000", "FundingRoundCode": "C", "Date": "2009-11-24", "Investor": "SV Life Sciences"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Oxford BioTherapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-07-30", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2010-05-04", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2012-06-18", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2007-10-29", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2010-05-04", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2012-06-18", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2010-05-04", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2012-06-18", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "12550010", "FundingRoundCode": "B", "Date": "2005-08-10", "Investor": "The Dow Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Oxford Immunotec", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2007-10-29", "Investor": "The Dow Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Oxyrane UK", "Amount": "26500000", "FundingRoundCode": "D", "Date": "2011-11-17", "Investor": "New Science Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "OyaGen", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2013-09-16", "Investor": "New York State Common Retirement Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "OyaGen", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2010-09-24", "Investor": "Trillium Group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Chemicals|Specialty Chemicals", "CompanyName": "P2 Science", "Amount": "650000", "FundingRoundCode": "NA", "Date": "2013-05-19", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Chemicals|Specialty Chemicals", "CompanyName": "P2 Science", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2013-03-17", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Chemicals|Specialty Chemicals", "CompanyName": "P2 Science", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2014-04-06", "Investor": "Elm Street Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Chemicals|Specialty Chemicals", "CompanyName": "P2 Science", "Amount": "650000", "FundingRoundCode": "NA", "Date": "2013-05-19", "Investor": "Elm Street Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-01-15", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "7720000", "FundingRoundCode": "C", "Date": "2005-08-31", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Gen-Probe"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Intel Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Intel Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-01-15", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "7720000", "FundingRoundCode": "C", "Date": "2005-08-31", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-01-15", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2007-01-15", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "7720000", "FundingRoundCode": "C", "Date": "2005-08-31", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Monsanto"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Morgan Stanley"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Morgan Stanley"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "1.09e+08", "FundingRoundCode": "F", "Date": "2010-07-14", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pacific Biosciences", "Amount": "6.8e+07", "FundingRoundCode": "E", "Date": "2009-10-01", "Investor": "T. Rowe Price"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Pain Therapeutics", "Amount": "1700000", "FundingRoundCode": "NA", "Date": "2015-09-21", "Investor": "National Institutes of Health"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Palatin Technologies", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-12-24", "Investor": "Horizon Technology Finance"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Palatin Technologies", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-12-24", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PamGene", "Amount": "11", "FundingRoundCode": "B", "Date": "2003-07-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Panacos Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2004-12-10", "Investor": "Great Point Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Panacos Pharmaceuticals", "Amount": "18300000", "FundingRoundCode": "C", "Date": "2004-05-18", "Investor": "Lakeview Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Panacos Pharmaceuticals", "Amount": "18300000", "FundingRoundCode": "C", "Date": "2004-05-18", "Investor": "Maryland Department of Business and Economic Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Panacos Pharmaceuticals", "Amount": "18300000", "FundingRoundCode": "C", "Date": "2004-05-18", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Panacos Pharmaceuticals", "Amount": "18300000", "FundingRoundCode": "C", "Date": "2004-05-18", "Investor": "New England Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Panacos Pharmaceuticals", "Amount": "18300000", "FundingRoundCode": "C", "Date": "2004-05-18", "Investor": "William Harris Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PanOptica", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2011-01-04", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PanOptica", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-04-15", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PanOptica", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2011-01-04", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PanOptica", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2014-04-15", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Paragon Bioservices", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2014-10-28", "Investor": "Camden Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Paragon Bioservices", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2014-10-28", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Parasol Therapeutics", "Amount": "3250000", "FundingRoundCode": "A", "Date": "2009-05-10", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Parasol Therapeutics", "Amount": "3250000", "FundingRoundCode": "A", "Date": "2009-05-10", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Parasol Therapeutics", "Amount": "3250000", "FundingRoundCode": "A", "Date": "2009-05-10", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Paratek Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "H", "Date": "2007-10-26", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Paratek Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "H", "Date": "2007-10-26", "Investor": "D.E. Shaw & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ParentPlus", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2007-12-13", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Pareto Biotechnologies", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-11-14", "Investor": "Breakout Labs"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Medical|Startups", "CompanyName": "Parion Sciences", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2014-09-16", "Investor": "Cystic Fibrosis Foundation"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Parkinsor", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-01-01", "Investor": "NextStart"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "2708333", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "Launch Tennessee"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "1243879", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "Launch Tennessee"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2014-02-27", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2012-03-01", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2013-03-01", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "2708333", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "1243879", "FundingRoundCode": "NA", "Date": "2013-06-01", "Investor": "Mountain Group Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "NA", "FundingRoundCode": "A", "Date": "2008-10-16", "Investor": "Nashville Capital Network, Investment Arm"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2014-02-27", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2013-03-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pathfinder Technologies", "Amount": "2708333", "FundingRoundCode": "NA", "Date": "2012-06-01", "Investor": "TriStar Technology Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "PathGroup", "Amount": "19500000", "FundingRoundCode": "NA", "Date": "2010-01-12", "Investor": "Maranon Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-11-01", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2011-08-01", "Investor": "CB Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-11-01", "Investor": "CB Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2011-08-01", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-11-01", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2011-08-01", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2011-11-01", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathogenetix", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2013-10-30", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology|Environmental Innovation|Life Sciences|Manufacturing", "CompanyName": "PATHSENSORS", "Amount": "1755000", "FundingRoundCode": "NA", "Date": "2012-09-11", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2010-10-06", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2006-07-06", "Investor": "Novus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2010-10-06", "Investor": "Novus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2005-10-01", "Investor": "Novus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2006-07-06", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2010-10-06", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2006-07-06", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2010-10-06", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pathwork Diagnostics", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2006-07-06", "Investor": "Versant Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pattern Genomics", "Amount": "150000", "FundingRoundCode": "NA", "Date": "2013-03-21", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PaxVax", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2013-12-04", "Investor": "Blue Haven Initiative"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PaxVax", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2014-07-28", "Investor": "Blue Haven Initiative"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PaxVax", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2013-12-04", "Investor": "Ignition Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PaxVax", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2009-11-09", "Investor": "Ignition Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pear Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-03-19", "Investor": "5AM Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "23273200", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "41726900", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2012-11-13", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "6.9e+07", "FundingRoundCode": "C", "Date": "2010-10-19", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "15500000", "FundingRoundCode": "A", "Date": "2007-09-07", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2010-03-05", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2008-07-03", "Investor": "5AM Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "23273200", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "41726900", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2012-11-13", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "15500000", "FundingRoundCode": "A", "Date": "2007-09-07", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2010-03-05", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2008-07-03", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2008-07-03", "Investor": "Nektar Therapeutics"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "23273200", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "41726900", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2012-11-13", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "6.9e+07", "FundingRoundCode": "C", "Date": "2010-10-19", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "15500000", "FundingRoundCode": "A", "Date": "2007-09-07", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2010-03-05", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2008-07-03", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "23273200", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "41726900", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "D", "Date": "2012-11-13", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Medical|Pharmaceuticals", "CompanyName": "Pearl Therapeutics", "Amount": "6.9e+07", "FundingRoundCode": "C", "Date": "2010-10-19", "Investor": "Vatera Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pegasus Biologics", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2007-05-10", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pegasus Biologics", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2007-05-10", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pegasus Biologics", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2007-05-10", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pegasus Biologics", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2007-05-10", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pelikan Technologies", "Amount": "6.9e+07", "FundingRoundCode": "F", "Date": "2007-12-06", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Peloton Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2011-07-27", "Investor": "Remeditex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Peloton Therapeutics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2011-07-27", "Investor": "The Column Group"}, {"FundingRoundType": "seed", "CompanyCategory": "3D Printing|Biotechnology|GreenTech", "CompanyName": "Pembient", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-01-16", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "41200000", "FundingRoundCode": "A", "Date": "2003-03-12", "Investor": "Boston Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "8900000", "FundingRoundCode": "D", "Date": "2008-07-17", "Investor": "Boston Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "41200000", "FundingRoundCode": "A", "Date": "2003-03-12", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "18660000", "FundingRoundCode": "C", "Date": "2005-06-09", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "8900000", "FundingRoundCode": "D", "Date": "2008-07-17", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "41200000", "FundingRoundCode": "A", "Date": "2003-03-12", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "18660000", "FundingRoundCode": "C", "Date": "2005-06-09", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "8900000", "FundingRoundCode": "D", "Date": "2008-07-17", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "41200000", "FundingRoundCode": "A", "Date": "2003-03-12", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "18660000", "FundingRoundCode": "C", "Date": "2005-06-09", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "8900000", "FundingRoundCode": "D", "Date": "2008-07-17", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "41200000", "FundingRoundCode": "A", "Date": "2003-03-12", "Investor": "Vanguard Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Services", "CompanyName": "Peptimmune", "Amount": "18660000", "FundingRoundCode": "C", "Date": "2005-06-09", "Investor": "Vanguard Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Perfectus Biomed", "Amount": "151525", "FundingRoundCode": "NA", "Date": "2013-06-19", "Investor": "midVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perfint Healthcare", "Amount": "7200000", "FundingRoundCode": "B", "Date": "2010-07-01", "Investor": "Norwest Venture Partners - NVP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perfint Healthcare", "Amount": "8e+06", "FundingRoundCode": "C", "Date": "2011-12-01", "Investor": "Norwest Venture Partners - NVP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perfint Healthcare", "Amount": "1.4e+07", "FundingRoundCode": "D", "Date": "2013-01-01", "Investor": "Norwest Venture Partners - NVP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "Biofrontier Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2003-01-28", "Investor": "Biofrontier Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "Cape Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2003-01-28", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2003-01-28", "Investor": "Eli Lilly"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "Glynn Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2003-01-28", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "SB Life Science"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2003-01-28", "Investor": "SB Life Science"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2003-01-28", "Investor": "Unilever Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Perlegen Sciences", "Amount": "7.4e+07", "FundingRoundCode": "D", "Date": "2005-02-28", "Investor": "Zesiger Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Perlstein Lab PBC", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2014-07-31", "Investor": "Retrophin"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Perosphere", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-07-03", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Personal Genome Diagnostics (PGD)", "Amount": "21400000", "FundingRoundCode": "A", "Date": "2015-10-28", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Personal Genome Diagnostics (PGD)", "Amount": "21400000", "FundingRoundCode": "A", "Date": "2015-10-28", "Investor": "Windham Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Personalis", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2013-10-07", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Personalis", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2015-01-13", "Investor": "Lightspeed Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Personalis", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2013-10-07", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2005-08-26", "Investor": "Flagship Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2004-03-16", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "9750000", "FundingRoundCode": "NA", "Date": "2008-01-15", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "17380000", "FundingRoundCode": "C", "Date": "2009-08-31", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2005-08-26", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "9750000", "FundingRoundCode": "NA", "Date": "2008-01-15", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "17380000", "FundingRoundCode": "C", "Date": "2009-08-31", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "9750000", "FundingRoundCode": "NA", "Date": "2008-01-15", "Investor": "Musket Research Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "12400000", "FundingRoundCode": "B", "Date": "2005-08-26", "Investor": "Polaris Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2004-03-16", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "9750000", "FundingRoundCode": "NA", "Date": "2008-01-15", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pervasis Therapeutics", "Amount": "17380000", "FundingRoundCode": "C", "Date": "2009-08-31", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pfenex", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2009-12-09", "Investor": "Signet Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pfenex", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2009-12-09", "Investor": "The Dow Chemical Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharma Two B", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2012-10-23", "Investor": "JK&B Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PharmAbcine", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2009-09-16", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmaca", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2008-03-26", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmaca", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2008-03-26", "Investor": "Physic Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Medical Devices|Pharmaceuticals", "CompanyName": "Pharmaceutic Litho & Label", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-10-16", "Investor": "Ironwood Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Medical Devices|Pharmaceuticals", "CompanyName": "Pharmaceutic Litho & Label", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-10-16", "Investor": "Saugatuck Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Balyasny Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Carpe Diem Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Clarion Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Crestview Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "ClearArc Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Highbridge Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Nite Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmacopeia", "Amount": "7630000", "FundingRoundCode": "NA", "Date": "2005-07-27", "Investor": "Rima Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "PharmaDiagnostics", "Amount": "3700000", "FundingRoundCode": "B", "Date": "2010-01-21", "Investor": "Capital-E"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PharmAkea Therapeutics", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2013-10-07", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmaron Holding", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2011-02-24", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharmaron Holding", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2011-02-24", "Investor": "DCM"}, {"FundingRoundType": "secondary_market", "CompanyCategory": "Biotechnology", "CompanyName": "PharmAthene", "Amount": "19300000", "FundingRoundCode": "NA", "Date": "2009-07-27", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "secondary_market", "CompanyCategory": "Biotechnology", "CompanyName": "PharmAthene", "Amount": "19300000", "FundingRoundCode": "NA", "Date": "2009-07-27", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "secondary_market", "CompanyCategory": "Biotechnology", "CompanyName": "PharmAthene", "Amount": "19300000", "FundingRoundCode": "NA", "Date": "2009-07-27", "Investor": "MPM Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PharmatrophiX", "Amount": "10300000", "FundingRoundCode": "NA", "Date": "2015-11-20", "Investor": "Dolby Family Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pharnext", "Amount": "10630400", "FundingRoundCode": "NA", "Date": "2012-02-09", "Investor": "Parinvest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2012-06-05", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2012-06-05", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "6600000", "FundingRoundCode": "B", "Date": "2007-10-24", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-01-07", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2012-06-05", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "6600000", "FundingRoundCode": "B", "Date": "2007-10-24", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-01-07", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2012-06-05", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "6600000", "FundingRoundCode": "B", "Date": "2007-10-24", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-01-07", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2012-06-05", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseBio Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2010-01-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseRx", "Amount": "20216583", "FundingRoundCode": "A", "Date": "2008-02-28", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseRx", "Amount": "20216583", "FundingRoundCode": "A", "Date": "2008-02-28", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhaseRx", "Amount": "20216583", "FundingRoundCode": "A", "Date": "2008-02-28", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2007-03-08", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2002-03-11", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2007-03-08", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2007-03-08", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2002-03-11", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2007-03-08", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2002-03-11", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2007-03-08", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2007-03-08", "Investor": "J.P. Morgan Securities Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "5.5e+07", "FundingRoundCode": "C", "Date": "2007-03-08", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2002-03-11", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phenomix", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2002-03-11", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials", "CompanyName": "PhosImmune", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-08-12", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "30500000", "FundingRoundCode": "C", "Date": "2006-04-21", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2009-05-22", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "30500000", "FundingRoundCode": "C", "Date": "2006-04-21", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2009-05-22", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "30500000", "FundingRoundCode": "C", "Date": "2006-04-21", "Investor": "Hamilton BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2009-05-22", "Investor": "Hamilton BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "30500000", "FundingRoundCode": "C", "Date": "2006-04-21", "Investor": "Solstice Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "30500000", "FundingRoundCode": "C", "Date": "2006-04-21", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2009-05-22", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "30500000", "FundingRoundCode": "C", "Date": "2006-04-21", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PhotoThera", "Amount": "5e+07", "FundingRoundCode": "D", "Date": "2009-05-22", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phrixus Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-07-17", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Medical", "CompanyName": "Phthisis Diagnostics", "Amount": "435000", "FundingRoundCode": "A", "Date": "2011-04-21", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Medical", "CompanyName": "Phthisis Diagnostics", "Amount": "450000", "FundingRoundCode": "A", "Date": "2012-06-29", "Investor": "Militello Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics|Medical", "CompanyName": "Phthisis Diagnostics", "Amount": "435000", "FundingRoundCode": "A", "Date": "2011-04-21", "Investor": "Jennifer O'Daniel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylogix Inc.", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-03-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylogix Inc.", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-03-10", "Investor": "Biotechnology Value Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylogix Inc.", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-03-10", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylogix Inc.", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-03-10", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylogix Inc.", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2004-03-10", "Investor": "Radius Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylos", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2001-01-01", "Investor": "Lone Pine Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylos", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2001-01-01", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Phylos", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2001-01-01", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Physicians Endoscopy", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2004-02-11", "Investor": "Mellon Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Physicians Endoscopy", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-09-03", "Investor": "Pamlico Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PHYSICIANS IMMEDIATE CARE", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-07-26", "Investor": "LLR Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PHYSICIANS IMMEDIATE CARE", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-07-26", "Investor": "Anthem Inc (former WellPoint, Inc.)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Technology", "CompanyName": "Phytomedics", "Amount": "9e+06", "FundingRoundCode": "B", "Date": "2007-06-11", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Manufacturing|Technology", "CompanyName": "Phytomedics", "Amount": "7500000", "FundingRoundCode": "A", "Date": "2004-01-20", "Investor": "Burrill & Company"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Piedmont BioProducts", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-04-18", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "PIERIS Proteolab", "Amount": "8232745", "FundingRoundCode": "NA", "Date": "2014-11-26", "Investor": "Morrison & Foerster LLP."}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "PIERIS Proteolab", "Amount": "8232745", "FundingRoundCode": "NA", "Date": "2014-11-26", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PIERIS Proteolab", "Amount": "39300760.8627303", "FundingRoundCode": "B", "Date": "2008-03-27", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pili", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Pinta Biotherapeutics*", "Amount": "4294000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Pinta Biotherapeutics*", "Amount": "1005000", "FundingRoundCode": "NA", "Date": "2013-03-31", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PipelineRx", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-03-17", "Investor": "AMN Healthcare"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PipelineRx", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "AMN Healthcare"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PipelineRx", "Amount": "9100000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "McKesson Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Piramed", "Amount": "13200000", "FundingRoundCode": "A", "Date": "2003-07-09", "Investor": "JPMorgan Partners (JPMP)"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Plandai Biotechnology", "Amount": "15300000", "FundingRoundCode": "NA", "Date": "2014-02-10", "Investor": "Lincoln Park Capital Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Plasmonix", "Amount": "298264", "FundingRoundCode": "NA", "Date": "2012-06-07", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Plasmonix", "Amount": "231069", "FundingRoundCode": "A", "Date": "2013-11-13", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Plexxikon", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2004-05-26", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Plexxikon", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2004-05-26", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Plexxikon", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2004-05-26", "Investor": "Walden International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PLx Pharma", "Amount": "8273297", "FundingRoundCode": "NA", "Date": "2013-03-19", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PLx Pharma", "Amount": "8273297", "FundingRoundCode": "NA", "Date": "2013-03-19", "Investor": "UT Horizon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PNP Therapeutics", "Amount": "925000", "FundingRoundCode": "B", "Date": "2007-06-07", "Investor": "Greer Capital Advisors"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Podimetrics", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2013-03-27", "Investor": "Norwich Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Podimetrics", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2013-03-27", "Investor": "Rock Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "POINT Biomedical", "Amount": "2.5e+07", "FundingRoundCode": "E", "Date": "2008-01-01", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "POINT Biomedical", "Amount": "2.5e+07", "FundingRoundCode": "E", "Date": "2008-01-01", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "POINT Biomedical", "Amount": "2.5e+07", "FundingRoundCode": "E", "Date": "2008-01-01", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Medical|Pharmaceuticals", "CompanyName": "POINT Biomedical", "Amount": "2.5e+07", "FundingRoundCode": "E", "Date": "2008-01-01", "Investor": "Vedanta Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PointCare", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2008-04-24", "Investor": "Brook Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PolyMedix", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2010-04-01", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Polynova Cardiovascular", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2014-06-12", "Investor": "Accelerate Long Island"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Apothecary Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "D.E. Shaw & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "8.9e+07", "FundingRoundCode": "D", "Date": "2011-11-21", "Investor": "Eastern Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2003-12-10", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Goldman Sachs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "Goldman Sachs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2003-12-10", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "Prospect Street Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2003-12-10", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2003-12-10", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "60099999", "FundingRoundCode": "C", "Date": "2009-06-15", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Portola Pharmaceuticals", "Amount": "7e+07", "FundingRoundCode": "C", "Date": "2007-05-07", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Posit Science", "Amount": "5600000", "FundingRoundCode": "C", "Date": "2009-04-27", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Posit Science", "Amount": "5600000", "FundingRoundCode": "C", "Date": "2009-04-27", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Posit Science", "Amount": "5600000", "FundingRoundCode": "C", "Date": "2009-04-27", "Investor": "VSP Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Practical EHR Solutions", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2011-07-05", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Precipio Diagnostics", "Amount": "1800000", "FundingRoundCode": "B", "Date": "2013-10-28", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Precipio Diagnostics", "Amount": "1800000", "FundingRoundCode": "B", "Date": "2013-10-28", "Investor": "Enhanced Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Precipio Diagnostics", "Amount": "1800000", "FundingRoundCode": "B", "Date": "2013-10-28", "Investor": "Ironwood Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Precipio Diagnostics", "Amount": "1800000", "FundingRoundCode": "B", "Date": "2013-10-28", "Investor": "Kuzari Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precise Light Surgical", "Amount": "4500000", "FundingRoundCode": "NA", "Date": "2013-10-15", "Investor": "Life Sciences Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Precision Biologics", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-10-19", "Investor": "NantWorks"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision Biopsy", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2011-11-08", "Investor": "Allied Minds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision BioSciences", "Amount": "25600000", "FundingRoundCode": "A", "Date": "2015-05-11", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision BioSciences", "Amount": "25600000", "FundingRoundCode": "A", "Date": "2015-05-11", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision BioSciences", "Amount": "25600000", "FundingRoundCode": "A", "Date": "2015-05-11", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision BioSciences", "Amount": "25600000", "FundingRoundCode": "A", "Date": "2015-05-11", "Investor": "venBio"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PreCision Dermatology", "Amount": "6.7e+07", "FundingRoundCode": "NA", "Date": "2013-09-23", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PreCision Dermatology", "Amount": "6.7e+07", "FundingRoundCode": "NA", "Date": "2013-09-23", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PreCision Dermatology", "Amount": "6.7e+07", "FundingRoundCode": "NA", "Date": "2013-09-23", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PreCision Dermatology", "Amount": "6.7e+07", "FundingRoundCode": "NA", "Date": "2013-09-23", "Investor": "Golub Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PreCision Dermatology", "Amount": "6.7e+07", "FundingRoundCode": "NA", "Date": "2013-09-23", "Investor": "Longitude Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PreCision Dermatology", "Amount": "6.7e+07", "FundingRoundCode": "NA", "Date": "2013-09-23", "Investor": "Novaquest Capital Management"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PreCision Dermatology", "Amount": "6.7e+07", "FundingRoundCode": "NA", "Date": "2013-09-23", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision NanoSystem", "Amount": "13400000", "FundingRoundCode": "A", "Date": "2015-09-29", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision NanoSystem", "Amount": "13400000", "FundingRoundCode": "A", "Date": "2015-09-29", "Investor": "Rising Tide Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Precision NanoSystem", "Amount": "13400000", "FundingRoundCode": "A", "Date": "2015-09-29", "Investor": "Telegraph Hill Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Helomics", "Amount": "3.3e+07", "FundingRoundCode": "D", "Date": "2010-06-11", "Investor": "Bain Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Helomics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "1998-04-01", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Helomics", "Amount": "6e+07", "FundingRoundCode": "E", "Date": "2014-11-13", "Investor": "HealthCare Royalty Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2010-06-18", "Investor": "Flybridge Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2006-12-18", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2010-06-18", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "21750000", "FundingRoundCode": "B", "Date": "2008-10-16", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2010-06-18", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "21750000", "FundingRoundCode": "B", "Date": "2008-10-16", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2010-06-18", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Predictive Biosciences", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2010-06-18", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PregLem", "Amount": "31952662.7218935", "FundingRoundCode": "B", "Date": "2007-12-04", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Babies|Biotechnology|Parenting", "CompanyName": "Prenetics", "Amount": "2650000", "FundingRoundCode": "NA", "Date": "2014-12-03", "Investor": "500 Startups"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Presage Biosciences", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-11-01", "Investor": "David Wu"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2007-08-29", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "7977900", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2007-08-29", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "NA", "Date": "2009-07-10", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "7977900", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2007-08-29", "Investor": "Nexus Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2007-08-29", "Investor": "Panorama Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Presidio Pharmaceuticals", "Amount": "7977900", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Panorama Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2003-06-19", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2006-10-22", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-08-27", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2006-10-22", "Investor": "CNF Investments, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-08-27", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2003-06-19", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2006-10-22", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-08-27", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2003-06-19", "Investor": "Vivo Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2006-10-22", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-08-27", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2006-10-22", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Prestwick Pharmaceuticals, Inc.", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-08-27", "Investor": "Warburg Pincus"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Prevacus", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-02-28", "Investor": "Institute for the Commercialization of Public Research"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Prime Genomics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-07-16", "Investor": "Iron Yard Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2008-01-09", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-10-30", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-10-30", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2008-01-09", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-10-30", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2008-01-09", "Investor": "Invus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-10-30", "Investor": "Invus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2008-01-09", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeraDx (Primera Biosystems)", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-10-30", "Investor": "MPM Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "PrimeSource Healthcare Systems", "Amount": "5500000", "FundingRoundCode": "NA", "Date": "2013-08-26", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2012-10-29", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Principia BioPharma", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2014-04-22", "Investor": "SR One"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Galectin Therapeutics", "Amount": "489000", "FundingRoundCode": "NA", "Date": "2010-02-10", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proacta", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proacta", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-07", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proacta", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2007-02-07", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Probiodrug", "Amount": "5.4e+07", "FundingRoundCode": "B", "Date": "2009-11-02", "Investor": "Biogen Idec New Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Probiodrug", "Amount": "19422000", "FundingRoundCode": "NA", "Date": "2012-01-04", "Investor": "Biogen Idec New Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProCertus BioPharm", "Amount": "2300000", "FundingRoundCode": "A", "Date": "2007-05-10", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProCure Treatment Centers", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2011-02-01", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Profectus Biosciences", "Amount": "7291206", "FundingRoundCode": "NA", "Date": "2014-04-18", "Investor": "Cross Atlantic Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Profectus Biosciences", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2007-06-15", "Investor": "Cross Atlantic Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Profex", "Amount": "15500000", "FundingRoundCode": "A", "Date": "2008-08-28", "Investor": "Trident Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Profusa", "Amount": "2759821", "FundingRoundCode": "NA", "Date": "2013-09-10", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "Arcturus Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "DFJ Frontier"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "Draper Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "Funk Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "Gideon Hixon Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2011-11-03", "Investor": "Health Evolution Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "540000", "FundingRoundCode": "B", "Date": "2006-11-21", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prolacta Bioscience", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2007-05-23", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "21500000", "FundingRoundCode": "D", "Date": "2012-03-07", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-05-24", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "21500000", "FundingRoundCode": "D", "Date": "2012-03-07", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-05-24", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "21500000", "FundingRoundCode": "D", "Date": "2012-03-07", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-05-24", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "21500000", "FundingRoundCode": "D", "Date": "2012-03-07", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-05-24", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promedior", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2006-05-24", "Investor": "Trellis Bioscience"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promentis Pharmaceuticals", "Amount": "1687000", "FundingRoundCode": "NA", "Date": "2009-08-31", "Investor": "Golden Angels Investors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Promentis Pharmaceuticals", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Golden Angels Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promentis Pharmaceuticals", "Amount": "2900000", "FundingRoundCode": "B", "Date": "2014-01-17", "Investor": "Golden Angels Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Promethera Biosciences", "Amount": "31475320", "FundingRoundCode": "B", "Date": "2012-03-28", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Assisitive Technology|Biotechnology|Clean Technology|Nanotechnology", "CompanyName": "Promuc", "Amount": "350001", "FundingRoundCode": "NA", "Date": "2014-03-04", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "Apjohn ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "Hopen Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2014-01-13", "Investor": "Capital Midwest Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "Capital Midwest Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "The Amherst Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProNAi Therapeutics", "Amount": "59500000", "FundingRoundCode": "D", "Date": "2014-04-21", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pronota", "Amount": "7360000", "FundingRoundCode": "B", "Date": "2009-06-29", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pronota", "Amount": "7800000", "FundingRoundCode": "A", "Date": "2006-04-19", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pronota", "Amount": "4774706", "FundingRoundCode": "C", "Date": "2012-01-20", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pronota", "Amount": "1950000", "FundingRoundCode": "B", "Date": "2009-10-30", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Pronota", "Amount": "4774706", "FundingRoundCode": "C", "Date": "2012-01-20", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pronutria Biosciences, Inc.", "Amount": "10800000", "FundingRoundCode": "A", "Date": "2013-10-22", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pronutria Biosciences, Inc.", "Amount": "3.9e+07", "FundingRoundCode": "C", "Date": "2015-05-28", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pronutria Biosciences, Inc.", "Amount": "NA", "FundingRoundCode": "B", "Date": "2013-12-11", "Investor": "Flagship Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Angels|Biotechnology|Deep Information Technology|Medical Devices|Venture Capital", "CompanyName": "Propel(x)", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "CLI Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Therapeutics", "CompanyName": "Prosensa", "Amount": "29766600", "FundingRoundCode": "NA", "Date": "2012-01-25", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Prosetta", "Amount": "3.1e+07", "FundingRoundCode": "D", "Date": "2015-12-04", "Investor": "Fred Alger Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protagonist Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-07-16", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protagonist Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-07-16", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protagonist Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-07-16", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protagonist Therapeutics", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2013-06-04", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protagonist Therapeutics", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2006-09-19", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protagonist Therapeutics", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2013-06-04", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protagonist Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-07-16", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protalix BioTherapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-10-14", "Investor": "Pfizer"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protein Forest", "Amount": "1.9e+07", "FundingRoundCode": "A", "Date": "2003-11-21", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Protein Forest", "Amount": "1.9e+07", "FundingRoundCode": "A", "Date": "2003-11-21", "Investor": "Flybridge Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2014-05-16", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2009-05-28", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2014-05-16", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2014-05-16", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2009-05-28", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2014-05-16", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-09-06", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2009-05-28", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2014-05-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-09-06", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2009-05-28", "Investor": "Prism Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2014-05-16", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2007-09-06", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteon Therapeutics", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2009-05-28", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteopure", "Amount": "40000", "FundingRoundCode": "NA", "Date": "2006-10-04", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteopure", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2006-10-27", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteopure", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2005-09-07", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteopure", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2006-03-21", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "70623000", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "70623000", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "Genzyme Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "70623000", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "70623000", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Proteostasis Therapeutics", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2015-09-08", "Investor": "Sanofi-Genzyme BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Specialty Chemicals", "CompanyName": "Proterro", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2012-12-01", "Investor": "Battelle Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Specialty Chemicals", "CompanyName": "Proterro", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2012-12-01", "Investor": "Braemar Energy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Specialty Chemicals", "CompanyName": "Proterro", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2012-12-01", "Investor": "Cultivian Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Specialty Chemicals", "CompanyName": "Proterro", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2012-12-01", "Investor": "Innovation Valley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Specialty Chemicals", "CompanyName": "Proterro", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2012-12-01", "Investor": "Middleland Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "6300000", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "NA", "FundingRoundCode": "B", "Date": "2003-12-19", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "62500000", "FundingRoundCode": "F", "Date": "2013-05-01", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "NA", "FundingRoundCode": "C", "Date": "2006-01-01", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "NA", "FundingRoundCode": "D", "Date": "2008-07-10", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "6300000", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "6300000", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "The Carlyle Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "6300000", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "6300000", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "62500000", "FundingRoundCode": "F", "Date": "2013-05-01", "Investor": "Oracle Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "31600000", "FundingRoundCode": "NA", "Date": "2014-01-21", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Mobile|Software", "CompanyName": "Proteus Digital Health", "Amount": "31600000", "FundingRoundCode": "NA", "Date": "2014-01-21", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProThera Biologics", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-09-05", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ProThera Biologics", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-09-05", "Investor": "Slater Technology Fund"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Proxsys", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-03-12", "Investor": "Clayton Associates"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Proxsys", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-03-12", "Investor": "FCA Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "PRSM Healthcare", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2013-09-19", "Investor": "BlueCross BlueShield Venture Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "PRSM Healthcare", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2013-09-19", "Investor": "HCA"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "PRSM Healthcare", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2013-09-19", "Investor": "Healthbox"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "PRSM Healthcare", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2013-09-19", "Investor": "Sandbox Industries"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "pSivida", "Amount": "7e+06", "FundingRoundCode": "NA", "Date": "2014-03-13", "Investor": "RA Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-03-07", "Investor": "Adage Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "26600000", "FundingRoundCode": "NA", "Date": "2005-11-10", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2004-06-23", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2004-01-07", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2001-09-19", "Investor": "Bay City Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "26600000", "FundingRoundCode": "NA", "Date": "2005-11-10", "Investor": "Bay City Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "26600000", "FundingRoundCode": "NA", "Date": "2005-11-10", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-03-07", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2001-09-19", "Investor": "CDI Bioscience"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2004-06-23", "Investor": "Delphi Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-03-07", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2004-01-07", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2001-09-19", "Investor": "Delphi Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-07-23", "Investor": "Delphi Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "26600000", "FundingRoundCode": "NA", "Date": "2005-11-10", "Investor": "Delphi Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2009-12-22", "Investor": "Delphi Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-03-07", "Investor": "Jennison Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-03-07", "Investor": "Longwood Founders Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2004-06-23", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2004-01-07", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2009-12-22", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2004-06-23", "Investor": "Vulcan Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "6e+07", "FundingRoundCode": "NA", "Date": "2013-03-07", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "E", "Date": "2004-01-07", "Investor": "Vulcan Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "PTC Therapeutics", "Amount": "26600000", "FundingRoundCode": "NA", "Date": "2005-11-10", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2011-08-15", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2009-03-11", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "30200000", "FundingRoundCode": "B", "Date": "2009-11-02", "Investor": "5AM Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-06-16", "Investor": "5AM Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-06-16", "Investor": "Altitude Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2011-08-15", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "30200000", "FundingRoundCode": "B", "Date": "2009-11-02", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-06-16", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2011-08-15", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2009-03-11", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "30200000", "FundingRoundCode": "B", "Date": "2009-11-02", "Investor": "Polaris Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmatrix", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2015-06-16", "Investor": "Polaris Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Pulmokine", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-03-03", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-03-08", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-05-07", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-01-31", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-03-08", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-01-31", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-03-08", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-05-07", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-01-31", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-03-08", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-05-07", "Investor": "MedVenture Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-01-31", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-03-08", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2007-05-07", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2012-01-31", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-09-17", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pulmonx", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-03-08", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pure life renal", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-05-09", "Investor": "Hamilton Lane"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pure life renal", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-05-09", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Pure life renal", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-05-09", "Investor": "Noro-Moseley Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "PureBrands", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2010-12-20", "Investor": "AFSquare"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Puridify", "Amount": "3405256.47772653", "FundingRoundCode": "A", "Date": "2015-10-21", "Investor": "SR One"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Puridify", "Amount": "1424811", "FundingRoundCode": "NA", "Date": "2014-05-29", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Putney", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2011-09-29", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Putney", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2011-09-29", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Q Holdings", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2008-02-15", "Investor": "EPIC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Q Holdings", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2008-02-15", "Investor": "Invitrogen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Q Holdings", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2008-02-15", "Investor": "Salt Lake Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Q Holdings", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2008-02-15", "Investor": "Toucan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Q Holdings", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2008-02-15", "Investor": "vSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QR Pharma", "Amount": "110000", "FundingRoundCode": "NA", "Date": "2012-01-17", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QR Pharma", "Amount": "5700000", "FundingRoundCode": "A", "Date": "2015-05-26", "Investor": "Delaware Crossing Investor Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QR Pharma", "Amount": "5700000", "FundingRoundCode": "A", "Date": "2015-05-26", "Investor": "Robin Hood Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QRxPharma", "Amount": "5e+05", "FundingRoundCode": "A", "Date": "2003-04-30", "Investor": "Plymouth Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QuaDPharma", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2012-11-20", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QuaDPharma", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2012-11-20", "Investor": "Rand Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "QuantaLife", "Amount": "17200000", "FundingRoundCode": "B", "Date": "2010-12-13", "Investor": "Paladin Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2012-11-15", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2012-11-15", "Investor": "Bain Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "Bain Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2012-11-15", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-25", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "18500000", "FundingRoundCode": "C", "Date": "2012-11-15", "Investor": "In-Q-Tel"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Biotechnology|Health Diagnostics", "CompanyName": "Quanterix", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2011-08-19", "Investor": "In-Q-Tel"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Quantros", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-07-31", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Quantum Biosystems", "Amount": "20500000", "FundingRoundCode": "B", "Date": "2015-02-09", "Investor": "Mizuho Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quantum Immunologics", "Amount": "2200000", "FundingRoundCode": "A", "Date": "2009-09-15", "Investor": "Mentor Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quantum OPS", "Amount": "1050000", "FundingRoundCode": "A", "Date": "2012-06-28", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quantum OPS", "Amount": "1050000", "FundingRoundCode": "A", "Date": "2012-06-28", "Investor": "PLSG Accelerator Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quartet Medicine", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2014-10-23", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quartet Medicine", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2014-10-23", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QuatRx Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "E", "Date": "2007-05-22", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QuatRx Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "E", "Date": "2007-05-22", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "QuatRx Pharmaceuticals", "Amount": "4.4e+07", "FundingRoundCode": "E", "Date": "2007-05-22", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quinnova Pharmaceuticals", "Amount": "17400000", "FundingRoundCode": "B", "Date": "2009-10-28", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quinnova Pharmaceuticals", "Amount": "13600000", "FundingRoundCode": "A", "Date": "2006-11-28", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quinnova Pharmaceuticals", "Amount": "17400000", "FundingRoundCode": "B", "Date": "2009-10-28", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quinnova Pharmaceuticals", "Amount": "17400000", "FundingRoundCode": "B", "Date": "2009-10-28", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Quinnova Pharmaceuticals", "Amount": "13600000", "FundingRoundCode": "A", "Date": "2006-11-28", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Quotient Clinical", "Amount": "62661128.6164423", "FundingRoundCode": "NA", "Date": "2008-09-03", "Investor": "TA Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Qwell Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2009-01-06", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ra Pharmaceuticals", "Amount": "58500000", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ra Pharmaceuticals", "Amount": "58500000", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Lightstone Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ra Pharmaceuticals", "Amount": "58500000", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ra Pharmaceuticals", "Amount": "58500000", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ra Pharmaceuticals", "Amount": "58500000", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ra Pharmaceuticals", "Amount": "58500000", "FundingRoundCode": "B", "Date": "2015-07-23", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "6.6e+07", "FundingRoundCode": "C", "Date": "2011-07-26", "Investor": "Brookside Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "21400000", "FundingRoundCode": "NA", "Date": "2011-12-16", "Investor": "Brookside Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "4.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "6.6e+07", "FundingRoundCode": "C", "Date": "2011-07-26", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "21400000", "FundingRoundCode": "NA", "Date": "2011-12-16", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "57500000", "FundingRoundCode": "B", "Date": "2007-04-02", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2008-11-20", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "6.6e+07", "FundingRoundCode": "C", "Date": "2011-07-26", "Investor": "MPM Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "21400000", "FundingRoundCode": "NA", "Date": "2011-12-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "57500000", "FundingRoundCode": "B", "Date": "2007-04-02", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2008-11-20", "Investor": "MPM Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "4.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-25", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "57500000", "FundingRoundCode": "B", "Date": "2007-04-02", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2008-11-20", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "6.6e+07", "FundingRoundCode": "C", "Date": "2011-07-26", "Investor": "Saints Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Radius Health", "Amount": "21400000", "FundingRoundCode": "NA", "Date": "2011-12-16", "Investor": "Saints Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2013-04-29", "Investor": "Acadia Woods Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "37500000", "FundingRoundCode": "D", "Date": "2011-01-25", "Investor": "Acadia Woods Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2013-04-29", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "37500000", "FundingRoundCode": "D", "Date": "2011-01-25", "Investor": "Alloy Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "3.5e+07", "FundingRoundCode": "NA", "Date": "2013-09-22", "Investor": "CRG"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "16500000", "FundingRoundCode": "E", "Date": "2014-03-03", "Investor": "GE Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2013-04-29", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "37500000", "FundingRoundCode": "D", "Date": "2011-01-25", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "16500000", "FundingRoundCode": "E", "Date": "2014-03-03", "Investor": "Northgate Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "2e+07", "FundingRoundCode": "E", "Date": "2013-04-29", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RainDance Technologies", "Amount": "37500000", "FundingRoundCode": "D", "Date": "2011-01-25", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RaNA Therapeutics", "Amount": "20700000", "FundingRoundCode": "A", "Date": "2012-01-18", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RaNA Therapeutics", "Amount": "20700000", "FundingRoundCode": "A", "Date": "2012-01-18", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RaNA Therapeutics", "Amount": "20700000", "FundingRoundCode": "A", "Date": "2012-01-18", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rani Therapeutics", "Amount": "NA", "FundingRoundCode": "B", "Date": "2013-08-28", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rani Therapeutics", "Amount": "15486363", "FundingRoundCode": "C", "Date": "2015-05-26", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rani Therapeutics", "Amount": "NA", "FundingRoundCode": "B", "Date": "2013-08-28", "Investor": "InCube Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rani Therapeutics", "Amount": "15486363", "FundingRoundCode": "C", "Date": "2015-05-26", "Investor": "InCube Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rani Therapeutics", "Amount": "15486363", "FundingRoundCode": "C", "Date": "2015-05-26", "Investor": "VentureHealth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Diagnostek", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2010-01-29", "Investor": "Peak Ridge Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Diagnostek", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2010-01-29", "Investor": "Rapid Diagnostek"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "6001413", "FundingRoundCode": "NA", "Date": "2014-04-11", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "18600000", "FundingRoundCode": "A", "Date": "2009-08-06", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "32600000", "FundingRoundCode": "B", "Date": "2013-06-26", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2015-04-29", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "6001413", "FundingRoundCode": "NA", "Date": "2014-04-11", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "32600000", "FundingRoundCode": "B", "Date": "2013-06-26", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2015-04-29", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "18600000", "FundingRoundCode": "A", "Date": "2009-08-06", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "6001413", "FundingRoundCode": "NA", "Date": "2014-04-11", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "32600000", "FundingRoundCode": "B", "Date": "2013-06-26", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Micro Biosystems", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2015-04-29", "Investor": "TPG Biotech"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Rapid Pathogen Screening", "Amount": "2.8e+07", "FundingRoundCode": "NA", "Date": "2014-10-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raptor Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-08-09", "Investor": "Dafna Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raptor Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-08-09", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raptor Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-08-09", "Investor": "Heights Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raptor Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-08-09", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raptor Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-08-09", "Investor": "Lincoln Park Capital Fund"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "RareCyte", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2012-08-21", "Investor": "Telegraph Hill Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ratio", "Amount": "343000", "FundingRoundCode": "NA", "Date": "2010-07-09", "Investor": "Golden Angels Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "Bear Stearns"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "Bear Stearns Health Innoventures L.P"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "Biogen Idec"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "Cogene Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "GE Capital Life Science and Technology Finance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "Hambrecht & Quist Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "Hambrecht & Quist Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "Milepost Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "Milepost Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2003-01-03", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Raven Biotechnologies", "Amount": "48300000", "FundingRoundCode": "D", "Date": "2005-10-12", "Investor": "Vulcan Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2012-04-17", "Investor": "BIP Opportunities Fund"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2013-06-27", "Investor": "BIP Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2012-04-17", "Investor": "BIP Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2013-06-27", "Investor": "C&B Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2012-04-17", "Investor": "C&B Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "4400000", "FundingRoundCode": "NA", "Date": "2013-06-27", "Investor": "Council Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2012-04-17", "Investor": "Council Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2010-09-27", "Investor": "Council Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "REACH Health", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2013-06-27", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Real Time Genomics", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2009-03-01", "Investor": "Catamount Ventures"}, {"FundingRoundType": "convertible_note", "CompanyCategory": "Biotechnology", "CompanyName": "RealBio Technology", "Amount": "1125000", "FundingRoundCode": "NA", "Date": "2009-12-04", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReaMetrix", "Amount": "3550000", "FundingRoundCode": "A", "Date": "2005-01-14", "Investor": "Mobius Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReaMetrix", "Amount": "2100000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Mobius Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReaMetrix", "Amount": "2100000", "FundingRoundCode": "NA", "Date": "2009-11-24", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reata Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2004-11-12", "Investor": "Ojai Goliad"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reata Pharmaceuticals", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2004-11-12", "Investor": "Startech Early Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-03-13", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2009-11-23", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-03-13", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2009-11-23", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-03-13", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2009-11-23", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-03-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-03-13", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2012-03-13", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Receptos", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2009-11-23", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Recombine", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2014-03-04", "Investor": "FirstMark Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Recombine", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2014-03-04", "Investor": "Vast Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Recombine", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2014-03-04", "Investor": "Matt Turck"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "RedHill Biopharma", "Amount": "8500000", "FundingRoundCode": "NA", "Date": "2013-12-31", "Investor": "Broadfin Capital"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "RedHill Biopharma", "Amount": "8500000", "FundingRoundCode": "NA", "Date": "2013-12-31", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Physicians", "CompanyName": "RedPath Integrated Pathology", "Amount": "6500000", "FundingRoundCode": "A", "Date": "2006-12-20", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Physicians", "CompanyName": "RedPath Integrated Pathology", "Amount": "6500000", "FundingRoundCode": "A", "Date": "2006-12-20", "Investor": "Inflexion Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Physicians", "CompanyName": "RedPath Integrated Pathology", "Amount": "6500000", "FundingRoundCode": "A", "Date": "2006-12-20", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Physicians", "CompanyName": "RedPath Integrated Pathology", "Amount": "1600000", "FundingRoundCode": "NA", "Date": "2011-05-16", "Investor": "Plymouth Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Redpoint Bio", "Amount": "10200000", "FundingRoundCode": "A", "Date": "2003-11-13", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Redpoint Bio", "Amount": "10200000", "FundingRoundCode": "A", "Date": "2003-11-13", "Investor": "Cargill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Redpoint Bio", "Amount": "10200000", "FundingRoundCode": "A", "Date": "2003-11-13", "Investor": "NJTC Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Redpoint Bio", "Amount": "10200000", "FundingRoundCode": "A", "Date": "2003-11-13", "Investor": "RK Ventures Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Redwood Bioscience", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2010-04-26", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Redwood Bioscience", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-06-27", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "5.1e+07", "FundingRoundCode": "E", "Date": "2012-12-17", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2007-03-27", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-12-17", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "5.1e+07", "FundingRoundCode": "E", "Date": "2012-12-17", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2007-03-27", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-12-17", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2007-03-27", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-12-17", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "5.1e+07", "FundingRoundCode": "E", "Date": "2012-12-17", "Investor": "RUSNANO"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "5.1e+07", "FundingRoundCode": "E", "Date": "2012-12-17", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "2.3e+07", "FundingRoundCode": "C", "Date": "2007-03-27", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Regado Biosciences", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2009-12-17", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Regentis Biomaterials", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2012-05-14", "Investor": "SCP Vitalife Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2015-01-21", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2015-01-21", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2015-01-21", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Janus Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "QVT Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2015-01-21", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGENXBIO", "Amount": "70500000", "FundingRoundCode": "D", "Date": "2015-05-20", "Investor": "Vivo Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2008-02-01", "Investor": "AC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "9200000", "FundingRoundCode": "D", "Date": "2014-02-14", "Investor": "Mizuho Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "4200000", "FundingRoundCode": "A", "Date": "2007-02-21", "Investor": "New Cycle Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2008-02-01", "Investor": "New Cycle Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "1600000", "FundingRoundCode": "NA", "Date": "2006-08-15", "Investor": "NIF SMBC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "4200000", "FundingRoundCode": "A", "Date": "2007-02-21", "Investor": "NIF SMBC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2008-02-01", "Investor": "NIF SMBC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "4200000", "FundingRoundCode": "A", "Date": "2007-02-21", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "REGiMMUNE Corporation", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2008-02-01", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Rejuvenon", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "BCM Technologies (BCMT)"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Rejuvenon", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Rejuvenon", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "Cogene Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Rejuvenon", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Rejuvenon", "Amount": "3.7e+07", "FundingRoundCode": "B", "Date": "2004-06-23", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reliant Technologies", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2007-04-19", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reliant Technologies", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2007-04-19", "Investor": "Meritech Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reliant Technologies", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2007-04-19", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "5050000", "FundingRoundCode": "B", "Date": "2006-10-22", "Investor": "BCM Technologies (BCMT)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-07-07", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "5050000", "FundingRoundCode": "B", "Date": "2006-10-22", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2012-03-28", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-07-07", "Investor": "Emergent Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2012-03-28", "Investor": "Emergent Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-07-07", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2012-03-28", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2012-03-28", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2009-07-07", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "5050000", "FundingRoundCode": "B", "Date": "2006-10-22", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relievant Medsystems", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2012-03-28", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relmada Therapeutics", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2012-07-24", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Relmada Therapeutics", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2012-07-24", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2007-10-29", "Investor": "5AM Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "62400000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "2600100", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2007-10-29", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2007-10-29", "Investor": "Delphi Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "62400000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2007-10-29", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "62400000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2007-10-29", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "62400000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "2600100", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "62400000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "2600100", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "62400000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Sibling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "3.3e+07", "FundingRoundCode": "A", "Date": "2007-10-29", "Investor": "Sprout Group"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "62400000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Relypsa", "Amount": "7e+07", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Remedy Pharmaceuticals", "Amount": "1024440", "FundingRoundCode": "NA", "Date": "2014-02-26", "Investor": "Broadview Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rempex Pharmaceuticals", "Amount": "67500000", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "Adams Street Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rempex Pharmaceuticals", "Amount": "67500000", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rempex Pharmaceuticals", "Amount": "67500000", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rempex Pharmaceuticals", "Amount": "67500000", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rempex Pharmaceuticals", "Amount": "67500000", "FundingRoundCode": "B", "Date": "2011-11-09", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RenaMed Biologics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2006-09-07", "Investor": "Apjohn ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RenaMed Biologics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2006-09-07", "Investor": "BD Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RenaMed Biologics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2006-09-07", "Investor": "Lurie Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RenaMed Biologics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2006-09-07", "Investor": "Merlin Biomed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RenaMed Biologics", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2006-09-07", "Investor": "North Coast Technology Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rennovia", "Amount": "16333333", "FundingRoundCode": "A", "Date": "2009-03-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rennovia", "Amount": "16333333", "FundingRoundCode": "A", "Date": "2009-03-01", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Renovar", "Amount": "1200000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "NEW Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Renovar", "Amount": "1200000", "FundingRoundCode": "B", "Date": "2006-11-30", "Investor": "Wisconsin Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Renovo", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2002-12-02", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Renovo", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2002-12-02", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Renovo", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2002-12-02", "Investor": "JPMorgan Partners (JPMP)"}, {"FundingRoundType": "seed", "CompanyCategory": "Beauty|Biotechnology|Cosmetics|Cosmetic Surgery", "CompanyName": "Repairogen", "Amount": "460000", "FundingRoundCode": "NA", "Date": "2014-01-03", "Investor": "Joanne Wilson"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Replidyne", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2002-04-19", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Replidyne", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2002-04-19", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Replidyne", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2002-04-19", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Medical", "CompanyName": "Replidyne", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2002-04-19", "Investor": "Sequel Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resistentia Pharmaceuticals", "Amount": "13960000", "FundingRoundCode": "C", "Date": "2006-09-26", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolve Therapeutics", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2011-05-17", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolve Therapeutics", "Amount": "5800000", "FundingRoundCode": "B", "Date": "2012-11-01", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolve Therapeutics", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2011-05-17", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolve Therapeutics", "Amount": "5800000", "FundingRoundCode": "B", "Date": "2012-11-01", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolve Therapeutics", "Amount": "5800000", "FundingRoundCode": "B", "Date": "2012-11-01", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolvyx Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2005-12-02", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolvyx Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2005-12-02", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resolvyx Pharmaceuticals", "Amount": "1.7e+07", "FundingRoundCode": "A", "Date": "2005-12-02", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Respirics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-09-27", "Investor": "Research Triangle Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Response Biomedical", "Amount": "2500000", "FundingRoundCode": "NA", "Date": "2014-02-12", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2014-11-10", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2007-08-13", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2011-08-03", "Investor": "Alloy Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2014-11-10", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2011-08-03", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2014-11-10", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2007-08-13", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2011-08-03", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2014-11-10", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2007-08-13", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Restoration Robotics", "Amount": "4.1e+07", "FundingRoundCode": "C", "Date": "2011-08-03", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Resverlogix", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Yorkville Advisors"}, {"FundingRoundType": "post_ipo_debt", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Retrophin", "Amount": "4.5e+07", "FundingRoundCode": "NA", "Date": "2014-07-01", "Investor": "Athyrium Capital Management, LP"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RetroSense Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-03-04", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RetroSense Therapeutics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "Blue Water Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RetroSense Therapeutics", "Amount": "6e+06", "FundingRoundCode": "B", "Date": "2015-11-12", "Investor": "Blue Water Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RetroSense Therapeutics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "Michigan Economic Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RetroSense Therapeutics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "Nerveda"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RetroSense Therapeutics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "SDL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RetroSense Therapeutics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "RetroVirox", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2015-03-12", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "CNF Investments, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "E", "Date": "2013-04-02", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "E", "Date": "2013-04-02", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "43200000", "FundingRoundCode": "C", "Date": "2007-12-12", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "43200000", "FundingRoundCode": "C", "Date": "2007-12-12", "Investor": "Medicis Pharmaceutical"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "3.3e+07", "FundingRoundCode": "E", "Date": "2013-04-02", "Investor": "NovaQuest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "NovaQuest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "43200000", "FundingRoundCode": "C", "Date": "2007-12-12", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "Shepherd Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "43200000", "FundingRoundCode": "C", "Date": "2007-12-12", "Investor": "Shepherd Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "43200000", "FundingRoundCode": "C", "Date": "2007-12-12", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "D", "Date": "2011-06-10", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Revance Therapeutics", "Amount": "43200000", "FundingRoundCode": "C", "Date": "2007-12-12", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reverse Medical", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2010-04-07", "Investor": "BioStar Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reverse Medical", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2010-04-07", "Investor": "Early Stage Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reverse Medical", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2010-04-07", "Investor": "Emergent Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Reverse Medical", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2010-04-07", "Investor": "Wexford Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2010-07-20", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "5.5e+07", "FundingRoundCode": "E", "Date": "2013-07-29", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "14999998", "FundingRoundCode": "E", "Date": "2013-04-16", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2010-07-20", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "5.5e+07", "FundingRoundCode": "E", "Date": "2013-07-29", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2007-04-30", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "14999998", "FundingRoundCode": "E", "Date": "2013-04-16", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2010-07-20", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "5.5e+07", "FundingRoundCode": "E", "Date": "2013-07-29", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "5.5e+07", "FundingRoundCode": "E", "Date": "2013-07-29", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "14999998", "FundingRoundCode": "E", "Date": "2013-04-16", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2010-07-20", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "5.5e+07", "FundingRoundCode": "E", "Date": "2013-07-29", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ReVision Optics", "Amount": "14999998", "FundingRoundCode": "E", "Date": "2013-04-16", "Investor": "ProQuest Investments"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Revolution Bioengineering", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-09-09", "Investor": "SOSV"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Revolution Bioengineering", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-09-09", "Investor": "Indie Bio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "28600000", "FundingRoundCode": "NA", "Date": "2015-10-20", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "12600000", "FundingRoundCode": "A", "Date": "2010-05-24", "Investor": "Cayuga Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2013-12-19", "Investor": "Cayuga Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2014-06-11", "Investor": "Cayuga Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "28600000", "FundingRoundCode": "NA", "Date": "2015-10-20", "Investor": "Cayuga Venture Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2014-01-15", "Investor": "Gefinor Capital"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-12-13", "Investor": "Gefinor Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "28600000", "FundingRoundCode": "NA", "Date": "2015-10-20", "Investor": "Gefinor Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "28600000", "FundingRoundCode": "NA", "Date": "2015-10-20", "Investor": "Limestone Capital Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "28600000", "FundingRoundCode": "NA", "Date": "2015-10-20", "Investor": "Onondaga Venture Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2013-12-19", "Investor": "Rand Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2014-06-11", "Investor": "Rand Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Rheonix", "Amount": "28600000", "FundingRoundCode": "NA", "Date": "2015-10-20", "Investor": "Rand Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RhinoCyte", "Amount": "930000", "FundingRoundCode": "A", "Date": "2006-08-07", "Investor": "Kentucky Science and Technology corp."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RhinoCyte", "Amount": "930000", "FundingRoundCode": "A", "Date": "2006-08-07", "Investor": "Kentucky Seed Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RhinoCyte", "Amount": "930000", "FundingRoundCode": "A", "Date": "2006-08-07", "Investor": "Queen City Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-08-13", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2012-06-13", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2010-03-15", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-08-13", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2012-11-27", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2012-06-13", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "A", "Date": "2010-03-15", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-08-13", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2012-11-27", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-08-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-08-13", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2012-11-27", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2013-09-10", "Investor": "The Michael J. Fox Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2012-06-13", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-08-13", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2012-11-27", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rhythm Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2015-08-13", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Ridge Diagnostics", "Amount": "1e+05", "FundingRoundCode": "A", "Date": "2012-03-07", "Investor": "Serra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rigel Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "NA", "Date": "2003-06-27", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rigel Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "NA", "Date": "2003-06-27", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rigel Pharmaceuticals", "Amount": "4.6e+07", "FundingRoundCode": "NA", "Date": "2003-06-27", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Rinat Neuroscience", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2003-08-20", "Investor": "Frantz Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Technology", "CompanyName": "Rinat Neuroscience", "Amount": "4e+07", "FundingRoundCode": "B", "Date": "2003-08-20", "Investor": "Rock Creek Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rincon Pharmaceuticals", "Amount": "4700000", "FundingRoundCode": "NA", "Date": "2005-11-15", "Investor": "Paperboy Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "RioGin", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-04-08", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roche NimbleGen", "Amount": "12750000", "FundingRoundCode": "F", "Date": "2004-11-02", "Investor": "Cargill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roche NimbleGen", "Amount": "12750000", "FundingRoundCode": "F", "Date": "2004-11-02", "Investor": "Topspin Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roche NimbleGen", "Amount": "12750000", "FundingRoundCode": "F", "Date": "2004-11-02", "Investor": "Venture Investors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Rockwell Medical", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2013-06-18", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Rodin Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-06-27", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rodin Therapeutics", "Amount": "12900000", "FundingRoundCode": "A", "Date": "2014-05-29", "Investor": "Atlas Venture"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Rodin Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-06-27", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rodin Therapeutics", "Amount": "12900000", "FundingRoundCode": "A", "Date": "2014-05-29", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "ROI\u00b2", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-06-26", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "47500000", "FundingRoundCode": "D", "Date": "2012-01-08", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-07-28", "Investor": "Gen-Probe"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-07-28", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "47500000", "FundingRoundCode": "D", "Date": "2012-01-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-07-28", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "47500000", "FundingRoundCode": "D", "Date": "2012-01-08", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-07-28", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roka Bioscience", "Amount": "47500000", "FundingRoundCode": "D", "Date": "2012-01-08", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roxro Pharma", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roxro Pharma", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Roxro Pharma", "Amount": "42700000", "FundingRoundCode": "B", "Date": "2007-06-12", "Investor": "Thomas Weisel Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "RPM Sustainable Technologies", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-03-22", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RQx Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2011-02-01", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RQx Pharmaceuticals", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2011-02-01", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rubicon Genomics", "Amount": "3500000", "FundingRoundCode": "B", "Date": "2002-10-01", "Investor": "Arch Development Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rubicon Genomics", "Amount": "3500000", "FundingRoundCode": "B", "Date": "2002-10-01", "Investor": "Aria Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rubicon Genomics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2015-07-15", "Investor": "BroadOak Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rubicon Genomics", "Amount": "3500000", "FundingRoundCode": "B", "Date": "2002-10-01", "Investor": "Duchossois Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rubicon Genomics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2015-07-15", "Investor": "Research Corporation Technologies"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RuiYi", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2014-03-27", "Investor": "5AM Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "RuiYi", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2014-06-11", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RuiYi", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2014-03-27", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "RuiYi", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2014-03-27", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rules-Based Medicine", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-10-15", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rules-Based Medicine", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-10-15", "Investor": "Equity Group Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Rules-Based Medicine", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-10-15", "Investor": "Stephens Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Ruxton Pharmaceuticals", "Amount": "5200000", "FundingRoundCode": "A", "Date": "2004-07-27", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "RXi Pharmaceuticals", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2012-10-05", "Investor": "National Cancer Institute"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "S*Bio", "Amount": "2.6e+07", "FundingRoundCode": "NA", "Date": "2008-10-20", "Investor": "5AM Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "S*Bio", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2010-09-23", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "S*Bio", "Amount": "112500000", "FundingRoundCode": "NA", "Date": "2009-01-21", "Investor": "Tragara"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2013-10-16", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2014-03-13", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2014-03-13", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2014-03-13", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2014-03-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2013-10-16", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "3.8e+07", "FundingRoundCode": "C", "Date": "2014-03-13", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SAGE Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2011-10-18", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sagent Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-06-14", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sagent Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "A", "Date": "2007-09-27", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sagent Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2008-09-04", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Saladax Biomedical", "Amount": "8400000", "FundingRoundCode": "C", "Date": "2010-03-30", "Investor": "Ben Franklin Technology Partners of Northeast Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Saladax Biomedical", "Amount": "8400000", "FundingRoundCode": "C", "Date": "2010-03-30", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Saladax Biomedical", "Amount": "8400000", "FundingRoundCode": "C", "Date": "2010-03-30", "Investor": "Golden Seeds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Saladax Biomedical", "Amount": "8400000", "FundingRoundCode": "C", "Date": "2010-03-30", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "non_equity_assistance", "CompanyCategory": "Biotechnology", "CompanyName": "Salient Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-08-18", "Investor": "Texas Venture Labs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Salient Pharmaceuticals", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2010-01-29", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Salmedix Inc", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2005-10-19", "Investor": "Cariden Technologies"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Salmedix Inc", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2005-10-19", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Pharmaceuticals", "CompanyName": "Salmedix Inc", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2005-10-19", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "SaludF\u00c1CIL", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-05-08", "Investor": "Venture Lab"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "SaludF\u00c1CIL", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-05-08", "Investor": "ALL VP | Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sangart", "Amount": "5e+07", "FundingRoundCode": "F", "Date": "2007-04-04", "Investor": "Leucadia National"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sangart", "Amount": "1e+08", "FundingRoundCode": "F", "Date": "2009-03-12", "Investor": "Leucadia National"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sangart", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2011-04-19", "Investor": "Leucadia National"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Health Care|Life Sciences", "CompanyName": "Sanguine", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2015-06-01", "Investor": "FundersClub"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Clinical Trials|Health Care|Life Sciences", "CompanyName": "Sanguine", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-02-23", "Investor": "INVENT Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Clinical Trials|Health Care|Life Sciences", "CompanyName": "Sanguine", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-02-23", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Clinical Trials|Health Care|Life Sciences", "CompanyName": "Sanguine", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2014-11-25", "Investor": "Seraph Group"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Clinical Trials|Health Care|Life Sciences", "CompanyName": "Sanguine", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2013-02-23", "Investor": "Seraph Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Santarus", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2003-05-22", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Santarus", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2003-05-22", "Investor": "Fog City Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Santarus", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2003-05-22", "Investor": "JPMorgan Partners (JPMP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Santarus", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2003-05-22", "Investor": "New England Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Santarus", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2003-05-22", "Investor": "St. Paul Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Santarus", "Amount": "51400000", "FundingRoundCode": "D", "Date": "2003-05-22", "Investor": "Windamere Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Santhera Pharmaceuticals Holding", "Amount": "18656467", "FundingRoundCode": "A", "Date": "2004-12-17", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "2.9e+07", "FundingRoundCode": "NA", "Date": "2006-12-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-01-24", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2011-07-18", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "2.9e+07", "FundingRoundCode": "NA", "Date": "2006-12-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-01-24", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2011-07-18", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2011-07-18", "Investor": "Rho Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SARcode Bioscience", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2011-07-18", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Satoris", "Amount": "5200000", "FundingRoundCode": "B", "Date": "2008-03-25", "Investor": "Brain Trust Accelerator Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Satoris", "Amount": "5200000", "FundingRoundCode": "B", "Date": "2008-03-25", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Satoris", "Amount": "5200000", "FundingRoundCode": "B", "Date": "2008-03-25", "Investor": "Rules-Based Medicine"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Scholar Rock", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-09-15", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Scholar Rock", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-09-15", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Scholar Rock", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-09-15", "Investor": "Kraft Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Scholar Rock", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2014-09-15", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Schrodinger", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2010-04-29", "Investor": "Cascade Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Schrodinger", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2012-12-12", "Investor": "Bill Gates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SciFluor Life Sciences", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2011-08-02", "Investor": "Allied Minds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SciFluor Life Sciences", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2015-04-21", "Investor": "Allied Minds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Scioderm", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2013-04-26", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Scioderm", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2014-12-18", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Scioderm", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2013-04-26", "Investor": "Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sciona", "Amount": "9900000", "FundingRoundCode": "C", "Date": "2006-04-03", "Investor": "BASF Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sciona", "Amount": "3400000", "FundingRoundCode": "NA", "Date": "2007-06-08", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sciona", "Amount": "9900000", "FundingRoundCode": "C", "Date": "2006-04-03", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sciona", "Amount": "9900000", "FundingRoundCode": "C", "Date": "2006-04-03", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "5e+06", "FundingRoundCode": "D", "Date": "2010-03-08", "Investor": "Commonwealth Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "6e+06", "FundingRoundCode": "D", "Date": "2009-03-09", "Investor": "Commonwealth Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "6e+06", "FundingRoundCode": "D", "Date": "2009-03-09", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "6e+06", "FundingRoundCode": "D", "Date": "2009-03-09", "Investor": "FLIR Systems"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "5e+06", "FundingRoundCode": "D", "Date": "2010-03-08", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "6e+06", "FundingRoundCode": "D", "Date": "2009-03-09", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "5e+06", "FundingRoundCode": "D", "Date": "2010-03-08", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "6e+06", "FundingRoundCode": "D", "Date": "2009-03-09", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "5e+06", "FundingRoundCode": "D", "Date": "2010-03-08", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "6e+06", "FundingRoundCode": "D", "Date": "2009-03-09", "Investor": "New Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "5e+06", "FundingRoundCode": "D", "Date": "2010-03-08", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "6e+06", "FundingRoundCode": "D", "Date": "2009-03-09", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "5e+06", "FundingRoundCode": "D", "Date": "2010-03-08", "Investor": "Rock Maple Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seahorse Bioscience", "Amount": "9400000", "FundingRoundCode": "NA", "Date": "2012-05-22", "Investor": "Jason Henrichs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Second Genome", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-05", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Second Genome", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2012-04-01", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Second Genome", "Amount": "11500000", "FundingRoundCode": "B", "Date": "2013-06-05", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Second Genome", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2012-04-01", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Securus Medical Group", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2013-10-29", "Investor": "3x5 Special Opportunity Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Securus Medical Group", "Amount": "750000", "FundingRoundCode": "A", "Date": "2011-08-01", "Investor": "JumpStart Inc."}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Securus Medical Group", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2012-07-25", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Securus Medical Group", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2013-10-29", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Securus Medical Group", "Amount": "750000", "FundingRoundCode": "A", "Date": "2011-08-01", "Investor": "RiverVest"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sedia Biosciences", "Amount": "2e+05", "FundingRoundCode": "NA", "Date": "2014-08-19", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seguro Surgical", "Amount": "125000", "FundingRoundCode": "NA", "Date": "2010-07-01", "Investor": "Dingman Center Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selah Genomics", "Amount": "9e+05", "FundingRoundCode": "A", "Date": "2013-06-11", "Investor": "Upstate Carolina Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2010-04-05", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "E", "Date": "2015-09-08", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "15100000", "FundingRoundCode": "B", "Date": "2009-02-25", "Investor": "Flagship Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2010-08-17", "Investor": "National Institute on Drug Abuse (NIDA)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "E", "Date": "2015-09-08", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2010-04-05", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "E", "Date": "2015-09-08", "Investor": "Osage Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2010-04-05", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "E", "Date": "2015-09-08", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "15100000", "FundingRoundCode": "B", "Date": "2009-02-25", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "E", "Date": "2015-09-08", "Investor": "Ridgeback Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "47250000", "FundingRoundCode": "D", "Date": "2011-10-27", "Investor": "RUSNANO"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2012-02-13", "Investor": "RUSNANO"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selecta Biosciences", "Amount": "3.8e+07", "FundingRoundCode": "E", "Date": "2015-09-08", "Investor": "Sanofi-Genzyme BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Selexys Pharmaceuticals Corporation", "Amount": "2.3e+07", "FundingRoundCode": "A", "Date": "2012-09-20", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Selventa", "Amount": "6500000", "FundingRoundCode": "A", "Date": "2003-09-08", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Semma Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-03-24", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Semma Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-03-24", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Semma Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-03-24", "Investor": "Medtronic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Healthcare Services|Medical", "CompanyName": "Semma Therapeutics", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-03-24", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Semprus BioSciences", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2008-12-14", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Semprus BioSciences", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2010-12-13", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Semprus BioSciences", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2010-12-13", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Semprus BioSciences", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2010-12-13", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Semprus BioSciences", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2010-12-13", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Alpha Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Chestnut Ridge Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Defiance Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Heights Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Hudson Bay Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Linden Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Midsummer Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Next View Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senesco Technologies", "Amount": "11500000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senhwa Biosciences", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2013-12-12", "Investor": "H&Q Asia Pacific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Senhwa Biosciences", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2013-12-12", "Investor": "WI Harper Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sensible Medical Innovations", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2013-11-11", "Investor": "Boston Scientific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sensible Medical Innovations", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2013-11-11", "Investor": "SCP Vitalife Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SensiGen", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2007-05-15", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequel Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-09-27", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequel Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-09-27", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequel Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-09-27", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequel Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-09-27", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequel Pharmaceuticals", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-09-27", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sequenta", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-10-20", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sequenta", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2013-07-02", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sequenta", "Amount": "8460000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sequenta", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2013-07-02", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sequenta", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2010-12-08", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sequenta", "Amount": "8460000", "FundingRoundCode": "NA", "Date": "2012-01-01", "Investor": "Farzad (Zod) Nazem"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sequenta", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2010-12-08", "Investor": "Farzad (Zod) Nazem"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequoia Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2005-03-20", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequoia Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2007-01-09", "Investor": "Aberdare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequoia Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "B", "Date": "2005-03-20", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequoia Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2007-01-09", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sequoia Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2007-01-09", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "19300000", "FundingRoundCode": "A", "Date": "2011-11-15", "Investor": "Catalyst Health & Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2015-01-07", "Investor": "Catalyst Health & Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2014-11-18", "Investor": "Catalyst Health & Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "1400000", "FundingRoundCode": "A", "Date": "2011-01-04", "Investor": "Catalyst Health & Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "19300000", "FundingRoundCode": "A", "Date": "2011-11-15", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2015-01-07", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2014-11-18", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "19300000", "FundingRoundCode": "A", "Date": "2011-11-15", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2015-01-07", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "19300000", "FundingRoundCode": "A", "Date": "2011-11-15", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "2e+07", "FundingRoundCode": "B", "Date": "2015-01-07", "Investor": "Upstart Life Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sera Prognostics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2014-11-18", "Investor": "Upstart Life Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SeraCare Life Sciences", "Amount": "8.2e+07", "FundingRoundCode": "NA", "Date": "2012-04-24", "Investor": "Linden Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2005-10-06", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2005-10-06", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2005-10-06", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Mitsubishi Corporation Life Sciences Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Pearl Street Venture Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2005-10-06", "Investor": "Ritchie Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Ritchie Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2005-10-06", "Investor": "Seaflower Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Seaflower Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2005-10-06", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Serenex", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2007-06-28", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seres Health", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-05-23", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seres Health", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-05-23", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seres Health", "Amount": "NA", "FundingRoundCode": "A", "Date": "2012-11-27", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seres Health", "Amount": "4.8e+07", "FundingRoundCode": "C", "Date": "2014-12-02", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seres Health", "Amount": "NA", "FundingRoundCode": "B", "Date": "2014-05-23", "Investor": "Mayo Clinic Rochester"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SetPoint Medical", "Amount": "30607151", "FundingRoundCode": "A", "Date": "2013-08-08", "Investor": "Boston Scientific"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SetPoint Medical", "Amount": "30607151", "FundingRoundCode": "A", "Date": "2013-08-08", "Investor": "Covidien Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SetPoint Medical", "Amount": "30607151", "FundingRoundCode": "A", "Date": "2013-08-08", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SetPoint Medical", "Amount": "30607151", "FundingRoundCode": "A", "Date": "2013-08-08", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SetPoint Medical", "Amount": "30607151", "FundingRoundCode": "A", "Date": "2013-08-08", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SetPoint Medical", "Amount": "30607151", "FundingRoundCode": "A", "Date": "2013-08-08", "Investor": "Topspin Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "3280000", "FundingRoundCode": "NA", "Date": "2011-12-16", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-05-11", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2014-08-13", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2012-06-13", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2014-08-13", "Investor": "LabCorp"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-05-11", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2014-08-13", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2012-06-13", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Seventh Sense Biosystems", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2011-05-11", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals|Venture Capital", "CompanyName": "SFJ Pharmaceuticals", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals|Venture Capital", "CompanyName": "SFJ Pharmaceuticals", "Amount": "3.5e+07", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals|Venture Capital", "CompanyName": "SFJ Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Pharmaceuticals|Venture Capital", "CompanyName": "SFJ Pharmaceuticals", "Amount": "2.1e+07", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGB", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2012-01-17", "Investor": "Finistere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGB", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2012-01-17", "Investor": "Flint Hills Resources"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGB", "Amount": "9400000", "FundingRoundCode": "A", "Date": "2010-09-14", "Investor": "Flint Hills Resources"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGB", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2012-01-17", "Investor": "Life Technologies"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGB", "Amount": "9400000", "FundingRoundCode": "A", "Date": "2010-09-14", "Investor": "Life Technologies"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGB", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2012-01-17", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGX Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-11-20", "Investor": "Great Point Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SGX Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-11-20", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Lumi Shanghai", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2010-04-01", "Investor": "DCM"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Lumi Shanghai", "Amount": "NA", "FundingRoundCode": "A", "Date": "2012-11-01", "Investor": "DCM"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-11-01", "Investor": "Base Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "25000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Base Ventures"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-11-01", "Investor": "Better Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "25000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Better Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "China Rock Capital"}, {"FundingRoundType": "angel", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2012-11-01", "Investor": "FF Angel LLC"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "FF Angel LLC"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2013-02-28", "Investor": "FF Angel LLC"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2013-08-01", "Investor": "FF Angel LLC"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "Marc Bell Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-07-01", "Investor": "Scrum Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "Scrum Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "Cyan Banister"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "Erik Moore"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2013-02-28", "Investor": "Erik Moore"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2013-08-01", "Investor": "Erik Moore"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "Kirill Makharinsky"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "750000", "FundingRoundCode": "NA", "Date": "2013-02-28", "Investor": "Kirill Makharinsky"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2013-08-01", "Investor": "Kirill Makharinsky"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Medical|Mobile", "CompanyName": "Share Practice", "Amount": "1300000", "FundingRoundCode": "NA", "Date": "2014-03-25", "Investor": "Scott Banister"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sharp Edge Labs", "Amount": "6e+05", "FundingRoundCode": "B", "Date": "2014-08-19", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sharp Edge Labs", "Amount": "6e+05", "FundingRoundCode": "B", "Date": "2014-08-19", "Investor": "Newlin Investment Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Shaser", "Amount": "2999999", "FundingRoundCode": "NA", "Date": "2010-03-31", "Investor": "Stata Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Siamab Therapeutics", "Amount": "1200000", "FundingRoundCode": "B", "Date": "2014-02-05", "Investor": "Beacon Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Siamab Therapeutics", "Amount": "1200000", "FundingRoundCode": "B", "Date": "2014-02-05", "Investor": "Desert Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sideris Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2013-10-22", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sideris Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2013-10-22", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sideris Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "A", "Date": "2013-10-22", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sierra Surgical", "Amount": "7100000", "FundingRoundCode": "A", "Date": "2007-08-15", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sierra Surgical", "Amount": "14500000", "FundingRoundCode": "B", "Date": "2008-07-27", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sierra Surgical", "Amount": "7100000", "FundingRoundCode": "A", "Date": "2007-08-15", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sierra Surgical", "Amount": "14500000", "FundingRoundCode": "B", "Date": "2008-07-27", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Signostics", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2015-11-17", "Investor": "KKR (Kohlberg Kravis Roberts & Co.)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "1.9e+07", "FundingRoundCode": "D", "Date": "2007-06-07", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "9350000", "FundingRoundCode": "C", "Date": "2006-07-17", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "1.9e+07", "FundingRoundCode": "E", "Date": "2009-01-12", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "1.9e+07", "FundingRoundCode": "D", "Date": "2007-06-07", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "1.5e+07", "FundingRoundCode": "G", "Date": "2013-06-28", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "15335540", "FundingRoundCode": "F", "Date": "2012-03-15", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2013-09-26", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "1.9e+07", "FundingRoundCode": "D", "Date": "2007-06-07", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "1.5e+07", "FundingRoundCode": "G", "Date": "2013-06-28", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "15335540", "FundingRoundCode": "F", "Date": "2012-03-15", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "9350000", "FundingRoundCode": "C", "Date": "2006-07-17", "Investor": "Prolog Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Singulex", "Amount": "4e+07", "FundingRoundCode": "NA", "Date": "2013-09-26", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sirigen", "Amount": "3830000", "FundingRoundCode": "NA", "Date": "2010-10-01", "Investor": "Persistence Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirion Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2007-04-10", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirion Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2007-04-10", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirion Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "B", "Date": "2007-04-10", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirna Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2003-04-23", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirna Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2003-04-23", "Investor": "Granite Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirna Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2003-04-23", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirna Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2003-04-23", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirna Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2003-04-23", "Investor": "Techno Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sirna Therapeutics", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2003-04-23", "Investor": "Venrock"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Sirnaomics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-12-26", "Investor": "Maryland Department of Business and Economic Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "3400000", "FundingRoundCode": "A", "Date": "2011-08-16", "Investor": "Cleveland Clinic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2011-02-07", "Investor": "Cleveland Clinic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "3400000", "FundingRoundCode": "A", "Date": "2011-08-16", "Investor": "Early Stage Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "3400000", "FundingRoundCode": "A", "Date": "2011-08-16", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "3400000", "FundingRoundCode": "A", "Date": "2011-08-16", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2011-02-07", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "3400000", "FundingRoundCode": "A", "Date": "2011-08-16", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SironRX Therapeutics", "Amount": "3400000", "FundingRoundCode": "A", "Date": "2011-08-16", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2006-04-19", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2005-03-08", "Investor": "Black River Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2005-03-08", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2004-12-01", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2005-03-08", "Investor": "Cargill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2006-04-19", "Investor": "Genzyme Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2005-03-08", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2004-12-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2005-03-08", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "1.3e+07", "FundingRoundCode": "A", "Date": "2004-12-01", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "Sirtris Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2005-03-08", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sitari Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2013-11-22", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sitari Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2013-11-22", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2003-01-10", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2004-07-14", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2005-04-06", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2004-07-14", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "9e+06", "FundingRoundCode": "B", "Date": "2002-12-04", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2005-04-06", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2005-04-06", "Investor": "EuclidSR Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2004-07-14", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2005-04-06", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2004-07-14", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2005-04-06", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2005-04-06", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2004-07-14", "Investor": "St. Paul Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SkinMedica", "Amount": "9e+06", "FundingRoundCode": "B", "Date": "2002-12-04", "Investor": "Windamere Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SmartCells", "Amount": "4100000", "FundingRoundCode": "D", "Date": "2009-05-01", "Investor": "Angel Healthcare Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SmartCells", "Amount": "4100000", "FundingRoundCode": "D", "Date": "2009-05-01", "Investor": "Beacon Street Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SmartCells", "Amount": "NA", "FundingRoundCode": "C", "Date": "2008-05-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SmartCells", "Amount": "4100000", "FundingRoundCode": "D", "Date": "2009-05-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SmartCells", "Amount": "NA", "FundingRoundCode": "B", "Date": "2006-05-01", "Investor": "Cherrystone Angel Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SmartCells", "Amount": "4100000", "FundingRoundCode": "D", "Date": "2009-05-01", "Investor": "Converge Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SmartZyme", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2015-10-27", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "Arrowpoint Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2010-03-16", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "Delos Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "26600000", "FundingRoundCode": "B", "Date": "2013-08-27", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2010-03-16", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "EcoR1 Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "26600000", "FundingRoundCode": "B", "Date": "2013-08-27", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2010-03-16", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "26600000", "FundingRoundCode": "B", "Date": "2013-08-27", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2010-03-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-04-03", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "9e+06", "FundingRoundCode": "A", "Date": "2010-03-16", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syndax Pharmaceuticals", "Amount": "8e+07", "FundingRoundCode": "C", "Date": "2015-08-24", "Investor": "Tavistock Life Sciences"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Sofie Biosciences", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2010-12-08", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sofie Biosciences", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2013-10-15", "Investor": "Cycad Group"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Sofie Biosciences", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-10-17", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Soligenix", "Amount": "5904277", "FundingRoundCode": "NA", "Date": "2010-07-02", "Investor": "Brio Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Soligenix", "Amount": "5904277", "FundingRoundCode": "NA", "Date": "2010-07-02", "Investor": "Dafna Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Soligenix", "Amount": "5904277", "FundingRoundCode": "NA", "Date": "2010-07-02", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Soligenix", "Amount": "5904277", "FundingRoundCode": "NA", "Date": "2010-07-02", "Investor": "OpusPoint Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Soligenix", "Amount": "5904277", "FundingRoundCode": "NA", "Date": "2010-07-02", "Investor": "Rockmore Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Soligenix", "Amount": "5904277", "FundingRoundCode": "NA", "Date": "2010-07-02", "Investor": "Rosalind Capital Partners"}, {"FundingRoundType": "post_ipo_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Soligenix", "Amount": "7100000", "FundingRoundCode": "NA", "Date": "2013-06-26", "Investor": "Third Security"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Biologics", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2012-12-28", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Biologics", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2013-01-04", "Investor": "venBio"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Neurosciences", "Amount": "8.5e+07", "FundingRoundCode": "B", "Date": "2006-11-08", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Neurosciences", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2005-07-01", "Investor": "Morgan Stanley Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Neurosciences", "Amount": "8.5e+07", "FundingRoundCode": "B", "Date": "2006-11-08", "Investor": "Morgan Stanley Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Neurosciences", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2005-07-01", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Neurosciences", "Amount": "8.5e+07", "FundingRoundCode": "B", "Date": "2006-11-08", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Neurosciences", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2005-07-01", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Solstice Neurosciences", "Amount": "8.5e+07", "FundingRoundCode": "B", "Date": "2006-11-08", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SolveBio", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2014-05-13", "Investor": "Andreessen Horowitz"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SolveBio", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2014-05-13", "Investor": "SV Angel"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SolveBio", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2014-05-13", "Investor": "Max Levchin"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SomaLogic", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SomaLogic", "Amount": "16500000", "FundingRoundCode": "NA", "Date": "2014-11-17", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somanta Pharmaceuticals", "Amount": "3670000", "FundingRoundCode": "NA", "Date": "2006-01-31", "Investor": "Alpha Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somanta Pharmaceuticals", "Amount": "3670000", "FundingRoundCode": "NA", "Date": "2006-01-31", "Investor": "SCO Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somanta Pharmaceuticals", "Amount": "1250000", "FundingRoundCode": "NA", "Date": "2005-08-22", "Investor": "SCO Capital Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "SOMARK Innovations", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-02-02", "Investor": "Finistere Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "SOMARK Innovations", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-02-02", "Investor": "Med-Pharmex"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "SOMARK Innovations", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-02-02", "Investor": "St. Louis Arch Angels"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "SOMARK Innovations", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2009-02-02", "Investor": "T2 Venture Creation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somaxon Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2004-06-15", "Investor": "CDIB BioScience Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somaxon Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2004-06-15", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somaxon Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2004-06-15", "Investor": "Fog City Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somaxon Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2004-06-15", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Somaxon Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "B", "Date": "2004-06-15", "Investor": "Windamere Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SonarMed", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2010-09-16", "Investor": "BioCrossroads"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SonarMed", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2010-09-16", "Investor": "Queen City Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SonarMed", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2010-09-16", "Investor": "Spring Mill Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SonarMed", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2010-09-16", "Investor": "StepStone Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "9200000", "FundingRoundCode": "C", "Date": "2012-06-28", "Investor": "Fjord Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2014-09-04", "Investor": "Fjord Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "Fjord Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2014-09-04", "Investor": "Meritech Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "9200000", "FundingRoundCode": "C", "Date": "2012-06-28", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "3.5e+07", "FundingRoundCode": "D", "Date": "2014-09-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2013-06-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Sonendo", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-03-24", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonexa Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2008-01-31", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonexa Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2008-01-31", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonexa Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2008-01-31", "Investor": "Mitsubishi Corporation Life Sciences Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonexa Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2008-01-31", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2011-02-14", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-05-21", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-05-21", "Investor": "EDF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2011-02-14", "Investor": "EDF Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2011-02-14", "Investor": "Emergent Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2011-02-14", "Investor": "InCube Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-05-21", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2011-02-14", "Investor": "MedVenture Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2011-02-14", "Investor": "Split Rock Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-05-21", "Investor": "The Angels' Forum"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sonoma Orthopedics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-05-21", "Investor": "The Halo Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "4.7e+07", "FundingRoundCode": "B", "Date": "2004-09-24", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "4.7e+07", "FundingRoundCode": "B", "Date": "2004-09-24", "Investor": "Commerce Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2003-03-10", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2003-03-10", "Investor": "GE Capital Life Science and Technology Finance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2003-03-10", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2003-03-10", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "4.7e+07", "FundingRoundCode": "B", "Date": "2004-09-24", "Investor": "NewSpring Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2003-03-10", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2003-03-10", "Investor": "Seaflower Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "4.7e+07", "FundingRoundCode": "B", "Date": "2004-09-24", "Investor": "Seaflower Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "4.7e+07", "FundingRoundCode": "B", "Date": "2004-09-24", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "A", "Date": "2003-03-10", "Investor": "TL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sopherion Therapeutics", "Amount": "4.7e+07", "FundingRoundCode": "B", "Date": "2004-09-24", "Investor": "TL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sophia Genetics", "Amount": "13750000", "FundingRoundCode": "B", "Date": "2014-07-07", "Investor": "Invoke Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sophiris Bio", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2014-05-17", "Investor": "Aspire Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sophiris Bio", "Amount": "3.5e+07", "FundingRoundCode": "NA", "Date": "2010-09-29", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "6500000", "FundingRoundCode": "D", "Date": "2014-05-15", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "21800000", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2011-06-30", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "2533000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "18056217", "FundingRoundCode": "NA", "Date": "2012-08-08", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "6500000", "FundingRoundCode": "D", "Date": "2014-05-15", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "21800000", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2011-06-30", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "6500000", "FundingRoundCode": "D", "Date": "2014-05-15", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "21800000", "FundingRoundCode": "B", "Date": "2010-09-13", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "3.6e+07", "FundingRoundCode": "B", "Date": "2011-06-30", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "2533000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sorbent Therapeutics", "Amount": "18056217", "FundingRoundCode": "NA", "Date": "2012-08-08", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sosei", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2003-08-01", "Investor": "Mitsui & Co. Global Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sosei", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2003-08-01", "Investor": "Nomura Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sosei", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2003-08-01", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "seed", "CompanyCategory": "Bioinformatics|Biotechnology|Technology", "CompanyName": "Sothic Bioscience Limited", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2015-04-30", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Healthcare Services", "CompanyName": "Sound Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "C", "Date": "2013-10-16", "Investor": "KEC Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spark Therapeutics", "Amount": "72800000", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spark Therapeutics", "Amount": "72800000", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Deerfield"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spark Therapeutics", "Amount": "72800000", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Rock Springs Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spark Therapeutics", "Amount": "72800000", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spark Therapeutics", "Amount": "72800000", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spark Therapeutics", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2013-10-22", "Investor": "The Children's Hospital of Philadelphia"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spark Therapeutics", "Amount": "72800000", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Technology", "CompanyName": "Spectral Genomics", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2004-03-15", "Investor": "Bacterial Barcodes"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Technology", "CompanyName": "Spectral Genomics", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2004-03-15", "Investor": "Baylor College of Medicine"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Technology", "CompanyName": "Spectral Genomics", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2004-03-15", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Technology", "CompanyName": "Spectral Genomics", "Amount": "9300000", "FundingRoundCode": "B", "Date": "2004-03-15", "Investor": "Techxas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spero Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2015-06-08", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spero Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2015-06-08", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spero Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2015-06-08", "Investor": "Kraft Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spero Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2015-06-08", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spero Therapeutics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2015-06-08", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spherics", "Amount": "26400000", "FundingRoundCode": "C", "Date": "2005-05-13", "Investor": "Advent International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spherics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2002-08-16", "Investor": "CB Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spherics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2002-08-16", "Investor": "Eastman Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spherics", "Amount": "26400000", "FundingRoundCode": "C", "Date": "2005-05-13", "Investor": "Oakwood Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spherics", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2002-08-16", "Investor": "Zero Stage Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SphynKx Therapeutics", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2012-01-18", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Spinal Kinetics", "Amount": "3.4e+07", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "De Novo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Spinal Kinetics", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2004-03-13", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Spinal Kinetics", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2004-03-13", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Spinal Kinetics", "Amount": "3.4e+07", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Spinal Kinetics", "Amount": "3.4e+07", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Spinal Kinetics", "Amount": "3.4e+07", "FundingRoundCode": "NA", "Date": "2014-06-04", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Spinal Restoration", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-10-23", "Investor": "Austin Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Spinal Restoration", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-10-23", "Investor": "Comerica Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Spinal Restoration", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-10-23", "Investor": "MB Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Spinal Restoration", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2012-10-23", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Spinifex Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2014-04-10", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "SpinX Technologies", "Amount": "12483000", "FundingRoundCode": "B", "Date": "2005-09-06", "Investor": "ePlanet Capital"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Spring Bank Pharmaceuticals", "Amount": "3900000", "FundingRoundCode": "NA", "Date": "2011-05-05", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Springleaf Therapeutics", "Amount": "19047501", "FundingRoundCode": "B", "Date": "2011-07-08", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Springleaf Therapeutics", "Amount": "4230000", "FundingRoundCode": "A", "Date": "2009-11-30", "Investor": "Flybridge Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Springleaf Therapeutics", "Amount": "19047501", "FundingRoundCode": "B", "Date": "2011-07-08", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Springleaf Therapeutics", "Amount": "4230000", "FundingRoundCode": "A", "Date": "2009-11-30", "Investor": "North Bridge Venture Partners & Growth Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SQZ Biotech", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2015-06-24", "Investor": "20/20 HealthCare Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "SQZ Biotech", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2013-10-29", "Investor": "MassChallenge"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SQZ Biotech", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2015-06-24", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "1600000", "FundingRoundCode": "B", "Date": "2007-04-23", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "1600000", "FundingRoundCode": "B", "Date": "2007-04-23", "Investor": "BlueTree Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "1600000", "FundingRoundCode": "B", "Date": "2007-04-23", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "210000", "FundingRoundCode": "NA", "Date": "2006-03-21", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "1600000", "FundingRoundCode": "B", "Date": "2007-04-23", "Investor": "Meyer Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "1600000", "FundingRoundCode": "B", "Date": "2007-04-23", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "90000", "FundingRoundCode": "NA", "Date": "2006-02-23", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "210000", "FundingRoundCode": "NA", "Date": "2006-03-21", "Investor": "Pittsburgh Life Sciences Greenhouse"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "1600000", "FundingRoundCode": "B", "Date": "2007-04-23", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StageMark", "Amount": "1600000", "FundingRoundCode": "B", "Date": "2007-04-23", "Investor": "UNIVERSITY CITY SCIENCE CENTER"}, {"FundingRoundType": "venture", "CompanyCategory": "All Students|Automotive|Biotechnology|Clean Technology|Consumer Internet|E-Commerce|Entrepreneur|Nonprofits|Startups", "CompanyName": "StartX", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2013-02-07", "Investor": "AT&T"}, {"FundingRoundType": "venture", "CompanyCategory": "All Students|Automotive|Biotechnology|Clean Technology|Consumer Internet|E-Commerce|Entrepreneur|Nonprofits|Startups", "CompanyName": "StartX", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2013-02-07", "Investor": "Cisco"}, {"FundingRoundType": "venture", "CompanyCategory": "All Students|Automotive|Biotechnology|Clean Technology|Consumer Internet|E-Commerce|Entrepreneur|Nonprofits|Startups", "CompanyName": "StartX", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2013-02-07", "Investor": "Groupon"}, {"FundingRoundType": "grant", "CompanyCategory": "All Students|Automotive|Biotechnology|Clean Technology|Consumer Internet|E-Commerce|Entrepreneur|Nonprofits|Startups", "CompanyName": "StartX", "Amount": "8e+05", "FundingRoundCode": "NA", "Date": "2012-08-23", "Investor": "Kauffman Foundation"}, {"FundingRoundType": "grant", "CompanyCategory": "All Students|Automotive|Biotechnology|Clean Technology|Consumer Internet|E-Commerce|Entrepreneur|Nonprofits|Startups", "CompanyName": "StartX", "Amount": "3600000", "FundingRoundCode": "NA", "Date": "2013-09-04", "Investor": "Stanford University"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "STAT-Diagnostica", "Amount": "28966470", "FundingRoundCode": "B", "Date": "2013-05-06", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Industrial Automation|Innovation Engineering|Software", "CompanyName": "Synthego", "Amount": "8294226", "FundingRoundCode": "A", "Date": "2013-07-05", "Investor": "Menlo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Industrial Automation|Innovation Engineering|Software", "CompanyName": "Synthego", "Amount": "8294226", "FundingRoundCode": "A", "Date": "2013-07-05", "Investor": "WI Harper Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Stem CentRx", "Amount": "2e+08", "FundingRoundCode": "F", "Date": "2014-05-30", "Investor": "Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Stem CentRx", "Amount": "2.5e+08", "FundingRoundCode": "G", "Date": "2015-09-09", "Investor": "Fidelity Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Stem CentRx", "Amount": "2.5e+08", "FundingRoundCode": "G", "Date": "2015-09-09", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Stem CentRx", "Amount": "23526990", "FundingRoundCode": "NA", "Date": "2011-03-16", "Investor": "Stuart Peterson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StemBioSys", "Amount": "8e+06", "FundingRoundCode": "A", "Date": "2015-04-14", "Investor": "Targeted Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemgent", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2009-03-01", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Stemgent", "Amount": "2700000", "FundingRoundCode": "NA", "Date": "2009-11-25", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemgent", "Amount": "10627591", "FundingRoundCode": "B", "Date": "2011-06-10", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Stemgent", "Amount": "2700000", "FundingRoundCode": "NA", "Date": "2009-11-25", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemgent", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2009-03-01", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemgent", "Amount": "10627591", "FundingRoundCode": "B", "Date": "2011-06-10", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemina Biomarker Discovery", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2007-12-19", "Investor": "DaneVest Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemina Biomarker Discovery", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2009-11-12", "Investor": "DaneVest Tech Fund Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemina Biomarker Discovery", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2007-12-19", "Investor": "Phenomenelle Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemina Biomarker Discovery", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2009-11-12", "Investor": "Phenomenelle Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stemina Biomarker Discovery", "Amount": "1100000", "FundingRoundCode": "A", "Date": "2009-11-12", "Investor": "Wisconsin Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "Stemline Therapeutics", "Amount": "12500000", "FundingRoundCode": "A", "Date": "2008-04-09", "Investor": "Pequot Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stereotaxis", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "A.G. Edwards & Sons"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stereotaxis", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "Advantage Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stereotaxis", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "Alafi Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stereotaxis", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stereotaxis", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "Portage Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stereotaxis", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "Stifel Nicolaus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Strand Diagnostics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2012-03-28", "Investor": "NantWorks"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StrataGent Life Sciences", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-05-11", "Investor": "Aphelion Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StrataGent Life Sciences", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-05-11", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "StrataGent Life Sciences", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-05-11", "Investor": "Quantum Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stromedix", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stromedix", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2007-03-22", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stromedix", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stromedix", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stromedix", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2007-03-22", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stromedix", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Stromedix", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "Red Abbey Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Caxton Advantage Life Sciences Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Merlin Nexus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "OpusPoint Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Sunesis Pharmaceuticals", "Amount": "43500000", "FundingRoundCode": "NA", "Date": "2009-04-07", "Investor": "Vision Capital Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Surface Logix", "Amount": "19900000", "FundingRoundCode": "D", "Date": "2007-03-24", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Surface Logix", "Amount": "19900000", "FundingRoundCode": "D", "Date": "2007-03-24", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Surface Oncology", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Surface Oncology", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Surface Oncology", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Surface Oncology", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2015-01-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "36500000", "FundingRoundCode": "C", "Date": "2010-11-17", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2007-12-10", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2009-03-30", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2013-12-11", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "16500000", "FundingRoundCode": "C", "Date": "2012-05-08", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "36500000", "FundingRoundCode": "C", "Date": "2010-11-17", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2013-12-11", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "16500000", "FundingRoundCode": "C", "Date": "2012-05-08", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2013-12-11", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2013-12-11", "Investor": "Eli Lilly"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "36500000", "FundingRoundCode": "C", "Date": "2010-11-17", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "16500000", "FundingRoundCode": "C", "Date": "2012-05-08", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "36500000", "FundingRoundCode": "C", "Date": "2010-11-17", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2013-12-11", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "16500000", "FundingRoundCode": "C", "Date": "2012-05-08", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "1e+06", "FundingRoundCode": "A", "Date": "2006-01-01", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "36500000", "FundingRoundCode": "C", "Date": "2010-11-17", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2007-12-10", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "1.5e+07", "FundingRoundCode": "B", "Date": "2009-03-30", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "305000", "FundingRoundCode": "NA", "Date": "2007-10-16", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "2.6e+07", "FundingRoundCode": "D", "Date": "2013-12-11", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Sutro Biopharma", "Amount": "16500000", "FundingRoundCode": "C", "Date": "2012-05-08", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Swallow Solutions", "Amount": "2060130", "FundingRoundCode": "A", "Date": "2015-03-13", "Investor": "NEW Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Swallow Solutions", "Amount": "2060130", "FundingRoundCode": "A", "Date": "2015-03-13", "Investor": "Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Swallow Solutions", "Amount": "2060130", "FundingRoundCode": "A", "Date": "2015-03-13", "Investor": "Wisconsin Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Software", "CompanyName": "Sway Medical Technologies", "Amount": "750000", "FundingRoundCode": "A", "Date": "2013-06-21", "Investor": "Various Angel Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Swift Biosciences", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2013-10-17", "Investor": "Fletcher Spaght Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Swift Biosciences", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2013-10-17", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Swift Biosciences", "Amount": "3e+06", "FundingRoundCode": "A", "Date": "2010-08-19", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Swift Biosciences", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2013-10-17", "Investor": "Renaissance Venture Capital Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sword Diagnostics", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2006-10-13", "Investor": "Jumpstart New Jersey Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sword Diagnostics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2005-04-01", "Investor": "Jumpstart New Jersey Angel Network"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sword Diagnostics", "Amount": "1600000", "FundingRoundCode": "A", "Date": "2006-10-13", "Investor": "NJTC Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sword Diagnostics", "Amount": "1490000", "FundingRoundCode": "B", "Date": "2007-03-05", "Investor": "NJTC Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Sword Diagnostics", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2005-04-01", "Investor": "NJTC Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SymBio Pharmaceuticals", "Amount": "2.4e+07", "FundingRoundCode": "E", "Date": "2011-02-25", "Investor": "Cephalon"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Green", "CompanyName": "Symbiota", "Amount": "7500000", "FundingRoundCode": "A", "Date": "2014-11-13", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Symic Biomedical", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2015-12-01", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Symic Biomedical", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2015-01-05", "Investor": "Lilly Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Symic Biomedical", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2015-08-27", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Symphogen", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2004-11-05", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Symphogen", "Amount": "42108000", "FundingRoundCode": "NA", "Date": "2009-02-02", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Symphogen", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2006-01-10", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Symphogen", "Amount": "130910000", "FundingRoundCode": "NA", "Date": "2011-01-06", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Symphogen", "Amount": "135400000", "FundingRoundCode": "F", "Date": "2011-02-14", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Symphogen", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2006-01-10", "Investor": "Takeda Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Symphony Dynamo", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-04-19", "Investor": "Symphony Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "3e+07", "FundingRoundCode": "F", "Date": "2009-04-15", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2011-03-21", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "1.2e+07", "FundingRoundCode": "F", "Date": "2009-10-22", "Investor": "Baker Brothers Advisors LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "1.2e+07", "FundingRoundCode": "F", "Date": "2009-10-22", "Investor": "Covera Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2011-03-21", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "1.2e+07", "FundingRoundCode": "F", "Date": "2009-10-22", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "3e+07", "FundingRoundCode": "F", "Date": "2009-04-15", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "1.2e+07", "FundingRoundCode": "F", "Date": "2009-10-22", "Investor": "Tullis Health Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2011-03-21", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synageva BioPharma", "Amount": "1.2e+07", "FundingRoundCode": "F", "Date": "2009-10-22", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Medical Devices", "CompanyName": "SynchroPET", "Amount": "725000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "Accelerate Long Island"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Medical Devices", "CompanyName": "SynchroPET", "Amount": "725000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "Long Island Angel Network"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Medical Devices", "CompanyName": "SynchroPET", "Amount": "725000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "New York Angels"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Medical Devices", "CompanyName": "SynchroPET", "Amount": "725000", "FundingRoundCode": "NA", "Date": "2015-07-07", "Investor": "Topspin Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Synereca Pharmaceuticals", "Amount": "1400000", "FundingRoundCode": "NA", "Date": "2014-09-16", "Investor": "i2E"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synereca Pharmaceuticals", "Amount": "6e+05", "FundingRoundCode": "NA", "Date": "2015-08-04", "Investor": "i2E"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synlogic", "Amount": "29400000", "FundingRoundCode": "A", "Date": "2014-07-22", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synlogic", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2014-10-07", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synlogic", "Amount": "29400000", "FundingRoundCode": "A", "Date": "2014-07-22", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synosia Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2010-10-12", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synosia Therapeutics", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2009-01-01", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synosia Therapeutics", "Amount": "32500000", "FundingRoundCode": "NA", "Date": "2007-01-05", "Investor": "5AM Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synosia Therapeutics", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2010-10-12", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synosia Therapeutics", "Amount": "2.9e+07", "FundingRoundCode": "B", "Date": "2009-01-01", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synosia Therapeutics", "Amount": "32500000", "FundingRoundCode": "NA", "Date": "2007-01-05", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Synta Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2004-01-14", "Investor": "Caxton Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Synta Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2004-01-14", "Investor": "Galleon Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Synta Pharmaceuticals", "Amount": "5e+07", "FundingRoundCode": "C", "Date": "2004-01-14", "Investor": "SunAmerica"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syntaxin", "Amount": "2.9e+07", "FundingRoundCode": "C", "Date": "2010-11-11", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syntaxin", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2007-10-31", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syntaxin", "Amount": "2.9e+07", "FundingRoundCode": "C", "Date": "2010-11-11", "Investor": "LSP BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syntaxin", "Amount": "2.9e+07", "FundingRoundCode": "C", "Date": "2010-11-11", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syntaxin", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2007-10-31", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synthace", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-12-05", "Investor": "SOSV"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synthetic Genomics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2005-12-23", "Investor": "Biotechonomy"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synthetic Genomics", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2005-12-23", "Investor": "DFJ Frontier"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synthorx", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2014-04-21", "Investor": "Avalon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Synthorx", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2014-04-21", "Investor": "Correlation Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syntropharma", "Amount": "1932043", "FundingRoundCode": "A", "Date": "2006-11-24", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syntropharma", "Amount": "640000", "FundingRoundCode": "NA", "Date": "2009-12-29", "Investor": "Highland Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "B", "Date": "2014-10-27", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "B", "Date": "2014-10-27", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "B", "Date": "2014-10-27", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-04-11", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "B", "Date": "2014-10-27", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2013-04-11", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "B", "Date": "2014-10-27", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Syros Pharmaceuticals", "Amount": "5.3e+07", "FundingRoundCode": "B", "Date": "2014-10-27", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Syrrx", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2000-08-04", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Syrrx", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2000-08-04", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Syrrx", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2000-08-04", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Syrrx", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2000-08-04", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Taigen", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2009-01-01", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Taigen", "Amount": "3.8e+07", "FundingRoundCode": "B", "Date": "2004-03-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Pharmaceuticals", "CompanyName": "Taligen Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2008-01-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Pharmaceuticals", "CompanyName": "Taligen Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2008-01-01", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Pharmaceuticals", "CompanyName": "Taligen Therapeutics", "Amount": "3750000", "FundingRoundCode": "A", "Date": "2005-08-01", "Investor": "High Country Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Pharmaceuticals", "CompanyName": "Taligen Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2008-01-01", "Investor": "High Country Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Pharmaceuticals", "CompanyName": "Taligen Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2008-01-01", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Talima Therapeutics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2005-04-01", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Talima Therapeutics", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2007-05-29", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Talima Therapeutics", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2007-05-29", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Talima Therapeutics", "Amount": "2e+06", "FundingRoundCode": "NA", "Date": "2005-04-01", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Talima Therapeutics", "Amount": "1.9e+07", "FundingRoundCode": "B", "Date": "2007-05-29", "Investor": "U.S. Venture Partners (USVP)"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Tansna Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-02-19", "Investor": "BioGenerator"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Tansna Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-09-20", "Investor": "iSELECT FUND"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TapImmune", "Amount": "1275000", "FundingRoundCode": "NA", "Date": "2010-06-20", "Investor": "Iroquois Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-03-20", "Investor": "Bison Capital Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2002-12-05", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2002-12-05", "Investor": "CDIB BioScience Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-03-20", "Investor": "Cogene Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2002-12-05", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2002-12-05", "Investor": "EuclidSR Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "4.6e+07", "FundingRoundCode": "B", "Date": "2002-12-05", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Targacept", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2003-03-20", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TargAnox", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2009-03-14", "Investor": "Ascent Biomedical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TargAnox", "Amount": "5100000", "FundingRoundCode": "A", "Date": "2009-03-14", "Investor": "Partners Innovation Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TargeGen", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-01-15", "Investor": "Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TargeGen", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-01-15", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TargeGen", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2004-01-15", "Investor": "William Blair Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Energy", "CompanyName": "Targeted Growth", "Amount": "22300000", "FundingRoundCode": "D", "Date": "2007-02-07", "Investor": "AllianceBernstein"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Energy", "CompanyName": "Targeted Growth", "Amount": "22300000", "FundingRoundCode": "D", "Date": "2007-02-07", "Investor": "Capricorn Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Energy", "CompanyName": "Targeted Growth", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2006-05-22", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Energy", "CompanyName": "Targeted Growth", "Amount": "22300000", "FundingRoundCode": "D", "Date": "2007-02-07", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Energy", "CompanyName": "Targeted Growth", "Amount": "1e+07", "FundingRoundCode": "D", "Date": "2006-05-22", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Agriculture|Biotechnology|Energy", "CompanyName": "Targeted Growth", "Amount": "22300000", "FundingRoundCode": "D", "Date": "2007-02-07", "Investor": "WRF Capital"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "13500000", "FundingRoundCode": "NA", "Date": "2013-03-18", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "18300000", "FundingRoundCode": "B", "Date": "2011-04-13", "Investor": "Flagship Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2015-10-27", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2009-06-25", "Investor": "Flagship Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "13500000", "FundingRoundCode": "NA", "Date": "2013-03-18", "Investor": "Flybridge Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "18300000", "FundingRoundCode": "B", "Date": "2011-04-13", "Investor": "Flybridge Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2009-06-25", "Investor": "Flybridge Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "13500000", "FundingRoundCode": "NA", "Date": "2013-03-18", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "18300000", "FundingRoundCode": "B", "Date": "2011-04-13", "Investor": "Polaris Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2015-10-27", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2009-06-25", "Investor": "Polaris Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "3.2e+07", "FundingRoundCode": "NA", "Date": "2015-10-27", "Investor": "RA Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "13500000", "FundingRoundCode": "NA", "Date": "2013-03-18", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TARIS Biomedical", "Amount": "18300000", "FundingRoundCode": "B", "Date": "2011-04-13", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tarsa Therapeutics", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-05-29", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tarsa Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2012-03-16", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tarsa Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2012-03-16", "Investor": "Marker"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Tarsa Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-08-13", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tarsa Therapeutics", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2010-01-17", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tarsa Therapeutics", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2012-03-16", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Tarsa Therapeutics", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-08-13", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "TB Biosciences", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-07-18", "Investor": "Ben Franklin Technology Partners of Northeast Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "TB Biosciences", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-07-18", "Investor": "NYU Innovation Venture Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "TB Biosciences", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2013-07-18", "Investor": "Originate Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "NGI", "Amount": "11795700", "FundingRoundCode": "A", "Date": "2007-12-19", "Investor": "Genzyme Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Techpool Bio-Pharma", "Amount": "20480000", "FundingRoundCode": "NA", "Date": "2009-06-05", "Investor": "Starr International Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Bio-Pharm|Biotechnology|Therapeutics", "CompanyName": "Telesta Therapeutics", "Amount": "28600000", "FundingRoundCode": "NA", "Date": "2015-08-20", "Investor": "Consonance Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Telormedix", "Amount": "7925456", "FundingRoundCode": "B", "Date": "2013-12-02", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Telormedix", "Amount": "8300000", "FundingRoundCode": "B", "Date": "2012-02-28", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tendyne Holdings", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2014-04-09", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-10-15", "Investor": "Bain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-06-23", "Investor": "Bain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2008-11-19", "Investor": "Bain Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-06-23", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "33600000", "FundingRoundCode": "D", "Date": "2013-07-01", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-10-15", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2008-11-19", "Investor": "Deerfield Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2008-11-19", "Investor": "J&J Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-10-15", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-06-23", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2005-08-03", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-10-15", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-06-23", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2008-11-19", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2005-08-03", "Investor": "L Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-10-15", "Investor": "Oak Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-06-23", "Investor": "Oak Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2008-11-19", "Investor": "Oak Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.9e+07", "FundingRoundCode": "A", "Date": "2005-08-03", "Investor": "Oak Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-10-15", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2007-10-15", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "5e+07", "FundingRoundCode": "B", "Date": "2006-06-23", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2008-11-19", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tengion", "Amount": "2.1e+07", "FundingRoundCode": "C", "Date": "2008-11-19", "Investor": "Safeguard Scientifics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tensha Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2011-09-12", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Terapio", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2009-11-30", "Investor": "Sante Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Terapio", "Amount": "1700000", "FundingRoundCode": "NA", "Date": "2008-06-18", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tercica", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2003-07-18", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tercica", "Amount": "21500000", "FundingRoundCode": "A", "Date": "2002-03-27", "Investor": "Genentech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tercica", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2003-07-18", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tercica", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2003-07-18", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tercica", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2003-07-18", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tercica", "Amount": "4.4e+07", "FundingRoundCode": "B", "Date": "2003-07-18", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TESARO", "Amount": "1.01e+08", "FundingRoundCode": "B", "Date": "2011-06-21", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TESARO", "Amount": "1.01e+08", "FundingRoundCode": "B", "Date": "2011-06-21", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TESARO", "Amount": "6e+07", "FundingRoundCode": "A", "Date": "2010-05-28", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TESARO", "Amount": "1.01e+08", "FundingRoundCode": "B", "Date": "2011-06-21", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TESARO", "Amount": "1.01e+08", "FundingRoundCode": "B", "Date": "2011-06-21", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TESARO", "Amount": "1.01e+08", "FundingRoundCode": "B", "Date": "2011-06-21", "Investor": "T. Rowe Price"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tethys BioScience", "Amount": "NA", "FundingRoundCode": "C", "Date": "2008-01-10", "Investor": "Intel Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tethys BioScience", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2009-11-09", "Investor": "Intel Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tethys BioScience", "Amount": "NA", "FundingRoundCode": "C", "Date": "2008-01-10", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tethys BioScience", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2009-11-09", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tethys BioScience", "Amount": "5400000", "FundingRoundCode": "A", "Date": "2005-10-31", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tethys BioScience", "Amount": "NA", "FundingRoundCode": "C", "Date": "2008-01-10", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tethys BioScience", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2009-11-09", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Tetra Discovery", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2013-09-30", "Investor": "Grand Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Tetra Discovery", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-09-03", "Investor": "Grand Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Tetra Discovery", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2015-09-03", "Investor": "Michigan"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2010-09-27", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "Latterell Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "Novitas Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "C", "Date": "2010-09-27", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "TetraLogic Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "C", "Date": "2010-08-10", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2010-06-01", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-07", "Investor": "CMEA Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "10040000", "FundingRoundCode": "A", "Date": "2006-11-27", "Investor": "CMEA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2010-06-01", "Investor": "Excel Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2010-06-01", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "10040000", "FundingRoundCode": "A", "Date": "2006-11-27", "Investor": "Fidelity Biosciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-07", "Investor": "Fidelity Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2010-06-01", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "10040000", "FundingRoundCode": "A", "Date": "2006-11-27", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-07", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2010-06-01", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "10040000", "FundingRoundCode": "A", "Date": "2006-11-27", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-07", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2010-06-01", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "10040000", "FundingRoundCode": "A", "Date": "2006-11-27", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Tetraphase Pharmaceuticals", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2008-08-07", "Investor": "Skyline Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Carbon|Solar", "CompanyName": "Thar Geothermal", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-06-30", "Investor": "Innovation Works"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Thar Pharmaceuticals", "Amount": "1242000", "FundingRoundCode": "NA", "Date": "2009-12-21", "Investor": "Innovation Works"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Thar Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-09-22", "Investor": "Innovation Works"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Hospitals", "CompanyName": "The Advisory Board Company", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-11-27", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "The Jackson Laboratory", "Amount": "5.8e+07", "FundingRoundCode": "NA", "Date": "2011-09-30", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Therachon", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2015-09-30", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Therachon", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2015-09-30", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Therachon", "Amount": "3.5e+07", "FundingRoundCode": "A", "Date": "2015-09-30", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2013-03-25", "Investor": "Alexandria Real Estate Equities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2013-03-25", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2013-03-25", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2013-03-25", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2013-03-25", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2013-03-25", "Investor": "MidCap Financial"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "1500000", "FundingRoundCode": "B", "Date": "2010-03-17", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2013-03-25", "Investor": "MPM Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2013-03-25", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Therapeutics", "CompanyName": "Theraclone Sciences", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2013-03-25", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theramyt Novobiologics", "Amount": "4500000", "FundingRoundCode": "A", "Date": "2013-10-11", "Investor": "Accel"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Theranos", "Amount": "9100000", "FundingRoundCode": "B", "Date": "2006-02-21", "Investor": "ATA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Theranos", "Amount": "28500000", "FundingRoundCode": "C", "Date": "2006-11-17", "Investor": "ATA Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Theranos", "Amount": "9100000", "FundingRoundCode": "B", "Date": "2006-02-21", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Theranos", "Amount": "5800000", "FundingRoundCode": "A", "Date": "2005-02-11", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Theranos", "Amount": "28500000", "FundingRoundCode": "C", "Date": "2006-11-17", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Theranostics Health", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2012-12-28", "Investor": "Maryland Venture Fund"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Theravance", "Amount": "129375000", "FundingRoundCode": "NA", "Date": "2010-11-29", "Investor": "GlaxoSmithKline"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theravasc", "Amount": "2350000", "FundingRoundCode": "A", "Date": "2010-09-27", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theravasc", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2010-01-06", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theravasc", "Amount": "2350000", "FundingRoundCode": "A", "Date": "2010-09-27", "Investor": "North Coast Angel Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theravasc", "Amount": "2350000", "FundingRoundCode": "A", "Date": "2010-09-27", "Investor": "Physicians Investment Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theravasc", "Amount": "2350000", "FundingRoundCode": "A", "Date": "2010-09-27", "Investor": "Portal Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theravasc", "Amount": "5e+05", "FundingRoundCode": "NA", "Date": "2010-01-06", "Investor": "Portal Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Theravasc", "Amount": "2350000", "FundingRoundCode": "A", "Date": "2010-09-27", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "THERAVECTYS", "Amount": "18913020", "FundingRoundCode": "D", "Date": "2013-10-16", "Investor": "Tethys BioScience"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "TheraVida", "Amount": "3600000", "FundingRoundCode": "NA", "Date": "2010-07-06", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TheraVida", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2012-04-01", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Thermalin Diabetes", "Amount": "250000", "FundingRoundCode": "NA", "Date": "2010-03-29", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thermalin Diabetes", "Amount": "2850000", "FundingRoundCode": "A", "Date": "2011-03-28", "Investor": "JumpStart Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thesan Pharmaceuticals", "Amount": "4.9e+07", "FundingRoundCode": "B", "Date": "2014-02-24", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thesan Pharmaceuticals", "Amount": "4.9e+07", "FundingRoundCode": "B", "Date": "2014-02-24", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Third Wave Technologies", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2007-12-10", "Investor": "Deerfield Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thrasos", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2012-10-25", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thrasos", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2012-10-25", "Investor": "MP Healthcare Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thrasos", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2012-10-25", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thrasos", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2015-03-31", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Thrasos", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2012-10-25", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Threshold Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Threshold Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Threshold Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Threshold Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Threshold Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness|Health Care", "CompanyName": "Threshold Pharmaceuticals", "Amount": "4.1e+07", "FundingRoundCode": "B", "Date": "2004-01-14", "Investor": "Three Arch Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ThromboVision", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2007-09-13", "Investor": "National Healthcare Services"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tianjin GreenBio Materials", "Amount": "3450000", "FundingRoundCode": "NA", "Date": "2010-12-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tianjin GreenBio Materials", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2008-03-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tigris Pharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-01-17", "Investor": "NGN Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tigris Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "C", "Date": "2010-09-28", "Investor": "Riverbank Capital Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tigris Pharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-01-17", "Investor": "Riverbank Capital Securities"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tigris Pharmaceuticals", "Amount": "6500000", "FundingRoundCode": "C", "Date": "2010-09-28", "Investor": "Sonostar Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tigris Pharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "B", "Date": "2007-01-17", "Investor": "Wexford Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tioga Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2010-02-17", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tioga Pharmaceuticals", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2006-01-09", "Investor": "Forward Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tioga Pharmaceuticals", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2010-02-17", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tioga Pharmaceuticals", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2006-01-09", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tioga Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2012-04-12", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tissue Regeneration Systems", "Amount": "4600000", "FundingRoundCode": "B", "Date": "2013-08-22", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Bioinformatics|Biotechnology", "CompanyName": "TissueInformatics", "Amount": "12500000", "FundingRoundCode": "NA", "Date": "2002-01-24", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Analytics|Bioinformatics|Biotechnology", "CompanyName": "TissueInformatics", "Amount": "12500000", "FundingRoundCode": "NA", "Date": "2002-01-24", "Investor": "InforMax Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Tissuetech", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2015-06-24", "Investor": "Ballast Point Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Tissuetech", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-08-22", "Investor": "Ballast Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Tissuetech", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2013-08-22", "Investor": "Ballast Point Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Tissuetech", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2015-06-24", "Investor": "River Cities Capital Funds"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Tissuetech", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2013-08-22", "Investor": "River Cities Capital Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Tissuetech", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2013-08-22", "Investor": "River Cities Capital Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "TM Bioscience", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2005-11-23", "Investor": "Laurus Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "TM Bioscience", "Amount": "4e+06", "FundingRoundCode": "NA", "Date": "2006-11-28", "Investor": "Laurus Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TNG Pharmaceuticals", "Amount": "4600000", "FundingRoundCode": "A", "Date": "2014-02-06", "Investor": "Bluegrass Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TNG Pharmaceuticals", "Amount": "4600000", "FundingRoundCode": "A", "Date": "2014-02-06", "Investor": "Texas Halo Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2010-09-29", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2007-08-02", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2010-09-29", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2007-08-02", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2010-09-29", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2007-08-02", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "B", "Date": "2010-09-29", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "3.1e+07", "FundingRoundCode": "A", "Date": "2007-08-02", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Tobira Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-06-30", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tokai Pharmaceuticals", "Amount": "2.3e+07", "FundingRoundCode": "D", "Date": "2011-09-20", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tokai Pharmaceuticals", "Amount": "35500000", "FundingRoundCode": "E", "Date": "2013-05-15", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tokai Pharmaceuticals", "Amount": "2.2e+07", "FundingRoundCode": "D", "Date": "2009-06-09", "Investor": "Apple Tree Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolera Therapeutics", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2012-10-16", "Investor": "Hopen Life Science Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolera Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2008-06-16", "Investor": "Hopen Therapeutics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolera Therapeutics", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2012-10-16", "Investor": "Southwest Michigan First Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolera Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2008-06-16", "Investor": "Southwest Michigan First Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolera Therapeutics", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2012-10-16", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolera Therapeutics", "Amount": "NA", "FundingRoundCode": "A", "Date": "2008-06-16", "Investor": "Triathlon Medical Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolero Pharmaceuticals", "Amount": "22400000", "FundingRoundCode": "B", "Date": "2014-11-05", "Investor": "Fred Alger Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Bear Stearns Health Innoventures L.P"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Duke University"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Genentech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2003-01-10", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2001-10-24", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Lehman Brothers Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2003-01-10", "Investor": "Mizuho Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2003-01-10", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2001-10-24", "Investor": "Rho Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2001-10-24", "Investor": "Skyline Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2003-01-10", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "1.7e+07", "FundingRoundCode": "B", "Date": "2001-10-24", "Investor": "Vertex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "6.1e+07", "FundingRoundCode": "D", "Date": "2006-10-21", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tolerx", "Amount": "3.5e+07", "FundingRoundCode": "C", "Date": "2003-01-10", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Topica Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2011-10-18", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Topica Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2011-10-18", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Topica Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2011-10-18", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Topokine Therapeutics", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-04-02", "Investor": "Schooner Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TRACON Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2014-09-22", "Investor": "Brookline Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TRACON Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2014-09-22", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TRACON Pharmaceuticals", "Amount": "2.7e+07", "FundingRoundCode": "B", "Date": "2014-09-22", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TRACON Pharmaceuticals", "Amount": "1.4e+07", "FundingRoundCode": "A", "Date": "2011-04-20", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-03-15", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-04-15", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-03-15", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-04-15", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-03-15", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-04-15", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "4e+07", "FundingRoundCode": "A", "Date": "2007-03-15", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Tragara", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2010-04-15", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "Hamilton BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "Montreux Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "Peninsula Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Transcept Pharmaceuticals", "Amount": "4e+07", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "500 Startups"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "AME Cloud Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "2800000", "FundingRoundCode": "NA", "Date": "2014-02-14", "Investor": "AME Cloud Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Data Collective"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "2800000", "FundingRoundCode": "NA", "Date": "2014-02-14", "Investor": "Data Collective"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "2800000", "FundingRoundCode": "NA", "Date": "2014-02-14", "Investor": "Google Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "1200000", "FundingRoundCode": "NA", "Date": "2012-11-28", "Investor": "Google Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "IA Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "2800000", "FundingRoundCode": "NA", "Date": "2014-02-14", "Investor": "IA Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "1200000", "FundingRoundCode": "NA", "Date": "2012-11-28", "Investor": "Silicon Badia"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "1750000", "FundingRoundCode": "A", "Date": "2014-07-01", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-12-01", "Investor": "Y Combinator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Robotics", "CompanyName": "Transcriptic", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2015-02-19", "Investor": "Paul Buchheit"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Transgenomic", "Amount": "7e+06", "FundingRoundCode": "B", "Date": "2014-03-06", "Investor": "Third Security"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Cogene Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Diamond Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Greer Capital Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Oakwood Medical Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Pacific Horizon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "POSCO BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransMolecular", "Amount": "33200000", "FundingRoundCode": "C", "Date": "2004-03-01", "Investor": "Tullis-Dickerson"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransPharma Medical", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2006-07-24", "Investor": "Argonaut Private Equity"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransPharma Medical", "Amount": "1.8e+07", "FundingRoundCode": "C", "Date": "2006-07-24", "Investor": "TIF Ventures Pte"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TransTech Pharma", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2010-06-08", "Investor": "Forest Laboratories"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Tranzyme", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-05-13", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Tranzyme", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-11-01", "Investor": "H.I.G. Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Tranzyme", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-05-13", "Investor": "Pacific Rim Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Tranzyme", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-05-13", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Tranzyme", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-11-01", "Investor": "Quaker BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Tranzyme", "Amount": "NA", "FundingRoundCode": "A", "Date": "2005-05-13", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical|Therapeutics", "CompanyName": "Tranzyme", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2007-11-01", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Travanti Pharma", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2006-07-27", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Travanti Pharma", "Amount": "7500000", "FundingRoundCode": "B", "Date": "2006-07-27", "Investor": "Spring Bay Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Traversa Therapeutics", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2009-04-07", "Investor": "Mesa Verde Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Traversa Therapeutics", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2008-02-04", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Traverse Biosciences", "Amount": "1e+05", "FundingRoundCode": "NA", "Date": "2014-06-09", "Investor": "Accelerate Long Island"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Traycer Diagnostic Systems", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2008-01-23", "Investor": "Rev1 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trellis Bioscience", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-02-14", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trellis Bioscience", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2007-02-14", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TRELYS", "Amount": "1250000", "FundingRoundCode": "NA", "Date": "2013-04-01", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-07-14", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2008-03-01", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "6e+07", "FundingRoundCode": "C", "Date": "2013-05-09", "Investor": "Forest Laboratories"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-07-14", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2008-03-01", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-07-14", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2008-03-01", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2010-07-14", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevena", "Amount": "2.4e+07", "FundingRoundCode": "A", "Date": "2008-03-01", "Investor": "Polaris Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Trevi Therapeutics", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2015-01-08", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trevi Therapeutics", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2014-11-06", "Investor": "TPG Biotech"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Trice Orthopedics", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2013-11-27", "Investor": "BioStar Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Tricida", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2015-03-04", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Tricida", "Amount": "1e+07", "FundingRoundCode": "A", "Date": "2014-09-04", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-13", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2006-07-18", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2006-07-18", "Investor": "GSK Venture Fund"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-13", "Investor": "Lilly Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-13", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2002-09-25", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2006-07-18", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "7500000", "FundingRoundCode": "NA", "Date": "2009-11-13", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2002-09-25", "Investor": "Tenex Greenhouse Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trinity Biosystems", "Amount": "2.1e+07", "FundingRoundCode": "B", "Date": "2006-07-18", "Investor": "Tenex Greenhouse Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SHYFT", "Amount": "1.5e+07", "FundingRoundCode": "A", "Date": "2013-12-17", "Investor": "Health Enterprise Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "SHYFT", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2014-04-07", "Investor": "Milestone Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Triton Algae Innovations", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2013-09-04", "Investor": "Heliae"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Trius Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-02-28", "Investor": "InterWest Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Trius Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-02-28", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Trius Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2007-02-28", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Trivitron Healthcare", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2007-11-02", "Investor": "ePlanet Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "TrovaGene", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-07-01", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "TrovaGene", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-07-01", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Services Industry", "CompanyName": "Trubion Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-07-14", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Services Industry", "CompanyName": "Trubion Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-07-14", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Services Industry", "CompanyName": "Trubion Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-07-14", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Services Industry", "CompanyName": "Trubion Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-07-14", "Investor": "Prospect Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Services Industry", "CompanyName": "Trubion Pharmaceuticals", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2004-07-14", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-04-07", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-12-03", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-04-07", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-12-03", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-12-03", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-04-07", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-12-03", "Investor": "OrbiMed"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "3.5e+07", "FundingRoundCode": "B", "Date": "2015-04-07", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "True North Therapeutics", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2015-12-03", "Investor": "SR One"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Pharmaceuticals", "CompanyName": "Turing Pharmaceuticals", "Amount": "9e+07", "FundingRoundCode": "A", "Date": "2015-08-10", "Investor": "Martin Shkreli"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Turnstone Biologics", "Amount": "11300000", "FundingRoundCode": "A", "Date": "2015-10-27", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "Healthbox"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "Intermountain Healthcare"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-01-01", "Investor": "Park City Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "3900000", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "Peak Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "2300000", "FundingRoundCode": "A", "Date": "2014-12-04", "Investor": "Peak Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-01-01", "Investor": "Peak Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-01-01", "Investor": "Salt Lake Life Science Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Genetic Testing|Health Care|Software", "CompanyName": "Tute Genomics", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-01-01", "Investor": "Wilmington Pharmatech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care Information Technology|Medical", "CompanyName": "Twinstrand Therapeutics", "Amount": "6704285", "FundingRoundCode": "NA", "Date": "2003-02-28", "Investor": "Western Technology Investment"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "9110714", "FundingRoundCode": "A", "Date": "2014-02-10", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Illumina"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Paladin Capital Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Paladin Capital Group"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-09-30", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "2.6e+07", "FundingRoundCode": "B", "Date": "2014-05-27", "Investor": "Tao Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Twist Bioscience", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2015-06-09", "Investor": "Joby Pritzker"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TyRx Pharma", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2010-12-08", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TyRx Pharma", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2010-12-08", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "TyRx Pharma", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2010-12-08", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ultivue", "Amount": "5150000", "FundingRoundCode": "A", "Date": "2015-10-13", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "75000005", "FundingRoundCode": "NA", "Date": "2012-12-31", "Investor": "Adage Capital Management"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "75000005", "FundingRoundCode": "NA", "Date": "2012-12-31", "Investor": "BlackRock Private Equity Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2011-06-20", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "15100000", "FundingRoundCode": "A", "Date": "2012-07-30", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "75000005", "FundingRoundCode": "NA", "Date": "2012-12-31", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2011-06-20", "Investor": "Pappas Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "75000005", "FundingRoundCode": "NA", "Date": "2012-12-31", "Investor": "Pappas Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2011-06-20", "Investor": "TPG Biotechnology Partners"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Ultragenyx Pharmaceutical", "Amount": "75000005", "FundingRoundCode": "NA", "Date": "2012-12-31", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Services", "CompanyName": "Unchained Labs", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2015-02-12", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Services", "CompanyName": "Unchained Labs", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2015-02-12", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Union Biometrica", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2000-01-01", "Investor": "Brook Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Union Spring Pharmaceuticals", "Amount": "5e+06", "FundingRoundCode": "A", "Date": "2009-10-01", "Investor": "Blue Chip Venture Company"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "UniQure", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-07-01", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-06-11", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2014-10-21", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-06-11", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2014-10-21", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-06-11", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-06-11", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-06-11", "Investor": "Sanofi-Genzyme BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "1.2e+07", "FundingRoundCode": "A", "Date": "2014-10-21", "Investor": "Sanofi-Genzyme BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-06-11", "Investor": "Seattle Genetics"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "UNUM Therapeutics", "Amount": "6.5e+07", "FundingRoundCode": "B", "Date": "2015-06-11", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "40259226", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2010-07-07", "Investor": "Affinity Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "40259226", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2010-07-07", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "40259226", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2010-07-07", "Investor": "Maverick Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "40259226", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2010-07-07", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "40259226", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Uptake Medical", "Amount": "17500000", "FundingRoundCode": "B", "Date": "2010-07-07", "Investor": "WRF Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "US Biologic", "Amount": "625000", "FundingRoundCode": "NA", "Date": "2014-05-06", "Investor": "Launch Tennessee"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "US Biologic", "Amount": "625000", "FundingRoundCode": "NA", "Date": "2014-10-03", "Investor": "Launch Tennessee"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "US Biologic", "Amount": "625000", "FundingRoundCode": "NA", "Date": "2014-05-06", "Investor": "XMi High Growth Development Fund"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "US Biologic", "Amount": "625000", "FundingRoundCode": "NA", "Date": "2014-10-03", "Investor": "XMi High Growth Development Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "US HealthVest", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2013-03-04", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "US HealthVest", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2013-03-04", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "US HealthVest", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2013-03-04", "Investor": "Trevi Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "US HealthVest", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2013-03-04", "Investor": "Carl Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "US HealthVest", "Amount": "3.6e+07", "FundingRoundCode": "A", "Date": "2013-03-04", "Investor": "Richard Kresch"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaccsys", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2008-06-20", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaccsys", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2008-06-20", "Investor": "The Column Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaccsys", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2008-06-20", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Valerion Therapeutics, LLC", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2012-03-05", "Investor": "KLP Enterprises"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes", "CompanyName": "Valeritas", "Amount": "1.5e+08", "FundingRoundCode": "C", "Date": "2011-09-12", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes", "CompanyName": "Valeritas", "Amount": "1.5e+08", "FundingRoundCode": "C", "Date": "2011-09-12", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes", "CompanyName": "Valeritas", "Amount": "1.5e+08", "FundingRoundCode": "C", "Date": "2011-09-12", "Investor": "HLM Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes", "CompanyName": "Valeritas", "Amount": "1.5e+08", "FundingRoundCode": "C", "Date": "2011-09-12", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes", "CompanyName": "Valeritas", "Amount": "1.5e+08", "FundingRoundCode": "C", "Date": "2011-09-12", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes", "CompanyName": "Valeritas", "Amount": "1.5e+08", "FundingRoundCode": "C", "Date": "2011-09-12", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diabetes", "CompanyName": "Valeritas", "Amount": "1.5e+08", "FundingRoundCode": "C", "Date": "2011-09-12", "Investor": "Welsh, Carson, Anderson & Stowe"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Vandalia Research", "Amount": "750000", "FundingRoundCode": "A", "Date": "2008-05-01", "Investor": "Mountaineer Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Vandalia Research", "Amount": "750000", "FundingRoundCode": "A", "Date": "2008-05-01", "Investor": "West Virginia Jobs Investment Trust"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vanson HaloSource", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2005-03-17", "Investor": "Alexander Hutton Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vanson HaloSource", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2005-03-17", "Investor": "Mars"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vanson HaloSource", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2005-03-17", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vantia Therapeutics", "Amount": "6500000", "FundingRoundCode": "B", "Date": "2011-07-06", "Investor": "SV Life Sciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "3x5 Special Opportunity Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.9e+07", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "3x5 Special Opportunity Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "20500000", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.9e+07", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "Cross Creek Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "20500000", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "GE Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.9e+07", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "GE Asset Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "20500000", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "Integral Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "Integral Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.9e+07", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "Integral Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "20500000", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.9e+07", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "Kaiser Permanente Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.9e+07", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "Morgenthaler Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "20500000", "FundingRoundCode": "NA", "Date": "2008-08-14", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.4e+07", "FundingRoundCode": "B", "Date": "2014-04-03", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "2.9e+07", "FundingRoundCode": "A", "Date": "2013-04-25", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vapotherm", "Amount": "11250000", "FundingRoundCode": "E", "Date": "2007-11-01", "Investor": "QuestMark Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Magnetics", "Amount": "7e+06", "FundingRoundCode": "A", "Date": "2012-02-22", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Pathways", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2010-11-01", "Investor": "Ascension Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Pathways", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2010-11-01", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Pathways", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-06-24", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Pathways", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-06-24", "Investor": "Square 1 Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Pathways", "Amount": "1.4e+07", "FundingRoundCode": "B", "Date": "2010-11-01", "Investor": "Arcus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Pharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2012-09-12", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vascular Pharmaceuticals", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2012-09-12", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VasoGenix", "Amount": "4e+05", "FundingRoundCode": "NA", "Date": "2009-01-29", "Investor": "Kansas Bioscience Authority"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaxart", "Amount": "9e+06", "FundingRoundCode": "B", "Date": "2010-03-04", "Investor": "Care Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaxart", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2007-11-15", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaxart", "Amount": "3500000", "FundingRoundCode": "B", "Date": "2010-01-14", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaxart", "Amount": "3300000", "FundingRoundCode": "A", "Date": "2007-11-15", "Investor": "Quantum Technology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaxart", "Amount": "3500000", "FundingRoundCode": "B", "Date": "2010-01-14", "Investor": "Quantum Technology Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Pharmaceuticals", "CompanyName": "Vaxess Technologies", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2013-12-01", "Investor": "Massachusetts Life Sciences Center"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Life Sciences|Pharmaceuticals", "CompanyName": "Vaxess Technologies", "Amount": "3750000", "FundingRoundCode": "A", "Date": "2013-05-23", "Investor": "Norwich Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vaximm", "Amount": "8e+06", "FundingRoundCode": "NA", "Date": "2011-01-12", "Investor": "Merck & Co."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-06-14", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2006-10-25", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-06-14", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "23100000", "FundingRoundCode": "B", "Date": "2004-03-12", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2006-10-25", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-06-14", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "23100000", "FundingRoundCode": "B", "Date": "2004-03-12", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2006-10-25", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-06-14", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "23100000", "FundingRoundCode": "B", "Date": "2004-03-12", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2006-10-25", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-06-14", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2006-10-25", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "3e+07", "FundingRoundCode": "D", "Date": "2009-06-14", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "23100000", "FundingRoundCode": "B", "Date": "2004-03-12", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VaxInnate", "Amount": "4e+07", "FundingRoundCode": "C", "Date": "2006-10-25", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Velomedix", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2009-11-11", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Velomedix", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2009-11-11", "Investor": "Longitude Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Velomedix", "Amount": "3500000", "FundingRoundCode": "A", "Date": "2009-11-11", "Investor": "Wavepoint Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Veniti", "Amount": "13500000", "FundingRoundCode": "A", "Date": "2011-03-07", "Investor": "Hambrecht & Quist Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Veniti", "Amount": "13500000", "FundingRoundCode": "A", "Date": "2011-03-07", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Veniti", "Amount": "1.7e+07", "FundingRoundCode": "C", "Date": "2015-03-10", "Investor": "Tekla Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "50602514", "FundingRoundCode": "B", "Date": "2014-09-23", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2010-01-13", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "26600000", "FundingRoundCode": "A", "Date": "2007-03-06", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "50602514", "FundingRoundCode": "B", "Date": "2014-09-23", "Investor": "Celgene"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "50602514", "FundingRoundCode": "B", "Date": "2014-09-23", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2010-01-13", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "26600000", "FundingRoundCode": "A", "Date": "2007-03-06", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "50602514", "FundingRoundCode": "B", "Date": "2014-09-23", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2010-01-13", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "26600000", "FundingRoundCode": "A", "Date": "2007-03-06", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "50602514", "FundingRoundCode": "B", "Date": "2014-09-23", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Pharmaceuticals", "CompanyName": "VentiRx Pharmaceuticals", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2010-01-13", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Beauty|Biotechnology|Medical Devices", "CompanyName": "Venus Concept", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-05-22", "Investor": "Longitude Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Beauty|Biotechnology|Medical Devices", "CompanyName": "Venus Concept", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2015-11-03", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2013-06-28", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2010-06-11", "Investor": "Domain Associates"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "14950000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2013-06-28", "Investor": "GE Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2013-06-28", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2010-06-11", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "14950000", "FundingRoundCode": "NA", "Date": "2012-10-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2013-06-28", "Investor": "TPG Biotech"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2010-06-11", "Investor": "TPG Biotechnology Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "C", "Date": "2013-06-28", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Health Diagnostics", "CompanyName": "Veracyte", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2010-06-11", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2011-07-14", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2011-07-14", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-11-11", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2011-07-14", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2010-11-16", "Investor": "Bessemer Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-11-11", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2011-07-14", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2010-11-16", "Investor": "Cardinal Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-11-11", "Investor": "Longwood Founders Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2011-07-14", "Investor": "Longwood Founders Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2010-11-16", "Investor": "Longwood Founders Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2011-11-11", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "3.2e+07", "FundingRoundCode": "B", "Date": "2011-07-14", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Verastem", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2010-11-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verax Biomedical", "Amount": "2540000", "FundingRoundCode": "E", "Date": "2007-12-17", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verax Biomedical", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2007-06-21", "Investor": "Bioventures Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verax Biomedical", "Amount": "2540000", "FundingRoundCode": "E", "Date": "2007-12-17", "Investor": "CNF Investments, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verax Biomedical", "Amount": "2540000", "FundingRoundCode": "E", "Date": "2007-12-17", "Investor": "KB Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "7e+06", "FundingRoundCode": "C", "Date": "2007-07-12", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2009-11-02", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "7e+06", "FundingRoundCode": "C", "Date": "2007-07-12", "Investor": "Monitor Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2009-11-02", "Investor": "Monitor Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2010-02-11", "Investor": "Monitor Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-05-10", "Investor": "Monitor Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2014-03-28", "Investor": "Monitor Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "7e+06", "FundingRoundCode": "C", "Date": "2007-07-12", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2009-11-02", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "9e+06", "FundingRoundCode": "NA", "Date": "2010-02-11", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2011-05-10", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2014-03-28", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "7e+06", "FundingRoundCode": "C", "Date": "2007-07-12", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verdezyne", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2009-11-02", "Investor": "Tech Coast Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Verenium", "Amount": "9e+07", "FundingRoundCode": "NA", "Date": "2008-08-06", "Investor": "British Petroleum (BP)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Health Care", "CompanyName": "Vermillion", "Amount": "13242500", "FundingRoundCode": "NA", "Date": "2013-05-24", "Investor": "Oracle Investment Management Inc."}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2010-01-17", "Investor": "Aweida Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2010-01-17", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2008-07-15", "Investor": "CHL Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2008-07-15", "Investor": "Foundation Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2010-01-17", "Investor": "Flare Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2010-01-17", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "1.2e+07", "FundingRoundCode": "C", "Date": "2008-07-15", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "4192607", "FundingRoundCode": "B", "Date": "2007-03-01", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "725000", "FundingRoundCode": "A", "Date": "2006-04-25", "Investor": "Mercury Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vertos Medical", "Amount": "15500000", "FundingRoundCode": "D", "Date": "2010-01-17", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-10-29", "Investor": "Ann Arbor SPARK"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2014-10-28", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2014-08-21", "Investor": "Cultivian Sandbox Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2014-10-28", "Investor": "Michigan Accelerator Fund I"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2014-08-21", "Investor": "Michigan Accelerator Fund I"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2014-10-28", "Investor": "Open Prairie"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "10200000", "FundingRoundCode": "B", "Date": "2012-05-08", "Investor": "Open Prairie"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2014-08-21", "Investor": "Open Prairie"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "4e+06", "FundingRoundCode": "C", "Date": "2014-10-28", "Investor": "Southwest Michigan First Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "10200000", "FundingRoundCode": "B", "Date": "2012-05-08", "Investor": "Southwest Michigan First Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vestaron Corporation", "Amount": "1e+07", "FundingRoundCode": "C", "Date": "2014-08-21", "Investor": "Southwest Michigan First Life Science Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Vested Health", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "Adena Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Vested Health", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "Mountaineer Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health and Wellness", "CompanyName": "Vested Health", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2003-01-10", "Investor": "West Virginia Jobs Investment Trust"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VetCentric", "Amount": "14500000", "FundingRoundCode": "NA", "Date": "2002-12-12", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VetCentric", "Amount": "14500000", "FundingRoundCode": "NA", "Date": "2002-12-12", "Investor": "Sherbrooke Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VetCentric", "Amount": "14500000", "FundingRoundCode": "NA", "Date": "2002-12-12", "Investor": "Staenberg Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VetCentric", "Amount": "14500000", "FundingRoundCode": "NA", "Date": "2002-12-12", "Investor": "The Aurora Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VetCentric", "Amount": "14500000", "FundingRoundCode": "NA", "Date": "2002-12-12", "Investor": "Three Arch Partners"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "VGTI Florida", "Amount": "3600000", "FundingRoundCode": "NA", "Date": "2013-07-15", "Investor": "National Institutes of Health"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "VIA Pharmaceuticals", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2009-03-13", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCell", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2004-01-02", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCell", "Amount": "4.8e+07", "FundingRoundCode": "NA", "Date": "2000-11-14", "Investor": "Stephens Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2007-07-16", "Investor": "Asset Management Ventures (AMV)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "BD Ventures"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "16600000", "FundingRoundCode": "NA", "Date": "2014-09-11", "Investor": "California Institute for Regenerative Medicine"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "DFJ Portage Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "Headland Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "10600000", "FundingRoundCode": "C", "Date": "2013-07-10", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2007-07-16", "Investor": "Johnson & Johnson Development Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "Pacific Horizon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2007-07-16", "Investor": "Pacific Horizon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "10600000", "FundingRoundCode": "C", "Date": "2013-07-10", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2.5e+07", "FundingRoundCode": "C", "Date": "2007-07-16", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViaCyte", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2006-05-03", "Investor": "The Vertical Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "24999997", "FundingRoundCode": "B", "Date": "2009-07-07", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-10-21", "Investor": "Astellas Venture Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "24999997", "FundingRoundCode": "B", "Date": "2009-07-07", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2007-06-07", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-10-21", "Investor": "Hatteras Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "2e+05", "FundingRoundCode": "A", "Date": "2005-08-26", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "24999997", "FundingRoundCode": "B", "Date": "2009-07-07", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "4e+06", "FundingRoundCode": "A", "Date": "2007-06-07", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-10-21", "Investor": "Intersouth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "24999997", "FundingRoundCode": "B", "Date": "2009-07-07", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "6e+07", "FundingRoundCode": "D", "Date": "2014-10-21", "Investor": "Lilly Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viamet Pharmaceuticals", "Amount": "24999997", "FundingRoundCode": "B", "Date": "2009-07-07", "Investor": "Lurie Investment Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Vicept Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2010-06-30", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Vicept Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2010-06-30", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Medical", "CompanyName": "Vicept Therapeutics", "Amount": "1.6e+07", "FundingRoundCode": "A", "Date": "2010-06-30", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-09-02", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-01-23", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2010-08-25", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2013-05-21", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "26700000", "FundingRoundCode": "NA", "Date": "2015-07-24", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2013-12-17", "Investor": "Aisling Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "5e+07", "FundingRoundCode": "NA", "Date": "2015-06-30", "Investor": "CRG"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-09-02", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2010-08-25", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2013-05-21", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2013-12-17", "Investor": "F-Prime Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-01-23", "Investor": "Fidelity Biosciences"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "26700000", "FundingRoundCode": "NA", "Date": "2015-07-24", "Investor": "Fidelity Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2013-12-17", "Investor": "Hercules Technology Growth Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-09-02", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-01-23", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2010-08-25", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2013-05-21", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "26700000", "FundingRoundCode": "NA", "Date": "2015-07-24", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2013-12-17", "Investor": "Kearny Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2011-09-02", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2.5e+07", "FundingRoundCode": "B", "Date": "2008-01-23", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "4.5e+07", "FundingRoundCode": "C", "Date": "2012-03-13", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2010-08-25", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "1.5e+07", "FundingRoundCode": "D", "Date": "2013-05-21", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "26700000", "FundingRoundCode": "NA", "Date": "2015-07-24", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "ViewRay", "Amount": "3e+07", "FundingRoundCode": "NA", "Date": "2013-12-17", "Investor": "OrbiMed Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vigilant Biosciences", "Amount": "5500000", "FundingRoundCode": "B", "Date": "2015-02-24", "Investor": "venVelo"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViOptix", "Amount": "12200000", "FundingRoundCode": "D", "Date": "2008-01-10", "Investor": "Channel Medical Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViOptix", "Amount": "9200000", "FundingRoundCode": "C", "Date": "2004-11-10", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virdante Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-11-25", "Investor": "Biogen Idec"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virdante Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-11-25", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virdante Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-11-25", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virdante Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-11-25", "Investor": "Osage University Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virdante Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-11-25", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virdante Pharmaceuticals", "Amount": "3e+07", "FundingRoundCode": "A", "Date": "2009-11-25", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2014-07-16", "Investor": "AbbVie Biotech Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2010-01-14", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2014-07-16", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2010-06-16", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2014-07-16", "Investor": "Perceptive Advisors"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2010-01-14", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2014-07-16", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "1e+07", "FundingRoundCode": "B", "Date": "2010-06-16", "Investor": "Sutter Hill Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "8e+06", "FundingRoundCode": "B", "Date": "2014-07-16", "Investor": "TPG Biotechnology Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Virobay", "Amount": "3e+05", "FundingRoundCode": "NA", "Date": "2010-01-14", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Viron Therapeutics", "Amount": "2e+07", "FundingRoundCode": "A", "Date": "2006-05-16", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ViroXis", "Amount": "2500000", "FundingRoundCode": "A", "Date": "2010-10-15", "Investor": "Texas Wide Open for Business"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VirtualScopics", "Amount": "3800000", "FundingRoundCode": "C", "Date": "2003-02-10", "Investor": "Trillium Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VisEn Medical", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VisEn Medical", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "Merck Capital Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VisEn Medical", "Amount": "5e+06", "FundingRoundCode": "B", "Date": "2008-04-21", "Investor": "Spinnaker Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VistaGen Therapeutics", "Amount": "1e+06", "FundingRoundCode": "NA", "Date": "2008-12-22", "Investor": "California Institute for Regenerative Medicine"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VistaGen Therapeutics", "Amount": "3750000", "FundingRoundCode": "NA", "Date": "2007-08-10", "Investor": "Montaur Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "8100000", "FundingRoundCode": "A", "Date": "2013-12-02", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "26099699", "FundingRoundCode": "A", "Date": "2012-11-09", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Cycad Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "8100000", "FundingRoundCode": "A", "Date": "2013-12-02", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "26099699", "FundingRoundCode": "A", "Date": "2012-11-09", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Flagship Ventures"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2010-08-10", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "8100000", "FundingRoundCode": "A", "Date": "2013-12-02", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "26099699", "FundingRoundCode": "A", "Date": "2012-11-09", "Investor": "Lux Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2010-08-10", "Investor": "Lux Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Merck Research Laboratories"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "8100000", "FundingRoundCode": "A", "Date": "2013-12-02", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "26099699", "FundingRoundCode": "A", "Date": "2012-11-09", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Polaris Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "6e+06", "FundingRoundCode": "NA", "Date": "2010-08-10", "Investor": "Polaris Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visterra", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2014-10-02", "Investor": "Vertex Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Visualase", "Amount": "5200000", "FundingRoundCode": "B", "Date": "2012-05-01", "Investor": "Medtronic"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Vital Therapies", "Amount": "28100000", "FundingRoundCode": "C", "Date": "2007-10-10", "Investor": "Delphi Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Vital Therapies", "Amount": "4347018", "FundingRoundCode": "NA", "Date": "2012-02-02", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Vital Therapies", "Amount": "28100000", "FundingRoundCode": "C", "Date": "2007-10-10", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vital Vio", "Amount": "NA", "FundingRoundCode": "A", "Date": "2013-07-30", "Investor": "SOSV"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "VitaPath Genetics", "Amount": "328000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VitaPath Genetics", "Amount": "4710000", "FundingRoundCode": "C", "Date": "2012-04-01", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VitaPath Genetics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2009-11-02", "Investor": "Mohr Davidow Ventures"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "VitaPath Genetics", "Amount": "328000", "FundingRoundCode": "NA", "Date": "2012-07-01", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VitaPath Genetics", "Amount": "4710000", "FundingRoundCode": "C", "Date": "2012-04-01", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VitaPath Genetics", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2009-11-02", "Investor": "XSeed Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Cosmetics|Testing", "CompanyName": "Vitargent", "Amount": "NA", "FundingRoundCode": "A", "Date": "2015-01-23", "Investor": "WI Harper Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vivaldi Biosciences", "Amount": "2e+06", "FundingRoundCode": "A", "Date": "2007-05-18", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VLST Corporation", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2006-06-16", "Investor": "Amgen"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VLST Corporation", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2006-06-16", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VLST Corporation", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2006-06-16", "Investor": "MedImmune Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VLST Corporation", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2006-06-16", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VLST Corporation", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2006-06-16", "Investor": "OVP Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VLST Corporation", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2006-06-16", "Investor": "Texas Pacific Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VLST Corporation", "Amount": "5.5e+07", "FundingRoundCode": "B", "Date": "2006-06-16", "Investor": "WRF Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VM Discovery", "Amount": "970000", "FundingRoundCode": "B", "Date": "2006-01-03", "Investor": "Amkey Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "VM Discovery", "Amount": "970000", "FundingRoundCode": "B", "Date": "2006-01-03", "Investor": "ONSET Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Voyager Therapeutics", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-04-13", "Investor": "Brookside Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Voyager Therapeutics", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-04-13", "Investor": "Casdin Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Voyager Therapeutics", "Amount": "4.5e+07", "FundingRoundCode": "A", "Date": "2014-02-12", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Voyager Therapeutics", "Amount": "6e+07", "FundingRoundCode": "B", "Date": "2015-04-13", "Investor": "Wellington Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vtesse", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2014-01-07", "Investor": "Alexandria Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vtesse", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2014-01-07", "Investor": "Bay City Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vtesse", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2014-01-07", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Vtesse", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2014-01-07", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wave Life Sciences", "Amount": "6.6e+07", "FundingRoundCode": "B", "Date": "2015-08-18", "Investor": "Foresite Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wave Life Sciences", "Amount": "6.6e+07", "FundingRoundCode": "B", "Date": "2015-08-18", "Investor": "Jennison Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wave Life Sciences", "Amount": "6.6e+07", "FundingRoundCode": "B", "Date": "2015-08-18", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wave Life Sciences", "Amount": "6.6e+07", "FundingRoundCode": "B", "Date": "2015-08-18", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wave Life Sciences", "Amount": "1.8e+07", "FundingRoundCode": "A", "Date": "2015-02-02", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wave Life Sciences", "Amount": "6.6e+07", "FundingRoundCode": "B", "Date": "2015-08-18", "Investor": "Redmile Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "15900000", "FundingRoundCode": "D", "Date": "2011-05-12", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2007-05-31", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "16500000", "FundingRoundCode": "NA", "Date": "2012-04-09", "Investor": "Accuitive Medical Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "16500000", "FundingRoundCode": "NA", "Date": "2012-04-09", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "15900000", "FundingRoundCode": "D", "Date": "2011-05-12", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2007-05-31", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "16500000", "FundingRoundCode": "NA", "Date": "2012-04-09", "Investor": "DeNovo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "15900000", "FundingRoundCode": "D", "Date": "2011-05-12", "Investor": "Gund Investment, LLC"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "15900000", "FundingRoundCode": "D", "Date": "2011-05-12", "Investor": "Versant Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WaveTec Vision", "Amount": "1.3e+07", "FundingRoundCode": "B", "Date": "2007-05-31", "Investor": "Versant Ventures"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Webmedx", "Amount": "NA", "FundingRoundCode": "NA", "Date": "1996-10-01", "Investor": "Birchmere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WellAWARE Systems", "Amount": "7500000", "FundingRoundCode": "A", "Date": "2009-12-08", "Investor": ".406 Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WellAWARE Systems", "Amount": "7500000", "FundingRoundCode": "A", "Date": "2009-12-08", "Investor": "Valhalla Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellfount", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2011-04-20", "Investor": "Arboretum Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellfount", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2014-03-26", "Investor": "Deerfield"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WellGen", "Amount": "3e+06", "FundingRoundCode": "NA", "Date": "2004-03-25", "Investor": "Amphion Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WellGen", "Amount": "9500000", "FundingRoundCode": "C", "Date": "2007-10-29", "Investor": "Amphion Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellpartner", "Amount": "16100000", "FundingRoundCode": "D", "Date": "2008-08-05", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellpartner", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2007-03-27", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellpartner", "Amount": "16100000", "FundingRoundCode": "D", "Date": "2008-08-05", "Investor": "Integra Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellpartner", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2007-03-27", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellpartner", "Amount": "16100000", "FundingRoundCode": "D", "Date": "2008-08-05", "Investor": "Mediphase Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellpartner", "Amount": "7500000", "FundingRoundCode": "C", "Date": "2007-03-27", "Investor": "Montlake Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wellpartner", "Amount": "1.4e+07", "FundingRoundCode": "NA", "Date": "2005-01-12", "Investor": "Scorpion Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WILEX", "Amount": "27070000", "FundingRoundCode": "NA", "Date": "2010-03-23", "Investor": "Yorkville Advisors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wilmington Pharmaceuticals", "Amount": "1300000", "FundingRoundCode": "B", "Date": "2006-10-26", "Investor": "Emergent Growth Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Wilmington Pharmaceuticals", "Amount": "1300000", "FundingRoundCode": "B", "Date": "2006-10-26", "Investor": "Wilmington Investor Network"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Winston Pharmaceuticals", "Amount": "375000", "FundingRoundCode": "NA", "Date": "2012-04-09", "Investor": "National Institutes of Health"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WuXi AppTec", "Amount": "1.1e+07", "FundingRoundCode": "NA", "Date": "2005-02-01", "Investor": "NewSpring Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "WuXi AppTec", "Amount": "6.3e+07", "FundingRoundCode": "G", "Date": "2008-07-01", "Investor": "Warburg Pincus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Xagenic", "Amount": "11798141", "FundingRoundCode": "B", "Date": "2015-07-09", "Investor": "BDC Capital Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Xagenic", "Amount": "25500000", "FundingRoundCode": "B", "Date": "2014-07-14", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Diagnostics", "CompanyName": "Xagenic", "Amount": "11798141", "FundingRoundCode": "B", "Date": "2015-07-09", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "87783861", "FundingRoundCode": "D", "Date": "2009-10-30", "Investor": "AIG Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-07-27", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "87783861", "FundingRoundCode": "D", "Date": "2009-10-30", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-07-27", "Investor": "Apax Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-07-27", "Investor": "Blue Chip Venture Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "87783861", "FundingRoundCode": "D", "Date": "2009-10-30", "Investor": "Blue Chip Venture Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-07-27", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-06-23", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "87783861", "FundingRoundCode": "D", "Date": "2009-10-30", "Investor": "Essex Woodlands Health Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-07-27", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2e+07", "FundingRoundCode": "C", "Date": "2004-06-23", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "87783861", "FundingRoundCode": "D", "Date": "2009-10-30", "Investor": "HealthCare Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2007-07-27", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "87783861", "FundingRoundCode": "D", "Date": "2009-10-30", "Investor": "MPM Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xanodyne", "Amount": "87783861", "FundingRoundCode": "D", "Date": "2009-10-30", "Investor": "Union Spring Pharmaceuticals"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Analytics|Bio-Pharm|Biotechnology|Pharmaceuticals", "CompanyName": "Xceleron Inc.", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-01-20", "Investor": "Albion Investors"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Diagnostics|Life Sciences", "CompanyName": "Xcell Biosciences", "Amount": "120000", "FundingRoundCode": "NA", "Date": "2014-10-15", "Investor": "Illumina Accelerator"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xcellerex", "Amount": "3.1e+07", "FundingRoundCode": "C", "Date": "2007-10-12", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xcellerex", "Amount": "3.1e+07", "FundingRoundCode": "C", "Date": "2007-10-12", "Investor": "VantagePoint Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2006-01-05", "Investor": "Bay Area Equity Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2004-12-01", "Investor": "Bay Area Equity Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "NA", "Date": "2009-10-07", "Investor": "Bristol-Myers Squibb"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "Bristol-Myers Squibb"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2006-01-05", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "NA", "Date": "2009-10-07", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2004-12-01", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "NA", "Date": "2009-10-07", "Investor": "DAG Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "Duff, Ackerman and Goodrich"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2006-01-05", "Investor": "Integral Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "NA", "Date": "2009-10-07", "Investor": "Integral Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "Integral Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2004-12-01", "Investor": "Integral Capital Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2006-01-05", "Investor": "Intel Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "Intel Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2006-01-05", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "NA", "Date": "2009-10-07", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2004-12-01", "Investor": "Kleiner Perkins Caufield & Byers"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "NA", "Date": "2009-10-07", "Investor": "New Leaf Venture Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-09-12", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2012-09-12", "Investor": "Silicon Valley Bank"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2006-01-05", "Investor": "Texas Pacific Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "26500000", "FundingRoundCode": "NA", "Date": "2006-01-05", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "2e+07", "FundingRoundCode": "D", "Date": "2004-12-01", "Investor": "Sprout Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "NA", "Date": "2009-10-07", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Diagnostics|Fitness|Health and Wellness|Health Care|Health Diagnostics", "CompanyName": "CareDx", "Amount": "14400000", "FundingRoundCode": "F", "Date": "2009-08-05", "Investor": "TPG Growth"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xdynia", "Amount": "50000", "FundingRoundCode": "NA", "Date": "2012-02-21", "Investor": "CIT GAP Funds"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Xencor", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2007-10-25", "Investor": "Merlin Nexus"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Xencor", "Amount": "1.5e+07", "FundingRoundCode": "E", "Date": "2007-10-25", "Investor": "Oxford Bioscience Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenetic Biosciences", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2014-01-31", "Investor": "Baxter International"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenex Disinfection Services", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2015-01-27", "Investor": "Battery Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenex Disinfection Services", "Amount": "11300000", "FundingRoundCode": "NA", "Date": "2013-11-21", "Investor": "Battery Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenex Disinfection Services", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2015-01-27", "Investor": "RK Ventures Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenex Disinfection Services", "Amount": "11300000", "FundingRoundCode": "NA", "Date": "2013-11-21", "Investor": "RK Ventures Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenex Disinfection Services", "Amount": "2.5e+07", "FundingRoundCode": "NA", "Date": "2015-01-27", "Investor": "Targeted Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenex Disinfection Services", "Amount": "11300000", "FundingRoundCode": "NA", "Date": "2013-11-21", "Investor": "Targeted Technology Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenex Disinfection Services", "Amount": "11300000", "FundingRoundCode": "NA", "Date": "2013-11-21", "Investor": "Richard Yoo"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenome", "Amount": "1e+07", "FundingRoundCode": "NA", "Date": "2007-11-27", "Investor": "Amylin Pharmaceuticals"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenoport", "Amount": "43900000", "FundingRoundCode": "NA", "Date": "2002-06-01", "Investor": "ARCH Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenoport", "Amount": "NA", "FundingRoundCode": "D", "Date": "2004-12-07", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenoport", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2004-01-14", "Investor": "GGV Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenoport", "Amount": "43900000", "FundingRoundCode": "NA", "Date": "2002-06-01", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xenoport", "Amount": "3.7e+07", "FundingRoundCode": "C", "Date": "2004-01-14", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xeris Pharmaceuticals", "Amount": "1500000", "FundingRoundCode": "A", "Date": "2011-12-12", "Investor": "Central Texas Angel Network"}, {"FundingRoundType": "non_equity_assistance", "CompanyCategory": "Biotechnology", "CompanyName": "Xeris Pharmaceuticals", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-12-20", "Investor": "Texas Venture Labs"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xradia", "Amount": "7e+06", "FundingRoundCode": "D", "Date": "2007-03-08", "Investor": "Harris & Harris Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xytis", "Amount": "24500000", "FundingRoundCode": "B", "Date": "2006-01-09", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Xytis", "Amount": "24500000", "FundingRoundCode": "B", "Date": "2006-01-09", "Investor": "Sanderling Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "14400000", "FundingRoundCode": "D", "Date": "2011-08-11", "Investor": "Aperture Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2006-11-13", "Investor": "Ben Franklin Technology Partners of Southeastern Pennsylvania"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2006-11-13", "Investor": "BioAdvance"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "14400000", "FundingRoundCode": "D", "Date": "2011-08-11", "Investor": "Burrill & Company"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "4e+06", "FundingRoundCode": "B", "Date": "2006-11-13", "Investor": "Osage Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "14400000", "FundingRoundCode": "D", "Date": "2011-08-11", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "14500000", "FundingRoundCode": "C", "Date": "2007-11-26", "Investor": "Palo Alto Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "14400000", "FundingRoundCode": "D", "Date": "2011-08-11", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Yaupon Therapeutics", "Amount": "14500000", "FundingRoundCode": "C", "Date": "2007-11-26", "Investor": "Vivo Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2012-12-04", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "4.5e+07", "FundingRoundCode": "E", "Date": "2013-12-04", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2010-03-29", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2011-07-07", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2012-12-04", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "5180000", "FundingRoundCode": "A", "Date": "2006-09-11", "Investor": "Atlas Venture"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "4.5e+07", "FundingRoundCode": "E", "Date": "2013-12-04", "Investor": "Brookside Capital"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-04-17", "Investor": "MidCap Financial"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "2e+07", "FundingRoundCode": "NA", "Date": "2014-04-17", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "4.5e+07", "FundingRoundCode": "E", "Date": "2013-12-04", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "2.8e+07", "FundingRoundCode": "B", "Date": "2010-03-29", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "3.3e+07", "FundingRoundCode": "C", "Date": "2011-07-07", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "2.1e+07", "FundingRoundCode": "D", "Date": "2012-12-04", "Investor": "Third Rock Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zafgen", "Amount": "4.5e+07", "FundingRoundCode": "E", "Date": "2013-12-04", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zalicus", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2004-03-10", "Investor": "Boston Millennia Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zalicus", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2004-03-10", "Investor": "Canaan Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zalicus", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2004-03-10", "Investor": "Easton Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zalicus", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2004-03-10", "Investor": "Flagship Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zalicus", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2004-03-10", "Investor": "TL Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zalicus", "Amount": "3e+07", "FundingRoundCode": "C", "Date": "2004-03-10", "Investor": "Yasuda Enterprise Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Incubators|Renewable Energies|Technology", "CompanyName": "ZeaKal", "Amount": "3800000", "FundingRoundCode": "A", "Date": "2013-03-26", "Investor": "Finistere Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Incubators|Renewable Energies|Technology", "CompanyName": "ZeaKal", "Amount": "3800000", "FundingRoundCode": "A", "Date": "2013-03-26", "Investor": "Kapyon Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zelos Therapeutics", "Amount": "5531017", "FundingRoundCode": "A", "Date": "2004-10-05", "Investor": "Seaflower Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zeltiq Aesthetics", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2010-06-03", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zeltiq Aesthetics", "Amount": "20300000", "FundingRoundCode": "B", "Date": "2007-10-29", "Investor": "Advanced Technology Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zeltiq Aesthetics", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2010-06-03", "Investor": "Aisling Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zeltiq Aesthetics", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2010-06-03", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zeltiq Aesthetics", "Amount": "20300000", "FundingRoundCode": "B", "Date": "2007-10-29", "Investor": "Frazier Healthcare Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zeltiq Aesthetics", "Amount": "2.5e+07", "FundingRoundCode": "D", "Date": "2010-06-03", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zeltiq Aesthetics", "Amount": "25124200", "FundingRoundCode": "C", "Date": "2008-07-22", "Investor": "Venrock"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zephyr Technology", "Amount": "8864965", "FundingRoundCode": "C", "Date": "2012-05-16", "Investor": "3M New Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zephyr Technology", "Amount": "8864965", "FundingRoundCode": "C", "Date": "2012-05-16", "Investor": "Alsop Louie Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zephyr Technology", "Amount": "2e+06", "FundingRoundCode": "B", "Date": "2009-07-07", "Investor": "Motorola Solutions Venture Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zephyr Technology", "Amount": "8864965", "FundingRoundCode": "C", "Date": "2012-05-16", "Investor": "Motorola Solutions Venture Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Hardware|Health Care|Medical Devices", "CompanyName": "Zephyrus Biosciences", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-09-10", "Investor": "Life Science Angels"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Hardware|Health Care|Medical Devices", "CompanyName": "Zephyrus Biosciences", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-09-10", "Investor": "Mission Bay Capital"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Hardware|Health Care|Medical Devices", "CompanyName": "Zephyrus Biosciences", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-09-10", "Investor": "StartX"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Hardware|Health Care|Medical Devices", "CompanyName": "Zephyrus Biosciences", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-09-10", "Investor": "The Angels' Forum"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Hardware|Health Care|Medical Devices", "CompanyName": "Zephyrus Biosciences", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-09-10", "Investor": "Jenny Rooke"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology|Hardware|Health Care|Medical Devices", "CompanyName": "Zephyrus Biosciences", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2014-09-10", "Investor": "Jesse Robbins"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care|Medical", "CompanyName": "Zeptosens", "Amount": "8323094", "FundingRoundCode": "B", "Date": "2001-02-27", "Investor": "Techno Venture Management"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "ZetrOZ", "Amount": "625000", "FundingRoundCode": "NA", "Date": "2014-09-19", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZetrOZ", "Amount": "2600000", "FundingRoundCode": "A", "Date": "2013-04-21", "Investor": "Connecticut Innovations"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZetrOZ", "Amount": "2600000", "FundingRoundCode": "A", "Date": "2013-04-21", "Investor": "Fort Point Angels"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "ZetrOZ", "Amount": "5e+06", "FundingRoundCode": "NA", "Date": "2014-10-17", "Investor": "Horizon Technology Finance"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "ZetrOZ", "Amount": "625000", "FundingRoundCode": "NA", "Date": "2014-09-19", "Investor": "National Space Biomedical Research Institute"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZetrOZ", "Amount": "2600000", "FundingRoundCode": "A", "Date": "2013-04-21", "Investor": "Oleg Uritsky"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ziarco", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2014-11-10", "Investor": "Amgen Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ziarco", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2014-11-10", "Investor": "BV Investment Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ziarco", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2014-11-10", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ziarco", "Amount": "3.3e+07", "FundingRoundCode": "B", "Date": "2014-11-10", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ziarco Pharma", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2012-11-05", "Investor": "Biotechnology Value Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Ziarco Pharma", "Amount": "6e+06", "FundingRoundCode": "A", "Date": "2012-11-05", "Investor": "Pfizer Venture Investments"}, {"FundingRoundType": "private_equity", "CompanyCategory": "Biotechnology", "CompanyName": "Zinc Ahead", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2013-06-21", "Investor": "Accel-KKR"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZirMed", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2010-12-10", "Investor": "Sequoia Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-07-13", "Investor": "Chicago Growth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "35004188", "FundingRoundCode": "B", "Date": "2009-12-15", "Investor": "Chicago Growth Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "35957968", "FundingRoundCode": "B", "Date": "2009-10-05", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "6e+07", "FundingRoundCode": "A", "Date": "2006-08-28", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-07-13", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2008-01-09", "Investor": "Clarus Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "35957968", "FundingRoundCode": "B", "Date": "2009-10-05", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "6e+07", "FundingRoundCode": "A", "Date": "2006-08-28", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-07-13", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2008-01-09", "Investor": "Domain Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "6e+07", "FundingRoundCode": "A", "Date": "2006-08-28", "Investor": "Life Science Angels"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "35957968", "FundingRoundCode": "B", "Date": "2009-10-05", "Investor": "Oxford Finance Corporation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "35957968", "FundingRoundCode": "B", "Date": "2009-10-05", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "6e+07", "FundingRoundCode": "A", "Date": "2006-08-28", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-07-13", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.8e+07", "FundingRoundCode": "B", "Date": "2008-01-09", "Investor": "Scale Venture Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "6e+07", "FundingRoundCode": "A", "Date": "2006-08-28", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology|Health Care", "CompanyName": "Zogenix", "Amount": "1.5e+07", "FundingRoundCode": "NA", "Date": "2010-07-13", "Investor": "Thomas, McNerney & Partners"}, {"FundingRoundType": "debt_financing", "CompanyCategory": "Biotechnology", "CompanyName": "Zosano Pharma", "Amount": "3030000", "FundingRoundCode": "NA", "Date": "2013-09-19", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zosano Pharma", "Amount": "9e+07", "FundingRoundCode": "A", "Date": "2007-11-15", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zosano Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-08-06", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zosano Pharma", "Amount": "9e+07", "FundingRoundCode": "A", "Date": "2007-11-15", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zosano Pharma", "Amount": "3e+07", "FundingRoundCode": "B", "Date": "2009-08-06", "Investor": "ProQuest Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2012-10-23", "Investor": "3x5 Special Opportunity Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "3x5 Special Opportunity Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "Adage Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2012-10-23", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "Alta Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2012-10-23", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "Devon Park BioVentures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2012-10-23", "Investor": "Partisan Management Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "792000", "FundingRoundCode": "NA", "Date": "2010-12-20", "Investor": "Partisan Management Group"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "RA Capital Management"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2012-10-23", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "RiverVest"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "4.6e+07", "FundingRoundCode": "C", "Date": "2012-10-23", "Investor": "Salem Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "Salem Partners"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZS Pharma", "Amount": "5.5e+07", "FundingRoundCode": "D", "Date": "2014-03-05", "Investor": "Sofinnova Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "AME Cloud Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "Data Collective"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "Draper Fisher Jurvetson (DFJ)"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "HVF"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "Innovation Endeavors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "Obvious Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "4.4e+07", "FundingRoundCode": "A", "Date": "2015-06-16", "Investor": "True Ventures"}, {"FundingRoundType": "seed", "CompanyCategory": "Biotechnology", "CompanyName": "Zymergen", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2014-01-01", "Investor": "Jenny Rooke"}, {"FundingRoundType": "undisclosed", "CompanyCategory": "Biotechnology", "CompanyName": "Zymetis", "Amount": "NA", "FundingRoundCode": "NA", "Date": "2007-01-01", "Investor": "Dingman Center Angels"}, {"FundingRoundType": "grant", "CompanyCategory": "Biotechnology", "CompanyName": "Zymetis", "Amount": "1500000", "FundingRoundCode": "NA", "Date": "2010-01-31", "Investor": "Maryland Department of Business and Economic Development"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zyngenia", "Amount": "2.5e+07", "FundingRoundCode": "A", "Date": "2010-09-09", "Investor": "New Enterprise Associates"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZYOMYX", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2013-06-30", "Investor": "Bill & Melinda Gates Foundation"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZYOMYX", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2013-06-30", "Investor": "Mylan"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "ZYOMYX", "Amount": "1.2e+07", "FundingRoundCode": "B", "Date": "2013-06-30", "Investor": "Jenny Rooke"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zystor", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2004-12-16", "Investor": "Apjohn ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zystor", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2004-12-16", "Investor": "Hexagon Investments"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zystor", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2004-12-16", "Investor": "Mason Wells Biomediacl Fund"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zystor", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2004-12-16", "Investor": "Prolog Ventures"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zystor", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2004-12-16", "Investor": "State of Wisconsin Investment Board"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zystor", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2004-12-16", "Investor": "Stonehenge Capital"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zystor", "Amount": "8500000", "FundingRoundCode": "A", "Date": "2004-12-16", "Investor": "Venture Investors"}, {"FundingRoundType": "venture", "CompanyCategory": "Biotechnology", "CompanyName": "Zytoprotec", "Amount": "2686600", "FundingRoundCode": "A", "Date": "2013-01-29", "Investor": "Baxter International"}]